
<html lang="en"     class="pb-page"  data-request-id="b6e3fef0-df84-4b0a-a617-6075392a14c1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-22;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/jm300975f;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Systematic in Vivo Screening of a Series of 1-Propyl-4-arylpiperidines against Dopaminergic and Serotonergic Properties in Rat Brain: A Scaffold-Jumping Approach" /></meta><meta name="dc.Creator" content="Cecilia  Mattsson" /></meta><meta name="dc.Creator" content="Theresa  Andreasson" /></meta><meta name="dc.Creator" content="Nicholas  Waters" /></meta><meta name="dc.Creator" content="Clas  Sonesson" /></meta><meta name="dc.Description" content="A series of 1-propyl-4-arylpiperidines were synthesized and their effects on the dopaminergic and serotonergic systems tested in vivo and in vitro. Scaffold jumping among five- and six-membered bic..." /></meta><meta name="Description" content="A series of 1-propyl-4-arylpiperidines were synthesized and their effects on the dopaminergic and serotonergic systems tested in vivo and in vitro. Scaffold jumping among five- and six-membered bic..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 17, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300975f" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300975f" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300975f" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300975f" /></link>
        
    
    

<title>Systematic in Vivo Screening of a Series of 1-Propyl-4-arylpiperidines against Dopaminergic and Serotonergic Properties in Rat Brain: A Scaffold-Jumping Approach | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300975f" /></meta><meta property="og:title" content="Systematic in Vivo Screening of a Series of 1-Propyl-4-arylpiperidines against Dopaminergic and Serotonergic Properties in Rat Brain: A Scaffold-Jumping Approach" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0018.jpeg" /></meta><meta property="og:description" content="A series of 1-propyl-4-arylpiperidines were synthesized and their effects on the dopaminergic and serotonergic systems tested in vivo and in vitro. Scaffold jumping among five- and six-membered bicyclic aryl rings attached to the piperidine ring had a marked impact on these effects. Potent and selective dopamine D2 receptor antagonists were generated from 3-indoles, 3-benzoisoxazoles, 3-benzimidazol-2-one, and 3-benzothiophenes. In contrast, 3-benzofuran was a potent and selective inhibitor of monoamine oxidase (MAO) A. The effects of the synthesized compounds on 3,4-dihydroxyphenylacetic acid (DOPAC) levels correlated very well with their affinity for dopamine D2 receptors and MAO A. In the 4-arylpiperidine series, the most promising compound for development was the 6-chloro-3-(1-propyl-4-piperidyl)-1H-benzimidazol-2-one (19), which displayed typical dopamine D2 receptor antagonist properties in vivo but produced only a partial reduction on spontaneous locomotor activity. This indicates that the compound may have a lower propensity to induce parkinsonism in patients." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300975f"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300975f">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300975f&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300975f&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300975f&amp;href=/doi/10.1021/jm300975f" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 9735-9750</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm3009508" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm301002f" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/jm400509x"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Systematic in Vivo Screening of a Series of 1-Propyl-4-arylpiperidines against Dopaminergic and Serotonergic Properties in Rat Brain: A Scaffold-Jumping Approach</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cecilia++Mattsson">Cecilia Mattsson</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Theresa++Andreasson">Theresa Andreasson</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas++Waters">Nicholas Waters</a></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Clas++Sonesson">Clas Sonesson</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">NeuroSearch Sweden AB, Arvid Wallgrens Backe 20, SE-413 46 Gothenburg, Sweden</span></div><div class="corresp-info"><strong>*</strong>Phone: +46 (0)31 772 7739. Fax: +46 (0)31 772 0601. E-mail: <a href="/cdn-cgi/l/email-protection#88ebfbc8e6edfdfae7fbede9faebe0a6ebe7e5"><span class="__cf_email__" data-cfemail="6f0c1c2f010a1a1d001c0a0e1d0c07410c0002">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300975f&amp;href=/doi/10.1021%2Fjm300975f" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 9735â9750</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 8, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 July 2012</li><li><span class="item_label"><b>Published</b> online</span>17 October 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300975f" title="DOI URL">https://doi.org/10.1021/jm300975f</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9735%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DCecilia%2BMattsson%252C%2BTheresa%2BAndreasson%252C%2BNicholas%2BWaters%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D22%26contentID%3Djm300975f%26title%3DSystematic%2Bin%2BVivo%2BScreening%2Bof%2Ba%2BSeries%2Bof%2B1-Propyl-4-arylpiperidines%2Bagainst%2BDopaminergic%2Band%2BSerotonergic%2BProperties%2Bin%2BRat%2BBrain%253A%2BA%2BScaffold-Jumping%2BApproach%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9750%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300975f"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1222</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300975f" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Systematic in Vivo Screening of a Series of 1-Propyl-4-arylpiperidines against Dopaminergic and Serotonergic Properties in Rat Brain: A Scaffold-Jumping Approach&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Cecilia&quot;,&quot;last_name&quot;:&quot;Mattsson&quot;},{&quot;first_name&quot;:&quot;Theresa&quot;,&quot;last_name&quot;:&quot;Andreasson&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;Waters&quot;},{&quot;first_name&quot;:&quot;Clas&quot;,&quot;last_name&quot;:&quot;Sonesson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;9735-9750&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300975f&quot;},&quot;abstract&quot;:&quot;A series of 1-propyl-4-arylpiperidines were synthesized and their effects on the dopaminergic and serotonergic systems tested in vivo and in vitro. Scaffold jumping among five- and six-membered bicyclic aryl rings attached to the piperidine ring had a marked impact on these effects. Potent and selective dopamine D2 receptor antagonists were generated from 3-indoles, 3-benzoisoxazoles, 3-benzimidazol-2-one, and 3-benzothiophenes. In contrast, 3-benzofuran was a potent and selective inhibitor of monoamine oxidase (MAO) A. The effects of the synthesized compounds on 3,4-dihydroxyphenylacetic acid (DOPAC) levels correlated very well with their affinity for dopamine D2 receptors and MAO A. In the 4-arylpiperidine series, the most promising compound for development was the 6-chloro-3-(1-propyl-4-piperidyl)-1H-benzimidazol-2-one (19), which displayed typical dopamine D2 receptor antagonist properties in vivo but produced only a partial reduction on spontaneous locomotor activity. This indicates that the compound may&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300975f&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300975f" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300975f&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300975f" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300975f&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300975f" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300975f&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300975f&amp;href=/doi/10.1021/jm300975f" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300975f" /></input><a href="/doi/pdf/10.1021/jm300975f" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300975f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300975f%26sid%3Dliteratum%253Aachs%26pmid%3D23043306%26genre%3Darticle%26aulast%3DMattsson%26date%3D2012%26atitle%3DSystematic%2Bin%2BVivo%2BScreening%2Bof%2Ba%2BSeries%2Bof%2B1-Propyl-4-arylpiperidines%2Bagainst%2BDopaminergic%2Band%2BSerotonergic%2BProperties%2Bin%2BRat%2BBrain%253A%2BA%2BScaffold-Jumping%2BApproach%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D22%26spage%3D9735%26epage%3D9750%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jmcmar.2012.55.issue-22/production/jmcmar.2012.55.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of 1-propyl-4-arylpiperidines were synthesized and their effects on the dopaminergic and serotonergic systems tested in vivo and in vitro. Scaffold jumping among five- and six-membered bicyclic aryl rings attached to the piperidine ring had a marked impact on these effects. Potent and selective dopamine D<sub>2</sub> receptor antagonists were generated from 3-indoles, 3-benzoisoxazoles, 3-benzimidazol-2-one, and 3-benzothiophenes. In contrast, 3-benzofuran was a potent and selective inhibitor of monoamine oxidase (MAO) A. The effects of the synthesized compounds on 3,4-dihydroxyphenylacetic acid (DOPAC) levels correlated very well with their affinity for dopamine D<sub>2</sub> receptors and MAO A. In the 4-arylpiperidine series, the most promising compound for development was the 6-chloro-3-(1-propyl-4-piperidyl)-1<i>H</i>-benzimidazol-2-one (<b>19</b>), which displayed typical dopamine D<sub>2</sub> receptor antagonist properties in vivo but produced only a partial reduction on spontaneous locomotor activity. This indicates that the compound may have a lower propensity to induce parkinsonism in patients.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55280" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55280" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Dopamine type 2 (D<sub>2</sub>) receptors are located primarily in the basal ganglia of the mammalian brain but also occur in other structures of the brain, such as the cortex. The receptors, which are located at the neuronal membrane, belong to the monoamine subclass of the G-protein-coupled seven-transmembrane receptors (GPCRs).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In the brain, dopamine (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is released at synaptic and extrasynaptic sites, affecting postsynaptic, presynaptic, and dendritic dopamine D<sub>2</sub> receptor populations. Synaptic dopamine release is followed by fast reabsorption or degradation, which terminates dopamine signaling. Drugs that interact with the agonist-binding site of dopamine D<sub>2</sub> receptors can be described as antagonists, partial agonists, or full agonists, and a number of these drugs have well-established applications in the treatment of various neurological and psychiatric disorders.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Recently, a new class of dopamine D<sub>2</sub> ligands known as dopidines has been discovered. These compounds act as dopaminergic stabilizers, and the most clinically advanced is pridopidine<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> (ACR16, <b>2</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), currently in phase III development for the treatment of motor symptoms associated with Huntingtonâs disease (HD). In patients with HD, <b>2</b> (45 mg, twice daily) displayed an adverse-effect profile similar to that of placebo.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Furthermore, this adverse-effect profile was relatively benign compared with that of classical dopamine D<sub>2</sub> receptor antagonists (such as haloperidol),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> which are associated with severe adverse effects such as acute extrapyramidal symptoms (EPS).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The primary site of action of dopaminergic stabilizers is at dopamine D<sub>2</sub> receptors, where they display surmountable antagonism and fast-off kinetic properties.<a onclick="showRef(event, 'ref3 ref5 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref3 ref5 ref9 ref10">(3, 5, 9, 10)</a> From an in vivo perspective, these compounds stabilize dysregulated psychomotor functions (i.e., they reverse behavioral states originating from both hypo- and hyperdopaminergia while having only subtle effects on normal psychomotor activity).<a onclick="showRef(event, 'ref4 ref11'); return false;" href="javascript:void(0);" class="ref ref4 ref11">(4, 11)</a> The surmountable and fast-off receptor kinetics may account for the lack of reduction of spontaneous locomotor activity (LMA) across the full dose range (3.7â300 Î¼mol/kg, in rats) by allowing dopamine receptors to regain responsiveness to dopamine rapidly.<a onclick="showRef(event, 'ref3 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref5">(3, 5)</a> Neurochemical analysis of post-mortem brain tissue from freely moving rats shows that dopaminergic stabilizers induce an increase in the synthesis and release of dopamine in the basal ganglia (e.g., the striatum),<a onclick="showRef(event, 'ref4 ref11'); return false;" href="javascript:void(0);" class="ref ref4 ref11">(4, 11)</a> a hallmark of dopamine D<sub>2</sub> receptor antagonism. This further supports the hypothesis that dopaminergic stabilizers lack intrinsic activity at dopamine D<sub>2</sub> receptors. This unique mechanism of action contrasts with that of classical dopamine D<sub>2</sub> receptor antagonists (i.e., haloperidol and olanzapine)<a onclick="showRef(event, 'ref7 ref12'); return false;" href="javascript:void(0);" class="ref ref7 ref12">(7, 12)</a> and partial dopamine D<sub>2</sub> agonists (i.e., aripiprazole and bifeprunox).<a onclick="showRef(event, 'ref4 ref5 ref11 ref13'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref11 ref13">(4, 5, 11, 13)</a> Historically, dopaminergic stabilizers (<b>2</b> and (â)-OSU6162 (<b>3</b>), Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) were developed using agonist-like structural motifs that retained the hydrophilic nature of the agonist.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, careful modification of the pharmacophore elements essential for intrinsic activity at dopamine D<sub>2</sub> receptors produced compounds displaying fast-off kinetics and surmountable antagonist properties.<a onclick="showRef(event, 'ref15 ref3'); return false;" href="javascript:void(0);" class="ref ref15 ref3">(15, 3)</a> From structureâactivity relationship (SAR) investigations, it has been demonstrated that dopaminergic stabilizer properties are favored by a powerful electron-withdrawing substituent in meta position of the aryl (like the methylsulfone group; see compounds <b>2</b> and <b>3</b>) and a propyl substituent on the basic nitrogen.<a onclick="showRef(event, 'ref3 ref14'); return false;" href="javascript:void(0);" class="ref ref3 ref14">(3, 14)</a> It is interesting to note that the propyl substituent on the amine is also favored in several dopamine D<sub>2</sub> receptor agonists and has been referred to the propyl binding âpocketâ.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> In the search for new chemical scaffolds to serve as starting points for development of dopaminergic stabilizers, we examined whether it would be possible to start from a dopamine D<sub>2</sub> receptor antagonist (rather than agonist) motif. We also investigated whether chemical manipulations, such as reducing size and lipophilicity, could produce new dopaminergic stabilizers. Furthermore we focused our investigations on bicyclic cores within typical/atypical antipsychotics (i.e., dopamine D<sub>2</sub> receptor antagonists), such as sertindole (<b>4</b>),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> risperidone (<b>5</b>),<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> ziprasidone (<b>6</b>),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and pimozide (<b>7</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> These compounds are all high-affinity dopamine D<sub>2</sub> receptor ligands that have been optimized using the conventional methodology of increasing size and lipophilicity to improve affinity. These large lipophilic compounds are believed to interact with hydrophobic residues in the receptor cavity that are not involved in agonist interactions, thereby stabilizing the inactive state of dopamine D<sub>2</sub> receptors.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Dopamine D<sub>2</sub> receptor ligands: dopamine (<b>1</b>), the dopaminergic stabilizers pridopidine (<b>2</b>) and <i>S</i>-(â)-OSU6162 (<b>3</b>), atypical antipsychotics sertindole (<b>4</b>), risperidone (<b>5</b>), and ziprasidone (<b>6</b>), typical antipsychotic pimozide (<b>7</b>), generic structure of 1-propyl-4-arylpiperidines (<b>8</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, we hypothesized that the hydrophilic nature of the five-membered heteroaryl ring with a piperidine ring attached could serve as a starting point for the development of new dopaminergic stabilizers (<b>4</b>â<b>7</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). In addition, by removal of the cyclic âalkyl/arylâ ring(s) in the side chain attached to the basic amine, the propyl group known to be âoptimalâ for dopaminergic stabilizer properties would be retained (<b>8</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref3 ref14'); return false;" href="javascript:void(0);" class="ref ref3 ref14">(3, 14)</a> In order to fully explore the SAR for 1-propyl-4-arylpiperidines, a wide spectrum of core building blocks were included in the data set (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Many of these building blocks are often included in compounds with known effects on the dopaminergic and the serotonergic (5-hydroxytryptamine, 5-HT) systems in the brain.<a onclick="showRef(event, 'ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33">(25-33)</a> However, they have been imbedded in larger compounds and it is therefore harder to judge the contribution that each core building block makes with regard to SAR on the dopaminergic system (i.e., dopamine D<sub>2</sub> receptors). A few examples with small alkyl groups on the nitrogen are published, and generally these compounds have been built on 3-substituted indoles.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overview of 1-propyl-4-arylpiperidines and their bicyclic aryl core building blocks: <b>9</b>, 6-F, R<sup>1</sup> = H; <b>11</b>, 6-F, R<sup>1</sup> = methyl; <b>12</b>, 5-F, R<sup>1</sup> = methyl; <b>19</b>, R<sup>1</sup> = H; <b>20</b> R<sup>1</sup> = methyl.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Guillaume et al.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> have reported the tetrahydropyridine RU 24969 (<b>25</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) as a mixed dopamine and serotonin receptor agonist in vivo, although its affinity for dopamine receptors was very low (IC<sub>50</sub> > 5000 nM) and later reported to lack effects on dopamine synthesis in striatal regions in the rat brain.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The reported agonist-like effects on the dopamine receptor may therefore be questioned, and other mechanisms may underlie these effects. A report from Hunt et al. within tetrahydropyridine/piperidine indoles (<b>25</b>, <b>26</b>) also supports that these effects are not mediated via the dopamine system but are instead mediated via the 5-HT system.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Currently, <b>25</b> is classified as a serotonin 5-HT<sub>1A/1B</sub> agonist.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The corresponding propyl analogue RU 27592 (<b>27</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) was reported by Guillaume et al. to be a dopamine antagonist with affinity for both dopamine and 5-HT receptors (80 and 260 nM, respectively).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Other 3-substituted indoles, 1<i>H</i>-indazoles and 1,2-benzisoxazoles with a piperidine or piperidene ring, and small alkyl groups on the nitrogen have been reported to display effects on serotonin transporter protein (SERT),<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> as well as on serotonin 5-HT<sub>1D</sub>,<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40-42)</a> 5-HT<sub>1E/1F</sub>,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> 5-HT<sub>1F</sub>,<a onclick="showRef(event, 'ref27 ref44'); return false;" href="javascript:void(0);" class="ref ref27 ref44">(27, 44)</a> 5-HT<sub>1A/2A</sub>,<a onclick="showRef(event, 'ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47">(45-47)</a> 5-HT<sub>2A/2C</sub>,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> 5-HT<sub>2A</sub>,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and 5-HT<sub>6</sub> receptors.<a onclick="showRef(event, 'ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref50 ref51 ref52">(50-52)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Serotonin 5-HT<sub>1A/1B</sub> receptor agonist RU 24969 (tetrahydropyridine, <b>25</b>), RU23686 (piperidine, <b>26</b>), and the dopamine D<sub>2</sub> receptor antagonist RU 27592 (<b>27</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">On the basis of the generic structure <b>8</b> and the building blocks listed in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, we hereby report a systematic in vivo screening of 15 new compounds for their effects on dopamine and serotonin synthesis and turnover (i.e., effects on 3,4-dihydroxyphenylacetic acid [DOPAC] and 5-hydroxyindoleacetic acid [5-HIAA]) in rat brain and their effects on LMA. The new compounds were also tested for in vitro affinity for dopamine D<sub>2</sub>, dopamine type 3 receptor (D<sub>3</sub>), dopamine type 4 receptor (D<sub>4</sub>), serotonin 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>6</sub>, and adrenergic type 2A (Î±<sub>2A</sub>) receptor, and dopamine transporter protein (DAT) and SERT. During the in vivo screening process we discovered that some compounds displayed a âdopamine agonistâ-like effect on brain neurochemistry (i.e., a decrease in DOPAC levels), which was later revealed to be an effect of inhibition of flavin-containing monoamine oxidase A (MAO A), which metabolizes dopamine to DOPAC. Compoundsâ affinity for MAO A was therefore also included in the in vitro test panel. The synthesis and SAR of these new compounds will be discussed in this paper.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24118" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24118" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of 1-Propyl-4-arylpiperidines Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-iodopropane (PrI), K<sub>2</sub>CO<sub>3</sub>, acetonitrile (ACN), Î; (b) NaH, iodomethane, DMF.</p></p></figure><div class="NLM_p">The desired core piperidine building blocks have been used frequently before for synthesis and are described in the literature,<a onclick="showRef(event, 'ref19 ref29 ref32 ref34 ref53 ref54 ref55 ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref19 ref29 ref32 ref34 ref53 ref54 ref55 ref56 ref57 ref58">(19, 29, 32, 34, 53-58)</a> but many of them are also commercially available (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>): 6-fluoro-3-(4-piperidyl)-1<i>H</i>-indole, 5-fluoro-3-(4-piperidyl)-1<i>H</i>-indole, 4-(benzofuran-3-yl)piperidine, 6-fluoro-3-(4-piperidyl)-1,2-benzoxazole, 1-(4-piperidyl)indole, 1-(4-piperidyl)benzimidazole, 6-chloro-3-(4-piperidyl)-1<i>H</i>-benzimidazol-2-one, 4-(2-naphthyl)piperidine, and 4-(1-naphthyl)piperidine. The piperidines were alkylated with iodopropane, affording the desired products <b>9</b>, <b>10</b> (5-fluoro-3-(1-propyl-4-piperidyl)-1<i>H</i>-indole), <b>14</b>, <b>15</b>, <b>17</b>â<b>19</b>, and <b>22</b>â<b>23</b> in moderateâgood yields (26â87%, Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The indoles <b>9</b>, <b>10</b> and benzimidazol-2-one <b>19</b> were further methylated and yielded products <b>11</b>, <b>12</b>, and <b>20</b> in good yields (73â100%, Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Synthesis of compound <b>21</b> was performed according to Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> where the 1-(4-piperidyl)indolin-2-one was first alkylated (<b>28</b>) followed by oxidation to the corresponding isatin by treatment with hydrochloric acid (HCl)/ethanol (EtOH), yielding <b>21</b> in moderate yield (31%).<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 1-(1-Propyl-4-piperidyl)indoline-2,3-dione (<b>21</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PrI, K<sub>2</sub>CO<sub>3</sub>, ACN, Î; (b) EtOH, HCl.</p></p></figure><div class="NLM_p">Compound <b>16</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) was synthesized from 3-bromo-1<i>H</i>-indazole by lithiation with a mixture of <i>n</i>-butyllithium (<i>n</i>-BuLi)/<i>tert</i>-butyllithium (<i>t</i>-BuLi), generating the dianion of indazole at â78 Â°C, and quenching with 1-propylpiperidin-4-one yielded <b>29</b> in moderate yield (32%).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Subsequent treatments with trifluoroacetic acid (TFA) in a CH<sub>2</sub>Cl<sub>2</sub> solution gave <b>30</b> in excellent yield (100%). The tetrahydropyridine <b>30</b> was reduced by catalytic hydrogenation (Pd/C), affording the piperidine derivative <b>16</b> in moderate yield (46%, Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 3-(1-Propyl-4-piperidyl)-1<i>H</i>-indazole (<b>16</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>n</i>-BuLi (1 equiv), <i>t</i>-BuLi (2 equiv), 1-propylpiperidin-4-one, THF; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, Î; (d) Pd/C, H<sub>2</sub>, EtOH.</p></p></figure><div class="NLM_p">Compound <b>13</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) was synthesized from 3-bromobenzothiophene by lithiation with <i>n</i>-BuLi and quenching with 1-Boc-4-piperidone. Subsequent treatment with TFA in a CH<sub>2</sub>Cl<sub>2</sub> solution (for Boc deprotection and elimination of hydroxy group) yielded 3-substituted benzothiophene <b>31</b> in moderate yield (35%).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The secondary amine <b>31</b> was treated with iodopropane and afforded <b>32</b> in excellent yield (100%) followed by reduction with catalytic hydrogenation (Pd/C), which afforded the piperidine derivative <b>13</b> in moderate yield (38%, Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). The 2-substituted benzothiophen derivate <b>24</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) was synthesized by the same sequence, by lithiation with <i>n</i>-BuLi regioselective at the 2-position, from benzothiophene (room temperature). Subsequent treatment with TFA yielded <b>33</b> in moderate yield (39%).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The secondary amine <b>33</b> was treated with iodopropane and afforded <b>34</b> in excellent yield (100%), followed by reduction with catalytic hydrogenation (Pd/C), affording the piperidine derivative <b>24</b> in moderate yield (22%, Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 4-(Benzothiophen-3-yl)-1-propylpiperidine (<b>13</b>) and 4-(Benzothiophen-2-yl)-1-propylpiperidine (<b>24</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>n</i>-BuLi, 1-Boc-4-piperidone, diethyl ether, THF; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, Î; (c) PrI, K<sub>2</sub>CO<sub>3</sub>, ACN, Î; (d) Pd/C, H<sub>2</sub>, methanol, HAc, HCl.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87048" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87048" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> In Vitro</h3><div class="NLM_p last">All target compounds (<b>9</b> and <b>11</b>â<b>24)</b> were evaluated in competition binding assays in human embryonic kidney (HEK) 293 cells transfected with human dopamine D<sub>2</sub> short form (D<sub>2S</sub>) receptors using two different ligands: the antagonist [<sup>3</sup>H]methylspiperone, which labels the low-affinity dopamine D<sub>2</sub> receptor state (D<sub>2</sub><sup>Low</sup>), and the agonist [<sup>3</sup>H]7-OH DPAT (7-hydroxy-2-<i>N</i>,<i>N</i>-dipropyl-2-aminotetralin), which labels the high-affinity dopamine D<sub>2</sub> receptor state (D<sub>2</sub><sup>High</sup>).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> In addition, the compounds were tested for affinity to the human SERT, using [<sup>3</sup>H]imipramine as the ligand in Chinese hamster ovary (CHO) cells<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> and affinity for MAO A from rat cerebral cortex, using [<sup>3</sup>H]Ro 41-1049 as the ligand (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Some compounds were also further screened for affinity to serotonin 5-HT<sub>1A</sub>,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> 5-HT<sub>2A</sub>,<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> 5-HT<sub>6</sub>,<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> D<sub>3</sub>,<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> D<sub>4</sub>,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> adrenergic Î±<sub>2A</sub> receptors<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> and DAT<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> (Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The agonist affinity state of dopamine D<sub>2</sub> receptors (D<sub>2</sub><sup>High</sup> or D<sub>2</sub><sup>Low</sup>) is dependent on the degree of guanine nucleotide-binding protein (G-protein) coupling.<a onclick="showRef(event, 'ref71 ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref71 ref72 ref73">(71-73)</a> Antagonists are thought to bind approximately equally well to both receptor states.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> A dopamine D<sub>2</sub> receptor that is uncoupled from a G-protein is considered to be in its low-affinity state, whereas coupling of the G-protein (a process promoted by agonists) gives a high-affinity state. By use of an agonist and antagonist as the [<sup>3</sup>H]ligand, the affinity for D<sub>2</sub><sup>High</sup> and D<sub>2</sub><sup>Low</sup> can be determined, and the ratio between these two affinities (<i>K</i><sub>i</sub><sup>Low</sup>/<i>K</i><sub>i</sub><sup>High</sup>) correlates with the intrinsic activity of the compound (antagonists display ratios around 1 and agonists >50).<a onclick="showRef(event, 'ref3 ref74'); return false;" href="javascript:void(0);" class="ref ref3 ref74">(3, 74)</a> From the results listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, it can be concluded that in general, the target compounds bind with slightly higher affinity to the dopamine D<sub>2</sub><sup>High</sup> state than to the dopamine D<sub>2</sub><sup>Low</sup> state. However, none of them displayed a high enough ratio to produce intrinsic activity that could be detected in vivo by measuring effects on DOPAC levels (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). It can also be concluded that compounds <b>14</b>, <b>23</b>, and <b>24</b> bind with high affinity to MAO A while remaining compounds lack affinity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In addition, most of the target compounds bind with fairly high affinity for SERT, except for <b>15</b>, <b>16</b>, and <b>19</b>â<b>21</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). From the results in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, none of the tested compounds (<b>9</b>, <b>14</b>, <b>15</b>, <b>23</b>, <b>24</b>) bind with high affinity to 5-HT<sub>1A</sub>, dopamine D<sub>4</sub> and DAT (less than 67% displacement at 1 Î¼M), while nearly 100% displacement (at 1 Î¼M) was obtained at the 5-HT<sub>2A</sub> receptor (<b>9</b>, <b>23</b>, <b>24</b>). In addition, compound <b>9</b> was found to have affinity for Î±<sub>2</sub> receptors (91% displacement) and compound <b>15</b> for dopamine D<sub>3</sub> receptors (83%).</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> In Vivo</h3><div class="NLM_p">The typical in vivo effects of dopamine D<sub>2</sub> receptor antagonists are dose-dependent increases in the synthesis and release of dopamine in the striatum, measured as an increase in DOPAC levels (up to a maximum of 300â400% of control), plus a concomitant potent reduction in spontaneous LMA in partly habituated rats, which is a hallmark for a potential risk for EPS in patients (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, risperidone, pimozide, and ziprasidone). Generally, they also bind with high affinity to dopamine D<sub>2</sub> receptors (<i>K</i><sub>i</sub> < 12 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). All target compounds (<b>9</b> and <b>11</b>â<b>24</b>) were evaluated for doseâresponse effects on DOPAC and 5-HIAA levels and LMA (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>; the effect on LMA is reported at the dose when the compound reaches its maximal effect on DOPAC). In addition, the reported effect on LMA is during the last 45 min of the behavioral session, which is regarded as the hypoactive state of the animal (and is the point during which dopaminergic stabilizers increase LMA compared with dopamine D<sub>2</sub> receptor antagonists, which decrease LMA; Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Data for Compounds <b>9</b> and <b>11</b>â<b>24</b> and Reference Compounds<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0012.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0013.gif" alt="" id="GRAPHIC-d493e1229-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Binding affinities (apparent <i>K</i><sub>i</sub>) with [<sup>3</sup>H]7-OH-DPAT as ligand for dopamine D<sub>2S</sub> receptor (ag) (h), [<sup>3</sup>H]methylspiperone as ligand for D<sub>2S</sub> receptor (ant.) (h), [<sup>3</sup>H]Ro 41-1049 as ligand for MAO A (rat), and [<sup>3</sup>H]imipramine as ligand for SERT (h).</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">From Kongsamut et al., CHO cells, dopamine D<sub>2L</sub> receptor (ant.) binding with [<sup>3</sup>H]methylspiperone.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">From Di Santo et al.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">IC<sub>50</sub> less than 50% displacement at the highest concentration tested (1.0 Ã 10<sup>â4</sup> M).</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Confidence intervals are reported in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">Data from Pettersson et al.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></p></div><div class="footnote" id="t1fn7"><sup>Table g</sup><p class="last">Not calculated because of missing binding values. Abbreviations: [<sup>3</sup>H]7-OH-DPAT, [<sup>3</sup>H]7-hydroxy-<i>N</i>,<i>N</i>-dipropyl-2-aminotetralin; Ro 41-1049, <i>N</i>-(2-aminoethyl)-5-(<i>m</i>-fluorophenyl)-4-thiazole carboxamide HCl; ag, agonist; ant., antagonist; CHO, Chinese hamster ovary; D<sub>2L</sub>, dopamine type 2 long receptor; D<sub>2S</sub><sup>Low</sup> dopamine type 2 short receptor low-affinity state; D<sub>2S</sub><sup>High</sup> dopamine type 2 short receptor high-affinity state; MAO A, monoamine oxidase A enzyme; h, human; NT, not tested; n.c., not calculated.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vivo Data for Compounds <b>9</b> and <b>11</b>â<b>24</b> and Reference Compounds in Rats</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0014.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0015.gif" alt="" id="GRAPHIC-d493e1358-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Post-mortem neurochemistry analysis of striatal DOPAC levels compared with saline control (<i>n</i> = 4).</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Post-mortem neurochemistry analysis striatal 5-HIAA levels compared with saline control (<i>n</i> = 4).</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">LMA 15â60 min after subcutaneous injection, measured at 25 Hz, compared with saline control. To compare the LMA of different compounds, the lowest dose required to produce a maximal DOPAC response was selected.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Calculated using methodology described by Ponten et al.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">Data from Ponten et al.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></p></div><div class="footnote" id="t2fn6"><sup>Table f</sup><p class="last">Calculated logarithm of the compoundâs partition coefficient between <i>n</i>-octanol and water with Advanced Chemistry Development (ACD), version 12 (Toronto, Canada).</p></div><div class="footnote" id="t2fn7"><sup>Table g</sup><p class="last">Not calculated because of decreasing values in dose response.</p></div><div class="footnote" id="t2fn8"><sup>Table h</sup><p class="last">Data from Pettersson et al.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> â, <i>P</i> <0.05 using Studentâs <i>t</i> test. Abbreviations: n.c., not calculated; DOPAC, 3,4-dihydroxyphenylacetic acid; 5-HIAA, 5-hydroxyindoleacetic acid; LMA, locomotor activity; IA, inactive.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Selectivity Data for Compounds <b>9</b>, <b>14</b>, <b>15</b>, <b>23</b>, and <b>24</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0016.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Inhibition of control specific binding at 1 Î¼M reported with [<sup>3</sup>H]8-OH-DPAT as ligand for 5-HT<sub>1A</sub> (ag) (h), [<sup>3</sup>H]ketanserin as ligand for 5-HT<sub>2A</sub> (ant.) (h), [<sup>3</sup>H]UK 14.304 as ligand for Î±<sub>2</sub> (nonselective) (ag) (h), [<sup>3</sup>H]7-OH-DPAT as ligand for D<sub>3</sub> (ag) (h), [<sup>3</sup>H]methylspiperone as ligand for D<sub>4</sub> (ant.) (h), and [<sup>3</sup>H]BTCP as ligand for DAT (ant.) (h).</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Î±<sub>2</sub> nonselective binding. Abbreviations: [<sup>3</sup>H]8-OH-DPAT, [<sup>3</sup>H]8-hydroxy-<i>N</i>,<i>N</i>-dipropyl-2-aminotetralin; [<sup>3</sup>H]LSD, [<sup>3</sup>H]lysergic acid diethylamide; [<sup>3</sup>H]UK 14.304, 5-bromo-6-(imidazoline-2-yl)aminoquinoxaline tartrate; [<sup>3</sup>H]7-OH-DPAT, [<sup>3</sup>H]7-hydroxy-<i>N</i>,<i>N</i>-dipropyl-2-aminotetralin; [<sup>3</sup>H]BTCP, [<sup>3</sup>H]<i>N</i>-[1-(2-benzo(<i>b</i>)thiophenyl)cyclohexyl]piperidine; 5-HT, serotonin; Î±<sub>2</sub>, adrenergic receptor; D<sub>3</sub>, dopamine type 3 receptor; D<sub>4</sub>, dopamine type 4 receptor; DAT, dopamine transporter protein; ag, agonist; ant., antagonist; h, human; IC<sub>50</sub>, half maximal inhibitory concentration; <i>K</i><sub>i</sub>, inhibition constant; NT, not tested.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Selectivity Data for Compound <b>19</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0017.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Binding affinities (apparent <i>K</i><sub>i</sub>) with [<sup>3</sup>H]8-OH-DPAT as ligand for 5-HT<sub>1A</sub> (ag) (h), [<sup>3</sup>H]ketanserin as ligand for 5-HT<sub>2A</sub> (ant.) (h), [<sup>3</sup>H]LSD as ligand for 5-HT<sub>6</sub> (ag) (h), [<sup>3</sup>H]UK 14.304 as ligand for Î±<sub>2A</sub> (ag) (h), and [<sup>3</sup>H]7-OH-DPAT as ligand for D<sub>3</sub> (ag) (h).</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Inhibition of control specific binding at 1 Î¼M reported with [<sup>3</sup>H]methylspiperone as ligand for D<sub>4</sub> (ant.) (h) and [<sup>3</sup>H]BTCP as ligand for DAT (ant.) (h).</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Confidence intervals are reported in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">IC<sub>50</sub> less than 25% displacement at the highest concentration tested (1.0 Ã 10<sup>â4</sup> M). Abbreviations: [<sup>3</sup>H]8-OH-DPAT, [<sup>3</sup>H]8-hydroxy-<i>N</i>,<i>N</i>-dipropyl-2-aminotetralin; [<sup>3</sup>H]7-OH-DPAT, [<sup>3</sup>H]7-hydroxy-<i>N</i>,<i>N</i>-dipropyl-2-aminotetralin; [<sup>3</sup>H]BTCP, [<sup>3</sup>H]<i>N</i>-[1-(2-benzo(<i>b</i>)thiophenyl)cyclohexyl]piperidine; [<sup>3</sup>H]LSD, [<sup>3</sup>H]lysergic acid diethylamide; [<sup>3</sup>H]UK 14.304, 5-bromo-6-(imidazoline-2-yl)aminoquinoxaline tartrate; 5-HT, serotonin; Î±<sub>2A</sub>, adrenergic type 2A receptor; D<sub>3</sub>, dopamine type 3 receptor; D<sub>4</sub>, dopamine type 4 receptor; DAT, dopamine transporter protein; ag, agonist; ant., antagonist; h, human; IC<sub>50</sub>, half-maximal inhibitory concentration; <i>K</i><sub>i</sub>, inhibition constant.</p></div></div><div></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18416" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18416" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Effects on Dopamine D<sub>2</sub> Receptors in Vitro and in Vivo</h3><div class="NLM_p">Changing the bicyclic ring structure of <b>8</b> was found to have a marked impact on the dopaminergic and serotonergic system (i.e., effects on DOPAC and 5-HIAA levels, binding to dopamine D<sub>2</sub> and SERT receptors) and affinity for MAO A (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). As can be seen in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, the indole structures (<b>9</b> and <b>12</b>) and 1,2-benzisoxazole (<b>15</b>) were potent and efficacious dopamine D<sub>2</sub> receptor antagonists, inducing an increase in DOPAC levels with an ED<sub>50</sub> of 3â4 Î¼mol/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and a strong reduction of LMA (<10% of control). These effects were similar to those of the classical dopamine D<sub>2</sub> receptor antagonists risperidone, pimozide, and ziprasidone, which have comparable potency on DOPAC levels and LMA (pimozide and ziprasidone have an ED<sub>50</sub> of 1.6 and 1.2 Î¼mol/kg; risperidone is slightly more potent at 0.5 Î¼mol/kg). The binding affinities for dopamine D<sub>2</sub> receptors further supported the potency of these new compounds, with an affinity of 27, 32, and 194 nM for <b>9</b>, <b>12</b>, and <b>15,</b> respectively, for D<sub>2</sub><sup>Low</sup> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). However, compound <b>15</b> had a binding affinity of 34 nM for D<sub>2</sub><sup>High</sup>, which correlates better with its in vivo potency than the affinity for D<sub>2</sub><sup>Low</sup>. It is noteworthy that the reported in vitro affinity of pimozide, ziprasidone, and risperidone for D<sub>2</sub> receptors is 11.7, 8.5, and 2.7 nM, respectively (D<sub>2</sub><sup>Low</sup>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). This means that dopamine D<sub>2</sub> receptor affinity correlates very well with the different in vivo potencies observed, including also <b>9</b>, <b>12</b>, and <b>15</b> (<i>R</i><sup>2</sup> = 0.92 between in vitro dopamine D<sub>2</sub><sup>High</sup> receptor affinity and ED<sub>50</sub> for DOPAC for these six compounds, <a class="ref internalNav" href="#notes-1" aria-label="Figure 1S">Figure 1S</a>). Risperidone is approximately 10-fold more potent in vitro than <b>9</b>, <b>12</b>, and <b>15</b>, and this is in agreement with a 6- to 8-fold greater potency in vivo.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo DOPAC (% of control) dose response in rat striatum for selected compounds and reference compounds. Controls are indicated with a white bar. <b>9</b>, <b>13</b>, <b>14</b>, <b>16</b>â<b>19</b>, <b>22</b>â<b>24</b> in doses 3.7, 11, 33, and 100 Î¼mol/kg. <b>15</b>: 1.2, 3.7, 11, and 33 Î¼mol/kg. Ziprasidone: 0.2, 0.7, 2.1, and 6.4 Î¼mol/kg. Pimozide: 0.2, 0.6, 1.9, and 5.8 Î¼mol/kg. Risperidone: 0.07, 0.2, 0.7, and 2.4 Î¼mol/kg. Moclobemide: 1.4, 4, 12, and 37 Î¼mol/kg. Statistical significance is assessed using <i>t</i> test (two-tailed) versus controls: (â) <i>P</i> < 0.05, (ââ) <i>P</i> < 0.01, (âââ) <i>P</i> < 0.001. Error bars indicate standard error of the mean (SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">However, there is one compound in this new series that does not show a correlation between in vitro and in vivo potency: the benzimidazole-2-one <b>19</b> (ED<sub>50</sub> = 7 Î¼mol/kg for DOPAC), which was found to be more or less equally potent and efficacious as, for example, <b>9</b> in vivo (ED<sub>50</sub> = 4.1 Î¼mol/kg for DOPAC). In contrast, its affinity in vitro for dopamine D<sub>2</sub> receptors was 10-fold lower (and 32- to 137-fold lower compared with the classical dopamine D<sub>2</sub> receptor antagonists). Compound <b>19</b> was one of the most hydrophilic compound in this series (clogP = 3.0), and it is possible that the more lipophilic compounds (<b>9</b>, <b>12</b>, and <b>15</b>) have a higher protein-binding degree, distributing to lipophilic compartments other than the brain, meaning that higher doses are needed to reach the target (i.e., dopamine D<sub>2</sub> receptors). As such, the âtrueâ difference in potency may be masked. An alternative explanation could be differences in metabolic stability, but CYP450 turnover indicated that these compounds had the same stability (data not shown). Furthermore, given that all compounds were administered subcutaneously, the likelihood of problems with absorption or effects on first pass metabolism is minimized. One further interesting observation for <b>19</b> was that despite having similar potency and efficacy on DOPAC levels as <b>9</b>, <b>12</b>, and <b>15</b>, it displayed only a weak effect on spontaneous LMA. A reduction in spontaneous LMA can be caused by many substances that are not dopamine D<sub>2</sub> receptor antagonists, including histamine type 1 (H<sub>1</sub>) and adrenergic Î±<sub>1</sub> receptor blockers and reserpine (by depleting dopamine levels).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> By itself, this is therefore indicative only of general central nervous system depression. The dopamine D<sub>3</sub> receptor has been suggested to be involved in the control of LMA as a postsynaptic inhibitory receptor, and thereby dopamine D<sub>3</sub> agonists induce a decrease and antagonists an increase in LMA.<a onclick="showRef(event, 'ref78 ref79 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref78 ref79 ref80 ref81">(78-81)</a> It is interesting to note that compound <b>19</b> displays some affinity for dopamine D<sub>3</sub> (6-fold lower than for dopamine D<sub>2</sub>, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), and this may partly explain the lower potency in decreasing LMA (dopamine D<sub>3</sub> counteracting the effects on dopamine D<sub>2</sub>). But since compound <b>15</b> binds to dopamine D<sub>3</sub> as well (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) and since risperidone, ziprasidone, and pimozide are known to bind with high affinity to dopamine D<sub>3</sub> receptors,<a onclick="showRef(event, 'ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref82 ref83">(82, 83)</a> it seems to be an unlikely explanation that the dopamine D<sub>3</sub> receptor affinity will contribute to the different effects on LMA for <b>15</b>, <b>19</b>, risperidone, pimozide, and ziprasidone. However, we believe that the reduction in LMA seen with these compounds is mainly related to in vivo blocking of dopamine D<sub>2</sub> receptors, and therefore, a different explanation is needed for why <b>19</b> only partially reduced the LMA compared with pimozide, risperidone, ziprasidone, <b>9</b>, <b>12</b>, and <b>15</b>. We demonstrated recently that there is a correlation between affinity for dopamine D<sub>2</sub><sup>Low</sup> and effects on spontaneous LMA.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> A compound such as the dopaminergic stabilizer <b>2</b> has a very low affinity for dopamine D<sub>2</sub><sup>Low</sup> (<i>K</i><sub>i</sub> = 175â50 nM)<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> but induces an increase in DOPAC to the same extent as the most potent and efficacious dopamine D<sub>2</sub> receptor antagonists. However, in sharp contrast to these compounds, <b>2</b> induces an increase in spontaneous LMA (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Its unique mechanism of action (surmountable, low affinity, and fast-off receptor kinetics) may account for the increase in spontaneous LMA, since it is believed to allow dopamine receptors to rapidly regain responsiveness to the released dopamine.<a onclick="showRef(event, 'ref3 ref5 ref9'); return false;" href="javascript:void(0);" class="ref ref3 ref5 ref9">(3, 5, 9)</a> Tighter binding to dopamine D<sub>2</sub> receptors therefore means that responsiveness to dopamine is reduced, which consequently reduces spontaneous LMA. In agreement with this, compound <b>19</b> binds moderately to dopamine D<sub>2</sub><sup>Low</sup> (<i>K</i><sub>i</sub> = 371 nM) and demonstrates only a partial reduction in LMA. We have not measured the receptor dissociation kinetics for <b>19</b>, but we predict fast-off receptor kinetics, based on the chemical properties for <b>19</b> and the overlap with properties reported by Tresadern et al., to be crucial.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> However, despite the predicted fast-off kinetics, compound <b>19</b> does not share the unique effects seen for the dopaminergic stabilizer <b>2</b> (i.e., an increase in LMA when reaching maximal effects on DOPAC), and <b>19</b> is therefore not regarded as a new dopaminergic stabilizer. On the basis of this finding, we can conclude that in addition to the surmountable antagonism and fast-off kinetics, a low affinity for dopamine D<sub>2</sub> receptors is also needed for a compound to be classified as a dopaminergic stabilizer. Additional notable SAR for the new series of compounds was that methylation of the indole nitrogen slightly decreased the affinity for dopamine D<sub>2</sub> receptors, which was further supported by lesser effects on DOPAC levels (comparing <b>9</b> and <b>11</b>). However, moving the fluoro atom from position 6 to 5 recovered the affinity and in vivo potency/efficacy (<b>12</b>). The reversed indole (<b>17</b>) and 1-naphthyl (<b>22</b>) were found to have weak effects on DOPAC levels compared with the indoles (<b>9</b>, <b>11</b>, <b>12</b>) and 1,2-benzisoxazole (<b>15</b>), and for these compounds the highest dose (100 Î¼mol/kg) may not have been sufficient to reach the possible maximal effect on DOPAC levels (300â400% increase). In addition, the effect on LMA was also weak, if any. It is interesting to note that 1-naphthyl <b>22</b> bound with high affinity to dopamine D<sub>2</sub><sup>High</sup> (41 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), although this did not correlate well with in vivo potency. The corresponding benzimidazole (<b>18</b>) and isatin (<b>21</b>) were found to be completely devoid of effects on DOPAC levels, which correlates with their very low affinity for dopamine D<sub>2</sub> receptors.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vivo and in Vitro Effects on MAO A and DOPAC Levels</h3><div class="NLM_p">The most surprising effects among the target compounds were those observed in compounds that induced a dose-dependent decrease in DOPAC levels (<b>14</b>, <b>23</b>, and <b>24</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Dopamine D<sub>2</sub> receptor agonists are known to reduce DOPAC levels, but when we investigated further the effects in vivo (e.g., effects on 3-methoxytyramine, 3-MT), the profiles of these three compounds were shown to be very similar to that of moclobemide (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), a known selective and reversible inhibitor of MAO A.<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84, 85)</a> This was further supported by subsequent affinity screening, where these three compounds displayed high affinity for MAO A (92, 63, and 18 nM for <b>14</b>, <b>23</b>, and <b>24</b>, respectively) but lacked essential affinity for dopamine D<sub>2</sub> receptors (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The most striking effect was the replacement of the sulfur in 3-benzothiophene <b>13</b> (a dopamine D<sub>2</sub> receptor antagonist lacking affinity for MAO A, 13â990 nM; Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) with oxygen (3-benzofuran <b>14</b>), which resulted in loss of much of the dopamine D<sub>2</sub> receptor affinity but increased the affinity for MAO A by 1000-fold (92 nM). From a SAR perspective this is a very unexpected finding, especially given that oxygen and sulfur belong to the same atom âfamilyâ. Similarly, it was surprising to discover that moving the position of attachment for the naphthalene ring from position 1 (<b>22</b>) to 2 (<b>23</b>) switched the selectivity from dopamine D<sub>2</sub> receptor to MAO A. This is easier to understand from a SAR perspective, since this relates to geometrical aspects and it seems that substitution in the âparaâ position of the aromatic ring (methine carbon in <b>23</b>) is not tolerated by dopamine D<sub>2</sub> receptors but is by MAO A. This is also in agreement with what has been reported by Pettersson et al. for para-substituted phenylpiperidines<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> and is further supported by the finding of 2-benzothiophene <b>24</b>. Compound <b>24</b> also mimicked the reported MAO A inhibitor brofaromine (<b>35</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).<a onclick="showRef(event, 'ref85 ref87'); return false;" href="javascript:void(0);" class="ref ref85 ref87">(85, 87)</a></div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structure of monoamine oxidase A (MAO A) inhibitor brofaromine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Relationship between in Vivo DOPAC and in Vitro Dopamine D<sub>2</sub> Receptor and MAO A</h3><div class="NLM_p">Once released, dopamine is metabolized primarily by MAO A to its main metabolite DOPAC, and an increased release of dopamine therefore leads to higher levels of DOPAC. However, if MAO A is inhibited, this metabolism is blocked, and in agreement with this, inhibitors of MAO A (e.g., moclobemide) reduce striatal DOPAC levels. MAO A inhibition and dopamine D<sub>2</sub> receptor antagonsim have opposing effects on DOPAC levels. As such, we investigated whether these two counteracting effects could explain why some compounds did not produce the maximal increase (350â400%) in DOPAC levels that would be expected from dopamine D<sub>2</sub> receptor antagonism. We also examined whether this could explain why some compounds (e.g., 1-naphthalene <b>22</b>) had less potent effects on DOPAC levels compared with their in vitro potency. Finally, the effects of 2<i>H</i>-indazole <b>16</b> on DOPAC levels (which plateau at a maximum 227% of control rather than the expected 350â400%) may be explained by such a counteracting mechanism. The effect on DOPAC levels was modeled against the binding affinity for dopamine D<sub>2</sub> receptors, MAO A, and SERT, using partial least-squares (PLS) regression.<a onclick="showRef(event, 'ref88 ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref88 ref89 ref90">(88-90)</a> Compounds for which it was not possible to measure a <i>K</i><sub>i</sub> value have been excluded from the modeling. A two-component model with <i>Q</i><sup>2</sup> of 0.85 and a <i>R</i><sup>2</sup><i>Y</i> of 0.93 was obtained (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), in which binding to MAO A and dopamine D<sub>2</sub> receptors modeled very well the effect on observed DOPAC levels. The affinity for SERT had a minor contribution to the model and is therefore hard to interpret. On the basis of this result, we conclude that the overall effect of any particular compound on DOPAC levels results from a combination of its ability to antagonize dopamine D<sub>2</sub> receptors and inhibit MAO A, which both counteract each other. Compounds <b>22</b> and <b>16</b> fit well with this model and support the hypothesis that less potent effects on DOPAC levels are due to inhibition of MAO A. It is also worth mentioning that the MAO A inhibitor moclobemide displays low affinity for MAO A (<i>K</i><sub>i</sub> = 11â500 nM) but is still able to inhibit the enzyme efficiently. As such, the low affinity observed for some of the new compounds may at first glance appear insufficient to explain the effects on DOPAC levels; however, the supporting evidence indicates that low affinity is an important contributor to the net effect on DOPAC.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Partial least-squares (PLS) regression on 3,4-dihydroxyphenylacetic acid (DOPAC) was modeled against the binding affinity for dopamine D<sub>2</sub> receptors, monoamine oxidase A (MAO A) and serotonin transporter protein (SERT).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Effects on Affinity for SERT and 5-HIAA Levels in Vivo</h3><div class="NLM_p last">The compounds were also screened for their effects on 5-HIAA levels in the rat striatum, which can be decreased by direct stimulation of serotonin 5-HT<sub>1A</sub> receptors (e.g., by agonists such as (+)-8-OH-DPAT<a onclick="showRef(event, 'ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref91 ref92">(91, 92)</a>) or indirectly by increased synaptic levels of 5-HT (e.g., by selective serotonin reuptake inhibitors, SSRIs, such as citalopram, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).<a onclick="showRef(event, 'ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref93 ref94">(93, 94)</a> In general, there was no effect on 5-HIAA levels among the compounds tested, with the exceptions of 1-naphthalene <b>22</b> and 3-benzothiophene <b>13</b>, which induced a partial but statistically significant decrease in 5-HIAA levels that was comparable with the effects of citalopram. These effects also correlated with the affinity for the SERT protein (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In addition, 2-naphthalene <b>23</b> and 2-benzothiophene <b>24</b> induced a statistically significant decrease in 5-HIAA, although these two compounds were also potent MAO A inhibitors (moclobemide is also known to induce a decrease in 5-HIAA levels)<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84, 85)</a> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The reason for the decrease in 5-HIAA levels following treatment with <b>23</b> and <b>24</b> can therefore be inhibition of MAO A or SERT or a combination of the two. Furthermore, the low in vitro binding affinities of 1,2-benzisoxazole <b>15</b>, 1<i>H</i>-indazole <b>16</b>, benzimidazolones <b>19</b> and <b>20</b>, and isatin <b>21</b> for SERT indicate that these structural motifs are not tolerated in the interaction with the SERT protein (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). From a SAR perspective, it is interesting to note that these five compounds have a heteroatom in the 2-position of the five-membered ring while remaining compounds that display affinity for SERT have a methine carbon in the 2-position.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Compound <b>19</b> Additional in Vivo and in Vitro Data</h3><div class="NLM_p last">Despite not being classified as a dopaminergic stabilizer, compound <b>19</b> showed an interesting pharmacological profile for further characterization in animal models of psychoses. Compound <b>19</b> was found to counteract both <i>d</i>-amphetamine- and MK-801-induced hyperlocomotion, which were reduced to 4% and 42% of control, respectively (see <a class="ref internalNav" href="#notes-1" aria-label="Table 4S">Table 4S</a>). The effects were comparable with the effects observed for typical/atypical antipsychotic drugs and dopaminergic stabilizers such as <b>2</b>.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a><b>19</b> was also found to be selective for dopamine D<sub>2</sub> receptors compared with dopamine D<sub>3</sub> (6-fold), D<sub>4</sub>, serotonin 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>6</sub>, and adrenergic Î±<sub>2A</sub> receptors, DAT and SERT transporters, and MAO A enzyme (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). In summary, <b>19</b> demonstrated selective dopamine D<sub>2</sub> receptor antagonism and indicated a low propensity to induce EPS in patients, which warrants further characterization in different animal models.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85061" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85061" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Scaffold jumping among five- and six-membered bicyclic aryl rings attached to the piperidine ring had a marked impact on the effects of compounds on the dopaminergic and serotonergic systems. Potent and selective dopamine D<sub>2</sub> receptor antagonists were achieved using 3-indoles, 3-benzoisoxazoles, 3-benzimidazol-2-one, and 3-benzothiophenes, although 3-isatin and 3-benzimidazole were devoid of activity. In contrast, 3-benzofuran was a potent and selective MAO A inhibitor. Effects on DOPAC levels correlated very well with affinity for dopamine D<sub>2</sub> receptors and MAO A. This correlation may explain why some compounds did not reach a full dopamine D<sub>2</sub> receptor antagonist effect in vivo, since MAO A inhibition would have counteracted the increase in DOPAC levels following dopamine D<sub>2</sub> receptor blockade. It is clear that none of the new compounds mimicked the behavioral effects of the dopaminergic stabilizer pridopidine, most likely because of retention in high affinity for both dopamine D<sub>2</sub><sup>High</sup> and D<sub>2</sub><sup>Low</sup>. This prevents rapid responsiveness to synaptically released dopamine, hampering subsequent increases in behavioral activity. Thus, previous development of dopaminergic stabilizers from dopamine agonist motifs seems to offer an advantage with respect to the interaction with the dopamine D<sub>2</sub> receptor. Among the compounds tested, <b>19</b> was the most interesting, demonstrating efficacy in several animal models of psychosis with only a partial reduction of spontaneous LMA, indicating it may have very low propensity to induce EPS in patients.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64471" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64471" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Chemistry. General</h3><div class="NLM_p last"><sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded in CD<sub>3</sub>OD, CDCl<sub>3</sub>, or DMSO-<i>d</i><sub>6</sub> at 300 and 75 MHz, respectively, using a Varian XL 300 spectrometer (Varian, Darmstadt, Germany), or at 400 and 100 MHz, respectively, using a Mercury Plus 400 spectrometer (Varian, Darmstadt, Germany). Chemical shifts are reported as Î´ values (ppm) relative to an internal standard (tetramethylsilane). Low-resolution mass spectra were recorded on a HP 5970A instrument (Agilent Technologies, Stockholm, Sweden) operating at an ionization potential of 70 eV. The mass detector was interfaced with a HP5700 gas chromatograph (Agilent Technologies, Stockholm, Sweden) equipped with a fused silica column (11 m, 0.22 mm i.d.) coated with cross-linked SE-54 (film thickness 0.3 mm, He gas, flow 40 cm/s). Electrospray ionization mass spectra were recorded on Agilent 1200 series liquid chromatography/mass selective detector (Agilent Technologies, Stockholm, Sweden). The microwave heating was performed in a Smith synthesizer single-mode microwave cavity producing continuous irradiation at 2450 MHz (Personal Chemistry AB, Uppsala, Sweden). For further instructions see Alterman et al.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Elemental analyses were performed by MikroKemi AB (Uppsala, Sweden). Melting points were determined with BÃ¼chi 545 instrument (Kebo Lab, Goteborg, Sweden) and are uncorrected. For flash chromatography, silica gel 60 (0.040â0.063 mm, VWR, no. 109385) was used. The amine products were converted to the corresponding salts by dissolving the free base in methanol or ethanol and adding 1 equiv of oxalic acid or ethanolic HCl solution. The solvent was removed and azeotroped with absolute ethanol in vacuo followed by recrystallization from appropriate solvents. Purity of all target compounds was assessed as greater than 95% by elemental analysis (C, H, N).</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure for the Alkylation of the 4-Arylpiperidines/piperidenes (<b>9</b>, <b>10</b>, <b>14</b>, <b>15</b>, <b>17</b>â<b>19</b>, <b>22</b>, <b>23</b>, <b>32</b>, <b>34</b>)</h3><div class="NLM_p last">The 4-arylpiperidine (1 equiv, 2.5 mmol) was dissolved in ACN (50 mL), and iodopropane (1.2 equiv) and K<sub>2</sub>CO<sub>3</sub> (3 equiv) were added. The mixture was refluxed for 15 h, cooled to ambient temperature, and K<sub>2</sub>CO<sub>3</sub> was filtered off and subsequently washed with ACN (2 Ã 50 mL). The combined organic phases were concentrated in vacuo. The residue was purified with flash chromatography using an ethyl acetate (EtOAc)âMeOH or CH<sub>2</sub>Cl<sub>2</sub>âMeOH gradient to give the title compounds.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure for the Methylation of 1-Propyl-4-arylpiperidine Core NH Position (<b>11</b>, <b>12</b>, and <b>20</b>)</h3><div class="NLM_p last">1-Propyl-4-arylpiperidine (1 equiv, 1 mmol) was dissolved in 2 mL of anhydrous DMF at 0 Â°C, and NaH at 60% dispersion in mineral oil (1.1 equiv) was added. The mixture was stirred under N<sub>2</sub> at ambient temperature until evolution of H<sub>2</sub> gas ceased (â¼30 min). Iodomethane (1.1 equiv) was added, and the mixture was allowed to stir for 2 h at room temperature. Brine was added, and the reaction mixture was extracted with EtOAc (2 Ã 50 mL). The organic portion was dried (MgSO<sub>4</sub>), and the solvent was removed under reduced pressure. The residue was purified by flash chromatography on silica gel (isooctane/EtOAc/MeOH gradient) to give the title compounds.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 4-(Benzothiophen-3-yl)-1-propylpiperidine (<b>13</b>)</h3><div class="NLM_p last">To a solution of <b>32</b> (0.26 g, 1.01 mmol) in MeOH (10 mL) were added concentrated HAc (1 mL) and Pd/C (0.26 g) under N<sub>2</sub>. The reaction mixture was hydrogenated under H<sub>2</sub> (50 psi) for 30 h. Filtration and evaporation of the filtrate afforded the crude product as the HAc salt. Aqueous Na<sub>2</sub>CO<sub>3</sub> (10%, 50 mL) and EtOAc (50 mL) were added and the phases separated. The water layer was extracted with EtOAc (2 Ã 50 mL), and the combined organic phases were dried (MgSO<sub>4</sub>) and evaporated to dryness in vacuo. The residue was purified by flash column chromatography with EtOAc/MeOH gradient to give the title compound in 38% yield (0.10 g, 0.38 mmol). MS <i>m</i>/<i>z</i> (relative intensity, 70 eV) 259 (M<sup>+</sup>, 27), 231 (17), 230 (bp), 115 (28), 98 (38). ESIMS: <i>m</i>/<i>z</i> 260.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) Î´ = 0.96 (t, <i>J =</i> 7.20 Hz, 3H), 1.55â1.82 (m, 2H), 1.84â2.04 (m, 2H), 2.08â2.31 (m, 2H), 2.53 (br s, 2H), 2.90â3.18 (m, 2H), 3.20â3.35 (m, 1H), 3.55 (d, <i>J =</i> 11.23 Hz, 2H), 7.43 (quin, <i>J =</i> 7.14 Hz, 2H), 7.52 (s, 1H), 7.99 (dd, <i>J =</i> 16.36, 7.57 Hz, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6,</sub> 75 MHz) Î´ = 10.95, 17.14, 29.01, 32.91, 51.84, 57.37, 121.15, 121.73, 123.00, 123.98, 124.38, 137.74, 138.97, 139.81. The amine was converted to the oxalate salt and recrystallized in MeOH/diethyl ether, mp 182â184 Â°C. Anal. (C<sub>16</sub>H<sub>21</sub>NSÂ·<sup>4</sup>/<sub>3</sub>C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>).</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 4-(Benzothiophen-2-yl)-1-propylpiperidine (<b>24</b>)</h3><div class="NLM_p last">To a solution of <b>34</b> (0.37 g, 1.43 mmol) in MeOH (10 mL) were added concentrated HCl (1 mL) and Pd/C (0.6 g) under N<sub>2</sub>. The reaction mixture was hydrogenated under H<sub>2</sub> (50 psi) for 15 h. Filtration and evaporation of the filtrate afforded 0.3 g of crude product as the HCl salt. Aqueous Na<sub>2</sub>CO<sub>3</sub> (10%, 50 mL) and EtOAc (50 mL) were added and the phases separated. The water layer was extracted with EtOAc (2 Ã 50 mL), and the combined organic phases were dried (MgSO<sub>4</sub>) and evaporated to dryness in vacuo. The residue was purified by flash column chromatography with EtOAc/MeOH gradient to give the title compound in 22% yield (0.083 g, 0.31 mmol). MS <i>m</i>/<i>z</i> (relative intensity, 70 eV) 259 (M<sup>+</sup>, 30), 231 (17), 230 (bp), 115 (22), 98 (15). ESIMS: <i>m</i>/<i>z</i> 260.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 300 MHz) Î´ = 0.92 (t, <i>J =</i> 7.45 Hz, 3H), 1.53 (dd, <i>J =</i> 15.87, 7.57 Hz, 2H), 1.81 (dd, <i>J =</i> 12.21, 2.44 Hz, 2H), 1.92â2.18 (m, 4H), 2.29 (m, 2H), 2.84 (t, <i>J =</i> 11.84 Hz, 1H), 2.99 (d, <i>J =</i> 11.96 Hz, 2H), 7.05 (s, 1H), 7.16â7.46 (m, 2H), 7.55â7.94 (m, 2H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 75 MHz) Î´ = 12.29, 20.65, 34.64, 39.14, 54.63, 61.90, 120.04, 123.06, 124.00, 124.65, 125.16, 140.07, 141.46, 151.87. The amine was converted to the oxalate salt and recrystallized in MeOH, mp 200â201 Â°C. Anal. (C<sub>16</sub>H<sub>21</sub>NSÂ·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 4-(Benzothiophen-3-yl)-1,2,3,6-tetrahydropyridine (<b>31</b>)</h3><div class="NLM_p last">To a solution of 3-bromobenzothiophene (4.0 g, 18.8 mmol) in dry diethyl ether (10 mL) at â78 Â°C, <i>n</i>-butyllithium in hexane (2.5 M, 8.24 mL, 20.6 mmol) was added. The mixture was stirred at â78 Â°C under an N<sub>2</sub> atmosphere for 20 min. 1-Boc-4-piperidone (3.74 g, 9.38 mmol) in dry diethyl ether (10 mL) was added via syringe. The solution was stirred for an additional 1 h. The reaction mixture was then diluted with aqueous NH<sub>4</sub>Cl, and the phases were separated. The aqueous phase was extracted with ethyl acetate (3 Ã 100 mL) and the combined organic phase was washed with brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo to give (4.54 g, 72%) of crude <i>tert</i>-butyl 4-(benzothiophen-3-yl)-4-hydroxypiperidine-1-carboxylate. MS <i>m</i>/<i>z</i> (relative intensity, 70 eV) 333 (M<sup>+</sup>, 13), 233 (47) 188 (52), 162 (55), 57 (bp). ESIMS: <i>m</i>/<i>z</i> 356.0 (M + Na)<sup>+</sup> . The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (100 mL). TFA (8 mL) was added, and the mixture was stirred at room temperature for 15 h. The reaction mixture was poured out on ice, basified with aqueous 10% Na<sub>2</sub>CO<sub>3</sub> to pH 10, and extracted with EtOAc (3 Ã 100 mL). The combined organic phase was dried (MgSO<sub>4</sub>) and concentrated in vacuo to give crude product, 2.34 g. The residue was purified by flash chromatography using EtOAc/MeOH gradient as eluent, affording <b>31</b> (1.42 g, 35%). MS <i>m</i>/<i>z</i> (relative intensity, 70 eV) 215 (M<sup>+</sup>, bp), 214 (54) 186 (64), 171 (37), 147 (26). ESIMS: <i>m</i>/<i>z</i> 216.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 300 MHz) Î´ = 2.78 (br s, 2H), 3.43 (t, <i>J</i> = 6.0 Hz, 2H), 3.84 (d, <i>J</i> = 2.70 Hz, 2H), 6.06 (t, <i>J</i> = 1.80 Hz, 1H), 7.31â7.42 (m, 2H), 7.51 (s, 1H), 7.86 (d, <i>J</i> = 6.9 Hz, 1H), 7.97 (d, <i>J</i> = 7.8 Hz, 1H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 75 MHz) Î´ = 27.12, 42.35, 43.35, 120.22, 123.90, 123.92, 124.64, 125.46, 125.59, 132.80, 137.67, 138.29, 141.94.</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 4-(Benzothiophen-3-yl)-1-propyl-3,6-dihydro-2<i>H</i>-pyridine (<b>32</b>)</h3><div class="NLM_p last"><b>31</b> was alkylated by the above general procedure and was obtained in 100% yield. MS <i>m</i>/<i>z</i> (relative intensity, 70 eV) 257 (M<sup>+</sup>, 74), 256 (33), 228 (bp), 185 (36), 147 (28). ESIMS: <i>m</i>/<i>z</i> 258.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 300 MHz) Î´ = 0.89 (t, <i>J =</i> 7.32 Hz, 3H), 1.50 (sxt, <i>J =</i> 7.62 Hz, 2H), 2.29 (d, <i>J =</i> 8.06 Hz, 2H), 2.48 (d, <i>J =</i> 1.95 Hz, 4H), 3.01 (s, 2H), 5.92 (br s, 1H), 6.78â7.56 (m, 3H), 7.78 (d, <i>J =</i> 7.81 Hz, 1H), 7.90 (d, <i>J =</i> 7.57 Hz, 1H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 75 MHz) Î´ = 12.35, 20.73, 30.56, 51.15, 53.54, 61.31, 123.16, 123.85, 124.15, 124.51, 125.16, 125.31, 132.18, 138.68, 138.92, 141.94.</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 4-(Benzothiophen-2-yl)-1,2,3,6-tetrahydropyridine (<b>33</b>)</h3><div class="NLM_p last">To a solution of benzothiophene (0.5 g, 3.72 mmol) in dry THF (10 mL) at â78 Â°C, <i>n</i>-buthyllithium in hexane (2.5 M, 1.63 mL, 4.09 mmol) was added. The mixture was stirred at â78 Â°C under an N<sub>2</sub> atmosphere for 2 h and then allowed to warm to room temperature for 2 h. 1-Boc-4-piperidone (0.74 g, 3.72 mmol) in dry THF (5 mL) was added via syringe. The solution was stirred for an additional 30 min. The reaction mixture was then diluted with aqueous NH<sub>4</sub>Cl, and the phases were separated. The aqueous phase was extracted with ethyl acetate (3 Ã 50 mL) and the combined organic phase was washed with brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo to give 1.26 g (95%) of crude <i>tert</i>-butyl 4-(benzothiophen-2-yl)-4-hydroxypiperidine-1-carboxylate. MS <i>m</i>/<i>z</i> (relative intensity, 70 eV) 333 (M<sup>+</sup>, 13), 233 (63), 188 (34), 162 (37), 57 (bp). ESIMS: <i>m</i>/<i>z</i> 356.0 (M + Na)<sup>+</sup>. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (50 mL), and TFA (2 mL) was added. The mixture was stirred at room temperature for 15 h. The reaction mixture was poured out on ice, basified with aqueous 10% Na<sub>2</sub>CO<sub>3</sub> to pH 10, and extracted with EtOAc (3 Ã 50 mL). The combined organic phase was dried (MgSO<sub>4</sub>) and concentrated in vacuo to give 0.43 g of crude <b>33</b>. The residue was purified by flash chromatography using EtOAc/MeOH gradient as eluent, affording <b>33</b> (0.32 g, 39%). MS <i>m</i>/<i>z</i> (relative intensity, 70 eV) 215 (M<sup>+</sup>, bp), 214 (67), 186 (49), 147 (25), 115 (22). ESIMS: <i>m</i>/<i>z</i> 216.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 300 MHz) Î´ = 2.36 (br s, 2H), 2.87 (t, <i>J</i> = 5.74 Hz, 2H), 3.29 (d, <i>J</i> = 2.69 Hz, 2H), 6.09 (br s, 1H), 7.07 (s, 1H), 7.15â7.38 (m, 2H), 7.65 (dd, <i>J</i> = 14.16, 6.35 Hz, 2H). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 75 MHz) Î´ = 27.71, 43.29, 45.47, 119.58, 122.92, 124.50, 125.36, 125.52, 131.58, 139.61, 141.70, 146.42.</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4-(Benzothiophen-2-yl)-1-propyl-3,6-dihydro-2<i>H</i>-pyridine (<b>34</b>)</h3><div class="NLM_p last"><b>33</b> was alkylated by the above general procedure, and 100% yield was obtained. MS <i>m</i>/<i>z</i> (relative intensity, 70 eV) 257 (M<sup>+</sup>, 77), 256 (33), 228 (bp), 185 (29), 147 (28). ESIMS: <i>m</i>/<i>z</i> 258.0 (M + H)<sup>+</sup>. <sup>13</sup>C NMR (CD<sub>3</sub>OD, 75 MHz) Î´ = 12.15, 20.59, 28.10, 50.79, 53.48, 61.00, 120.19, 122.85, 123.59, 124.52, 125.36, 125.58, 131.41, 139.73, 141.69, 145.51.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31"><a href="/doi/suppl/10.1021/jm300975f">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28064" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28064" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Statistical data on in vitro binding, raw data for in vivo DOPAC, PLS methods, linear regression of ED<sub>50</sub>, biological methods, and experimental details of the synthesis of <b>9</b>â<b>12</b>, <b>14</b>â<b>23</b>, <b>28</b>â<b>30</b>; plot of ED<sub>50</sub> vs p<i>K</i><sub>i</sub> in a separate pdf file. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300975f/suppl_file/jm300975f_si_001.pdf">jm300975f_si_001.pdf (706.96 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300975f/suppl_file/jm300975f_si_002.pdf">jm300975f_si_002.pdf (50.47 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300975f" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23172" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23172" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clas Sonesson</span> - <span class="hlFld-Affiliation affiliation">NeuroSearch Sweden AB, Arvid
Wallgrens Backe 20, SE-413 46 Gothenburg, Sweden</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e08393a08e8595928f938581928388ce838f8d"><span class="__cf_email__" data-cfemail="d7b4a497b9b2a2a5b8a4b2b6a5b4bff9b4b8ba">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cecilia Mattsson</span> - <span class="hlFld-Affiliation affiliation">NeuroSearch Sweden AB, Arvid
Wallgrens Backe 20, SE-413 46 Gothenburg, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Theresa Andreasson</span> - <span class="hlFld-Affiliation affiliation">NeuroSearch Sweden AB, Arvid
Wallgrens Backe 20, SE-413 46 Gothenburg, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas Waters</span> - <span class="hlFld-Affiliation affiliation">NeuroSearch Sweden AB, Arvid
Wallgrens Backe 20, SE-413 46 Gothenburg, Sweden</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d493e3107-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06164" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06164" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Anna Sandahl for help with the synthetic chemistry and Elisabeth Ljung, Marianne Thorngren, Kirsten SÃ¶nniksen, Boel Svanberg, Anna-Carin Jansson, and ThÃ©rese Carlsson for their work with behavioral and neurochemical experiments and analyses, and SÃ¶ren Lagerkvist is thanked for calculating ED<sub>50</sub> values for the tested compounds. For reviewing the manuscript, we thank Fredrik Pettersson and Abigail Woollard.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i33" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i33"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i34" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i34"> Abbreviations Used</h2><tr><td class="NLM_term">EPS</td><td class="NLM_def"><p class="first last">extrapyramidal symptoms</p></td></tr><tr><td class="NLM_term">LMA</td><td class="NLM_def"><p class="first last">locomotor activity</p></td></tr><tr><td class="NLM_term">DOPAC</td><td class="NLM_def"><p class="first last">3,4-dihydroxyphenylacetic acid</p></td></tr><tr><td class="NLM_term">5-HIAA</td><td class="NLM_def"><p class="first last">5-hydroxyindoleacetic acid</p></td></tr><tr><td class="NLM_term">3-MT</td><td class="NLM_def"><p class="first last">3-metoxytyramine</p></td></tr><tr><td class="NLM_term">MAO A</td><td class="NLM_def"><p class="first last">monoamine oxidase enzyme A</p></td></tr><tr><td class="NLM_term">D<sub>2</sub></td><td class="NLM_def"><p class="first last">dopamine type 2 receptor</p></td></tr><tr><td class="NLM_term">D<sub>3</sub></td><td class="NLM_def"><p class="first last">dopamine type 3 receptor</p></td></tr><tr><td class="NLM_term">D<sub>4</sub></td><td class="NLM_def"><p class="first last">dopamine type 4 receptor</p></td></tr><tr><td class="NLM_term">Î±<sub>2A</sub></td><td class="NLM_def"><p class="first last">adrenergic type 2A receptor</p></td></tr><tr><td class="NLM_term">L-DOPA</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">l</span>-3,4-dihydroxyphenylalanine</p></td></tr><tr><td class="NLM_term">ACN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">ag</td><td class="NLM_def"><p class="first last">agonist</p></td></tr><tr><td class="NLM_term">ant.</td><td class="NLM_def"><p class="first last">antagonist</p></td></tr><tr><td class="NLM_term">IA</td><td class="NLM_def"><p class="first last">inactive</p></td></tr><tr><td class="NLM_term">NT</td><td class="NLM_def"><p class="first last">not tested</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">clogP</td><td class="NLM_def"><p class="first last">calculated log of the partition coefficient</p></td></tr><tr><td class="NLM_term">PLS</td><td class="NLM_def"><p class="first last">partial least-squares</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">G-protein</td><td class="NLM_def"><p class="first last">guanine nucleotide-binding protein</p></td></tr><tr><td class="NLM_term">D<sub>2S</sub></td><td class="NLM_def"><p class="first last">dopamine D<sub>2</sub> short</p></td></tr><tr><td class="NLM_term">D<sub>2L</sub></td><td class="NLM_def"><p class="first last">dopamine D<sub>2</sub> long</p></td></tr><tr><td class="NLM_term">D<sub>2</sub><sup>High</sup></td><td class="NLM_def"><p class="first last">dopamine D<sub>2</sub> high affinity state</p></td></tr><tr><td class="NLM_term">D<sub>2</sub><sup>Low</sup></td><td class="NLM_def"><p class="first last">dopamine D<sub>2</sub> low affinity state</p></td></tr><tr><td class="NLM_term">nc</td><td class="NLM_def"><p class="first last">not calculated</p></td></tr><tr><td class="NLM_term">[<sup>3</sup>H]8-OH-DPAT</td><td class="NLM_def"><p class="first last">[<sup>3</sup>H]8-hydroxy-<i>N</i>,<i>N</i>-dipropyl-2-aminotetralin</p></td></tr><tr><td class="NLM_term">[<sup>3</sup>H]7-OH-DPAT</td><td class="NLM_def"><p class="first last">[<sup>3</sup>H]7-hydroxy-<i>N</i>,<i>N</i>-dipropyl-2-aminotetralin</p></td></tr><tr><td class="NLM_term">[<sup>3</sup>H]UK 14.304</td><td class="NLM_def"><p class="first last">5-bromo-6-(imidazoline-2-yl)aminoquinoxaline tartrate</p></td></tr><tr><td class="NLM_term">Ro 41-1049</td><td class="NLM_def"><p class="first last"><i>N</i>-(2-aminoethyl)-5-(<i>m</i>-fluorophenyl)-4-thiazolecarboxamide HCl</p></td></tr><tr><td class="NLM_term">[<sup>3</sup>H]LSD</td><td class="NLM_def"><p class="first last">[<sup>3</sup>H]lysergic acid diethylamide</p></td></tr><tr><td class="NLM_term">[<sup>3</sup>H]BTCP</td><td class="NLM_def"><p class="first last">[<sup>3</sup>H]<i>N</i>-[1-(2-benzo(<i>b</i>)thiophenyl)cyclohexyl]piperidine</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20465" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20465" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 95 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Johnson, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanasekaran, N.</span><span> </span><span class="NLM_article-title">The G-protein family and their interaction with receptors</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">â</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1210%2Fedrv-10-3-317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=2550214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaL1MXlvVOlsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1989&pages=317-331&author=G.+L.+Johnsonauthor=N.+Dhanasekaran&title=The+G-protein+family+and+their+interaction+with+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The G-protein family and their interaction with receptors</span></div><div class="casAuthors">Johnson, Gary L.; Dhanasekaran, N.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-31</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    </div><div class="casAbstract">A review, with 130 refs., is given on the structures of GTP-binding proteins (G-proteins), and on the mechanisms by which G-proteins regulate signal transduction from cell surface to effector systems for the control of cell functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8KJIeQf8rzrVg90H21EOLACvtfcHk0lhSSBhx1ElLjQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlvVOlsLc%253D&md5=c9568a413de1a85704510f50f1929b8e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1210%2Fedrv-10-3-317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fedrv-10-3-317%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DG.%2BL.%26aulast%3DDhanasekaran%26aufirst%3DN.%26atitle%3DThe%2520G-protein%2520family%2520and%2520their%2520interaction%2520with%2520receptors%26jtitle%3DEndocr.%2520Rev.%26date%3D1989%26volume%3D10%26spage%3D317%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Carlsson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span> </span><span class="NLM_article-title">Schizophrenia: from dopamine to glutamate and back</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">â</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.2174%2F0929867043456034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=14965231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1Sqsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=267-277&author=M.+L.+Carlssonauthor=A.+Carlssonauthor=M.+Nilsson&title=Schizophrenia%3A+from+dopamine+to+glutamate+and+back"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Schizophrenia: From dopamine to glutamate and back</span></div><div class="casAuthors">Carlsson, M. L.; Carlsson, A.; Nilsson, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-277</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The first part of the present review describes the exciting journey of dopamine stabilizers, starting in the early 1980s with the development of the partial dopamine agonist (-)-3-PPP of phenylpiperidine structure, via various compds. with aminotetraline structure with preferential autoreceptor antagonist properties, and then back again to phenylpiperidine compds. carrying substituents on the arom. ring that transformed them from partial dopamine agonists to partial dopamine receptor antagonists, such as OSU6162.  OSU6162 was brought to the clinic and has in preliminary trials showed antidyskinetic and antipsychotic efficacy.  The second part of this review describes results from a hypoglutamatergia mouse model for cognitive symptoms of schizophrenia, where the authors have tested traditional neuroleptics, new generation antipsychotics with marked 5-HT2 vs dopamine D2 receptor blockade as well as a dopamine stabilizer belonging to the partial dopamine receptor antagonist category.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJFFyjWDKxJrVg90H21EOLACvtfcHk0litODWWBTQj4g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1Sqsrw%253D&md5=bd91fb8937d3d3c49e746902c843f54a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F0929867043456034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043456034%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsson%26aufirst%3DM.%2BL.%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DM.%26atitle%3DSchizophrenia%253A%2520from%2520dopamine%2520to%2520glutamate%2520and%2520back%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D267%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Pettersson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponten, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonesson, C.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2510</span><span class="NLM_x">â</span> <span class="NLM_lpage">2520</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901689v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2510-2520&author=F.+Petterssonauthor=H.+Pontenauthor=N.+Watersauthor=S.+Watersauthor=C.+Sonesson&title=Synthesis+and+evaluation+of+a+set+of+4-phenylpiperidines+and+4-phenylpiperazines+as+D2+receptor+ligands+and+the+discovery+of+the+dopaminergic+stabilizer+4-%5B3-%28methylsulfonyl%29phenyl%5D-1-propylpiperidine+%28huntexil%2C+pridopidine%2C+ACR16%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm901689v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901689v%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DF.%26aulast%3DPonten%26aufirst%3DH.%26aulast%3DWaters%26aufirst%3DN.%26aulast%3DWaters%26aufirst%3DS.%26aulast%3DSonesson%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520a%2520set%2520of%25204-phenylpiperidines%2520and%25204-phenylpiperazines%2520as%2520D2%2520receptor%2520ligands%2520and%2520the%2520discovery%2520of%2520the%2520dopaminergic%2520stabilizer%25204-%255B3-%2528methylsulfonyl%2529phenyl%255D-1-propylpiperidine%2520%2528huntexil%252C%2520pridopidine%252C%2520ACR16%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2510%26epage%3D2520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ponten, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kullingsjo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagerkvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonesson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N.</span><span> </span><span class="NLM_article-title">In vivo pharmacology of the dopaminergic stabilizer pridopidine</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">644</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">â</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2Fj.ejphar.2010.07.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=20667452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVejs7fF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=644&publication_year=2010&pages=88-95&author=H.+Pontenauthor=J.+Kullingsjoauthor=S.+Lagerkvistauthor=P.+Martinauthor=F.+Petterssonauthor=C.+Sonessonauthor=S.+Watersauthor=N.+Waters&title=In+vivo+pharmacology+of+the+dopaminergic+stabilizer+pridopidine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo pharmacology of the dopaminergic stabilizer pridopidine</span></div><div class="casAuthors">Ponten, Henrik; Kullingsjoe, Johan; Lagerkvist, Soeren; Martin, Peter; Pettersson, Fredrik; Sonesson, Clas; Waters, Susanna; Waters, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">644</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pridopidine (ACR16) belongs to a new pharmacol. class of agents affecting the central nervous system called dopaminergic stabilizers.  Dopaminergic stabilizers act primarily at dopamine type 2 (D2) receptors and display state-dependent behavioral effects.  This article aims to give an overview of the preclin. neurochem. and behavioral in vivo pharmacol. properties of pridopidine.  Pridopidine was given s.c. to male Sprague-Dawley rats (locomotor, microdialysis and tissue neurochem.) and i.p. to Swiss male mice (tail suspension test).  Pridopidine dose-dependently increased striatal tissue levels of the dopamine metabolite 3,4-dihydroxyphenylalanine (ED50 = 81 Î¼mol/kg), and prefrontal cortex dialyzate levels of dopamine and noradrenaline as measured by HPLC.  The agent reduced hyperlocomotion (D-amphetamine: ED50 = 54 Î¼mol/kg; MK-801: ED50 = 40 Î¼mol/kg), but preserved spontaneous locomotor activity, confirming state-dependent behavioral effects.  In addn., pridopidine significantly reduced immobility time in the tail suspension test.  We conclude that pridopidine state-dependently stabilizes psychomotor activity by the dual actions of functional dopamine D2 receptor antagonism and strengthening of cortical glutamate functions in various settings of perturbed neurotransmission.  The putative restoration of function in cortico-subcortical circuitry by pridopidine is likely to make it useful for ameliorating several neurol. and psychiatric disorders, including Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofLwicFY7QBLVg90H21EOLACvtfcHk0litODWWBTQj4g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVejs7fF&md5=35ffeeb53c88c491702e53e4d215620d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2010.07.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2010.07.023%26sid%3Dliteratum%253Aachs%26aulast%3DPonten%26aufirst%3DH.%26aulast%3DKullingsjo%26aufirst%3DJ.%26aulast%3DLagerkvist%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DPettersson%26aufirst%3DF.%26aulast%3DSonesson%26aufirst%3DC.%26aulast%3DWaters%26aufirst%3DS.%26aulast%3DWaters%26aufirst%3DN.%26atitle%3DIn%2520vivo%2520pharmacology%2520of%2520the%2520dopaminergic%2520stabilizer%2520pridopidine%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D644%26spage%3D88%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Dyhring, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonesson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophersen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N.</span><span> </span><span class="NLM_article-title">The dopaminergic stabilizers pridopidine (ACR16) and (â)-OSU6162 display dopamine D(2) receptor antagonism and fast receptor dissociation properties</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">628</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">â</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2Fj.ejphar.2009.11.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=19919834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFOksQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=628&publication_year=2010&pages=19-26&author=T.+Dyhringauthor=E.+O.+Nielsenauthor=C.+Sonessonauthor=F.+Petterssonauthor=J.+Karlssonauthor=P.+Svenssonauthor=P.+Christophersenauthor=N.+Waters&title=The+dopaminergic+stabilizers+pridopidine+%28ACR16%29+and+%28%E2%88%92%29-OSU6162+display+dopamine+D%282%29+receptor+antagonism+and+fast+receptor+dissociation+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The dopaminergic stabilizers pridopidine (ACR16) and (-)-OSU6162 display dopamine D2 receptor antagonism and fast receptor dissociation properties</span></div><div class="casAuthors">Dyhring, Tino; Nielsen, Elsebet O.; Sonesson, Clas; Pettersson, Fredrik; Karlsson, Jonas; Svensson, Peder; Christophersen, Palle; Waters, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">628</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">19-26</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new pharmacol. class of CNS ligands with the unique ability to stimulate or suppress motor and behavioral symptoms depending on the prevailing dopaminergic tone has been suggested as "dopaminergic stabilizers".  The mol. mode-of-action of dopaminergic stabilizers is not yet fully understood, but they are assumed to act via normalization of dopaminergic signaling, through interactions with the dopamine D2 receptor.  Here we have evaluated the dopaminergic stabilizers pridopidine (ACR16) and (-)-OSU6162, as well as the new compd. N-{[(2S)-5-chloro-7-(methylsulfonyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl}ethanamine (NS30678) in a series of cellular in vitro dopamine D2 receptor functional and binding assays.  Neither ACR16, (-)-OSU6162, nor NS30678 displayed detectable dopamine D2 receptor-mediated intrinsic activity, whereas they concn.-dependently antagonized dopamine-induced responses with IC50 values of 12.9 Î¼M, 5.8 Î¼M, and 7.0 nM, resp.  In contrast to the high-affinity typical antipsychotics haloperidol and raclopride, the dopaminergic stabilizers ACR16 and (-)-OSU6162 both displayed fast dopamine D2 receptor dissocn. properties, a feature that has previously been suggested as a contributing factor to antipsychotic atypicality and attributed mainly to low receptor affinity.  However, the finding that NS30678, which is equipotent to haloperidol and raclopride, also displays fast receptor dissocn., suggests that the agonist-like structural motif of the dopaminergic stabilizers tested is a crit. dissocn. rate determinant.  The results demonstrate that dopaminergic stabilizers exhibit fast competitive dopamine D2 receptor antagonism, possibly allowing for temporally variable and activity-dependent dopamine D2 receptor occupancy that may partly account for their unique stabilization of dopamine dependent behaviors in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodx8I0NzUww7Vg90H21EOLACvtfcHk0lg1ySdWFapQ7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFOksQ%253D%253D&md5=4e611bae1a80639f12d6e2374de748b8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.11.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.11.025%26sid%3Dliteratum%253Aachs%26aulast%3DDyhring%26aufirst%3DT.%26aulast%3DNielsen%26aufirst%3DE.%2BO.%26aulast%3DSonesson%26aufirst%3DC.%26aulast%3DPettersson%26aufirst%3DF.%26aulast%3DKarlsson%26aufirst%3DJ.%26aulast%3DSvensson%26aufirst%3DP.%26aulast%3DChristophersen%26aufirst%3DP.%26aulast%3DWaters%26aufirst%3DN.%26atitle%3DThe%2520dopaminergic%2520stabilizers%2520pridopidine%2520%2528ACR16%2529%2520and%2520%2528%25E2%2588%2592%2529-OSU6162%2520display%2520dopamine%2520D%25282%2529%2520receptor%2520antagonism%2520and%2520fast%2520receptor%2520dissociation%2520properties%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D628%26spage%3D19%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">de Yebenes, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landwehrmeyer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squitieri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saft, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnet, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sword, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rembratt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedroff, J.</span><span> </span><span class="NLM_article-title">Pridopidine for the treatment of motor function in patients with Huntingtonâs disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1049</span><span class="NLM_x">â</span> <span class="NLM_lpage">1057</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2FS1474-4422%2811%2970233-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=22071279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2gsbrO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=1049-1057&author=J.+G.+de+Yebenesauthor=B.+Landwehrmeyerauthor=F.+Squitieriauthor=R.+Reilmannauthor=A.+Rosserauthor=R.+A.+Barkerauthor=C.+Saftauthor=M.+K.+Magnetauthor=A.+Swordauthor=A.+Rembrattauthor=J.+Tedroff&title=Pridopidine+for+the+treatment+of+motor+function+in+patients+with+Huntington%E2%80%99s+disease+%28MermaiHD%29%3A+a+phase+3%2C+randomised%2C+double-blind%2C+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial</span></div><div class="casAuthors">de Yebenes, Justo Garcia; Landwehrmeyer, Bernhard; Squitieri, Ferdinando; Reilmann, Ralf; Rosser, Anne; Barker, Roger A.; Saft, Carsten; Magnet, Markus K.; Sword, Alastair; Rembratt, Asa; Tedroff, Joakim</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1049-1057</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Huntington's disease is a progressive neurodegenerative disorder, characterised by motor, cognitive, and behavioral deficits.  Pridopidine belongs to a new class of compds. known as dopaminergic stabilizers, and results from a small phase 2 study in patients with Huntington's disease suggested that this drug might improve voluntary motor function.  We aimed to assess further the effects of pridopidine in patients with Huntington's disease.  We undertook a 6 mo, randomised, double-blind, placebo-controlled trial to assess the efficacy of pridopidine in the treatment of motor deficits in patients with Huntington's disease.  Our primary endpoint was change in the modified motor score (mMS; derived from the unified Huntington's disease rating scale) at 26 wk.  We recruited patients with Huntington's disease from 32 European centers; patients were aged 30 years or older and had an mMS of 10 points or greater at baseline.  Patients were randomly assigned (1:1:1) to receive placebo, 45 mg per day pridopidine, or 90 mg per day pridopidine by use of centralised computer-generated codes.  Patients and investigators were masked to treatment assignment.  We also assessed the safety and tolerability profile of pridopidine.  For our primary anal., all patients were eligible for inclusion in our full anal. set, in which we used the last observation carried forward method for missing values.  We used an anal. of covariance model and the Bonferroni method to adjust for multiple comparisons.  We used a prespecified per-protocol population as our sensitivity anal.  The Î± level was 0.025 for our primary anal. and 0.05 overall.  This trial is registered with ClinicalTrials.gov, no. NCT00665223.  At 26 wk, in our full anal. set the difference in mean mMS was -0.99 points (97.5% CI -2.08 to 0.10, p = 0.042) in patients who received 90 mg per day pridopidine (n = 145) vs. those who received placebo (n = 144), and -0.36 points (-1.44 to 0.72, p = 0.456) in those who received 45 mg per day pridopidine (n = 148) vs. those who received placebo.  At the 90 mg per day dose, in our per-protocol population (n = 114), the redn. in the mMS was of -1.29 points (-2.47 to -0.12; p = 0.014) compared with placebo (n = 120).  We did not identify any changes in non-motor endpoints at either dose.  Pridopidine was well tolerated and had an adverse event profile similar to that of placebo.  This study did not provide evidence of efficacy as measured by the mMS, but a potential effect of pridopidine on the motor phenotype of Huntington's disease merits further investigation.  Pridopidine up to 90 mg per day was well tolerated in patients with Huntington's disease.  Funding: NeuroSearch A/S.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVDXQbNRAMqLVg90H21EOLACvtfcHk0lg1ySdWFapQ7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2gsbrO&md5=ed31da6ccaad5c90745d35aacbbb6f4a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2811%2970233-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252811%252970233-2%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BYebenes%26aufirst%3DJ.%2BG.%26aulast%3DLandwehrmeyer%26aufirst%3DB.%26aulast%3DSquitieri%26aufirst%3DF.%26aulast%3DReilmann%26aufirst%3DR.%26aulast%3DRosser%26aufirst%3DA.%26aulast%3DBarker%26aufirst%3DR.%2BA.%26aulast%3DSaft%26aufirst%3DC.%26aulast%3DMagnet%26aufirst%3DM.%2BK.%26aulast%3DSword%26aufirst%3DA.%26aulast%3DRembratt%26aufirst%3DA.%26aulast%3DTedroff%26aufirst%3DJ.%26atitle%3DPridopidine%2520for%2520the%2520treatment%2520of%2520motor%2520function%2520in%2520patients%2520with%2520Huntington%25E2%2580%2599s%2520disease%2520%2528MermaiHD%2529%253A%2520a%2520phase%25203%252C%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DLancet%2520Neurol.%26date%3D2011%26volume%3D10%26spage%3D1049%26epage%3D1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Niemegeers, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laduron, P. M.</span><span> </span><span class="NLM_article-title">Pharmacology and biochemistry of haloperidol</span> <span class="citation_source-journal">Proc. R. Soc. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span><span class="NLM_x">â</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1976&pages=3-8&issue=Suppl.+1&author=C.+J.+Niemegeersauthor=P.+M.+Laduron&title=Pharmacology+and+biochemistry+of+haloperidol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiemegeers%26aufirst%3DC.%2BJ.%26aulast%3DLaduron%26aufirst%3DP.%2BM.%26atitle%3DPharmacology%2520and%2520biochemistry%2520of%2520haloperidol%26jtitle%3DProc.%2520R.%2520Soc.%2520Med.%26date%3D1976%26volume%3D69%26issue%3DSuppl.%25201%26spage%3D3%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Casey, D. E.</span><span> </span><span class="NLM_article-title">Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia</span> <span class="citation_source-journal">Schizophr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">â</span> <span class="NLM_lpage">120</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2F0920-9964%2891%2990029-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=1674881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A280%3ADyaK3M3kvVOqsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1991&pages=109-120&author=D.+E.+Casey&title=Neuroleptic+drug-induced+extrapyramidal+syndromes+and+tardive+dyskinesia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia</span></div><div class="casAuthors">Casey D E</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-20</span>
        ISSN:<span class="NLM_cas:issn">0920-9964</span>.
    </div><div class="casAbstract">Neuroleptic (antipsychotic) drug-induced acute extrapyramidal syndromes (EPS) and the late onset tardive dyskinesia (TD) are the major side effects that limit the use of these highly efficacious agents.  The appropriate strategy for controlling these side effects is based on the clinical presentations, pathophysiological mechanisms, and contributions of patient and treatment-related risk factors.  New information about the mechanisms of action of neuroleptics and the long-term outcome of acute EPS and TD provide valuable insights into these syndromes.  The most effective method for maximizing the benefits and minimizing the risks of neuroleptics is to use the lowest effective dose of both neuroleptic and antiEPS drugs in patients who benefit from them.  The next major advancement will be to develop new compounds which effectively control psychotic symptoms and are free of the undesirable acute and tardive motor syndromes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMvSHYz0v3bjMsgLhIoICsfW6udTcc2eYsd0zVJoENnLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3kvVOqsg%253D%253D&md5=6b24bae598ccd63cb71ccd1d7b43b86d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2F0920-9964%2891%2990029-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0920-9964%252891%252990029-Q%26sid%3Dliteratum%253Aachs%26aulast%3DCasey%26aufirst%3DD.%2BE.%26atitle%3DNeuroleptic%2520drug-induced%2520extrapyramidal%2520syndromes%2520and%2520tardive%2520dyskinesia%26jtitle%3DSchizophr.%2520Res.%26date%3D1991%26volume%3D4%26spage%3D109%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Seeman, P.</span><span> </span><span class="NLM_article-title">An update of fast-off dopamine D2 atypical antipsychotics</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">1984</span><span class="NLM_x">â</span> <span class="NLM_lpage">1985</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1176%2Fappi.ajp.162.10.1984-a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=16199855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A280%3ADC%252BD2MritlSnsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2005&pages=1984-1985&author=P.+Seeman&title=An+update+of+fast-off+dopamine+D2+atypical+antipsychotics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">An update of fast-off dopamine D2 atypical antipsychotics</span></div><div class="casAuthors">Seeman Philip</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1984-5</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSS-FAqEvkJaeIHSmpohpd0fW6udTcc2ebHwczDts9qYrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MritlSnsQ%253D%253D&md5=8df195e141e5ef694e3a093ea91560df</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.162.10.1984-a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.162.10.1984-a%26sid%3Dliteratum%253Aachs%26aulast%3DSeeman%26aufirst%3DP.%26atitle%3DAn%2520update%2520of%2520fast-off%2520dopamine%2520D2%2520atypical%2520antipsychotics%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2005%26volume%3D162%26spage%3D1984%26epage%3D1985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Seeman, P.</span><span> </span><span class="NLM_article-title">Atypical antipsychotics: mechanism of action</span> <span class="citation_source-journal">Can. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">â</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=11873706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A280%3ADC%252BD387kt1Gmuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2002&pages=27-38&author=P.+Seeman&title=Atypical+antipsychotics%3A+mechanism+of+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Atypical antipsychotics: mechanism of action</span></div><div class="casAuthors">Seeman Philip</div><div class="citationInfo"><span class="NLM_cas:title">Canadian journal of psychiatry. Revue canadienne de psychiatrie</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-38</span>
        ISSN:<span class="NLM_cas:issn">0706-7437</span>.
    </div><div class="casAbstract">BACKGROUND:  Although the principal brain target that all antipsychotic drugs attach to is the dopamine D2 receptor, traditional or typical antipsychotics, by attaching to it, induce extrapyramidal signs and symptoms (EPS).  They also, by binding to the D2 receptor, elevate serum prolactin.  Atypical antipsychotics given in dosages within the clinically effective range do not bring about these adverse clinical effects.  To understand how these drugs work, it is important to examine the atypical antipsychotics' mechanism of action and how it differs from that of the more typical drugs.  METHOD:  This review analyzes the affinities, the occupancies, and the dissociation time-course of various antipsychotics at dopamine D2 receptors and at serotonin (5-HT) receptors, both in the test tube and in live patients.  RESULTS:  Of the 31 antipsychotics examined, the older traditional antipsychotics such as trifluperazine, pimozide, chlorpromazine, fluphenazine, haloperidol, and flupenthixol bind more tightly than dopamine itself to the dopamine D2 receptor, with dissociation constants that are lower than that for dopamine.  The newer, atypical antipsychotics such as quetiapine, remoxipride, clozapine, olanzapine, sertindole, ziprasidone, and amisulpride all bind more loosely than dopamine to the dopamine D2 receptor and have dissociation constants higher than that for dopamine.  These tight and loose binding data agree with the rates of antipsychotic dissociation from the human-cloned D2 receptor.  For instance, radioactive haloperidol, chlorpromazine, and raclopride all dissociate very slowly over a 30-minute time span, while radioactive quetiapine, clozapine, remoxipride, and amisulpride dissociate rapidly, in less than 60 seconds.  These data also match clinical brain-imaging findings that show haloperidol remaining constantly bound to D2 in humans undergoing 2 positron emission tomography (PET) scans 24 hours apart.  Conversely, the occupation of D2 by clozapine or quetiapine has mostly disappeared after 24 hours.  CONCLUSION:  Atypicals clinically help patients by transiently occupying D2 receptors and then rapidly dissociating to allow normal dopamine neurotransmission.  This keeps prolactin levels normal, spares cognition, and obviates EPS.  One theory of atypicality is that the newer drugs block 5-HT2A receptors at the same time as they block dopamine receptors and that, somehow, this serotonin-dopamine balance confers atypicality.  This, however, is not borne out by the results.  While 5-HT2A receptors are readily blocked at low dosages of most atypical antipsychotic drugs (with the important exceptions of remoxipride and amisulpride, neither of which is available for use in Canada) the dosages at which this happens are below those needed to alleviate psychosis.  In fact, the antipsychotic threshold occupancy of D2 for antipsychotic action remains at about 65% for both typical and atypical antipsychotic drugs, regardless of whether 5-HT2A receptors are blocked or not.  At the same time, the antipsychotic threshold occupancy of D2 for eliciting EPS remains at about 80% for both typical and atypical antipsychotics, regardless of the occupancy of 5-HT2A receptors.  RELEVANCE:  The "fast-off-D2" theory, on the other hand, predicts which antipsychotic compounds will or will not produce EPS and hyperprolactinemia and which compounds present a relatively low risk for tardive dyskinesia.  This theory also explains why L-dopa psychosis responds to low atypical antipsychotic dosages, and it suggests various individualized treatment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTiUF-43m1Le8ve_zCu79I8fW6udTcc2ebHwczDts9qYrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387kt1Gmuw%253D%253D&md5=2f9aa5d0349a96146da385b8be523641</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeeman%26aufirst%3DP.%26atitle%3DAtypical%2520antipsychotics%253A%2520mechanism%2520of%2520action%26jtitle%3DCan.%2520J.%2520Psychiatry%26date%3D2002%26volume%3D47%26spage%3D27%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Natesan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reckless, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobrega, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlow, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span> </span><span class="NLM_article-title">The dopamine stabilizers (<i>S</i>)-(â)-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(â)-OSU6162] and 4-(3-methanesulfonylphenyl)-1-propyl-piperidine (ACR16) show high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for motor side effects in the rat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">810</span><span class="NLM_x">â</span> <span class="NLM_lpage">818</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1124%2Fjpet.106.102905" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=16648369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslOltrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=810-818&author=S.+Natesanauthor=K.+A.+Svenssonauthor=G.+E.+Recklessauthor=J.+N.+Nobregaauthor=K.+B.+Barlowauthor=A.+M.+Johanssonauthor=S.+Kapur&title=The+dopamine+stabilizers+%28S%29-%28%E2%88%92%29-%283-methanesulfonyl-phenyl%29-1-propyl-piperidine+%5B%28%E2%88%92%29-OSU6162%5D+and+4-%283-methanesulfonylphenyl%29-1-propyl-piperidine+%28ACR16%29+show+high+in+vivo+D2+receptor+occupancy%2C+antipsychotic-like+efficacy%2C+and+low+potential+for+motor+side+effects+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The dopamine stabilizers (S)-(-)-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-methanesulfonylphenyl)-1-propyl-piperidine (ACR16) show high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for motor side effects in the rat</span></div><div class="casAuthors">Natesan, Sridhar; Svensson, Kjell A.; Reckless, Greg E.; Nobrega, Jose N.; Barlow, Karen B. L.; Johansson, Anette M.; Kapur, Shitij</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">810-818</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">"Dopamine stabilizers" are a new class of compds. that have the ability to reverse both hypo- as well as hyperdopaminergia in vivo.  This class, exemplified by the phenylpiperidines (S)-(-)-3-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [ACR16] although lacking high in vitro binding affinity for dopamine D2 receptor [(-)-OSU6162, Ki = 447 nM; ACR16, Ki > 1 Î¼M], shows functional actions, suggestive of their interaction.  Hence, we evaluated in vivo D2 occupancy of these agents in rats and correlated it to obsd. effects in a series of behavioral, neurochem., and endocrine models relevant to the dopamine system and antipsychotic effect.  Both (-)-OSU6162 and ACR16 showed robust dose-dependent striatal D2 occupancy with ED50 values of 5.27 and 18.99 mg/kg s.c., resp., and functional assays showed no partial agonism.  Over an occupancy range of 37 to 87% (3-60 mg/kg) for (-)-OSU6162 and 35 to 74% (10-60 mg/kg) for ACR16, we obsd. both inhibitory (amphetamine-induced locomotor activity) and stimulatory effects (in habituated rats).  Haloperidol, over a similar occupancy range (33-78%), potently inhibited psychostimulant activity and induced catalepsy, but it failed to activate habituated animals.  In the conditioned avoidance response assay, ACR16 was clearly more efficacious than (-)-OSU6162.  In addn., both these compds. demonstrated significant preferential Fos induction in the nucleus accumbens compared with the dorsolateral striatum, a strong predictor of atypical antipsychotic efficacy.  The results suggest that dopamine stabilizers exhibit locomotor stabilizing as well as antipsychotic-like effects, with low motor side effect liability, in a dose range that corresponds to high D2 in vivo occupancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB1QWPCh_MXrVg90H21EOLACvtfcHk0liI-fSG0SaNOw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslOltrY%253D&md5=9afa75bafba644f0ee8462d5f857b98f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.102905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.102905%26sid%3Dliteratum%253Aachs%26aulast%3DNatesan%26aufirst%3DS.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DReckless%26aufirst%3DG.%2BE.%26aulast%3DNobrega%26aufirst%3DJ.%2BN.%26aulast%3DBarlow%26aufirst%3DK.%2BB.%26aulast%3DJohansson%26aufirst%3DA.%2BM.%26aulast%3DKapur%26aufirst%3DS.%26atitle%3DThe%2520dopamine%2520stabilizers%2520%2528S%2529-%2528%25E2%2588%2592%2529-%25283-methanesulfonyl-phenyl%2529-1-propyl-piperidine%2520%255B%2528%25E2%2588%2592%2529-OSU6162%255D%2520and%25204-%25283-methanesulfonylphenyl%2529-1-propyl-piperidine%2520%2528ACR16%2529%2520show%2520high%2520in%2520vivo%2520D2%2520receptor%2520occupancy%252C%2520antipsychotic-like%2520efficacy%252C%2520and%2520low%2520potential%2520for%2520motor%2520side%2520effects%2520in%2520the%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D810%26epage%3D818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lund, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, P. J.</span><span> </span><span class="NLM_article-title">Olanzapine: an atypical antipsychotic for schizophrenia</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">â</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1517%2F14656566.1.2.305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=11249551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFSrtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=305-323&author=B.+C.+Lundauthor=P.+J.+Perry&title=Olanzapine%3A+an+atypical+antipsychotic+for+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Olanzapine: an atypical antipsychotic for schizophrenia</span></div><div class="casAuthors">Lund, Brian C.; Perry, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">305-323</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 104 refs.  Olanzapine is a serotonin-dopamine receptor antagonist primarily used in the treatment of psychotic illnesses.  It has been shown in numerous large trials to be as equally effective as haloperidol in the acute treatment and maintenance treatment of schizophrenia.  However, olanzapine was shown to be more effective than haloperidol in the treatment of neg. symptoms and to cause significantly fewer extrapyramidal symptoms.  Furthermore, early reports suggest that olanzapine produces less tardive dyskinesia than haloperidol, though longer follow-up data are needed.  Current studies have failed to demonstrate the efficacy of olanzapine in the treatment of refractory schizophrenia.  One comparison trial of olanzapine vs. risperidone has indicated similar efficacy.  Clin. trials in acute mania have found olanzapine to be more effective than placebo.  However, there is no role for olanzapine monotherapy in bipolar disorder given current studies.  Although olanzapine has shown a low rate of extrapyramidal symptoms, it is not without adverse effects.  Clin. significant wt. gain has been noted with olanzapine in each of the large clin. trials.  The degree of wt. gain is similar to clozapine and probably greater than that obsd. with risperidone.  The long-term medical consequence of atypical antipsychotic-induced wt. gain is not known at this time.  While generally considered first-line drugs from an efficacy and adverse effect standpoint, pharmacoeconomic studies are needed to justify the large acquisition cost of olanzapine compared to typical agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUh4daVwqMdbVg90H21EOLACvtfcHk0lhjnxgsh-YLpA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFSrtA%253D%253D&md5=96bdd62c4b133bf943d87327a56d2f29</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1517%2F14656566.1.2.305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.1.2.305%26sid%3Dliteratum%253Aachs%26aulast%3DLund%26aufirst%3DB.%2BC.%26aulast%3DPerry%26aufirst%3DP.%2BJ.%26atitle%3DOlanzapine%253A%2520an%2520atypical%2520antipsychotic%2520for%2520schizophrenia%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2000%26volume%3D1%26spage%3D305%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Cosi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carilla-Durand, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">AssiÃÂ©, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ormiere, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maraval, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leduc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span> </span><span class="NLM_article-title">Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">535</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">â</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2Fj.ejphar.2006.01.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=16554049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtFGmu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2006&pages=135-144&author=C.+Cosiauthor=E.+Carilla-Durandauthor=M.+B.+Assi%C3%83%C2%A9author=A.+M.+Ormiereauthor=M.+Maravalauthor=N.+Leducauthor=A.+Newman-Tancredi&title=Partial+agonist+properties+of+the+antipsychotics+SSR181507%2C+aripiprazole+and+bifeprunox+at+dopamine+D2+receptors%3A+G+protein+activation+and+prolactin+release"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release</span></div><div class="casAuthors">Cosi, Cristina; Carilla-Durand, Elisabeth; Assie, Marie Bernadette; Ormiere, Anne Marie; Maraval, Mireille; Leduc, Nathalie; Newman-Tancredi, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">135-144</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dopamine D2 receptor antagonists induce hyperprolactinemia depending on the extent of D2 receptor blockade.  We compared the effects of the new antipsychotic agents SSR181507, bifeprunox, and SLV313 with those of aripiprazole, clozapine, and haloperidol, on functional measures of dopamine D2 receptor activity in vitro and in vivo: [35S]-GTPÎ³S binding to membranes from Sf9 insect cells expressing human dopamine D2 Long (hD2 L) receptors, and serum prolactin levels in the rat.  All compds. antagonized apomorphine-induced G protein activation at dopamine hD2 L receptors.  Antagonist potencies of aripiprazole, bifeprunox and SLV313 were similar to haloperidol (pK b = 9.12), whereas SSR181507 (8.16) and clozapine (7.35) were less potent.  Haloperidol, SLV313 and clozapine were silent antagonists but SSR181507, bifeprunox and aripiprazole stimulated [35S]-GTPÎ³S binding by 17.5%, 26.3% and 25.6%, resp., relative to 100 Î¼M apomorphine (Emax = 100%). pEC50s were: SSR181507, 8.08; bifeprunox, 8.97; aripiprazole, 8.56.  These effects were antagonized by raclopride.  Following oral administration in vivo, the drugs increased prolactin release to different extents.  SLV313 and haloperidol potently (ED50 0.12 and 0.22 mg/kg p.o., resp.) stimulated prolactin release up to 86 and 83 ng/mL.  Aripiprazole potently (ED50 0.66 mg/kg p.o.) but partially (32 ng/mL) induced prolactin release.  SSR181507 (ED50 4.9 mg/kg p.o.) also partially (23 ng/mL) enhanced prolactin release.  Bifeprunox only weakly increased prolactin at high doses (13 ng/mL at 40 mg/kg) and clozapine only affected prolactin at the highest dose tested (41 ng/mL at 40 mg/kg).  Prolactin levels of the corresponding vehicle-treated animals were < 4.3 ng/mL.  These data show that (1) SSR181507, aripiprazole and bifeprunox, but not SLV313, are partial agonists at dopamine hD2 L receptors in vitro; (2) SSR181507, bifeprunox and aripiprazole exhibit reduced prolactin release in vivo compared with drugs that are neutral antagonists at dopamine D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrtKly85ekeLVg90H21EOLACvtfcHk0lhjnxgsh-YLpA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtFGmu74%253D&md5=f3d0bc9e55df9cfd8b48338824545c22</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.01.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.01.051%26sid%3Dliteratum%253Aachs%26aulast%3DCosi%26aufirst%3DC.%26aulast%3DCarilla-Durand%26aufirst%3DE.%26aulast%3DAssi%25C3%2583%25C2%25A9%26aufirst%3DM.%2BB.%26aulast%3DOrmiere%26aufirst%3DA.%2BM.%26aulast%3DMaraval%26aufirst%3DM.%26aulast%3DLeduc%26aufirst%3DN.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26atitle%3DPartial%2520agonist%2520properties%2520of%2520the%2520antipsychotics%2520SSR181507%252C%2520aripiprazole%2520and%2520bifeprunox%2520at%2520dopamine%2520D2%2520receptors%253A%2520G%2520protein%2520activation%2520and%2520prolactin%2520release%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D535%26spage%3D135%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Sonesson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikstrom, H.</span><span> </span><span class="NLM_article-title">Substituted (<i>S</i>)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structureâactivity relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2735</span><span class="NLM_x">â</span> <span class="NLM_lpage">2753</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00043a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2735-2753&author=C.+Sonessonauthor=C.+H.+Linauthor=L.+Hanssonauthor=N.+Watersauthor=K.+Svenssonauthor=A.+Carlssonauthor=M.+W.+Smithauthor=H.+Wikstrom&title=Substituted+%28S%29-phenylpiperidines+and+rigid+congeners+as+preferential+dopamine+autoreceptor+antagonists%3A+synthesis+and+structure%E2%80%93activity+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm00043a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00043a013%26sid%3Dliteratum%253Aachs%26aulast%3DSonesson%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DC.%2BH.%26aulast%3DHansson%26aufirst%3DL.%26aulast%3DWaters%26aufirst%3DN.%26aulast%3DSvensson%26aufirst%3DK.%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DM.%2BW.%26aulast%3DWikstrom%26aufirst%3DH.%26atitle%3DSubstituted%2520%2528S%2529-phenylpiperidines%2520and%2520rigid%2520congeners%2520as%2520preferential%2520dopamine%2520autoreceptor%2520antagonists%253A%2520synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2735%26epage%3D2753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolome, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span> </span><span class="NLM_article-title">Molecular properties affecting fast dissociation from the D2 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2231</span><span class="NLM_x">â</span> <span class="NLM_lpage">2241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2Fj.bmc.2011.02.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=21421319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFeht70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2231-2241&author=G.+Tresadernauthor=J.+M.+Bartolomeauthor=G.+J.+Macdonaldauthor=X.+Langlois&title=Molecular+properties+affecting+fast+dissociation+from+the+D2+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular properties affecting fast dissociation from the D2 receptor</span></div><div class="casAuthors">Tresadern, Gary; Bartolome, Jose Manuel; MacDonald, Gregor J.; Langlois, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2231-2241</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dopamine D2 receptor antagonism is the foundation of antipsychotic treatment.  Antipsychotic agents vary in how fast they dissoc. from the D2 receptors.  It has been proposed that the liability to exhibit side effects such as extra pyramidal symptoms may be the result of a slow rate of dissocn.  Compds. with a faster rate of dissocn., while still blocking efficiently the D2 receptors, will subsequently respond better to physiol. surges in dopamine transmission.  Therefore, work in our labs. has focussed on identifying fast dissocg. and selective D2 antagonists.  Biol. screening was performed to measure the affinity and extent of dissocn. for a large dataset of over 1800 D2 antagonists.  Subsequent univariate and multivariate statistical anal. revealed the mol. properties which differentiate fast and slow dissocg. compds.  It is shown that faster dissocg. antagonists are less lipophilic and have lower mol. wt.  There was a clear and expected inverse relationship with extent of dissocn. and binding affinity with more potent compds. tending to be slower dissocg.  However, within a range of comparable affinity both fast and slow dissocg. compds. were identified.  After de-correlating affinity and dissocn. the anal. revealed the important descriptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqilpQ8-EuD-LVg90H21EOLACvtfcHk0lhjnxgsh-YLpA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFeht70%253D&md5=574e106853b1cff1b6975c4bba979031</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DBartolome%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DLanglois%26aufirst%3DX.%26atitle%3DMolecular%2520properties%2520affecting%2520fast%2520dissociation%2520from%2520the%2520D2%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2231%26epage%3D2241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Liljefors, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogeso, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyttel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikstrom, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, A.</span><span> </span><span class="NLM_article-title">Pre- and postsynaptic dopaminergic activities of indolizidine and quinolizidine derivatives of 3-(3-hydroxyphenyl)-<i>N</i>-(<i>n</i>-propyl)piperidine (3-PPP). Further developments of a dopamine receptor model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">â</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00165a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=1015-1022&author=T.+Liljeforsauthor=K.+P.+Bogesoauthor=J.+Hyttelauthor=H.+Wikstromauthor=K.+Svenssonauthor=A.+Carlsson&title=Pre-+and+postsynaptic+dopaminergic+activities+of+indolizidine+and+quinolizidine+derivatives+of+3-%283-hydroxyphenyl%29-N-%28n-propyl%29piperidine+%283-PPP%29.+Further+developments+of+a+dopamine+receptor+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm00165a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00165a020%26sid%3Dliteratum%253Aachs%26aulast%3DLiljefors%26aufirst%3DT.%26aulast%3DBogeso%26aufirst%3DK.%2BP.%26aulast%3DHyttel%26aufirst%3DJ.%26aulast%3DWikstrom%26aufirst%3DH.%26aulast%3DSvensson%26aufirst%3DK.%26aulast%3DCarlsson%26aufirst%3DA.%26atitle%3DPre-%2520and%2520postsynaptic%2520dopaminergic%2520activities%2520of%2520indolizidine%2520and%2520quinolizidine%2520derivatives%2520of%25203-%25283-hydroxyphenyl%2529-N-%2528n-propyl%2529piperidine%2520%25283-PPP%2529.%2520Further%2520developments%2520of%2520a%2520dopamine%2520receptor%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D1015%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Malo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brive, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, P.</span><span> </span><span class="NLM_article-title">Selective pharmacophore models of dopamine D(1) and D(2) full agonists based on extended pharmacophore features</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">â</span> <span class="NLM_lpage">246</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=232-246&author=M.+Maloauthor=L.+Briveauthor=K.+Luthmanauthor=P.+Svensson&title=Selective+pharmacophore+models+of+dopamine+D%281%29+and+D%282%29+full+agonists+based+on+extended+pharmacophore+features"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalo%26aufirst%3DM.%26aulast%3DBrive%26aufirst%3DL.%26aulast%3DLuthman%26aufirst%3DK.%26aulast%3DSvensson%26aufirst%3DP.%26atitle%3DSelective%2520pharmacophore%2520models%2520of%2520dopamine%2520D%25281%2529%2520and%2520D%25282%2529%2520full%2520agonists%2520based%2520on%2520extended%2520pharmacophore%2520features%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D232%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Perregaard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogeso, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyttel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, C.</span><span> </span><span class="NLM_article-title">Noncataleptogenic, centrally acting dopamine D-2 and serotonin 5-HT2 antagonists within a series of 3-substituted 1-(4-fluorophenyl)-1<i>H</i>-indoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1092</span><span class="NLM_x">â</span> <span class="NLM_lpage">1101</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00084a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=1092-1101&author=J.+Perregaardauthor=J.+Arntauthor=K.+P.+Bogesoauthor=J.+Hyttelauthor=C.+Sanchez&title=Noncataleptogenic%2C+centrally+acting+dopamine+D-2+and+serotonin+5-HT2+antagonists+within+a+series+of+3-substituted+1-%284-fluorophenyl%29-1H-indoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm00084a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00084a014%26sid%3Dliteratum%253Aachs%26aulast%3DPerregaard%26aufirst%3DJ.%26aulast%3DArnt%26aufirst%3DJ.%26aulast%3DBogeso%26aufirst%3DK.%2BP.%26aulast%3DHyttel%26aufirst%3DJ.%26aulast%3DSanchez%26aufirst%3DC.%26atitle%3DNoncataleptogenic%252C%2520centrally%2520acting%2520dopamine%2520D-2%2520and%2520serotonin%25205-HT2%2520antagonists%2520within%2520a%2520series%2520of%25203-substituted%25201-%25284-fluorophenyl%2529-1H-indoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D1092%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Strupczewski, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stache, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glamkowski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huger, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. W.</span><span> </span><span class="NLM_article-title">Synthesis and neuroleptic activity of 3-(1-substituted-4-piperidinyl)-1,2-benzisoxazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">â</span> <span class="NLM_lpage">769</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00383a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=761-769&author=J.+T.+Strupczewskiauthor=R.+C.+Allenauthor=B.+A.+Gardnerauthor=B.+L.+Schmidauthor=U.+Stacheauthor=E.+J.+Glamkowskiauthor=M.+C.+Jonesauthor=D.+B.+Ellisauthor=F.+P.+Hugerauthor=R.+W.+Dunn&title=Synthesis+and+neuroleptic+activity+of+3-%281-substituted-4-piperidinyl%29-1%2C2-benzisoxazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm00383a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00383a012%26sid%3Dliteratum%253Aachs%26aulast%3DStrupczewski%26aufirst%3DJ.%2BT.%26aulast%3DAllen%26aufirst%3DR.%2BC.%26aulast%3DGardner%26aufirst%3DB.%2BA.%26aulast%3DSchmid%26aufirst%3DB.%2BL.%26aulast%3DStache%26aufirst%3DU.%26aulast%3DGlamkowski%26aufirst%3DE.%2BJ.%26aulast%3DJones%26aufirst%3DM.%2BC.%26aulast%3DEllis%26aufirst%3DD.%2BB.%26aulast%3DHuger%26aufirst%3DF.%2BP.%26aulast%3DDunn%26aufirst%3DR.%2BW.%26atitle%3DSynthesis%2520and%2520neuroleptic%2520activity%2520of%25203-%25281-substituted-4-piperidinyl%2529-1%252C2-benzisoxazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26spage%3D761%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Colpaert, F. C.</span><span> </span><span class="NLM_article-title">Discovering risperidone: the LSD model of psychopathology</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">â</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1038%2Fnrd1062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=12669030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFWktrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=315-320&author=F.+C.+Colpaert&title=Discovering+risperidone%3A+the+LSD+model+of+psychopathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Timeline: Discovering risperidone: the LSD model of psychopathology</span></div><div class="casAuthors">Colpaert, Francis C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">315-320</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In the 1970s and 1980s, Janssen Pharmaceutica Research, which had a broad interest in central nervous system disorders and nurtured intellectual freedom, developed original, and at times heretical, concepts.  It took decades for the scientific community to endorse some of these concepts.  Among them were such notions as an elementary particle of behavior, the introduction of response quality in receptor theory, and the idea that tolerance does not develop to opioids.  These concepts enabled the discovery of the antipsychotic risperidone, an unique full antagonist of the interoceptive effects of LSD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmM6nIWSVMyrVg90H21EOLACvtfcHk0lj9l8fxYm8EVw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFWktrs%253D&md5=357f8b3ab40c17a9332b4151bd0d5ead</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrd1062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1062%26sid%3Dliteratum%253Aachs%26aulast%3DColpaert%26aufirst%3DF.%2BC.%26atitle%3DDiscovering%2520risperidone%253A%2520the%2520LSD%2520model%2520of%2520psychopathology%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D315%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Howard, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, J. A.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">aSeeger, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zorn, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewing, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrone, J.</span><span> </span><span class="NLM_article-title">3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">â</span> <span class="NLM_lpage">148</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950625l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK2MXpvVaqtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=143-148&author=H.+R.+Howardauthor=J.+A.+Loweauthor=T.+F.+aSeegerauthor=P.+A.+Seymourauthor=S.+H.+Zornauthor=P.+R.+Maloneyauthor=F.+E.+Ewingauthor=M.+E.+Newmanauthor=A.+W.+Schmidtauthor=J.+S.+Furmanauthor=G.+L.+Robinsonauthor=E.+Jacksonauthor=C.+Johnsonauthor=J.+Morrone&title=3-Benzisothiazolylpiperazine+derivatives+as+potential+atypical+antipsychotic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">3-Benzisothiazolylpiperazine Derivatives as Potential Atypical Antipsychotic Agents</span></div><div class="casAuthors">Howard, Harry R.; Lowe, John A. III; Seeger, Thomas F.; Seymour, Patricia A.; Zorn, Stevin H.; Maloney, Patrick R.; Ewing, Frank E.; Newman, Michael E.; Schmidt, Anne W.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">143-8</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of substituted phenethyl derivs. of 3-benzisothiazolylpiperazine incorporating potent D2 and 5-HT2A antagonist activity was investigated as an approach to a novel atypical antipsychotic agent.  The in vitro profile of ziprasidone from this series is a combination of D2 receptor affinity comparable to the typical antipsychotic agent haloperidol and a 5-HT2A/D2 ratio comparable to the atypical agent clozapine.  In vivo ziprasidone possesses activity consistent with an efficacious antipsychotic agent with less tendency to induce extrapyramidal side effects in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0LPgTvSrwLbVg90H21EOLACvtfcHk0ljMmaiVusxUYA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpvVaqtb8%253D&md5=ef39132ebb9327c6749693e1d356cd53</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm950625l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950625l%26sid%3Dliteratum%253Aachs%26aulast%3DHoward%26aufirst%3DH.%2BR.%26aulast%3DLowe%26aufirst%3DJ.%2BA.%26aulast%3DaSeeger%26aufirst%3DT.%2BF.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DZorn%26aufirst%3DS.%2BH.%26aulast%3DMaloney%26aufirst%3DP.%2BR.%26aulast%3DEwing%26aufirst%3DF.%2BE.%26aulast%3DNewman%26aufirst%3DM.%2BE.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DFurman%26aufirst%3DJ.%2BS.%26aulast%3DRobinson%26aufirst%3DG.%2BL.%26aulast%3DJackson%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DMorrone%26aufirst%3DJ.%26atitle%3D3-Benzisothiazolylpiperazine%2520derivatives%2520as%2520potential%2520atypical%2520antipsychotic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D143%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Chouinard, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, T. A.</span><span> </span><span class="NLM_article-title">Pimozide in the treatment of chronic schizophrenic patients</span> <span class="citation_source-journal">Curr. Ther. Res. Clin. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">â</span> <span class="NLM_lpage">603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=4989691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A280%3ADyaE3c3osF2rtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1970&pages=598-603&author=G.+Chouinardauthor=H.+E.+Lehmannauthor=T.+A.+Ban&title=Pimozide+in+the+treatment+of+chronic+schizophrenic+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pimozide in the treatment of chronic schizophrenic patients</span></div><div class="casAuthors">Chouinard G; Lehmann H E; Ban T A</div><div class="citationInfo"><span class="NLM_cas:title">Current therapeutic research, clinical and experimental</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">598-603</span>
        ISSN:<span class="NLM_cas:issn">0011-393X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFg3NAyoSO8YNpW7w2tapOfW6udTcc2eahN9BN_NHBL7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3c3osF2rtg%253D%253D&md5=280a493535e8bbbee2cc9566185b20e4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChouinard%26aufirst%3DG.%26aulast%3DLehmann%26aufirst%3DH.%2BE.%26aulast%3DBan%26aufirst%3DT.%2BA.%26atitle%3DPimozide%2520in%2520the%2520treatment%2520of%2520chronic%2520schizophrenic%2520patients%26jtitle%3DCurr.%2520Ther.%2520Res.%2520Clin.%2520Exp.%26date%3D1970%26volume%3D12%26spage%3D598%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Goddard, W. A.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrol, R.</span><span> </span><span class="NLM_article-title">3-Dimensional structures of G protein-coupled receptors and binding sites of agonists and antagonists</span> <span class="citation_source-journal">J. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">1528S</span><span class="NLM_x">â</span> <span class="NLM_lpage">1538S</span><div class="note"><p class="first last">; discussion 1548S</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2007&pages=1528S-1538S&author=W.+A.+Goddardauthor=R.+Abrol&title=3-Dimensional+structures+of+G+protein-coupled+receptors+and+binding+sites+of+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoddard%26aufirst%3DW.%2BA.%26aulast%3DAbrol%26aufirst%3DR.%26atitle%3D3-Dimensional%2520structures%2520of%2520G%2520protein-coupled%2520receptors%2520and%2520binding%2520sites%2520of%2520agonists%2520and%2520antagonists%26jtitle%3DJ.%2520Nutr.%26date%3D2007%26volume%3D137%26spage%3D1528S%26epage%3D1538S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">AriÃ«ns, E. J.; Beld, A. J.; Rodrigues de Miranda, J. F.; Simonis, A. M.</span> In  <span class="citation_source-book">The Receptors: A Comprehensive Treatise</span>; <span class="NLM_contrib-group">OâBrien, R. D.</span>, Ed.; <span class="NLM_publisher-name">Plenum Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1979</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">1</span>, pp  <span class="NLM_fpage">33</span><span class="NLM_x">â</span> <span class="NLM_lpage">39</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1979&pages=33-39&author=E.+J.+Ari%C3%ABns&author=A.+J.+Beld&author=J.+F.+Rodrigues+de+Miranda&author=A.+M.+Simonisauthor=R.+D.+O%E2%80%99Brien&title=The+Receptors%3A+A+Comprehensive+Treatise"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAri%25C3%25ABns%26aufirst%3DE.%2BJ.%26btitle%3DThe%2520Receptors%253A%2520A%2520Comprehensive%2520Treatise%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DR.%2BD.%26pub%3DPlenum%2520Press%26date%3D1979%26volume%3D1%26spage%3D33%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Hayashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isogaya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriwaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumagai, H.</span><span> </span><span class="NLM_article-title">Design and synthesis of selective alpha1B adrenoceptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4045</span><span class="NLM_x">â</span> <span class="NLM_lpage">4047</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4045-4047&author=R.+Hayashiauthor=E.+Ohmoriauthor=M.+Isogayaauthor=M.+Moriwakiauthor=H.+Kumagai&title=Design+and+synthesis+of+selective+alpha1B+adrenoceptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DR.%26aulast%3DOhmori%26aufirst%3DE.%26aulast%3DIsogaya%26aufirst%3DM.%26aulast%3DMoriwaki%26aufirst%3DM.%26aulast%3DKumagai%26aufirst%3DH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520selective%2520alpha1B%2520adrenoceptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4045%26epage%3D4047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Hrib, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurcak, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgher, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerman, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roehr, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, A. T.</span><span> </span><span class="NLM_article-title">Benzisoxazole- and benzisothiazole-3-carboxamides as potential atypical antipsychotic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2308</span><span class="NLM_x">â</span> <span class="NLM_lpage">2314</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00041a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2308-2314&author=N.+J.+Hribauthor=J.+G.+Jurcakauthor=K.+L.+Burgherauthor=P.+G.+Conwayauthor=H.+B.+Hartmanauthor=L.+L.+Kermanauthor=J.+E.+Roehrauthor=A.+T.+Woods&title=Benzisoxazole-+and+benzisothiazole-3-carboxamides+as+potential+atypical+antipsychotic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm00041a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00041a009%26sid%3Dliteratum%253Aachs%26aulast%3DHrib%26aufirst%3DN.%2BJ.%26aulast%3DJurcak%26aufirst%3DJ.%2BG.%26aulast%3DBurgher%26aufirst%3DK.%2BL.%26aulast%3DConway%26aufirst%3DP.%2BG.%26aulast%3DHartman%26aufirst%3DH.%2BB.%26aulast%3DKerman%26aufirst%3DL.%2BL.%26aulast%3DRoehr%26aufirst%3DJ.%2BE.%26aulast%3DWoods%26aufirst%3DA.%2BT.%26atitle%3DBenzisoxazole-%2520and%2520benzisothiazole-3-carboxamides%2520as%2520potential%2520atypical%2520antipsychotic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2308%26epage%3D2314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krushinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinn, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nutter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gough, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaus, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. C.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6011</span><span class="NLM_x">â</span> <span class="NLM_lpage">6016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=6011-6016&author=D.+Zhangauthor=D.+Kohlmanauthor=J.+Krushinskiauthor=S.+Liangauthor=B.+P.+Yingauthor=J.+E.+Reillyauthor=S.+R.+Dinnauthor=D.+B.+Wainscottauthor=S.+Nutterauthor=W.+Goughauthor=D.+L.+Nelsonauthor=J.+M.+Schausauthor=Y.+C.+Xu&title=Design%2C+synthesis+and+evaluation+of+bicyclic+benzamides+as+novel+5-HT1F+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DKohlman%26aufirst%3DD.%26aulast%3DKrushinski%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DYing%26aufirst%3DB.%2BP.%26aulast%3DReilly%26aufirst%3DJ.%2BE.%26aulast%3DDinn%26aufirst%3DS.%2BR.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DNutter%26aufirst%3DS.%26aulast%3DGough%26aufirst%3DW.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DSchaus%26aufirst%3DJ.%2BM.%26aulast%3DXu%26aufirst%3DY.%2BC.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520bicyclic%2520benzamides%2520as%2520novel%25205-HT1F%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D6011%26epage%3D6016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ife, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meeson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span> </span><span class="NLM_article-title">Identification of a novel series of selective 5-HT7 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">â</span> <span class="NLM_lpage">1058</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1055-1058&author=I.+T.+Forbesauthor=D.+G.+Cooperauthor=E.+K.+Doddsauthor=S.+E.+Douglasauthor=A.+D.+Gribbleauthor=R.+J.+Ifeauthor=A.+P.+Lightfootauthor=M.+Meesonauthor=L.+P.+Campbellauthor=T.+Colemanauthor=G.+J.+Rileyauthor=D.+R.+Thomas&title=Identification+of+a+novel+series+of+selective+5-HT7+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DCooper%26aufirst%3DD.%2BG.%26aulast%3DDodds%26aufirst%3DE.%2BK.%26aulast%3DDouglas%26aufirst%3DS.%2BE.%26aulast%3DGribble%26aufirst%3DA.%2BD.%26aulast%3DIfe%26aufirst%3DR.%2BJ.%26aulast%3DLightfoot%26aufirst%3DA.%2BP.%26aulast%3DMeeson%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DL.%2BP.%26aulast%3DColeman%26aufirst%3DT.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26atitle%3DIdentification%2520of%2520a%2520novel%2520series%2520of%2520selective%25205-HT7%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1055%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Rocco, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinazze, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigschmidt, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley Wainscott, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlkeld, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span> </span><span class="NLM_article-title">Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2653</span><span class="NLM_x">â</span> <span class="NLM_lpage">2656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2653-2656&author=V.+P.+Roccoauthor=P.+G.+Spinazzeauthor=T.+J.+Kohnauthor=N.+A.+Honigschmidtauthor=D.+L.+Nelsonauthor=D.+Bradley+Wainscottauthor=L.+J.+Ahmadauthor=J.+Shawauthor=P.+G.+Threlkeldauthor=D.+T.+Wongauthor=K.+Takeuchi&title=Advances+toward+new+antidepressants+beyond+SSRIs%3A+1-aryloxy-3-piperidinylpropan-2-ols+with+dual+5-HT1A+receptor+antagonism%2FSSRI+activities.+Part+4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRocco%26aufirst%3DV.%2BP.%26aulast%3DSpinazze%26aufirst%3DP.%2BG.%26aulast%3DKohn%26aufirst%3DT.%2BJ.%26aulast%3DHonigschmidt%26aufirst%3DN.%2BA.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DBradley%2BWainscott%26aufirst%3DD.%26aulast%3DAhmad%26aufirst%3DL.%2BJ.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DThrelkeld%26aufirst%3DP.%2BG.%26aulast%3DWong%26aufirst%3DD.%2BT.%26aulast%3DTakeuchi%26aufirst%3DK.%26atitle%3DAdvances%2520toward%2520new%2520antidepressants%2520beyond%2520SSRIs%253A%25201-aryloxy-3-piperidinylpropan-2-ols%2520with%2520dual%25205-HT1A%2520receptor%2520antagonism%252FSSRI%2520activities.%2520Part%25204%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2653%26epage%3D2656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Andersen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perregaard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begtrup, M.</span><span> </span><span class="NLM_article-title">Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1<i>H</i>-indoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">4823</span><span class="NLM_x">â</span> <span class="NLM_lpage">4831</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00104a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=4823-4831&author=K.+Andersenauthor=J.+Perregaardauthor=J.+Arntauthor=J.+B.+Nielsenauthor=M.+Begtrup&title=Selective%2C+centrally+acting+serotonin+5-HT2+antagonists.+2.+Substituted+3-%284-fluorophenyl%29-1H-indoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm00104a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00104a007%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DK.%26aulast%3DPerregaard%26aufirst%3DJ.%26aulast%3DArnt%26aufirst%3DJ.%26aulast%3DNielsen%26aufirst%3DJ.%2BB.%26aulast%3DBegtrup%26aufirst%3DM.%26atitle%3DSelective%252C%2520centrally%2520acting%2520serotonin%25205-HT2%2520antagonists.%25202.%2520Substituted%25203-%25284-fluorophenyl%2529-1H-indoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D4823%26epage%3D4831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Strupczewski, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordeau, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glamkowski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilmot, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helsley, G. C.</span><span> </span><span class="NLM_article-title">3-[[(Aryloxy)alkyl]piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1119</span><span class="NLM_x">â</span> <span class="NLM_lpage">1131</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00007a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1119-1131&author=J.+T.+Strupczewskiauthor=K.+J.+Bordeauauthor=Y.+Chiangauthor=E.+J.+Glamkowskiauthor=P.+G.+Conwayauthor=R.+Corbettauthor=H.+B.+Hartmanauthor=M.+R.+Szewczakauthor=C.+A.+Wilmotauthor=G.+C.+Helsley&title=3-%5B%5B%28Aryloxy%29alkyl%5Dpiperidinyl%5D-1%2C2-benzisoxazoles+as+D2%2F5-HT2+antagonists+with+potential+atypical+antipsychotic+activity%3A+antipsychotic+profile+of+iloperidone+%28HP+873%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm00007a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00007a009%26sid%3Dliteratum%253Aachs%26aulast%3DStrupczewski%26aufirst%3DJ.%2BT.%26aulast%3DBordeau%26aufirst%3DK.%2BJ.%26aulast%3DChiang%26aufirst%3DY.%26aulast%3DGlamkowski%26aufirst%3DE.%2BJ.%26aulast%3DConway%26aufirst%3DP.%2BG.%26aulast%3DCorbett%26aufirst%3DR.%26aulast%3DHartman%26aufirst%3DH.%2BB.%26aulast%3DSzewczak%26aufirst%3DM.%2BR.%26aulast%3DWilmot%26aufirst%3DC.%2BA.%26aulast%3DHelsley%26aufirst%3DG.%2BC.%26atitle%3D3-%255B%255B%2528Aryloxy%2529alkyl%255Dpiperidinyl%255D-1%252C2-benzisoxazoles%2520as%2520D2%252F5-HT2%2520antagonists%2520with%2520potential%2520atypical%2520antipsychotic%2520activity%253A%2520antipsychotic%2520profile%2520of%2520iloperidone%2520%2528HP%2520873%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1119%26epage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigschmidt, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocco, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinazze, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlkeld, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span> </span><span class="NLM_article-title">Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1903</span><span class="NLM_x">â</span> <span class="NLM_lpage">1905</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1903-1905&author=K.+Takeuchiauthor=T.+J.+Kohnauthor=N.+A.+Honigschmidtauthor=V.+P.+Roccoauthor=P.+G.+Spinazzeauthor=D.+J.+Kochauthor=D.+L.+Nelsonauthor=D.+B.+Wainscottauthor=L.+J.+Ahmadauthor=J.+Shawauthor=P.+G.+Threlkeldauthor=D.+T.+Wong&title=Advances+toward+new+antidepressants+beyond+SSRIs%3A+1-aryloxy-3-piperidinylpropan-2-ols+with+dual+5-HT1A+receptor+antagonism%2FSSRI+activities.+Part+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DKohn%26aufirst%3DT.%2BJ.%26aulast%3DHonigschmidt%26aufirst%3DN.%2BA.%26aulast%3DRocco%26aufirst%3DV.%2BP.%26aulast%3DSpinazze%26aufirst%3DP.%2BG.%26aulast%3DKoch%26aufirst%3DD.%2BJ.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DAhmad%26aufirst%3DL.%2BJ.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DThrelkeld%26aufirst%3DP.%2BG.%26aulast%3DWong%26aufirst%3DD.%2BT.%26atitle%3DAdvances%2520toward%2520new%2520antidepressants%2520beyond%2520SSRIs%253A%25201-aryloxy-3-piperidinylpropan-2-ols%2520with%2520dual%25205-HT1A%2520receptor%2520antagonism%252FSSRI%2520activities.%2520Part%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1903%26epage%3D1905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Timms, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boot, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadmore, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tree, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedley, S.</span><span> </span><span class="NLM_article-title">SAR development of a selective 5-HT1D antagonist/serotonin reuptake inhibitor lead using rapid parallel synthesis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2469</span><span class="NLM_x">â</span> <span class="NLM_lpage">2472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2469-2472&author=G.+H.+Timmsauthor=J.+R.+Bootauthor=R.+J.+Broadmoreauthor=S.+L.+Carneyauthor=J.+Cooperauthor=J.+D.+Findlayauthor=J.+Gilmoreauthor=S.+Mitchellauthor=N.+A.+Mooreauthor=I.+Pullarauthor=G.+J.+Sangerauthor=R.+Tomlinsonauthor=B.+B.+Treeauthor=S.+Wedley&title=SAR+development+of+a+selective+5-HT1D+antagonist%2Fserotonin+reuptake+inhibitor+lead+using+rapid+parallel+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTimms%26aufirst%3DG.%2BH.%26aulast%3DBoot%26aufirst%3DJ.%2BR.%26aulast%3DBroadmore%26aufirst%3DR.%2BJ.%26aulast%3DCarney%26aufirst%3DS.%2BL.%26aulast%3DCooper%26aufirst%3DJ.%26aulast%3DFindlay%26aufirst%3DJ.%2BD.%26aulast%3DGilmore%26aufirst%3DJ.%26aulast%3DMitchell%26aufirst%3DS.%26aulast%3DMoore%26aufirst%3DN.%2BA.%26aulast%3DPullar%26aufirst%3DI.%26aulast%3DSanger%26aufirst%3DG.%2BJ.%26aulast%3DTomlinson%26aufirst%3DR.%26aulast%3DTree%26aufirst%3DB.%2BB.%26aulast%3DWedley%26aufirst%3DS.%26atitle%3DSAR%2520development%2520of%2520a%2520selective%25205-HT1D%2520antagonist%252Fserotonin%2520reuptake%2520inhibitor%2520lead%2520using%2520rapid%2520parallel%2520synthesis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2469%26epage%3D2472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Guillaume, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedelec, L.</span><span> </span><span class="NLM_article-title">Tetrahydro-1,2,3,6 pyridinyl-4)-3-1<i>H</i>-indoles: synthese, proprietes serotoninergique et anti-dopaminergiques</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">â</span> <span class="NLM_lpage">43</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1987&pages=33-43&author=J.+Guillaumeauthor=C.+Dumontauthor=J.+Laurentauthor=L.+Nedelec&title=Tetrahydro-1%2C2%2C3%2C6+pyridinyl-4%29-3-1H-indoles%3A+synthese%2C+proprietes+serotoninergique+et+anti-dopaminergiques"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuillaume%26aufirst%3DJ.%26aulast%3DDumont%26aufirst%3DC.%26aulast%3DLaurent%26aufirst%3DJ.%26aulast%3DNedelec%26aufirst%3DL.%26atitle%3DTetrahydro-1%252C2%252C3%252C6%2520pyridinyl-4%2529-3-1H-indoles%253A%2520synthese%252C%2520proprietes%2520serotoninergique%2520et%2520anti-dopaminergiques%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1987%26volume%3D22%26spage%3D33%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Carli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Invernizzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samanin, R.</span><span> </span><span class="NLM_article-title">Neurochemical and behavioural studies with RU-24969 in the rat</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">â</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=3128812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaL1cXhsVegtro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1988&pages=359-364&author=M.+Carliauthor=R.+Invernizziauthor=L.+Cervoauthor=R.+Samanin&title=Neurochemical+and+behavioural+studies+with+RU-24969+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Neurochemical and behavioral studies with RU-24969 in the rat</span></div><div class="casAuthors">Carli, Mirjana; Invernizzi, Roberto; Cervo, Luigi; Samanin, Rosario</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-64</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">The regional brain synthesis of serotonin (5-HT) and dopamine (DA) was studied in rats after various doses of 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole (RU-24969), a 5-HT1 receptor agonist.  The potential anxiolytic and antidepressant properties of the compd. were examd. as well.  RU-24969 at 0.62 mg/kg reduced 5-HT synthesis in the nucleus accumbens and hypothalamus, while with 1.25 and 2.5 mg/kg the effect was also seen in the striatum, hippocampus, brainstem and cortex.  RU-24969 at 2.5 and 5 mg/kg had no effect on DA synthesis in the striatum, while 5.0 mg/kg increased it in the nucleus accumbens.  At 2.5 and 5.0 mg/kg the drug increased the motor activity of rats measured during 1 h in activity cages, while 0.625 and 1.25 mg/kg had no effect.  Doses ranging 0.62-2.5 mg/kg reduced unpunished responding in a test of conditioned suppression of drinking.  Doses of 1.25 and 2.5 mg/kg also reduced punished responding.  Finally, of various doses, only 2.5 mg/kg reduced the duration of immobility of rats in the forced swimming test but the effects were due to running around the cylinder rather than to escape attempts.  Apparently, RU-24969 reduced 5-HT synthesis in all brain areas examd., with a preferential effect for the nucleus accumbens and hypothalamus.  At higher doses, there was also a specific increase in DA synthesis in the nucleus accumbens.  The compd. raised the level of activity of rats but no clear evidence of any potential anxiolytic or antidepressant properties was obtained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4FYd9WzSZiLVg90H21EOLACvtfcHk0lg1hyKgHz3_8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhsVegtro%253D&md5=0cd25aab06000cb399b11455e3743545</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarli%26aufirst%3DM.%26aulast%3DInvernizzi%26aufirst%3DR.%26aulast%3DCervo%26aufirst%3DL.%26aulast%3DSamanin%26aufirst%3DR.%26atitle%3DNeurochemical%2520and%2520behavioural%2520studies%2520with%2520RU-24969%2520in%2520the%2520rat%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D1988%26volume%3D94%26spage%3D359%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Hunt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberlander, C.</span><span> </span><span class="NLM_article-title">The interaction of indole derivatives with the serotonin receptor and non-dopaminergic circling behaviour</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">â</span> <span class="NLM_lpage">562</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=1981&pages=547-562&author=P.+Huntauthor=C.+Oberlander&title=The+interaction+of+indole+derivatives+with+the+serotonin+receptor+and+non-dopaminergic+circling+behaviour"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DP.%26aulast%3DOberlander%26aufirst%3DC.%26atitle%3DThe%2520interaction%2520of%2520indole%2520derivatives%2520with%2520the%2520serotonin%2520receptor%2520and%2520non-dopaminergic%2520circling%2520behaviour%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1981%26volume%3D133%26spage%3D547%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Doods, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkman, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Jonge, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoolen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilffert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmermans, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Zwieten, P. A.</span><span> </span><span class="NLM_article-title">Differential selectivities of RU 24969 and 8-OH-DPAT for the purported 5-HT1A and 5-HT1B binding sites. Correlation between 5-HT1A affinity and hypotensive activity</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">â</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2F0014-2999%2885%2990782-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=3160596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaL2MXkvFymsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1985&pages=363-370&author=H.+N.+Doodsauthor=H.+O.+Kalkmanauthor=A.+De+Jongeauthor=M.+J.+Thoolenauthor=B.+Wilffertauthor=P.+B.+Timmermansauthor=P.+A.+Van+Zwieten&title=Differential+selectivities+of+RU+24969+and+8-OH-DPAT+for+the+purported+5-HT1A+and+5-HT1B+binding+sites.+Correlation+between+5-HT1A+affinity+and+hypotensive+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Differential selectivities of RU 24969 and 8-OH-DPAT for the purported 5-HT1A and 5-HT1B binding sites.  Correlation between 5-HT1A affinity and hypotensive activity</span></div><div class="casAuthors">Doods, Henri N.; Kalkman, Hans O.; De Jonge, Adriaan; Thoolen, Martin J. M. C.; Wilffert, Bob; Timmermans, Pieter B. M. W. M.; Van Zwieten, Pieter A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">363-70</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">RU 24969  [66611-26-5] and 8-hydroxy-2-(dipropylamino)tetralin (8-OH-DPAT)  [78950-78-4] inhibited the specific binding of 3H-labeled 5-HT  [50-67-9] (2 nM) to rat brain membranes with shallow displacement curves.  The displacement data were best fitted with a model of 2 independent, high- and low-affinity binding sites.  Following addn. of spiperone (1 Î¼M) as a selective ligand for the putative 5-HT1A recognition site of [3H]5-HT, the displacement curve of RU 24969 underwent a leftward shift, whereas spiperone induced a shift to the right for the displacement curve of 8-OH-DPAT.  In contrast to spiperone, pindolol (1 Î¼M) shifted the displacement curve of RU 24969 to the right.  Apparently, RU 24969 possesses preference for the purported 5-HT1B subtype of central 5-HT1 recognition site.  The reported linear correlation between hypotensive activity following i.v. administration to anesthetized rats and affinity for the central 5-HT1 binding site could only be maintained by incorporation of the affinity of RU 24969 for its low- and 8-OH-DPAT for its high-affinity binding site.  Based on the proposal that the 5-HT1A site corresponds to the high-affinity site of 8-OH-DPAT and the low-affinity site of RU 24969, it is hypothesized that the late depressor phase of 5-HT agonists in rats is mediated by activation of peripheral (vascular) 5-HT receptors which have similarities with the 5-HT1A subtype of central 5-HT1 recognition site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXsY4hSk02U7Vg90H21EOLACvtfcHk0lg1hyKgHz3_8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXkvFymsL0%253D&md5=e6ac3a3923955c56f1c97bc73e1e3e4c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2885%2990782-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252885%252990782-4%26sid%3Dliteratum%253Aachs%26aulast%3DDoods%26aufirst%3DH.%2BN.%26aulast%3DKalkman%26aufirst%3DH.%2BO.%26aulast%3DDe%2BJonge%26aufirst%3DA.%26aulast%3DThoolen%26aufirst%3DM.%2BJ.%26aulast%3DWilffert%26aufirst%3DB.%26aulast%3DTimmermans%26aufirst%3DP.%2BB.%26aulast%3DVan%2BZwieten%26aufirst%3DP.%2BA.%26atitle%3DDifferential%2520selectivities%2520of%2520RU%252024969%2520and%25208-OH-DPAT%2520for%2520the%2520purported%25205-HT1A%2520and%25205-HT1B%2520binding%2520sites.%2520Correlation%2520between%25205-HT1A%2520affinity%2520and%2520hypotensive%2520activity%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1985%26volume%3D112%26spage%3D363%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Deskus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epperson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cipollina, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dextraze, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian-Cutrone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beno, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molski, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taber, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, R. J.</span><span> </span><span class="NLM_article-title">Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">â</span> <span class="NLM_lpage">3104</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3099-3104&author=J.+A.+Deskusauthor=J.+R.+Eppersonauthor=C.+P.+Sloanauthor=J.+A.+Cipollinaauthor=P.+Dextrazeauthor=J.+Qian-Cutroneauthor=Q.+Gaoauthor=B.+Maauthor=B.+R.+Benoauthor=G.+K.+Mattsonauthor=T.+F.+Molskiauthor=R.+G.+Krauseauthor=M.+T.+Taberauthor=N.+J.+Lodgeauthor=R.+J.+Mattson&title=Conformationally+restricted+homotryptamines+3.+Indole+tetrahydropyridines+and+cyclohexenylamines+as+selective+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeskus%26aufirst%3DJ.%2BA.%26aulast%3DEpperson%26aufirst%3DJ.%2BR.%26aulast%3DSloan%26aufirst%3DC.%2BP.%26aulast%3DCipollina%26aufirst%3DJ.%2BA.%26aulast%3DDextraze%26aufirst%3DP.%26aulast%3DQian-Cutrone%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DMattson%26aufirst%3DG.%2BK.%26aulast%3DMolski%26aufirst%3DT.%2BF.%26aulast%3DKrause%26aufirst%3DR.%2BG.%26aulast%3DTaber%26aufirst%3DM.%2BT.%26aulast%3DLodge%26aufirst%3DN.%2BJ.%26aulast%3DMattson%26aufirst%3DR.%2BJ.%26atitle%3DConformationally%2520restricted%2520homotryptamines%25203.%2520Indole%2520tetrahydropyridines%2520and%2520cyclohexenylamines%2520as%2520selective%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3099%26epage%3D3104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Matzen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Amsterdam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rautenberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiner, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyfried, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottcher, H.</span><span> </span><span class="NLM_article-title">5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1149</span><span class="NLM_x">â</span> <span class="NLM_lpage">1157</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9811054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtlKjtrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1149-1157&author=L.+Matzenauthor=C.+van+Amsterdamauthor=W.+Rautenbergauthor=H.+E.+Greinerauthor=J.+Hartingauthor=C.+A.+Seyfriedauthor=H.+Bottcher&title=5-HT+reuptake+inhibitors+with+5-HT%281B%2F1D%29+antagonistic+activity%3A+a+new+approach+toward+efficient+antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT reuptake inhibitors with 5-HT1B/1D antagonistic activity: a new approach toward efficient antidepressants</span></div><div class="casAuthors">Matzen, Lisa; Van Amsterdam, Christoph; Rautenberg, Wilfried; Greiner, Hartmut E.; Harting, Juergen; Seyfried, Christoph A.; Boettcher, Henning</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1149-1157</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of the authors' research program toward new, potential antidepressants, a series of unsym. ureas has been prepd. and evaluated as 5-HT reuptake inhibitors with 5-HT1B/1D antagonistic activities.  The design of these compds. was based on coupling of various indole derivs., previously shown to inhibit 5-HT reuptake, to three different aniline moieties, which are part of known 5-HT1B/1D ligands.  Binding expts. in rat frontal cortex using [125I]iodocyanopindolol, in calf striatum using [3H]5-HT, and in rat hippocampus using [3H]8-OH-DPAT as radioligands, resp., revealed significantly higher affinity at the 5-HT1B receptor as compared to the affinities for the 5-HT1A and 5-HT1D receptors for a no. of compds., among them 4-(5-fluoro-1H-indol-3-yl)piperidine-1-carboxylic acid [4-methoxy-3-(4-methylpiperazin-1-yl)phenyl]amide I (R = R2 = H; R1 = F), the corresponding 4-fluoro-1H-indol-3-yl analog I (R = F; R1 = R2 = H), and the corresponding 6-fluoro-1H-indol-3-yl analog I (R = R1 = H; R2 = F).  Conformational restriction of the aniline moiety in I only slightly enhanced the 5-HT1B affinity, whereas introduction of an aniline moiety with higher conformational flexibility resulted in a less potent 5-HT1B receptor ligand as compared to I.  The functional 5-HT1B/1D antagonistic activity was investigated using the rabbit saphenous vein model as well as the [3H]5-HT release from guinea pig cortical slices.  All new compds. tested in the rabbit saphenous vein model were shown to antagonize the sumatriptan-evoked contractile responses with pA2 values ranging from 7.3 to 8.7.  These observations were consistent with the results of the cortical slice model, in which the ureas were found to block the sumatriptan-induced inhibition of potassium-evoked [3H]5-HT release.  The 5-HT reuptake inhibition of the ureas detd. in rat brain synaptosomes was found to be either increased or decreased as compared to the uncoupled indole derivs. indicating that the reuptake inhibition shown by the ureas is not only due to the indole part but also affected by the aniline moiety of the mol.  Among this series of compds. described the ureas I seem to be the most interesting candidates showing both 5-HT reuptake inhibition and 5-HT1B/1D antagonism in vitro.  This dual pharmacol. profile should in theory lead to a pronounced enhancement in serotonergic neurotransmission and consequently to a more efficient treatment of depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPoXyqYo-xI7Vg90H21EOLACvtfcHk0ljUEIXJw6Av7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtlKjtrc%253D&md5=339f7c7e7c49ff88559984852971fdd2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm9811054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9811054%26sid%3Dliteratum%253Aachs%26aulast%3DMatzen%26aufirst%3DL.%26aulast%3Dvan%2BAmsterdam%26aufirst%3DC.%26aulast%3DRautenberg%26aufirst%3DW.%26aulast%3DGreiner%26aufirst%3DH.%2BE.%26aulast%3DHarting%26aufirst%3DJ.%26aulast%3DSeyfried%26aufirst%3DC.%2BA.%26aulast%3DBottcher%26aufirst%3DH.%26atitle%3D5-HT%2520reuptake%2520inhibitors%2520with%25205-HT%25281B%252F1D%2529%2520antagonistic%2520activity%253A%2520a%2520new%2520approach%2520toward%2520efficient%2520antidepressants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1149%26epage%3D1157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Lambert, G. A.</span><span> </span><span class="NLM_article-title">Preclinical neuropharmacology of naratriptan</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">â</span> <span class="NLM_lpage">316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=289-316&author=G.+A.+Lambert&title=Preclinical+neuropharmacology+of+naratriptan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DG.%2BA.%26atitle%3DPreclinical%2520neuropharmacology%2520of%2520naratriptan%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2005%26volume%3D11%26spage%3D289%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Sternfeld, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broughton, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiblin, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelley, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Street, L. J.</span><span> </span><span class="NLM_article-title">The chemical evolution of <i>N</i>,<i>N</i>-dimethyl-2-[5-(1,2,4-triazol-4-yl)-1<i>H</i>-indol-3-yl]ethylamine (L-741,604) and analogues: potent and selective agonists for 5-HT1D receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1825</span><span class="NLM_x">â</span> <span class="NLM_lpage">1830</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=1825-1830&author=F.+Sternfeldauthor=R.+Bakerauthor=H.+B.+Broughtonauthor=A.+R.+Guiblinauthor=R.+A.+Jelleyauthor=L.+J.+Street&title=The+chemical+evolution+of+N%2CN-dimethyl-2-%5B5-%281%2C2%2C4-triazol-4-yl%29-1H-indol-3-yl%5Dethylamine+%28L-741%2C604%29+and+analogues%3A+potent+and+selective+agonists+for+5-HT1D+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSternfeld%26aufirst%3DF.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DBroughton%26aufirst%3DH.%2BB.%26aulast%3DGuiblin%26aufirst%3DA.%2BR.%26aulast%3DJelley%26aufirst%3DR.%2BA.%26aulast%3DStreet%26aufirst%3DL.%2BJ.%26atitle%3DThe%2520chemical%2520evolution%2520of%2520N%252CN-dimethyl-2-%255B5-%25281%252C2%252C4-triazol-4-yl%2529-1H-indol-3-yl%255Dethylamine%2520%2528L-741%252C604%2529%2520and%2520analogues%253A%2520potent%2520and%2520selective%2520agonists%2520for%25205-HT1D%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26spage%3D1825%26epage%3D1830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Barf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikstrom, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauwels, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardif, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundmark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundell, S.</span><span> </span><span class="NLM_article-title">5-(Sulfonyl)oxy-tryptamines and ethylamino side chain restricted derivatives. Structureâaffinity relationships for h5-HT1B and h5-HT1D receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1469</span><span class="NLM_x">â</span> <span class="NLM_lpage">1479</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=1469-1479&author=T.+Barfauthor=H.+Wikstromauthor=P.+J.+Pauwelsauthor=C.+Palmierauthor=S.+Tardifauthor=M.+Lundmarkauthor=S.+Sundell&title=5-%28Sulfonyl%29oxy-tryptamines+and+ethylamino+side+chain+restricted+derivatives.+Structure%E2%80%93affinity+relationships+for+h5-HT1B+and+h5-HT1D+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarf%26aufirst%3DT.%26aulast%3DWikstrom%26aufirst%3DH.%26aulast%3DPauwels%26aufirst%3DP.%2BJ.%26aulast%3DPalmier%26aufirst%3DC.%26aulast%3DTardif%26aufirst%3DS.%26aulast%3DLundmark%26aufirst%3DM.%26aulast%3DSundell%26aufirst%3DS.%26atitle%3D5-%2528Sulfonyl%2529oxy-tryptamines%2520and%2520ethylamino%2520side%2520chain%2520restricted%2520derivatives.%2520Structure%25E2%2580%2593affinity%2520relationships%2520for%2520h5-HT1B%2520and%2520h5-HT1D%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1998%26volume%3D6%26spage%3D1469%26epage%3D1479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Brown, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avenell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span> </span><span class="NLM_article-title">BRL 54443 a potent agonist with selectivity for human cloned 5-HT1E and 5-HT1F receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">233P</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=1998&pages=233P&author=A.+M.+Brownauthor=K.+Avenellauthor=T.+J.+Youngauthor=M.+Hoauthor=R.+A.+Porterauthor=D.+N.+Middlemiss&title=BRL+54443+a+potent+agonist+with+selectivity+for+human+cloned+5-HT1E+and+5-HT1F+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DAvenell%26aufirst%3DK.%26aulast%3DYoung%26aufirst%3DT.%2BJ.%26aulast%3DHo%26aufirst%3DM.%26aulast%3DPorter%26aufirst%3DR.%2BA.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26atitle%3DBRL%252054443%2520a%2520potent%2520agonist%2520with%2520selectivity%2520for%2520human%2520cloned%25205-HT1E%2520and%25205-HT1F%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D123%26spage%3D233P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Choi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquess, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, S. D.</span><span> </span><span class="NLM_article-title">Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-<i>N</i>-[3-(1-methyl-4-piperidinyl)-1<i>H</i>-indol-5-yl]benzamide</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3609</span><span class="NLM_x">â</span> <span class="NLM_lpage">3616</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7011722" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3609-3616&author=S.+K.+Choiauthor=D.+Greenauthor=A.+Hoauthor=U.+Kleinauthor=D.+Marquessauthor=R.+Taylorauthor=S.+D.+Turner&title=Designing+selective%2C+high+affinity+ligands+of+5-HT1D+receptor+by+covalent+dimerization+of+5-HT1F+ligands+derived+from+4-fluoro-N-%5B3-%281-methyl-4-piperidinyl%29-1H-indol-5-yl%5Dbenzamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm7011722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7011722%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%2BK.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DA.%26aulast%3DKlein%26aufirst%3DU.%26aulast%3DMarquess%26aufirst%3DD.%26aulast%3DTaylor%26aufirst%3DR.%26aulast%3DTurner%26aufirst%3DS.%2BD.%26atitle%3DDesigning%2520selective%252C%2520high%2520affinity%2520ligands%2520of%25205-HT1D%2520receptor%2520by%2520covalent%2520dimerization%2520of%25205-HT1F%2520ligands%2520derived%2520from%25204-fluoro-N-%255B3-%25281-methyl-4-piperidinyl%2529-1H-indol-5-yl%255Dbenzamide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3609%26epage%3D3616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Nelson, D. L.</span><span> </span><span class="NLM_article-title">Structureâactivity relationships at 5-HT1A receptors: binding profiles and intrinsic activity</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1041</span><span class="NLM_x">â</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1991&pages=1041-1051&author=D.+L.+Nelson&title=Structure%E2%80%93activity+relationships+at+5-HT1A+receptors%3A+binding+profiles+and+intrinsic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DD.%2BL.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520at%25205-HT1A%2520receptors%253A%2520binding%2520profiles%2520and%2520intrinsic%2520activity%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1991%26volume%3D40%26spage%3D1041%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Hansch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J.</span><span> </span><span class="NLM_article-title">The structureâactivity relationship of inhibitors of serotonin uptake and receptor binding</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">â</span> <span class="NLM_lpage">453</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1991&pages=441-453&author=C.+Hanschauthor=J.+Caldwell&title=The+structure%E2%80%93activity+relationship+of+inhibitors+of+serotonin+uptake+and+receptor+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansch%26aufirst%3DC.%26aulast%3DCaldwell%26aufirst%3DJ.%26atitle%3DThe%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520inhibitors%2520of%2520serotonin%2520uptake%2520and%2520receptor%2520binding%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1991%26volume%3D5%26spage%3D441%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Agarwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlgren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herslof, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J. W.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Three-dimensional quantitative structureâactivity relationships of 5-HT receptor binding data for tetrahydropyridinylindole derivatives: a comparison of the Hansch and CoMFA methods</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">4006</span><span class="NLM_x">â</span> <span class="NLM_lpage">4014</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00077a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=4006-4014&author=A.+Agarwalauthor=P.+P.+Pearsonauthor=E.+W.+Taylorauthor=H.+B.+Liauthor=T.+Dahlgrenauthor=M.+Herslofauthor=Y.+Yangauthor=G.+Lambertauthor=D.+L.+Nelsonauthor=J.+W.+Regan&title=Three-dimensional+quantitative+structure%E2%80%93activity+relationships+of+5-HT+receptor+binding+data+for+tetrahydropyridinylindole+derivatives%3A+a+comparison+of+the+Hansch+and+CoMFA+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm00077a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00077a003%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DA.%26aulast%3DPearson%26aufirst%3DP.%2BP.%26aulast%3DTaylor%26aufirst%3DE.%2BW.%26aulast%3DLi%26aufirst%3DH.%2BB.%26aulast%3DDahlgren%26aufirst%3DT.%26aulast%3DHerslof%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLambert%26aufirst%3DG.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DRegan%26aufirst%3DJ.%2BW.%26atitle%3DThree-dimensional%2520quantitative%2520structure%25E2%2580%2593activity%2520relationships%2520of%25205-HT%2520receptor%2520binding%2520data%2520for%2520tetrahydropyridinylindole%2520derivatives%253A%2520a%2520comparison%2520of%2520the%2520Hansch%2520and%2520CoMFA%2520methods%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D4006%26epage%3D4014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Crawforth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodacre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourrain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marwood, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnor, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span> </span><span class="NLM_article-title">3-(4-Piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1<i>H</i>-indoles as bioavailable h5-HT2A antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2701</span><span class="NLM_x">â</span> <span class="NLM_lpage">2703</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2701-2703&author=J.+Crawforthauthor=S.+Goodacreauthor=R.+Maxeyauthor=S.+Bourrainauthor=S.+Patelauthor=R.+Marwoodauthor=D.+O%E2%80%99Connorauthor=R.+Herbertauthor=P.+Hutsonauthor=M.+Rowley&title=3-%284-Piperidinyl%29-+and+3-%288-aza-bicyclo%5B3.2.1%5Doct-3-yl%29-2-phenyl-1H-indoles+as+bioavailable+h5-HT2A+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrawforth%26aufirst%3DJ.%26aulast%3DGoodacre%26aufirst%3DS.%26aulast%3DMaxey%26aufirst%3DR.%26aulast%3DBourrain%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DMarwood%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DD.%26aulast%3DHerbert%26aufirst%3DR.%26aulast%3DHutson%26aufirst%3DP.%26aulast%3DRowley%26aufirst%3DM.%26atitle%3D3-%25284-Piperidinyl%2529-%2520and%25203-%25288-aza-bicyclo%255B3.2.1%255Doct-3-yl%2529-2-phenyl-1H-indoles%2520as%2520bioavailable%2520h5-HT2A%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2701%26epage%3D2703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Iwamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casey, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadden, J. S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">4-(6-Fluorobenzisoxazol-3-yl)piperidine, a risperidone metabolite with serotonergic activity of potential clinical significance</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">â</span> <span class="NLM_lpage">601</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK28Xntlyqu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=593-601&author=T.+Iwamuraauthor=C.+T.+Caseyauthor=R.+Youngauthor=M.+Dukatauthor=M.+Teitlerauthor=J.+S.+P.+Faddenauthor=R.+A.+Glennon&title=4-%286-Fluorobenzisoxazol-3-yl%29piperidine%2C+a+risperidone+metabolite+with+serotonergic+activity+of+potential+clinical+significance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">4-(6-Fluorobenzisoxazol-3-yl)piperidine, a risperidone metabolite with serotonergic activity of potential clinical significance</span></div><div class="casAuthors">Iwamura, Tatsunori; Casey, Christina T.; Young, Richard; Dukat, Malgorzata; Teitler, Milt; Fadden, James S. P.; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">593-601</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser</span>)
        </div><div class="casAbstract">Because 6-FBIP [4-(6-fluorobenzisoxazol-3-yl)piperidine] has been identified as a metabolite of the antipsychotic agent risperidone, and due to its structural resemblance to certain serotonin agonists, it was of interest to det. whether or not this metabolite possesses any 5-HT2 activity of its own.  In comparing the binding of this agent with that of its non-metabolite positional isomer control, 5-FBIP, it was found that 6-FBIP (5-HT2A Ki = 49 nM) binds with only 16-fold lower affinity than risperidone, whereas the affinity of 5-FBIP is approx. 1000-fold lower.  In tests of functional activity (inositol phosphate prodn., stimulus generalization in DOM-trained rats), however, 6-FBIP behaved as a 5-HT2 antagonist.  It is concluded that 6-FBIP, although weaker than risperidone, would likely act as a 5-HT2 antagonist if it was produced to any significant extent upon metab. of risperidone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrPQwYU_o_qbVg90H21EOLACvtfcHk0liBmGWsyFbzCw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xntlyqu78%253D&md5=b6f7a0939ffeb639ccd7024873d28c32</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIwamura%26aufirst%3DT.%26aulast%3DCasey%26aufirst%3DC.%2BT.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DFadden%26aufirst%3DJ.%2BS.%2BP.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3D4-%25286-Fluorobenzisoxazol-3-yl%2529piperidine%252C%2520a%2520risperidone%2520metabolite%2520with%2520serotonergic%2520activity%2520of%2520potential%2520clinical%2520significance%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D1996%26volume%3D6%26spage%3D593%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Mattsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonesson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandahl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiner, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gassen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plaschke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leibrock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottcher, H.</span><span> </span><span class="NLM_article-title">2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1<i>H</i>-indoles as novel 5-HT6 receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4230</span><span class="NLM_x">â</span> <span class="NLM_lpage">4234</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4230-4234&author=C.+Mattssonauthor=C.+Sonessonauthor=A.+Sandahlauthor=H.+E.+Greinerauthor=M.+Gassenauthor=J.+Plaschkeauthor=J.+Leibrockauthor=H.+Bottcher&title=2-Alkyl-3-%281%2C2%2C3%2C6-tetrahydropyridin-4-yl%29-1H-indoles+as+novel+5-HT6+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMattsson%26aufirst%3DC.%26aulast%3DSonesson%26aufirst%3DC.%26aulast%3DSandahl%26aufirst%3DA.%26aulast%3DGreiner%26aufirst%3DH.%2BE.%26aulast%3DGassen%26aufirst%3DM.%26aulast%3DPlaschke%26aufirst%3DJ.%26aulast%3DLeibrock%26aufirst%3DJ.%26aulast%3DBottcher%26aufirst%3DH.%26atitle%3D2-Alkyl-3-%25281%252C2%252C3%252C6-tetrahydropyridin-4-yl%2529-1H-indoles%2520as%2520novel%25205-HT6%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4230%26epage%3D4234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merce, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guitart, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Codony, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dordal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andaluz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monroy, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cubi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanfeliu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, H.</span><span> </span><span class="NLM_article-title">Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1781</span><span class="NLM_x">â</span> <span class="NLM_lpage">1795</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049615n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1781-1795&author=J.+Holenzauthor=R.+Merceauthor=J.+L.+Diazauthor=X.+Guitartauthor=X.+Codonyauthor=A.+Dordalauthor=G.+Romeroauthor=A.+Torrensauthor=J.+Masauthor=B.+Andaluzauthor=S.+Hernandezauthor=X.+Monroyauthor=E.+Sanchezauthor=E.+Hernandezauthor=R.+Perezauthor=R.+Cubiauthor=O.+Sanfeliuauthor=H.+Buschmann&title=Medicinal+chemistry+driven+approaches+toward+novel+and+selective+serotonin+5-HT6+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm049615n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049615n%26sid%3Dliteratum%253Aachs%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DMerce%26aufirst%3DR.%26aulast%3DDiaz%26aufirst%3DJ.%2BL.%26aulast%3DGuitart%26aufirst%3DX.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DDordal%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DG.%26aulast%3DTorrens%26aufirst%3DA.%26aulast%3DMas%26aufirst%3DJ.%26aulast%3DAndaluz%26aufirst%3DB.%26aulast%3DHernandez%26aufirst%3DS.%26aulast%3DMonroy%26aufirst%3DX.%26aulast%3DSanchez%26aufirst%3DE.%26aulast%3DHernandez%26aufirst%3DE.%26aulast%3DPerez%26aufirst%3DR.%26aulast%3DCubi%26aufirst%3DR.%26aulast%3DSanfeliu%26aufirst%3DO.%26aulast%3DBuschmann%26aufirst%3DH.%26atitle%3DMedicinal%2520chemistry%2520driven%2520approaches%2520toward%2520novel%2520and%2520selective%2520serotonin%25205-HT6%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1781%26epage%3D1795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Liu, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowal, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Identification of a series of benzoxazoles as potent 5-HT6 ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1115</span><span class="NLM_x">â</span> <span class="NLM_lpage">1117</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1115-1117&author=K.+G.+Liuauthor=J.+R.+Loauthor=T.+A.+Comeryauthor=G.+M.+Zhangauthor=J.+Y.+Zhangauthor=D.+M.+Kowalauthor=D.+L.+Smithauthor=L.+Diauthor=E.+H.+Kernsauthor=L.+E.+Schechterauthor=A.+J.+Robichaud&title=Identification+of+a+series+of+benzoxazoles+as+potent+5-HT6+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%2BG.%26aulast%3DLo%26aufirst%3DJ.%2BR.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DZhang%26aufirst%3DG.%2BM.%26aulast%3DZhang%26aufirst%3DJ.%2BY.%26aulast%3DKowal%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520of%2520a%2520series%2520of%2520benzoxazoles%2520as%2520potent%25205-HT6%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1115%26epage%3D1117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanao, M.</span><span> </span><span class="NLM_article-title">Synthesis of 4-(benzo[<i>b</i>]furan-2 or 3-yl)- and 4-(benzo[<i>b</i>]thiophen-3-yl)piperidines with 5-HT2 anatagonistic activity</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">â</span> <span class="NLM_lpage">451</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1993&pages=445-451&author=Y.+Watanabeauthor=H.+Yoshiwaraauthor=M.+Kanao&title=Synthesis+of+4-%28benzo%5Bb%5Dfuran-2+or+3-yl%29-+and+4-%28benzo%5Bb%5Dthiophen-3-yl%29piperidines+with+5-HT2+anatagonistic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DYoshiwara%26aufirst%3DH.%26aulast%3DKanao%26aufirst%3DM.%26atitle%3DSynthesis%2520of%25204-%2528benzo%255Bb%255Dfuran-2%2520or%25203-yl%2529-%2520and%25204-%2528benzo%255Bb%255Dthiophen-3-yl%2529piperidines%2520with%25205-HT2%2520anatagonistic%2520activity%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1993%26volume%3D30%26spage%3D445%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Freter, K.</span><span> </span><span class="NLM_article-title">3-Cycloalkenylindoles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2525</span><span class="NLM_x">â</span> <span class="NLM_lpage">2529</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00905a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1975&pages=2525-2529&author=K.+Freter&title=3-Cycloalkenylindoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjo00905a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00905a023%26sid%3Dliteratum%253Aachs%26aulast%3DFreter%26aufirst%3DK.%26atitle%3D3-Cycloalkenylindoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1975%26volume%3D40%26spage%3D2525%26epage%3D2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Henning, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattrell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhards, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leven, M.</span><span> </span><span class="NLM_article-title">Synthesis and neuroleptic activity of a series of 1-[1-(benzo-1,4-dioxan-2-ylmethyl)-4-piperidinyl]benzim idazolone derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">814</span><span class="NLM_x">â</span> <span class="NLM_lpage">819</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00388a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=814-819&author=R.+Henningauthor=R.+Lattrellauthor=H.+J.+Gerhardsauthor=M.+Leven&title=Synthesis+and+neuroleptic+activity+of+a+series+of+1-%5B1-%28benzo-1%2C4-dioxan-2-ylmethyl%29-4-piperidinyl%5Dbenzim+idazolone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm00388a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00388a012%26sid%3Dliteratum%253Aachs%26aulast%3DHenning%26aufirst%3DR.%26aulast%3DLattrell%26aufirst%3DR.%26aulast%3DGerhards%26aufirst%3DH.%2BJ.%26aulast%3DLeven%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520neuroleptic%2520activity%2520of%2520a%2520series%2520of%25201-%255B1-%2528benzo-1%252C4-dioxan-2-ylmethyl%2529-4-piperidinyl%255Dbenzim%2520idazolone%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D814%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budhu, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malkowitz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMartino, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrin, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lineberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emini, E. A.</span><span> </span><span class="NLM_article-title">Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2129</span><span class="NLM_x">â</span> <span class="NLM_lpage">2134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2129-2134&author=D.+Kimauthor=L.+Wangauthor=J.+J.+Haleauthor=C.+L.+Lynchauthor=R.+J.+Budhuauthor=M.+Maccossauthor=S.+G.+Millsauthor=L.+Malkowitzauthor=S.+L.+Gouldauthor=J.+A.+DeMartinoauthor=M.+S.+Springerauthor=D.+Hazudaauthor=M.+Millerauthor=J.+Kesslerauthor=R.+C.+Hrinauthor=G.+Carverauthor=A.+Carellaauthor=K.+Henryauthor=J.+Linebergerauthor=W.+A.+Schleifauthor=E.+A.+Emini&title=Potent+1%2C3%2C4-trisubstituted+pyrrolidine+CCR5+receptor+antagonists%3A+effects+of+fused+heterocycles+on+antiviral+activity+and+pharmacokinetic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DBudhu%26aufirst%3DR.%2BJ.%26aulast%3DMaccoss%26aufirst%3DM.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DMalkowitz%26aufirst%3DL.%26aulast%3DGould%26aufirst%3DS.%2BL.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DSpringer%26aufirst%3DM.%2BS.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DKessler%26aufirst%3DJ.%26aulast%3DHrin%26aufirst%3DR.%2BC.%26aulast%3DCarver%26aufirst%3DG.%26aulast%3DCarella%26aufirst%3DA.%26aulast%3DHenry%26aufirst%3DK.%26aulast%3DLineberger%26aufirst%3DJ.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26atitle%3DPotent%25201%252C3%252C4-trisubstituted%2520pyrrolidine%2520CCR5%2520receptor%2520antagonists%253A%2520effects%2520of%2520fused%2520heterocycles%2520on%2520antiviral%2520activity%2520and%2520pharmacokinetic%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2129%26epage%3D2134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Sasakura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugasawa, T.</span><span> </span><span class="NLM_article-title">Simple synthesis of 1-(azacycloalkyl)indoles using exclusive ortho Î±-chloroacetylation of <i>N</i>-(azacycloalkyl)anilines</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">â</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1080%2F00397918808057833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaL1MXlslCmsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1988&pages=265-273&author=K.+Sasakuraauthor=M.+Adachiauthor=T.+Sugasawa&title=Simple+synthesis+of+1-%28azacycloalkyl%29indoles+using+exclusive+ortho+%CE%B1-chloroacetylation+of+N-%28azacycloalkyl%29anilines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Simple synthesis of 1-(azacycloalkyl)indoles using exclusive ortho Î±-chloroacetylation of N-(azacycloalkyl)anilines</span></div><div class="casAuthors">Sasakura, Kazuyuki; Adachi, Makoto; Sugasawa, Tsutomu</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-73</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">Indoles I (n = 1,2; R1 = H, F; R2 = H, halo, OMe) were prepd. from the resp. 2-amino-2-chloroacetophenones II (R3 = Me, PhCH2) by sequential hydride redn., cyclization, dealkylation-acylation with ClCO2Et, and deacylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj8knwOjktlbVg90H21EOLACvtfcHk0lhJSMLnZYC_MA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlslCmsw%253D%253D&md5=2300a382688a562b45abff99971142ea</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1080%2F00397918808057833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397918808057833%26sid%3Dliteratum%253Aachs%26aulast%3DSasakura%26aufirst%3DK.%26aulast%3DAdachi%26aufirst%3DM.%26aulast%3DSugasawa%26aufirst%3DT.%26atitle%3DSimple%2520synthesis%2520of%25201-%2528azacycloalkyl%2529indoles%2520using%2520exclusive%2520ortho%2520%25CE%25B1-chloroacetylation%2520of%2520N-%2528azacycloalkyl%2529anilines%26jtitle%3DSynth.%2520Commun.%26date%3D1988%26volume%3D18%26spage%3D265%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Efange, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelson, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, T. P.</span><span> </span><span class="NLM_article-title">Molecular size and flexibility as determinants of selectivity in the oxidation of <i>N</i>-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs by monoamine oxidase A and B</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1278</span><span class="NLM_x">â</span> <span class="NLM_lpage">1283</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00061a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=1278-1283&author=S.+M.+Efangeauthor=R.+H.+Michelsonauthor=A.+K.+Tanauthor=M.+J.+Kruegerauthor=T.+P.+Singer&title=Molecular+size+and+flexibility+as+determinants+of+selectivity+in+the+oxidation+of+N-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine+analogs+by+monoamine+oxidase+A+and+B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm00061a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00061a020%26sid%3Dliteratum%253Aachs%26aulast%3DEfange%26aufirst%3DS.%2BM.%26aulast%3DMichelson%26aufirst%3DR.%2BH.%26aulast%3DTan%26aufirst%3DA.%2BK.%26aulast%3DKrueger%26aufirst%3DM.%2BJ.%26aulast%3DSinger%26aufirst%3DT.%2BP.%26atitle%3DMolecular%2520size%2520and%2520flexibility%2520as%2520determinants%2520of%2520selectivity%2520in%2520the%2520oxidation%2520of%2520N-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine%2520analogs%2520by%2520monoamine%2520oxidase%2520A%2520and%2520B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D1278%26epage%3D1283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">da Silva, J. F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garden, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, A. C.</span><span> </span><span class="NLM_article-title">The chemistry of isatins: a review from 1975 to 1999</span> <span class="citation_source-journal">J. Braz. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">â</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1590%2FS0103-50532001000300002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktFejt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=273-324&author=J.+F.+M.+da+Silvaauthor=S.+J.+Gardenauthor=A.+C.+Pinto&title=The+chemistry+of+isatins%3A+a+review+from+1975+to+1999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">The chemistry of isatins: a review from 1975 to 1999</span></div><div class="casAuthors">Da Silva, Joaquim F. M.; Garden, Simon J.; Pinto, Angelo C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Brazilian Chemical Society</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-324</span>CODEN:
                <span class="NLM_cas:coden">JOCSET</span>;
        ISSN:<span class="NLM_cas:issn">0103-5053</span>.
    
            (<span class="NLM_cas:orgname">Sociedade Brasileira de Quimica</span>)
        </div><div class="casAbstract">A review with 637 refs. on prepn., reactions, characterizations, technol. applications, and pharmacol. activities of isatins and derivs.  Isatins (1H-indole-2,3-dione) are synthetically versatile substrates, where they can be used for the synthesis of a large variety of heterocyclic compds., such as indoles and quinolines, and as precursors for drug synthesis.  Isatins have also been found in mammalian tissue and their function as a modulator of biochem. processes has been the subject of several discussions.  The advances in the use of isatins for org. synthesis during the last twenty-five years, as well as a survey of its biol. and pharmacol. properties are reported in this review and in the accompanying supplementary information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYGv727EJmgLVg90H21EOLACvtfcHk0lhJSMLnZYC_MA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktFejt7c%253D&md5=5263f260528fa9bf1a18aae0fef66371</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1590%2FS0103-50532001000300002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0103-50532001000300002%26sid%3Dliteratum%253Aachs%26aulast%3Dda%2BSilva%26aufirst%3DJ.%2BF.%2BM.%26aulast%3DGarden%26aufirst%3DS.%2BJ.%26aulast%3DPinto%26aufirst%3DA.%2BC.%26atitle%3DThe%2520chemistry%2520of%2520isatins%253A%2520a%2520review%2520from%25201975%2520to%25201999%26jtitle%3DJ.%2520Braz.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D12%26spage%3D273%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Welch, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanau, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whalen, W. M.</span><span> </span><span class="NLM_article-title">A novel synthesis of 3-substituted indazole derivatives</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">â</span> <span class="NLM_lpage">939</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1055%2Fs-1992-26268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK3sXmvFWj" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&pages=937-939&author=W.+M.+Welchauthor=C.+E.+Hanauauthor=W.+M.+Whalen&title=A+novel+synthesis+of+3-substituted+indazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A novel synthesis of 3-substituted indazole derivatives</span></div><div class="casAuthors">Welch, Willard M.; Hanau, Catherine E.; Whalen, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">937-9</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">The dianion prepd. from 3-bromo-1H-indazole (I; R= Br) and alkyllithium bases reacts with a variety of electrophiles to give the corresponding 3-monosubstituted 1H-indazole derivs. I [R = Me, Ac, Bz, PhC(:NH), PhCH(OH), PhCMe(OH), Me2C(OH), 1-hyroxy-1-cyclohexyl] in moderate yields.  This procedure is more general and shorter than earlier methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR1wBGc8c7-rVg90H21EOLACvtfcHk0lhJSMLnZYC_MA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmvFWj&md5=33db904e64a3471ebbd953771aec1636</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1055%2Fs-1992-26268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1992-26268%26sid%3Dliteratum%253Aachs%26aulast%3DWelch%26aufirst%3DW.%2BM.%26aulast%3DHanau%26aufirst%3DC.%2BE.%26aulast%3DWhalen%26aufirst%3DW.%2BM.%26atitle%3DA%2520novel%2520synthesis%2520of%25203-substituted%2520indazole%2520derivatives%26jtitle%3DSynthesis%26date%3D1992%26spage%3D937%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Grandy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchionni, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stofko, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frothingham, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke-Howie, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Server, A. C.</span><span> </span><span class="NLM_article-title">Cloning of the cDNA and gene for a human D2 dopamine receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">9762</span><span class="NLM_x">â</span> <span class="NLM_lpage">9766</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1989&pages=9762-9766&author=D.+K.+Grandyauthor=M.+A.+Marchionniauthor=H.+Makamauthor=R.+E.+Stofkoauthor=M.+Alfanoauthor=L.+Frothinghamauthor=J.+B.+Fischerauthor=K.+J.+Burke-Howieauthor=J.+R.+Bunzowauthor=A.+C.+Server&title=Cloning+of+the+cDNA+and+gene+for+a+human+D2+dopamine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DMarchionni%26aufirst%3DM.%2BA.%26aulast%3DMakam%26aufirst%3DH.%26aulast%3DStofko%26aufirst%3DR.%2BE.%26aulast%3DAlfano%26aufirst%3DM.%26aulast%3DFrothingham%26aufirst%3DL.%26aulast%3DFischer%26aufirst%3DJ.%2BB.%26aulast%3DBurke-Howie%26aufirst%3DK.%2BJ.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DServer%26aufirst%3DA.%2BC.%26atitle%3DCloning%2520of%2520the%2520cDNA%2520and%2520gene%2520for%2520a%2520human%2520D2%2520dopamine%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1989%26volume%3D86%26spage%3D9762%26epage%3D9766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Tatsumi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richelson, E.</span><span> </span><span class="NLM_article-title">Pharmacological profile of neuroleptics at human monoamine transporters</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">â</span> <span class="NLM_lpage">283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2FS0014-2999%2899%2900005-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=10193665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK1MXhs1OitLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=1999&pages=277-283&author=M.+Tatsumiauthor=K.+Jansenauthor=R.+D.+Blakelyauthor=E.+Richelson&title=Pharmacological+profile+of+neuroleptics+at+human+monoamine+transporters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of neuroleptics at human monoamine transporters</span></div><div class="casAuthors">Tatsumi, Masahiko; Jansen, Karen; Blakely, Randy D.; Richelson, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">277-283</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Using radioligand binding techniques, the authors detd. the equil. dissocn. consts. (KD) for 37 neuroleptics and one metabolite of a neuroleptic (haloperidol metabolite) for the human serotonin, norepinephrine, and dopamine transporters with [3H]imipramine, [3H]nisoxetine, and [3H]WIN35428, resp.  Among neuroleptics, the four most potent compds. at the human serotonin transporter were triflupromazine, fluperlapine, chlorpromazine, and ziprasidone (KD 24-39 nM); and at the norepinephrine transporter, chlorpromazine, zotepine, chlorprothixene, and promazine (KD 19-25 nM).  At the human dopamine transporter, only pimozide (KD=69) ziprasidone (KD=76) had notable potency.  These data may be useful in predicting therapeutic and adverse effects, including drug interactions of neuroleptics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk1A_X0jOFkrVg90H21EOLACvtfcHk0lj-30ESORHcBw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhs1OitLk%253D&md5=607c3d5404d625efb8b6558d78330f77</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2899%2900005-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252899%252900005-9%26sid%3Dliteratum%253Aachs%26aulast%3DTatsumi%26aufirst%3DM.%26aulast%3DJansen%26aufirst%3DK.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DPharmacological%2520profile%2520of%2520neuroleptics%2520at%2520human%2520monoamine%2520transporters%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D368%26spage%3D277%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Cesura, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galva, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imhof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Prada, M.</span><span> </span><span class="NLM_article-title">Characterization of the binding of [<sup>3</sup>H]Ro 41-1049 to the active site of human monoamine oxidase-A</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">â</span> <span class="NLM_lpage">366</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1990&pages=358-366&author=A.+M.+Cesuraauthor=M.+Bosauthor=M.+D.+Galvaauthor=R.+Imhofauthor=M.+Da+Prada&title=Characterization+of+the+binding+of+%5B3H%5DRo+41-1049+to+the+active+site+of+human+monoamine+oxidase-A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCesura%26aufirst%3DA.%2BM.%26aulast%3DBos%26aufirst%3DM.%26aulast%3DGalva%26aufirst%3DM.%2BD.%26aulast%3DImhof%26aufirst%3DR.%26aulast%3DDa%2BPrada%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520the%2520binding%2520of%2520%255B3H%255DRo%252041-1049%2520to%2520the%2520active%2520site%2520of%2520human%2520monoamine%2520oxidase-A%26jtitle%3DMol.%2520Pharmacol.%26date%3D1990%26volume%3D37%26spage%3D358%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Mulheron, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casanas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnovskaya, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gettys, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, J. R.</span><span> </span><span class="NLM_article-title">Human 5-HT1A receptor expressed in insect cells activates endogenous G(o)-like G protein(s)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">12954</span><span class="NLM_x">â</span> <span class="NLM_lpage">12962</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=12954-12962&author=J.+G.+Mulheronauthor=S.+J.+Casanasauthor=J.+M.+Arthurauthor=M.+N.+Garnovskayaauthor=T.+W.+Gettysauthor=J.+R.+Raymond&title=Human+5-HT1A+receptor+expressed+in+insect+cells+activates+endogenous+G%28o%29-like+G+protein%28s%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMulheron%26aufirst%3DJ.%2BG.%26aulast%3DCasanas%26aufirst%3DS.%2BJ.%26aulast%3DArthur%26aufirst%3DJ.%2BM.%26aulast%3DGarnovskaya%26aufirst%3DM.%2BN.%26aulast%3DGettys%26aufirst%3DT.%2BW.%26aulast%3DRaymond%26aufirst%3DJ.%2BR.%26atitle%3DHuman%25205-HT1A%2520receptor%2520expressed%2520in%2520insect%2520cells%2520activates%2520endogenous%2520G%2528o%2529-like%2520G%2520protein%2528s%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D12954%26epage%3D12962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Bonhaus, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSouza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salazar, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuppan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eglen, R. M.</span><span> </span><span class="NLM_article-title">The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">622</span><span class="NLM_x">â</span> <span class="NLM_lpage">628</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1111%2Fj.1476-5381.1995.tb14977.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=7582481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK2MXmtlOht7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1995&pages=622-628&author=D.+W.+Bonhausauthor=C.+Bachauthor=A.+DeSouzaauthor=F.+H.+Salazarauthor=B.+D.+Matsuokaauthor=P.+Zuppanauthor=H.+W.+Chanauthor=R.+M.+Eglen&title=The+pharmacology+and+distribution+of+human+5-hydroxytryptamine2B+%285-HT2B%29+receptor+gene+products%3A+comparison+with+5-HT2A+and+5-HT2C+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors</span></div><div class="casAuthors">Bonhaus, Douglas W.; Bach, Chinh; DeSouza, Andrea; Salazar, R. H. Rick; Matsuoka, Barbara D.; Zuppan, Patricia; Chan, Hardy W.; Eglen, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">622-8</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Scientific & Medical Division</span>)
        </div><div class="casAbstract">Full length clones of the human 5-HT2B receptor were isolated from human liver, kidney and pancreas.  The cloned human 5-HT2B receptors had a high degree of homol. (â¼80%) with the rat and mouse 5-HT2B receptors.  PCR amplification was used to det. the tissue distribution of human 5-HT2B receptor mRNA.  MRNA encoding the 5-HT2B receptor was expressed with greatest abundance in human liver and kidney.  Lower levels of expression were detected in cerebral cortex, whole brain, pancreas and spleen.  Expression was not detected in heart.  Northern blot anal. confirmed the presence of 5-HT2B receptor mRNA (a 2.4 kB sized band) in pancreas, liver and kidney.  An addnl. 3.2 kB sized band of hybridization was detected in liver and kidney.  This raises the possibility of a splice variant of the receptor or the presence of an addnl. homologous receptor.  The human 5-HT2B receptor was expressed in Cos-7 cells and its ligand binding characteristics were compared to similarly expressed human 5-HT2A and 5-HT2C receptors.  The ligand specificity of the human 5-HT2B receptor (5-HT > ritanserin > SB 204741 > spiperone) was distinct from that of the human 5-HT2A (ritanserin > spiperone > 5-HT > SB 204741) and 5-HT2C (ritanserin > 5-HT > spiperone = SB 204741) receptors.  On the basis of a higher affinity for ketanserin and a lower affinity for yohimbine the human 5-HT2B receptor also appeared to differ from the rat 5-HT2B receptor.  These findings confirm the sequence of the human 5-HT2B receptor and they demonstrate that the receptor has a widespread tissue distribution.  In addn., these data suggest that there are differences in ligand affinities between different species homologues of the receptor.  Finally, the finding of two distinct bands on the Northern blots of liver and kidney raises the possibility of splice variants or subtypes of 5-HT2B receptors, within these tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo79mR3s8H2nLVg90H21EOLACvtfcHk0lj-30ESORHcBw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtlOht7k%253D&md5=55752ff530149d3ac96e5d9082c3e5d6</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb14977.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb14977.x%26sid%3Dliteratum%253Aachs%26aulast%3DBonhaus%26aufirst%3DD.%2BW.%26aulast%3DBach%26aufirst%3DC.%26aulast%3DDeSouza%26aufirst%3DA.%26aulast%3DSalazar%26aufirst%3DF.%2BH.%26aulast%3DMatsuoka%26aufirst%3DB.%2BD.%26aulast%3DZuppan%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DH.%2BW.%26aulast%3DEglen%26aufirst%3DR.%2BM.%26atitle%3DThe%2520pharmacology%2520and%2520distribution%2520of%2520human%25205-hydroxytryptamine2B%2520%25285-HT2B%2529%2520receptor%2520gene%2520products%253A%2520comparison%2520with%25205-HT2A%2520and%25205-HT2C%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D115%26spage%3D622%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Monsma, F. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamblin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span> </span><span class="NLM_article-title">Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">â</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=7680751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK3sXktVWisb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1993&pages=320-327&author=F.+J.+Monsmaauthor=Y.+Shenauthor=R.+P.+Wardauthor=M.+W.+Hamblinauthor=D.+R.+Sibley&title=Cloning+and+expression+of+a+novel+serotonin+receptor+with+high+affinity+for+tricyclic+psychotropic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs</span></div><div class="casAuthors">Monsma, Frederick J., Jr.; Shen, Yong; Ward, Raymond P.; Hamblin, Mark W.; Sibley, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">320-7</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The polymerase chain reaction technique was used to selectively amplify a guanine nucleotide-binding protein-coupled receptor cDNA sequence from rat striatal mRNA that exhibits high homol. to previously cloned serotonin receptors.  Sequencing of a full length clone isolated from a rat striatal cDNA library revealed an open reading frame of 1311 base pairs, encoding a 437-residue protein with 7 hydrophobic regions.  Within these hydrophobic regions, this receptor was 36-41% identical to the following serotonin (5-HT) receptors: 5-HT2 > 5-HT1D > 5-HT1C > 5-HT1B > 5-HT1A > 5-HT1E.  Northern blots revealed a â¼4.2-kilobase transcript localized in various brain regions, with the following rank order of abundance: striatum Â» olfactory tubercle > cerebral cortex > hippocampus.  Expression of this clone in COS-7 cells resulted in the appearance of high affinity, saturable binding of (+)-[2-125I]iodolyzergic acid diethylamide ([125I]LSD) with a Kd of 1.26 nM.  Among endogenous biogenic amines, only 5-HT completely inhibited [125I]LSD binding (Ki = 150 nM).  The inhibition of [125I]LSD binding by other serotonergic agonists and antagonists revealed a pharmacol. profile that does not correlate with that of any previously described serotonin receptor subtype.  In addn., this receptor exhibits high affinity for a no. of tricyclic antipsychotic and antidepressant drugs, including clozapine, amoxipine, and amitriptyline.  In HEK-293 cells stably transfected with this receptor, serotonin elicits a potent stimulation of adenylyl cyclase activity, which is blocked by antipsychotic and antidepressant drugs.  The distinct structural and pharmacol. properties of this receptor site indicate that it represents a completely novel subtype of serotonin receptor.  Based on its affinity for tricyclic psychotropic drugs and its localization to limbic and cortical regions of the brain, it is likely that this receptor may play a role in several neuropsychiatric disorders that involve serotonergic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktsaVgvzJ9LVg90H21EOLACvtfcHk0ljbU_dnBgubtw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXktVWisb8%253D&md5=c8b46ab9e3591b6ea473459f18f006ea</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DWard%26aufirst%3DR.%2BP.%26aulast%3DHamblin%26aufirst%3DM.%2BW.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26atitle%3DCloning%2520and%2520expression%2520of%2520a%2520novel%2520serotonin%2520receptor%2520with%2520high%2520affinity%2520for%2520tricyclic%2520psychotropic%2520drugs%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D43%26spage%3D320%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Ricci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronzetti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felici, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amenta, F.</span><span> </span><span class="NLM_article-title">Labeling of dopamine D3 and D4 receptor subtypes in human peripheral blood lymphocytes with [<sup>3</sup>H]7-OH-DPAT: a combined radioligand binding assay and immunochemical study</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">â</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2FS0165-5728%2898%2900207-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=9916894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK1cXnvVWisLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=191-195&author=A.+Ricciauthor=E.+Bronzettiauthor=L.+Feliciauthor=S.+Grecoauthor=F.+Amenta&title=Labeling+of+dopamine+D3+and+D4+receptor+subtypes+in+human+peripheral+blood+lymphocytes+with+%5B3H%5D7-OH-DPAT%3A+a+combined+radioligand+binding+assay+and+immunochemical+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Labeling of dopamine D3 and D4 receptor subtypes in human peripheral blood lymphocytes with [3H]7-OH-DPAT: a combined radioligand binding assay and immunochemical study</span></div><div class="casAuthors">Ricci, Alberto; Bronzetti, Elena; Felici, Laura; Greco, Stefania; Amenta, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">191-195</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Mol. biol. studies have demonstrated that human peripheral blood lymphocytes express dopamine D2-like receptors belonging to the D3 and D4 receptor subtypes, whereas the characterization of these receptors using radioligand binding assay techniques provided conflicting results.  The preferential dopamine D3 receptor agonist [3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin ([3H]7-OH-DPAT) was used recently for labeling lymphocyte dopamine D3 receptor.  However, the selectivity of this compd. for the D3 receptor was questioned.  In this study we have investigated human peripheral blood lymphocyte dopamine receptor subtypes labeled by [3H]7-OH-DPAT using a conventional radioligand binding assay technique and antibodies against dopamine D2-like receptor subtypes.  [3H]7-OH-DPAT was specifically bound to intact human peripheral blood lymphocytes with a dissocn. const. (Kd) value of 0.32+0.03 nM and a max. d. of binding sites (Bmax) of 18.2+0.8 fmol/2Ã106 cells.  [3H]7-OH-DPAT binding was unaffected by antibodies against dopamine D2 and D2S receptors.  Anti-dopamine D3 and D4 receptor antibodies reduced [3H]7-OH-DPAT binding by about 53% and 32% resp.  Combination of anti D3 and D4 receptor antibodies reduced remarkably [3H]7-OH-DPAT binding.  The above results suggest that the dopamine receptor agonist [3H]7-OH-DPAT labels dopamine D3 and D4 receptor subtypes in human peripheral blood lymphocytes.  The use of antibodies raised against dopamine receptor subtypes in combination with radioligand binding assay may contribute to define receptor subtypes expressed by human peripheral blood lymphocytes in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8wJD81ec6E7Vg90H21EOLACvtfcHk0ljbU_dnBgubtw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvVWisLw%253D&md5=ed71ff6b6524ef876e5cb285c603b475</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2FS0165-5728%2898%2900207-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-5728%252898%252900207-0%26sid%3Dliteratum%253Aachs%26aulast%3DRicci%26aufirst%3DA.%26aulast%3DBronzetti%26aufirst%3DE.%26aulast%3DFelici%26aufirst%3DL.%26aulast%3DGreco%26aufirst%3DS.%26aulast%3DAmenta%26aufirst%3DF.%26atitle%3DLabeling%2520of%2520dopamine%2520D3%2520and%2520D4%2520receptor%2520subtypes%2520in%2520human%2520peripheral%2520blood%2520lymphocytes%2520with%2520%255B3H%255D7-OH-DPAT%253A%2520a%2520combined%2520radioligand%2520binding%2520assay%2520and%2520immunochemical%2520study%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D1998%26volume%3D92%26spage%3D191%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Tol, H. H. M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civelli, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niznik, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jovanovic, V.</span><span> </span><span class="NLM_article-title">Multiple dopamine D4 receptor variants in the human population</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">â</span> <span class="NLM_lpage">152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=1992&pages=149-152&author=H.+H.+M.+V.+Tolauthor=C.+M.+Wuauthor=H.-C.+Guanauthor=K.+Oharaauthor=J.+R.+Bunzowauthor=O.+Civelliauthor=J.+Kennedyauthor=P.+Seemanauthor=H.+B.+Niznikauthor=V.+Jovanovic&title=Multiple+dopamine+D4+receptor+variants+in+the+human+population"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTol%26aufirst%3DH.%2BH.%2BM.%2BV.%26aulast%3DWu%26aufirst%3DC.%2BM.%26aulast%3DGuan%26aufirst%3DH.-C.%26aulast%3DOhara%26aufirst%3DK.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DCivelli%26aufirst%3DO.%26aulast%3DKennedy%26aufirst%3DJ.%26aulast%3DSeeman%26aufirst%3DP.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26aulast%3DJovanovic%26aufirst%3DV.%26atitle%3DMultiple%2520dopamine%2520D4%2520receptor%2520variants%2520in%2520the%2520human%2520population%26jtitle%3DNature%26date%3D1992%26volume%3D358%26spage%3D149%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Nyronen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pihlavisto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peltonen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffren, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salminen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurster, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marjamaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanerva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katainen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laaksonen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savola, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheinin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. S.</span><span> </span><span class="NLM_article-title">Molecular mechanism for agonist-promoted alpha(2A)-adrenoceptor activation by norepinephrine and epinephrine</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1343</span><span class="NLM_x">â</span> <span class="NLM_lpage">1354</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=1343-1354&author=T.+Nyronenauthor=M.+Pihlavistoauthor=J.+M.+Peltonenauthor=A.+M.+Hoffrenauthor=M.+Varisauthor=T.+Salminenauthor=S.+Wursterauthor=A.+Marjamakiauthor=L.+Kanervaauthor=E.+Katainenauthor=L.+Laaksonenauthor=J.+M.+Savolaauthor=M.+Scheininauthor=M.+S.+Johnson&title=Molecular+mechanism+for+agonist-promoted+alpha%282A%29-adrenoceptor+activation+by+norepinephrine+and+epinephrine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNyronen%26aufirst%3DT.%26aulast%3DPihlavisto%26aufirst%3DM.%26aulast%3DPeltonen%26aufirst%3DJ.%2BM.%26aulast%3DHoffren%26aufirst%3DA.%2BM.%26aulast%3DVaris%26aufirst%3DM.%26aulast%3DSalminen%26aufirst%3DT.%26aulast%3DWurster%26aufirst%3DS.%26aulast%3DMarjamaki%26aufirst%3DA.%26aulast%3DKanerva%26aufirst%3DL.%26aulast%3DKatainen%26aufirst%3DE.%26aulast%3DLaaksonen%26aufirst%3DL.%26aulast%3DSavola%26aufirst%3DJ.%2BM.%26aulast%3DScheinin%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26atitle%3DMolecular%2520mechanism%2520for%2520agonist-promoted%2520alpha%25282A%2529-adrenoceptor%2520activation%2520by%2520norepinephrine%2520and%2520epinephrine%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D59%26spage%3D1343%26epage%3D1354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Pristupa, Z. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niznik, H. B.</span><span> </span><span class="NLM_article-title">Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [<sup>3</sup>H]WIN 35,428 and [<sup>3</sup>H]GBR 12,935 binding</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">â</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=8302271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFemu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=125-135&author=Z.+B.+Pristupaauthor=J.+M.+Wilsonauthor=B.+J.+Hoffmanauthor=S.+J.+Kishauthor=H.+B.+Niznik&title=Pharmacological+heterogeneity+of+the+cloned+and+native+human+dopamine+transporter%3A+disassociation+of+%5B3H%5DWIN+35%2C428+and+%5B3H%5DGBR+12%2C935+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding</span></div><div class="casAuthors">Pristupa, Zdenek B.; Wilson, Julie M.; Hoffman, Beth J.; Kish, Stephen J.; Niznik, Hyman B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-35</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Controversy exists as to whether the functional state of the dopamine (DA) transporter is identical to sites mediating the specific binding of selective DA transporter radioligands.  Therefore, the authors compared the pharmacol. profile of numerous dopamine transport substrates and inhibitors on [3H]DA uptake with the binding of [3H]WIN 35,428 and [3H]GBR 12,935 to COS-7 cells transiently expressing the cloned human DA transporter.  [3H]DA uptake and [3H]WIN 35,428 binding was specific, saturable, and to a single class of binding sites with an estd. Km/Vmax of â¼2 Î¼M and 6 pmol/min/105 cells for DA uptake and Kd/Bmax values of â¼10 nM and 113 fmol/105 cells for [3H]WIN 35,428.  [3H]DA uptake was inhibited in a concn.-dependent and uniphasic manner by dopaminergic agents with an appropriate rank order of potency for the DA transporter.  Although most uptake blockers inhibited [3H]WIN 35,428 binding in a uniphasic manner, WIN 35,428, Lu 19,005, D-amphetamine, and DA clearly displayed the presence of both high and low affinity components.  Comparison of the Ki values for the inhibition of [3H]DA uptake with [3H]WIN 35,428 binding reveals that, for uptake blockers and D-amphetamine, it is the high affinity component that shares pharmacol. identity with effects on DA uptake (r = 0.9985), whereas for DA it is the low affinity site.  In striking contrast, however, [3H]GBR 12,935 binding to COS-7 cells could not be made to exhibit a pharmacol. profile indicative of the DA transporter and suggests that the site regulating functional [3H]DA uptake may not be identical with sites labeled by [3H]GBR 12,935 in these cells.  Moreover, these sites appear unrelated to those previously described in native membranes as "piperazine acceptor" or P 450 proteins.  Comparison of Ki values and rank order of potency for the inhibition of [3H]WIN 35,428 or [3H]GBR 12,935 binding to human caudate membranes reveals pharmacol. homol., but not identity, with that of the cloned DA uptake process.  Taken together, these data suggest that 1) [3H]WIN 35,428 recognizes two sites of the DA transporter, of which only one appears to represent the functional state of the protein, and 2) [3H]WIN 35,428 and [3H]GBR 12,935 do not appear to bind the same functional form/state of the DA transporter.  Whether the nonidentity of binding sites is a manifestation of some post-translational regulatory event (e.g., phosphorylation/accessory binding protein) or caused by the existence of multiple mol. forms of the DA transporter is currently unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU2Vc8HuOAsLVg90H21EOLACvtfcHk0liP_r_4WmhzdQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFemu7c%253D&md5=a6ce271aad17d6f7f282bd716bbd1ddf</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPristupa%26aufirst%3DZ.%2BB.%26aulast%3DWilson%26aufirst%3DJ.%2BM.%26aulast%3DHoffman%26aufirst%3DB.%2BJ.%26aulast%3DKish%26aufirst%3DS.%2BJ.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26atitle%3DPharmacological%2520heterogeneity%2520of%2520the%2520cloned%2520and%2520native%2520human%2520dopamine%2520transporter%253A%2520disassociation%2520of%2520%255B3H%255DWIN%252035%252C428%2520and%2520%255B3H%255DGBR%252012%252C935%2520binding%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D45%26spage%3D125%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Sibley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lean, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creese, I.</span><span> </span><span class="NLM_article-title">Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">6351</span><span class="NLM_x">â</span> <span class="NLM_lpage">6361</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=6176582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaL38XktFyjs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1982&pages=6351-6361&author=D.+R.+Sibleyauthor=A.+D.+Leanauthor=I.+Creese&title=Anterior+pituitary+dopamine+receptors.+Demonstration+of+interconvertible+high+and+low+affinity+states+of+the+D-2+dopamine+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Anterior pituitary dopamine receptors.  Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor</span></div><div class="casAuthors">Sibley, David R.; De Lean, Andre; Creese, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6351-61</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The interactions of dopaminergic agonists and antagonists with binding sites in bovine anterior pituitary membranes have been investigated with radioligand-binding techniques and computer-modeling procedures.  3H-labeled agonist (3H-agonist) binding is stereospecific, reversible, saturable, and of high affinity.  The rank order of catecholamines, phenothiazines, and related drugs in competing for 3H-agonist binding is indicative of interactions with a D-2 dopamine receptor.  Both agonist/3H-agonist and antagonist/3H-agonist competition curves are monophasic and noncooperative, with computer anal. indicating a single class of binding sites.  Sp. 3H-agonist binding can be completely inhibited by guanine nucleotides.  guanyl-5'-yl imidodiphosphate  [34273-04-6] Is the most potent nucleotide, followed by GTP  [86-01-1] and GDP  [146-91-8] which are equipotent.  The equil. binding capacity for 3H-labeled antagonists (3H-antagonists) is twice that for 3H-agonists.  Unlabeled antagonists inhibit 3H-antagonist binding competitively and exhibit antagonist/3H-antagonist competition curves which model best to a state of homogeneous affinity.  In contrast, unlabeled agonists inhibit 3H-antagonist binding in a heterogeneous fashion displaying multiphasic competition curves which can be resolved into high- and low-affinity binding sites.  In the presence of satg. concns. of guanine nucleotides, however, the agonist/3H-antagonist curves model best to a single affinity state which is identical with the low-affinity state seen in control curves.  The binding data can be explained by postulating 2 states of the D-2 dopamine receptor, inducible by agonists but not antagonists and modulated by guanine nucleotides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPIbAAeUc1SLVg90H21EOLACvtfcHk0liP_r_4WmhzdQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XktFyjs7Y%253D&md5=a5474a2efe8c5e0c50e9bd939f759c9d</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DLean%26aufirst%3DA.%2BD.%26aulast%3DCreese%26aufirst%3DI.%26atitle%3DAnterior%2520pituitary%2520dopamine%2520receptors.%2520Demonstration%2520of%2520interconvertible%2520high%2520and%2520low%2520affinity%2520states%2520of%2520the%2520D-2%2520dopamine%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1982%26volume%3D257%26spage%3D6351%26epage%3D6361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Wreggett, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lean, A.</span><span> </span><span class="NLM_article-title">The ternary complex model. Its properties and application to ligand interactions with the D2-dopamine receptor of the anterior pituitary gland</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">â</span> <span class="NLM_lpage">227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1984&pages=214-227&author=K.+A.+Wreggettauthor=A.+De+Lean&title=The+ternary+complex+model.+Its+properties+and+application+to+ligand+interactions+with+the+D2-dopamine+receptor+of+the+anterior+pituitary+gland"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWreggett%26aufirst%3DK.%2BA.%26aulast%3DDe%2BLean%26aufirst%3DA.%26atitle%3DThe%2520ternary%2520complex%2520model.%2520Its%2520properties%2520and%2520application%2520to%2520ligand%2520interactions%2520with%2520the%2520D2-dopamine%2520receptor%2520of%2520the%2520anterior%2520pituitary%2520gland%26jtitle%3DMol.%2520Pharmacol.%26date%3D1984%26volume%3D26%26spage%3D214%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Hamblin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leff, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creese, I.</span><span> </span><span class="NLM_article-title">Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">â</span> <span class="NLM_lpage">887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1984&pages=877-887&author=M.+W.+Hamblinauthor=S.+E.+Leffauthor=I.+Creese&title=Interactions+of+agonists+with+D-2+dopamine+receptors%3A+evidence+for+a+single+receptor+population+existing+in+multiple+agonist+affinity-states+in+rat+striatal+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHamblin%26aufirst%3DM.%2BW.%26aulast%3DLeff%26aufirst%3DS.%2BE.%26aulast%3DCreese%26aufirst%3DI.%26atitle%3DInteractions%2520of%2520agonists%2520with%2520D-2%2520dopamine%2520receptors%253A%2520evidence%2520for%2520a%2520single%2520receptor%2520population%2520existing%2520in%2520multiple%2520agonist%2520affinity-states%2520in%2520rat%2520striatal%2520membranes%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1984%26volume%3D33%26spage%3D877%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Lahti, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figur, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piercey, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruppel, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. L.</span><span> </span><span class="NLM_article-title">Intrinsic activity determinations at the dopamine D2 guanine nucleotide-binding protein-coupled receptor: utilization of receptor state binding affinities</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">432</span><span class="NLM_x">â</span> <span class="NLM_lpage">439</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1992&pages=432-439&author=R.+A.+Lahtiauthor=L.+M.+Figurauthor=M.+F.+Pierceyauthor=P.+L.+Ruppelauthor=D.+L.+Evans&title=Intrinsic+activity+determinations+at+the+dopamine+D2+guanine+nucleotide-binding+protein-coupled+receptor%3A+utilization+of+receptor+state+binding+affinities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLahti%26aufirst%3DR.%2BA.%26aulast%3DFigur%26aufirst%3DL.%2BM.%26aulast%3DPiercey%26aufirst%3DM.%2BF.%26aulast%3DRuppel%26aufirst%3DP.%2BL.%26aulast%3DEvans%26aufirst%3DD.%2BL.%26atitle%3DIntrinsic%2520activity%2520determinations%2520at%2520the%2520dopamine%2520D2%2520guanine%2520nucleotide-binding%2520protein-coupled%2520receptor%253A%2520utilization%2520of%2520receptor%2520state%2520binding%2520affinities%26jtitle%3DMol.%2520Pharmacol.%26date%3D1992%26volume%3D42%26spage%3D432%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Kongsamut, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roehr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampe, D.</span><span> </span><span class="NLM_article-title">A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">â</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2FS0014-2999%2802%2902074-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=12176106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtlKjsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2002&pages=37-41&author=S.+Kongsamutauthor=J.+Kangauthor=X.+L.+Chenauthor=J.+Roehrauthor=D.+Rampe&title=A+comparison+of+the+receptor+binding+and+HERG+channel+affinities+for+a+series+of+antipsychotic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs</span></div><div class="casAuthors">Kongsamut, Sathapana; Kang, Jiesheng; Chen, Xiao-Liang; Roehr, Joachim; Rampe, David</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">450</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-41</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Many antipsychotic drugs produce QT interval prolongation on the ECG.  Blockade of the human cardiac K+ channel known as human ether-a-go-go-related gene (HERG) often underlies such clin. findings.  In fact, HERG channel inhibition is now commonly used as a screen to predict the ability of a drug to prolong QT interval.  However, the exact relation between HERG channel blockade, target receptor binding affinity and clin. QT prolongation is not known.  Using patch-clamp electrophysiol., the authors examd. a series of seven antipsychotic drugs for their ability to block HERG, and detd. their IC50 values.  The authors then compared these results to their binding affinities (Ki values) for the dopamine D2 receptor, the 5-HT2A receptor and, where available, to clin. QT prolongation data.  The authors found that sertindole, pimozide and thioridazine displayed little (<10-fold) or no selectivity for dopamine D2 or 5-HT2A receptors relative to their HERG channel affinities.  This lack of selectivity likely underlies the significant QT interval prolongation obsd. with administration of these drugs.  Of the other drugs tested (ziprasidone, quetiapine, risperidone and olanzapine), olanzapine displayed the greatest selectivity for dopamine D2 and 5-HT2A receptor binding (100-1000-fold) compared to its HERG channel IC50.  The authors also compared these HERG channel IC50 values to QT interval prolongation and plasma drug levels obtained in a recent clin. study.  The authors found that the ratio of total plasma drug concn. to HERG IC50 value was indicative of the degree of QT prolongation obsd.  Target receptor affinity and expected clin. plasma levels are important parameters to consider for the interpretation of HERG channel data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1PPyFCa8xyrVg90H21EOLACvtfcHk0ljEtIcrxeqQ8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtlKjsbo%253D&md5=8b5879e5d59e01dcd490e71d57844fdf</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902074-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902074-5%26sid%3Dliteratum%253Aachs%26aulast%3DKongsamut%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%2BL.%26aulast%3DRoehr%26aufirst%3DJ.%26aulast%3DRampe%26aufirst%3DD.%26atitle%3DA%2520comparison%2520of%2520the%2520receptor%2520binding%2520and%2520HERG%2520channel%2520affinities%2520for%2520a%2520series%2520of%2520antipsychotic%2520drugs%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D450%26spage%3D37%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Di Santo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Befani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meninno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agostinelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmegiani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirilli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferretti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallinella, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Torre, F.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological activities of pyrrolylethanoneamine derivatives, a novel class of monoamine oxidases inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4220</span><span class="NLM_x">â</span> <span class="NLM_lpage">4223</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050172c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4220-4223&author=R.+Di+Santoauthor=R.+Costiauthor=A.+Rouxauthor=M.+Articoauthor=O.+Befaniauthor=T.+Meninnoauthor=E.+Agostinelliauthor=P.+Palmegianiauthor=P.+Turiniauthor=R.+Cirilliauthor=R.+Ferrettiauthor=B.+Gallinellaauthor=F.+La+Torre&title=Design%2C+synthesis%2C+and+biological+activities+of+pyrrolylethanoneamine+derivatives%2C+a+novel+class+of+monoamine+oxidases+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm050172c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050172c%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BSanto%26aufirst%3DR.%26aulast%3DCosti%26aufirst%3DR.%26aulast%3DRoux%26aufirst%3DA.%26aulast%3DArtico%26aufirst%3DM.%26aulast%3DBefani%26aufirst%3DO.%26aulast%3DMeninno%26aufirst%3DT.%26aulast%3DAgostinelli%26aufirst%3DE.%26aulast%3DPalmegiani%26aufirst%3DP.%26aulast%3DTurini%26aufirst%3DP.%26aulast%3DCirilli%26aufirst%3DR.%26aulast%3DFerretti%26aufirst%3DR.%26aulast%3DGallinella%26aufirst%3DB.%26aulast%3DLa%2BTorre%26aufirst%3DF.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activities%2520of%2520pyrrolylethanoneamine%2520derivatives%252C%2520a%2520novel%2520class%2520of%2520monoamine%2520oxidases%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4220%26epage%3D4223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Brunton, L. L.; Chabner, B. A.; Knollmann, B. C.</span> <span class="citation_source-book">Goodman & Gilmanâs The Pharmacological Basis of Therapeutics</span>, <span class="NLM_edition">12</span>th ed.; <span class="NLM_publisher-name">Macmillan Publishing Co.</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">169</span><span class="NLM_x">â</span> <span class="NLM_lpage">649</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=169-649&author=L.+L.+Brunton&author=B.+A.+Chabner&author=B.+C.+Knollmann&title=Goodman+%26+Gilman%E2%80%99s+The+Pharmacological+Basis+of+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBrunton%26aufirst%3DL.%2BL.%26btitle%3DGoodman%2520%2526%2520Gilman%25E2%2580%2599s%2520The%2520Pharmacological%2520Basis%2520of%2520Therapeutics%26pub%3DMacmillan%2520Publishing%2520Co%26date%3D2012%26spage%3D169%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Svensson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling-Petersen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N.</span><span> </span><span class="NLM_article-title">Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">â</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2F0014-2999%2894%2990718-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=7843260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK2cXmsVKqtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=235-243&author=K.+Svenssonauthor=A.+Carlssonauthor=R.+M.+Huffauthor=T.+Kling-Petersenauthor=N.+Waters&title=Behavioral+and+neurochemical+data+suggest+functional+differences+between+dopamine+D2+and+D3+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors</span></div><div class="casAuthors">Svensson, Kjell; Carlsson, Arvid; Huff, Rita M.; Kling-Petersen, Torben; Waters, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">263</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-43</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">In an in vitro model for mitogenic activity in cloned Chinese hamster ovary (CHO) cells expressing rat dopamine D2 or D3 receptors, the EC50D2/EC50D3 ratios for the agonists, apomorphine, (+)-3-hydroxy-N-n-propyl-phenylpiperidine ((+)-3-PPP), quinpirole, R-(+)-7-hydroxy-2-(di-n-propylamino)tetralin (R-(+)-7-OH-DPAT) and pramipexole (SND919) were 0.36, 0.41, 1.3, 3.7 and 7.0, resp.  In locomotor activity expts. with actively exploring rats, the more dopamine D3 preferring agonists, R-(+)-7-OH-DPAT and pramipexole, were most efficacious to reduce locomotion.  The hypoactivity was also obsd. at doses that did not affect brain dopamine synthesis rate (DOPA accumulation) or release (measured in vivo dialysis expts.).  In contrast, for apomorphine, (+)-3-PPP and quinpirole there was a closer correlation between doses that reduced exploratory activity and doses that reduced brain dopamine release and synthesis.  The present data support the hypothesis that the functional dopamine D3 receptor is a postsynaptic receptor inhibitory on rat locomotion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4oEqICdKMX7Vg90H21EOLACvtfcHk0ljEtIcrxeqQ8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsVKqtLw%253D&md5=50d13ab9aa8207a262092c2c2b7ac4a6</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2894%2990718-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252894%252990718-8%26sid%3Dliteratum%253Aachs%26aulast%3DSvensson%26aufirst%3DK.%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DHuff%26aufirst%3DR.%2BM.%26aulast%3DKling-Petersen%26aufirst%3DT.%26aulast%3DWaters%26aufirst%3DN.%26atitle%3DBehavioral%2520and%2520neurochemical%2520data%2520suggest%2520functional%2520differences%2520between%2520dopamine%2520D2%2520and%2520D3%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D263%26spage%3D235%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Richtand, N. M.</span><span> </span><span class="NLM_article-title">Behavioral sensitization, alternative splicing, and D3 dopamine receptor-mediated inhibitory function</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2368</span><span class="NLM_x">â</span> <span class="NLM_lpage">2375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=2368-2375&author=N.+M.+Richtand&title=Behavioral+sensitization%2C+alternative+splicing%2C+and+D3+dopamine+receptor-mediated+inhibitory+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichtand%26aufirst%3DN.%2BM.%26atitle%3DBehavioral%2520sensitization%252C%2520alternative%2520splicing%252C%2520and%2520D3%2520dopamine%2520receptor-mediated%2520inhibitory%2520function%26jtitle%3DNeuropsychopharmacology%26date%3D2006%26volume%3D31%26spage%3D2368%26epage%3D2375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Kuballa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabrowska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swoboda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwiecinski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostrzewa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brus, R.</span><span> </span><span class="NLM_article-title">Central effects of nafadotride, a dopamine D3 receptor antagonist, in rats. Comparison with haloperidol and clozapine</span> <span class="citation_source-journal">Pharmacol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">â</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=15886414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslSlur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=161-169&author=G.+Kuballaauthor=P.+Nowakauthor=L.+Labusauthor=A.+Bortelauthor=J.+Dabrowskaauthor=M.+Swobodaauthor=A.+Kwiecinskiauthor=R.+M.+Kostrzewaauthor=R.+Brus&title=Central+effects+of+nafadotride%2C+a+dopamine+D3+receptor+antagonist%2C+in+rats.+Comparison+with+haloperidol+and+clozapine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Central effects of nafadotride, a dopamine D3 receptor antagonist, in rats. Comparison with haloperidol and clozapine</span></div><div class="casAuthors">Kuballa, Grzegorz; Nowak, Przemyslaw; Labus, Lukasz; Bortel, Aleksandra; Dabrowska, Joanna; Swoboda, Marek; Kwiecinski, Adam; Kostrzewa, Richard M.; Brus, Ryszard</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-169</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">1734-1140</span>.
    
            (<span class="NLM_cas:orgname">Polish Academy of Sciences, Institute of Pharmacology</span>)
        </div><div class="casAbstract">The aim of this study was to examine behavioral and biochem. effects of nafadotride, the new dopamine D3 receptor antagonist, and to compare it with haloperidol (dopamine D2 receptor antagonist) and clozapine (predominate dopamine D4 receptor antagonist).  Each drug was injected to adult male Wistar rats i.p., each at a single dose and for 14 consecutive days.  Thirty minutes after single or last injection of the examd. drugs, the following behavioral parameters were recorded: yawning, oral activity, locomotion, exploratory activity, catalepsy and coordination ability.  By HPLC/ED methods, we detd. the effects of the examd. antagonists on the levels of biogenic amines in striatum and hippocampus: dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 3-methoxytyramine (3-MT), 5-hydroxytryptamine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA) and noradrenaline (NA).  Addnl., DA and 5-HT synthesis rate was detd. in striatum and 5-HT in hippocampus.  The results of the study indicate that nafadotride, the dopamine D3 receptor antagonist, has a behavioral and biochem. profile of action different from that of haloperidol but partially similar to that of clozapine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppga5XeaA4HLVg90H21EOLACvtfcHk0lhydX7t4K7-Eg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslSlur0%253D&md5=50e518c3acfa79c93d5430aa903c4d26</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuballa%26aufirst%3DG.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DLabus%26aufirst%3DL.%26aulast%3DBortel%26aufirst%3DA.%26aulast%3DDabrowska%26aufirst%3DJ.%26aulast%3DSwoboda%26aufirst%3DM.%26aulast%3DKwiecinski%26aufirst%3DA.%26aulast%3DKostrzewa%26aufirst%3DR.%2BM.%26aulast%3DBrus%26aufirst%3DR.%26atitle%3DCentral%2520effects%2520of%2520nafadotride%252C%2520a%2520dopamine%2520D3%2520receptor%2520antagonist%252C%2520in%2520rats.%2520Comparison%2520with%2520haloperidol%2520and%2520clozapine%26jtitle%3DPharmacol.%2520Rep.%26date%3D2005%26volume%3D57%26spage%3D161%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Beaulieu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainetdinov, R. R.</span><span> </span><span class="NLM_article-title">The physiology, signaling, and pharmacology of dopamine receptors</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">â</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1124%2Fpr.110.002642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=21303898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=182-217&author=J.+M.+Beaulieuauthor=R.+R.+Gainetdinov&title=The+physiology%2C+signaling%2C+and+pharmacology+of+dopamine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">The physiology, signaling, and pharmacology of dopamine receptors</span></div><div class="casAuthors">Beaulieu, Jean-Martin; Gainetdinov, Raul R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-217</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiol. functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension.  Pharmacol. agents targeting dopaminergic neurotransmission have been clin. used in the management of several neurol. and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD1), and Tourette's syndrome.  Numerous advances have occurred in understanding the general structural, biochem., and functional properties of dopamine receptors that have led to the development of multiple pharmacol. active compds. that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics.  Recent progress in understanding the complex biol. of dopamine receptor-related signal transduction mechanisms has revealed that, in addn. to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as Î²-arrestins.  One of the future directions in managing dopamine-related pathol. conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacol.  In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms.  In addn., we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacol. and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplp84qmbSbA7Vg90H21EOLACvtfcHk0lhydX7t4K7-Eg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D&md5=53e6841062c98abe60c732692109e498</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.002642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.002642%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26atitle%3DThe%2520physiology%252C%2520signaling%252C%2520and%2520pharmacology%2520of%2520dopamine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D182%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Malmberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohell, N.</span><span> </span><span class="NLM_article-title">Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">â</span> <span class="NLM_lpage">754</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1993&pages=749-754&author=A.+Malmbergauthor=D.+M.+Jacksonauthor=A.+Erikssonauthor=N.+Mohell&title=Unique+binding+characteristics+of+antipsychotic+agents+interacting+with+human+dopamine+D2A%2C+D2B%2C+and+D3+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalmberg%26aufirst%3DA.%26aulast%3DJackson%26aufirst%3DD.%2BM.%26aulast%3DEriksson%26aufirst%3DA.%26aulast%3DMohell%26aufirst%3DN.%26atitle%3DUnique%2520binding%2520characteristics%2520of%2520antipsychotic%2520agents%2520interacting%2520with%2520human%2520dopamine%2520D2A%252C%2520D2B%252C%2520and%2520D3%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D43%26spage%3D749%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Schotte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gommeren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luyten, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gompel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesage, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Loore, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leysen, J. E.</span><span> </span><span class="NLM_article-title">Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">â</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1007%2FBF02245606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=8935801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK28XjsFGktLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=1996&pages=57-73&author=A.+Schotteauthor=P.+F.+Janssenauthor=W.+Gommerenauthor=W.+H.+Luytenauthor=P.+Van+Gompelauthor=A.+S.+Lesageauthor=K.+De+Looreauthor=J.+E.+Leysen&title=Risperidone+compared+with+new+and+reference+antipsychotic+drugs%3A+in+vitro+and+in+vivo+receptor+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding</span></div><div class="casAuthors">Schotte, A.; Janssen, P. F. M.; Gommeren, W.; Luyte, W. H. M. L.; Van Gompel, P.; Lesage, A. S.; De Loore, K.; Leysen, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">57-73</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Risperidone and its active metabolite 9-OH-risperidone were compared to ref. antipsychotic drugs (haloperidol, pipamperone, fluspirilene, clozapine, zotepine) and compds. under development (olanzapine, seroquel, sertindole, ORG-5222, ziprasidone) for in vitro binding to neurotransmitter receptors in brain tissue and on membranes of recombinant cells expressing cloned human receptors and for in vivo occupancy of neurotransmitter receptors in rat and guinea-pig brain following acute treatment (2 h, s.c.).  An ex vivo autoradiog. technique was applied to det. the receptor occupancy by the drugs administered in vivo.  Of particular interest are the central 5HT2A receptors and D2-type receptors.  Predominant 5HT2A receptor antagonism is supposed to add to an atypical profile of the antipsychotics (treatment of the neg. symptoms, low incidence of extrapyramidal side effects).  D2 antagonism is required for the treatment of a pos. symptoms.  A contribution of the new dopamine receptor subtypes D3 and in particular D4 receptors has been proposed.  In vitro, all compds., except the 'typical' antipsychotics haloperidol and fluspirilene, showed higher affinity for 5HT2A than for D2 receptors.  Subnanomolar affinity for human 5HT2A receptors was obsd. for ORG-5222, sertindole, risperidone, 9-OH-risperidone and zotepine displayed nanomolar affinity for human D2 receptors.  Sertindole and olanzapine were slightly less potent.  Pipamperone, clozapine and seroquel showed 2 orders of magnitude lower D2 affinity in vitro.  Clozapine, but even more so pipamperone, displayed higher affinity for D4 than for D2 receptors.  For most other compds., D4 affinity was only slightly lower than their D2 affinity.  Seroquel was totally devoid of D4 affinity.  None of the compds. had nanomolar affinity for D1 receptors; their affinity for D3 receptors was usually slightly lower than for D2 receptors.  In vivo, ORG-5222, risperidone, pipamperone, 9-OH-risperidone, sertindole, olanzapine, zotepine and clozapine maintained a higher potency for occupying 5HT2A than D2 receptors.  Risperidone and ORG-5222 had 5HT2A vs. D2 potency ratio of about 20.  Highest potency for 5HT2A receptor occupancy was obsd. for ORG-5222 followed by risperidone and olanzapine.  Ziprasidone exclusively occupied 5HT2/A receptors.  No regional selectivity for D2 receptor occupancy in mesolimbic vs. nigrostriatal areas was detected for any of the test compds.  Risperidone was conspicuous because of its more gradual occupancy of D2 receptors; none of the other compds. showed this property.  The various compds. also displayed high to moderate occupancy of adrenergic Î±1 receptors, except fluspirilene and ziprasidone.  Clozapine, zotepine, ORG-5222 and sertindole occupied even more Î±1 than D2 receptors.  Clozapine showed predominant occupancy of H1 receptors and occupied cholinergic receptors with equiv. potency to D2 receptors.  A stronger predominance of 5HT2A vs. D2 receptor occupancy combined with a more gradual occupancy of D2 receptors differentiates risperidone and its 9-OH-metabolite from the other antipsychotic compds. in this study.  The predominant 5HT2A receptor occupancy probably plays a role in the beneficial action of risperidone on the neg. symptoms of schizophrenia, whereas maintenance of a moderate occupancy of D2 receptors seems adequate for treating the pos. symptoms of schizophrenia.  A combined 5HT2A and D2 occupancy and the avoidance of D2 receptor overblockade are believed to reduce the risk for extrapyramidal symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLAZ3nduIqXbVg90H21EOLACvtfcHk0lhydX7t4K7-Eg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjsFGktLk%253D&md5=321c55116d797ff2f1ad67663354b82e</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1007%2FBF02245606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02245606%26sid%3Dliteratum%253Aachs%26aulast%3DSchotte%26aufirst%3DA.%26aulast%3DJanssen%26aufirst%3DP.%2BF.%26aulast%3DGommeren%26aufirst%3DW.%26aulast%3DLuyten%26aufirst%3DW.%2BH.%26aulast%3DVan%2BGompel%26aufirst%3DP.%26aulast%3DLesage%26aufirst%3DA.%2BS.%26aulast%3DDe%2BLoore%26aufirst%3DK.%26aulast%3DLeysen%26aufirst%3DJ.%2BE.%26atitle%3DRisperidone%2520compared%2520with%2520new%2520and%2520reference%2520antipsychotic%2520drugs%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520receptor%2520binding%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D1996%26volume%3D124%26spage%3D57%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Haefely, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesura, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorez, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherschlicht, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Prada, M.</span><span> </span><span class="NLM_article-title">Biochemistry and pharmacology of moclobemide, a prototype RIMA</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">S6</span><span class="NLM_x">â</span> <span class="NLM_lpage">S14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1992&pages=S6-S14&issue=Suppl.&author=W.+Haefelyauthor=W.+P.+Burkardauthor=A.+M.+Cesuraauthor=R.+Kettlerauthor=H.+P.+Lorezauthor=J.+R.+Martinauthor=J.+G.+Richardsauthor=R.+Scherschlichtauthor=M.+Da+Prada&title=Biochemistry+and+pharmacology+of+moclobemide%2C+a+prototype+RIMA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaefely%26aufirst%3DW.%26aulast%3DBurkard%26aufirst%3DW.%2BP.%26aulast%3DCesura%26aufirst%3DA.%2BM.%26aulast%3DKettler%26aufirst%3DR.%26aulast%3DLorez%26aufirst%3DH.%2BP.%26aulast%3DMartin%26aufirst%3DJ.%2BR.%26aulast%3DRichards%26aufirst%3DJ.%2BG.%26aulast%3DScherschlicht%26aufirst%3DR.%26aulast%3DDa%2BPrada%26aufirst%3DM.%26atitle%3DBiochemistry%2520and%2520pharmacology%2520of%2520moclobemide%252C%2520a%2520prototype%2520RIMA%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D1992%26volume%3D106%26issue%3DSuppl%26spage%3DS6%26epage%3DS14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Nair, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kin, N. M.</span><span> </span><span class="NLM_article-title">Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide</span> <span class="citation_source-journal">J. Psychiatry Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">â</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=7905288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A280%3ADyaK2c7ivVOmuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1993&pages=214-225&author=N.+P.+Nairauthor=S.+K.+Ahmedauthor=N.+M.+Kin&title=Biochemistry+and+pharmacology+of+reversible+inhibitors+of+MAO-A+agents%3A+focus+on+moclobemide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide</span></div><div class="casAuthors">Nair N P; Ahmed S K; Kin N M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatry & neuroscience : JPN</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">214-25</span>
        ISSN:<span class="NLM_cas:issn">1180-4882</span>.
    </div><div class="casAbstract">Moclobemide, p-chloro-N-[morpholinoethyl]benzamide, is a prototype of RIMA (reversible inhibitor of MAO-A) agents.  The compound possesses antidepressant efficacy that is comparable to that of tricyclic and polycyclic antidepressants.  In humans, moclobemide is rapidly absorbed after a single oral administration and maximum concentration in plasma is reached within an hour.  It is moderately to markedly bound to plasma proteins.  MAO-A inhibition rises to 80% within two hours; the duration of MAO inhibition is usually between eight and ten hours.  The activity of MAO is completely reestablished within 24 hours of the last dose, so that a quick switch to another antidepressant can be safely undertaken if clinical circumstances demand.  RIMAs are potent inhibitors of MAO-A in the brain; they increase the free cytosolic concentrations of norepinephrine, serotonin and dopamine in neuronal cells and in synaptic vesicles.  Extracellular concentrations of these monoamines also increase.  In the case of moclobemide, increase in the level of serotonin is the most pronounced.  Moclobemide administration also leads to increased monoamine receptor stimulation, reversal of reserpine induced behavioral effects, selective depression of REM sleep, down regulation of beta-adrenoceptors and increases in plasma prolactin and growth hormone levels.  It reduces scopolamine-induced performance decrement and alcohol induced performance deficit which suggest a neuroprotective role.  Tyramine potentiation with moclobemide and most other RIMA agents is negligible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkkbuPrv56yoMcDoIzZtNkfW6udTcc2eZtzXZkLBNMLbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7ivVOmuw%253D%253D&md5=6cf0e38d2f70d7771cec6b05f4c5e0a5</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNair%26aufirst%3DN.%2BP.%26aulast%3DAhmed%26aufirst%3DS.%2BK.%26aulast%3DKin%26aufirst%3DN.%2BM.%26atitle%3DBiochemistry%2520and%2520pharmacology%2520of%2520reversible%2520inhibitors%2520of%2520MAO-A%2520agents%253A%2520focus%2520on%2520moclobemide%26jtitle%3DJ.%2520Psychiatry%2520Neurosci.%26date%3D1993%26volume%3D18%26spage%3D214%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Pettersson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonesson, C.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of a set of para-substituted 4-phenylpiperidines and 4-phenylpiperazines as monoamine oxidase (MAO) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3242</span><span class="NLM_x">â</span> <span class="NLM_lpage">3249</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201692d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3242-3249&author=F.+Petterssonauthor=P.+Svenssonauthor=S.+Watersauthor=N.+Watersauthor=C.+Sonesson&title=Synthesis+and+evaluation+of+a+set+of+para-substituted+4-phenylpiperidines+and+4-phenylpiperazines+as+monoamine+oxidase+%28MAO%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm201692d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201692d%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DF.%26aulast%3DSvensson%26aufirst%3DP.%26aulast%3DWaters%26aufirst%3DS.%26aulast%3DWaters%26aufirst%3DN.%26aulast%3DSonesson%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520a%2520set%2520of%2520para-substituted%25204-phenylpiperidines%2520and%25204-phenylpiperazines%2520as%2520monoamine%2520oxidase%2520%2528MAO%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3242%26epage%3D3249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Lotufo-Neto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thase, M. E.</span><span> </span><span class="NLM_article-title">Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">â</span> <span class="NLM_lpage">247</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=226-247&author=F.+Lotufo-Netoauthor=M.+Trivediauthor=M.+E.+Thase&title=Meta-analysis+of+the+reversible+inhibitors+of+monoamine+oxidase+type+A+moclobemide+and+brofaromine+for+the+treatment+of+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLotufo-Neto%26aufirst%3DF.%26aulast%3DTrivedi%26aufirst%3DM.%26aulast%3DThase%26aufirst%3DM.%2BE.%26atitle%3DMeta-analysis%2520of%2520the%2520reversible%2520inhibitors%2520of%2520monoamine%2520oxidase%2520type%2520A%2520moclobemide%2520and%2520brofaromine%2520for%2520the%2520treatment%2520of%2520depression%26jtitle%3DNeuropsychopharmacology%26date%3D1999%26volume%3D20%26spage%3D226%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Wold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">SjÃ¶strÃ¶m, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, L.</span><span> </span><span class="NLM_article-title">PLS-regression: a basic tool of chemometrics</span> <span class="citation_source-journal">Chemom. Intell. Lab. Syst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">â</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2FS0169-7439%2801%2900155-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotF2mtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2001&pages=109-130&author=S.+Woldauthor=M.+Sj%C3%B6str%C3%B6mauthor=L.+Eriksson&title=PLS-regression%3A+a+basic+tool+of+chemometrics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">PLS-regression: a basic tool of chemometrics</span></div><div class="casAuthors">Wold, Svante; Sjostrom, Michael; Eriksson, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Chemometrics and Intelligent Laboratory Systems</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-130</span>CODEN:
                <span class="NLM_cas:coden">CILSEN</span>;
        ISSN:<span class="NLM_cas:issn">0169-7439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review on PLS-regression (PLSR) as a std. tool in chemometrics and used in chem. and engineering.  The underlying model and its assumption and commonly used diagnostics are discussed, together with the interpretation of resulting parameters.  Two examples are used as illustrations: first, a Quant. Structure-Activity Relationship (QSAR)/Quant. Structure Property Relationship (QSPR) data set of peptides is used to outline the development, interpretation, and refinement of a PLSR model.  Second, a data set from the manufg. of recycled paper is analyzed to illustrate time series modeling of process data by means of PLSR and time-lagged X-variables.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIKGNtaZZXqbVg90H21EOLACvtfcHk0ljbVmDYOWKIOw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotF2mtLw%253D&md5=2d7fd1e946600e138ac92699ebcc7e29</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2FS0169-7439%2801%2900155-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-7439%252801%252900155-1%26sid%3Dliteratum%253Aachs%26aulast%3DWold%26aufirst%3DS.%26aulast%3DSj%25C3%25B6str%25C3%25B6m%26aufirst%3DM.%26aulast%3DEriksson%26aufirst%3DL.%26atitle%3DPLS-regression%253A%2520a%2520basic%2520tool%2520of%2520chemometrics%26jtitle%3DChemom.%2520Intell.%2520Lab.%2520Syst.%26date%3D2001%26volume%3D58%26spage%3D109%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Wold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trygg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berglund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antti, H.</span><span> </span><span class="NLM_article-title">Some recent developments in PLS modeling</span> <span class="citation_source-journal">Chemom. Intell. Lab. Syst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">â</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2FS0169-7439%2801%2900156-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotF2mtLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2001&pages=131-150&author=S.+Woldauthor=J.+Tryggauthor=A.+Berglundauthor=H.+Antti&title=Some+recent+developments+in+PLS+modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Some recent developments in PLS modeling</span></div><div class="casAuthors">Wold, Svante; Trygg, Johan; Berglund, Anders; Antti, Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Chemometrics and Intelligent Laboratory Systems</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-150</span>CODEN:
                <span class="NLM_cas:coden">CILSEN</span>;
        ISSN:<span class="NLM_cas:issn">0169-7439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The original chemometrics partial least squares (PLS) model with two blocks of variables (X and Y), linearly related to each other, has had several enhancements/extensions since the beginning of 1980.  The multi-block and hierarchical PLS modeling for installing a priori knowledge of the data structure and simplifying the model interpretation, variable correction schemes for PLS with often similar objectives, nonlinear PLS, and prefiltered PLS, orthogonal signal correction (OSC) is discussed.  A very recent development, orthogonalized-PLS is included as a way to accomplish both OSC, and a simpler interpretation of the PLS model.  Time series, batch, and wavelets variants of PLS are discussed.  These PLS extensions are illustrated by examples from peptide quant. structure-activity relationships (QSAR) and multivariate characterization of pulp using NIR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVTh-HkFVRfbVg90H21EOLACvtfcHk0ljRQBK1m_AVLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotF2mtLo%253D&md5=c4796c8028ac3f95c79f6a7e4ff7c5a4</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2FS0169-7439%2801%2900156-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-7439%252801%252900156-3%26sid%3Dliteratum%253Aachs%26aulast%3DWold%26aufirst%3DS.%26aulast%3DTrygg%26aufirst%3DJ.%26aulast%3DBerglund%26aufirst%3DA.%26aulast%3DAntti%26aufirst%3DH.%26atitle%3DSome%2520recent%2520developments%2520in%2520PLS%2520modeling%26jtitle%3DChemom.%2520Intell.%2520Lab.%2520Syst.%26date%3D2001%26volume%3D58%26spage%3D131%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Wold, S.</span><span> </span><span class="NLM_article-title">Crossvalidatory estimation of the number of components in factor and principal components models</span> <span class="citation_source-journal">Technometrics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">â</span> <span class="NLM_lpage">405</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1978&pages=397-405&author=S.+Wold&title=Crossvalidatory+estimation+of+the+number+of+components+in+factor+and+principal+components+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWold%26aufirst%3DS.%26atitle%3DCrossvalidatory%2520estimation%2520of%2520the%2520number%2520of%2520components%2520in%2520factor%2520and%2520principal%2520components%2520models%26jtitle%3DTechnometrics%26date%3D1978%26volume%3D20%26spage%3D397%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Sharp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjorth, S.</span><span> </span><span class="NLM_article-title">Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">â</span> <span class="NLM_lpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2F0165-0270%2890%2990045-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=2259248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK3MXhtlKisrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1990&pages=83-90&author=T.+Sharpauthor=S.+Hjorth&title=Application+of+brain+microdialysis+to+study+the+pharmacology+of+the+5-HT1A+autoreceptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor</span></div><div class="casAuthors">Sharp. Trevor; Hjorth, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">83-90</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    </div><div class="casAbstract">A review, with 38 refs., of the application of in vivo brain microdialysis in detecting extracellular 5-HT derived from serotoninergic neurons and changes with respect to neuronal activity and the actions of 5-HT1A receptor agonists and antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIxajqAjhMYbVg90H21EOLACvtfcHk0ljRQBK1m_AVLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhtlKisrk%253D&md5=cd618503cec2515d00170a6216927cf5</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2F0165-0270%2890%2990045-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0270%252890%252990045-H%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DT.%26aulast%3DHjorth%26aufirst%3DS.%26atitle%3DApplication%2520of%2520brain%2520microdialysis%2520to%2520study%2520the%2520pharmacology%2520of%2520the%25205-HT1A%2520autoreceptor%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D1990%26volume%3D34%26spage%3D83%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Teismann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferger, B.</span><span> </span><span class="NLM_article-title">In vivo effects of the putative cognitive enhancer KA-672.HCl in comparison with 8-hydroxy-2-(di-<i>N</i>-propylamino) tetralin and haloperidol on dopamine, 3,4-dihydroxypheny-lacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions</span> <span class="citation_source-journal">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">â</span> <span class="NLM_lpage">348</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2FS0278-5846%2899%2900088-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=10800755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitlWmsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2000&pages=337-348&author=P.+Teismannauthor=B.+Ferger&title=In+vivo+effects+of+the+putative+cognitive+enhancer+KA-672.HCl+in+comparison+with+8-hydroxy-2-%28di-N-propylamino%29+tetralin+and+haloperidol+on+dopamine%2C+3%2C4-dihydroxypheny-lacetic+acid%2C+serotonin+and+5-hydroxyindoleacetic+acid+levels+in+striatal+and+cortical+brain+regions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo effects of the putative cognitive enhancer KA-672.HCl in comparison with 8-hydroxy-2-(di-N-propylamino) tetralin and haloperidol on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions</span></div><div class="casAuthors">Teismann, Peter; Ferger, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">337-348</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">1. KA-672.HCl (7-methoxy-6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propoxy]- 3,4-dimethyl-2H-1-benzopyran-2-one hydrochloride), designed as a cognitive enhancer, has been investigated through behavioral and binding studies.  However, little is known about its biochem. effects on the dopaminergic and serotoninergic system in vivo.  2. In the present study the authors investigated the effects of KA-672.HCl (0.1 mg/kg and 1 mg/kg), 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) (1 mg/kg), haloperidol (0.1 mg/kg) and a mixt. of haloperidol and 8-OH-DPAT on dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) levels, in striatum and cerebral cortex of rats.  3. Male Wistar rats received an i.p. injection of the drugs or vehicle 1 h before striatal and cortical brain tissues were dissected out for neurochem. anal.  4. KA-672.HCl, 8-OH-DPAT and haloperidol significantly reduced striatal DA levels, whereas only KA-672.HCl significantly reduced cortical DA levels.  8-OH-DPAT and haloperidol induced a significant increase in cortical DOPAC levels but only haloperidol significantly elevated the striatal DOPAC content.  In contrast, only the higher dose of KA-672.HCl elevated striatal DOPAC levels.  Furthermore, KA-672.HCl significantly reduced striatal 5-HT levels and slightly elevated striatal 5-HIAA concns.  8-OH-DPAT significantly decreased striatal 5-HIAA levels.  All substances were able to enhance the cortical and striatal DA turnover.  5. The cortical and striatal 5-HT turnover was significantly decreased following 8-OH-DPAT treatment and significantly increased in the striatum after haloperidol and KA-672.HCl treatment.  6. The data suggest that KA-672.HCl possesses D2 antagonistic as well as 5-HT1A agonistic properties.  However, addnl. mechanisms of actions by interaction with other neurotransmitter systems such as acetylcholine, excitatory or inhibitory amino acids need to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbycKqtGVPSbVg90H21EOLACvtfcHk0ljRQBK1m_AVLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitlWmsrc%253D&md5=0451e61f77f104cf9cf0c33f08b72c7c</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2FS0278-5846%2899%2900088-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0278-5846%252899%252900088-3%26sid%3Dliteratum%253Aachs%26aulast%3DTeismann%26aufirst%3DP.%26aulast%3DFerger%26aufirst%3DB.%26atitle%3DIn%2520vivo%2520effects%2520of%2520the%2520putative%2520cognitive%2520enhancer%2520KA-672.HCl%2520in%2520comparison%2520with%25208-hydroxy-2-%2528di-N-propylamino%2529%2520tetralin%2520and%2520haloperidol%2520on%2520dopamine%252C%25203%252C4-dihydroxypheny-lacetic%2520acid%252C%2520serotonin%2520and%25205-hydroxyindoleacetic%2520acid%2520levels%2520in%2520striatal%2520and%2520cortical%2520brain%2520regions%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2000%26volume%3D24%26spage%3D337%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Stenfors, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S. B.</span><span> </span><span class="NLM_article-title">Changes in extracellular 5-HIAA concentrations as measured by in vivo microdialysis technique in relation to changes in 5-HT release</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">â</span> <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1007%2Fs00213-003-1736-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=14735290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyktbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2004&pages=119-128&author=C.+Stenforsauthor=S.+B.+Ross&title=Changes+in+extracellular+5-HIAA+concentrations+as+measured+by+in+vivo+microdialysis+technique+in+relation+to+changes+in+5-HT+release"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Changes in extracellular 5-HIAA concentrations as measured by in vivo microdialysis technique in relation to changes in 5-HT release</span></div><div class="casAuthors">Stenfors, Carina; Ross, Svante B.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-128</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  The cerebral microdialysis technique was widely used to monitor the release of 5-hydroxytryptamine (5-HT).  The extracellular concn. of 5-HT has generally been shown to change after pharmacol. manipulation as expected.  Extracellular levels of the metabolite, 5-hydroxyindoleacetic acid (5-HIAA) does not always change in the same direction as 5-HT and has therefore generally been thought to be of no interest as a marker for 5-HT release.  The aim of the present review is to analyze the connection between changes in extracellular levels of 5-HT and 5-HIAA evoked by various pharmacol. means.  Literature on in vivo microdialysis studies measuring extracellular 5-HT and 5-HIAA was analyzed with special attention to the great importance of the 5-HT re-uptake mechanism in detg. their extracellular concns.  When the 5-HT reuptake mechanism is intact changes in extracellular levels of 5-HT and 5-HIAA go in the same directions, e.g decrease after compds. that decrease 5-HT release and increase after compds. that enhance 5-HT release.  Because the extracellular 5-HIAA concns. is 100-1000 times higher than that of 5-HT similar percentage changes imply that a very small part of the released 5-HT reaches the microdialysis probe under these conditions.  When the 5-HT reuptake mechanism is blocked the extracellular 5-HT increases whereas extracellular 5-HIAA decreases mainly because of the 5-HT1B receptor-induced decrease in 5-HT release but in part also because of the inhibition of reuptake of 5-HT, both resulting in decreased formation of 5-HIAA.  Drug-induced changes in extracellular 5-HIAA levels can give valuable information on the effects of these drugs on the 5-HT release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4nRPLe5dLq7Vg90H21EOLACvtfcHk0ljRQBK1m_AVLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyktbY%253D&md5=34723a838fa068619999c51cb31a999a</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1007%2Fs00213-003-1736-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-003-1736-z%26sid%3Dliteratum%253Aachs%26aulast%3DStenfors%26aufirst%3DC.%26aulast%3DRoss%26aufirst%3DS.%2BB.%26atitle%3DChanges%2520in%2520extracellular%25205-HIAA%2520concentrations%2520as%2520measured%2520by%2520in%2520vivo%2520microdialysis%2520technique%2520in%2520relation%2520to%2520changes%2520in%25205-HT%2520release%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D2004%26volume%3D172%26spage%3D119%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Wong, P. T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, W. L.</span><span> </span><span class="NLM_article-title">Interaction of the dopaminergic and serotonergic systems in the rat striatum: effects of selective antagonists and uptake inhibitors</span> <span class="citation_source-journal">Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">â</span> <span class="NLM_lpage">119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2F0168-0102%2895%2990023-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=7501296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK2MXos1CntL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1995&pages=115-119&author=P.+T.+H.+Wongauthor=H.+Fengauthor=W.+L.+Teo&title=Interaction+of+the+dopaminergic+and+serotonergic+systems+in+the+rat+striatum%3A+effects+of+selective+antagonists+and+uptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of the dopaminergic and serotonergic systems in the rat striatum: effects of selective antagonists and uptake inhibitors</span></div><div class="casAuthors">Wong, P.T.-H.; Feng, H.; Teo, W.L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Research (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-19</span>CODEN:
                <span class="NLM_cas:coden">NERADN</span>;
        ISSN:<span class="NLM_cas:issn">0168-0102</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The effects of some selective dopamine (DA) and 5-hydroxytryptamine (5-HT) antagonists and uptake inhibitors on the outflow of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the striatum were studied using microdialysis in conscious rats.  Eticlopride (D2 antagonist, 2.5 mg/kg) increased HVA but decreased 5-HIAA, while nomifensine (DA uptake inhibitor, 10 mg/kg) decreased both.  Mianserin (5-HT2 antagonist, 2 mg/kg) and citalopram (5-HT uptake inhibitor, 11 mg/kg) also decreased both HVA and 5-HIAA.  The selectivity of these drugs and the time course of their effects on HVA and 5-HIAA suggested that the dopaminergic drugs may affect the serotonergic systems primarily via changes in extraneuronal DA and conversely, serotonergic drugs affect the dopaminergic systems via changes in extraneuronal 5-HT.  The results obtained are consistent with current evidence that DA and 5-HT release from striatal terminals are regulated by D2 and 5-HT1B autoreceptors, resp.  They also support the idea that, in the rat striatum, presynaptic inhibitory heteroreceptors are a major mechanism that contributes to a reciprocal interaction of the dopaminergic and serotonergic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFdTVxpihY_bVg90H21EOLACvtfcHk0liTheWmmFqe5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXos1CntL8%253D&md5=064ec18fba2b43e0f55c39ddf55d76a3</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2F0168-0102%2895%2990023-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0168-0102%252895%252990023-3%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BT.%2BH.%26aulast%3DFeng%26aufirst%3DH.%26aulast%3DTeo%26aufirst%3DW.%2BL.%26atitle%3DInteraction%2520of%2520the%2520dopaminergic%2520and%2520serotonergic%2520systems%2520in%2520the%2520rat%2520striatum%253A%2520effects%2520of%2520selective%2520antagonists%2520and%2520uptake%2520inhibitors%26jtitle%3DNeurosci.%2520Res.%26date%3D1995%26volume%3D23%26spage%3D115%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Alterman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span> </span><span class="NLM_article-title">Fast microwave-assisted preparation of aryl and vinyl nitriles and the corresponding tetrazoles from organo-halides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">7984</span><span class="NLM_x">â</span> <span class="NLM_lpage">7989</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0009954" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=7984-7989&author=M.+Altermanauthor=A.+Hallberg&title=Fast+microwave-assisted+preparation+of+aryl+and+vinyl+nitriles+and+the+corresponding+tetrazoles+from+organo-halides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fjo0009954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0009954%26sid%3Dliteratum%253Aachs%26aulast%3DAlterman%26aufirst%3DM.%26aulast%3DHallberg%26aufirst%3DA.%26atitle%3DFast%2520microwave-assisted%2520preparation%2520of%2520aryl%2520and%2520vinyl%2520nitriles%2520and%2520the%2520corresponding%2520tetrazoles%2520from%2520organo-halides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D7984%26epage%3D7989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yulia L.  Volodina</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Tikhomirov</span>, <span class="hlFld-ContribAuthor ">Lyubov G.  Dezhenkova</span>, <span class="hlFld-ContribAuthor ">Alla A.  Ramonova</span>, <span class="hlFld-ContribAuthor ">Anastasia V.  Kononova</span>, <span class="hlFld-ContribAuthor ">Daria V.  Andreeva</span>, <span class="hlFld-ContribAuthor ">Dmitry N.  Kaluzhny</span>, <span class="hlFld-ContribAuthor ">Dominique  Schols</span>, <span class="hlFld-ContribAuthor ">Mikhail M.  Moisenovich</span>, <span class="hlFld-ContribAuthor ">Andrey E.  Shchekotikhin</span>, <span class="hlFld-ContribAuthor ">Alexander A.  Shtil</span>. </span><span class="cited-content_cbyCitation_article-title">Thiophene-2-carboxamide derivatives of anthraquinone: A new potent antitumor chemotype. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>221 </em>, 113521. <a href="https://doi.org/10.1016/j.ejmech.2021.113521" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113521</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113521%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThiophene-2-carboxamide%252Bderivatives%252Bof%252Banthraquinone%25253A%252BA%252Bnew%252Bpotent%252Bantitumor%252Bchemotype%26aulast%3DVolodina%26aufirst%3DYulia%2BL.%26date%3D2021%26volume%3D221%26spage%3D113521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun  Wu</span>, <span class="hlFld-ContribAuthor ">Ke-Jia  Wu</span>, <span class="hlFld-ContribAuthor ">Jin-Biao  Liu</span>, <span class="hlFld-ContribAuthor ">Wanhe  Wang</span>, <span class="hlFld-ContribAuthor ">Chung-Hang  Leung</span>, <span class="hlFld-ContribAuthor ">Dik-Lung  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-guided discovery of a luminescent theranostic toolkit for living cancer cells and the imaging behavior effect. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (42)
                                     , 11404-11412. <a href="https://doi.org/10.1039/D0SC04576D" title="DOI URL">https://doi.org/10.1039/D0SC04576D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC04576D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC04576D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DStructure-guided%252Bdiscovery%252Bof%252Ba%252Bluminescent%252Btheranostic%252Btoolkit%252Bfor%252Bliving%252Bcancer%252Bcells%252Band%252Bthe%252Bimaging%252Bbehavior%252Beffect%26aulast%3DWu%26aufirst%3DChun%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D42%26spage%3D11404%26epage%3D11412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petr  MatouÅ¡</span>, <span class="hlFld-ContribAuthor ">Michal  KadanÃ­k</span>, <span class="hlFld-ContribAuthor ">Marek  TimorackÃ½</span>, <span class="hlFld-ContribAuthor ">JiÅÃ­  KuneÅ¡</span>, <span class="hlFld-ContribAuthor ">Jana  MaÅÃ­kovÃ¡</span>, <span class="hlFld-ContribAuthor ">AleÅ¡  RÅ¯Å¾iÄka</span>, <span class="hlFld-ContribAuthor ">Pavel  KoÄovskÃ½</span>, <span class="hlFld-ContribAuthor ">Milan  Pour</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleophile-assisted cyclization of Î²-propargylamino acrylic compounds catalyzed by gold(
              i
              ): a rapid construction of multisubstituted tetrahydropyridines and their fused derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (21)
                                     , 3356-3367. <a href="https://doi.org/10.1039/D0QO00653J" title="DOI URL">https://doi.org/10.1039/D0QO00653J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00653J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00653J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DNucleophile-assisted%252Bcyclization%252Bof%252B%2525CE%2525B2-propargylamino%252Bacrylic%252Bcompounds%252Bcatalyzed%252Bby%252Bgold%252528%252Bi%252B%252529%25253A%252Ba%252Brapid%252Bconstruction%252Bof%252Bmultisubstituted%252Btetrahydropyridines%252Band%252Btheir%252Bfused%252Bderivatives%26aulast%3DMatou%25C5%25A1%26aufirst%3DPetr%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D21%26spage%3D3356%26epage%3D3367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rafid S.  Dawood</span>, <span class="hlFld-ContribAuthor ">Sudad A.  Dayl</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, identification and molecular docking studies of
              N
              -functionalized piperidine derivatives linked to 1,2,3-triazole ring. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2020,</strong> <em>50 </em>
                                    (16)
                                     , 2422-2431. <a href="https://doi.org/10.1080/00397911.2020.1776876" title="DOI URL">https://doi.org/10.1080/00397911.2020.1776876</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2020.1776876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2020.1776876%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DSynthesis%25252C%252Bidentification%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bof%252BN%252B-functionalized%252Bpiperidine%252Bderivatives%252Blinked%252Bto%252B1%25252C2%25252C3-triazole%252Bring%26aulast%3DDawood%26aufirst%3DRafid%2BS.%26date%3D2020%26date%3D2020%26volume%3D50%26issue%3D16%26spage%3D2422%26epage%3D2431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">GaÃ«tan  Maertens</span>, <span class="hlFld-ContribAuthor ">Oscar M.  Saavedra</span>, <span class="hlFld-ContribAuthor ">Vito  Vece</span>, <span class="hlFld-ContribAuthor ">Miguel A. Vilchis  Reyes</span>, <span class="hlFld-ContribAuthor ">Sofiane  Hocine</span>, <span class="hlFld-ContribAuthor ">Esat  Ãney</span>, <span class="hlFld-ContribAuthor ">Bertrand  Goument</span>, <span class="hlFld-ContribAuthor ">Olivier  Mirguet</span>, <span class="hlFld-ContribAuthor ">Arnaud  Le Tiran</span>, <span class="hlFld-ContribAuthor ">Philippe  Gloanec</span>, <span class="hlFld-ContribAuthor ">Stephen  Hanessian</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of bridged piperidine and piperazine isosteres. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (15)
                                     , 2627-2630. <a href="https://doi.org/10.1016/j.bmcl.2018.06.038" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.06.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.06.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.06.038%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bbridged%252Bpiperidine%252Band%252Bpiperazine%252Bisosteres%26aulast%3DMaertens%26aufirst%3DGa%25C3%25ABtan%26date%3D2018%26volume%3D28%26issue%3D15%26spage%3D2627%26epage%3D2630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">4-(Hetero)Arylpiperidines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 155-193. <a href="https://doi.org/10.1002/9781118686263.ch5" title="DOI URL">https://doi.org/10.1002/9781118686263.ch5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch5%26sid%3Dliteratum%253Aachs%26atitle%3D4-%252528Hetero%252529Arylpiperidines%26date%3D2018%26date%3D2018%26spage%3D155%26epage%3D193%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yinggao  Meng</span>, <span class="hlFld-ContribAuthor ">Bingnan  Wang</span>, <span class="hlFld-ContribAuthor ">Linning  Ren</span>, <span class="hlFld-ContribAuthor ">Qiongli  Zhao</span>, <span class="hlFld-ContribAuthor ">Wenquan  Yu</span>, <span class="hlFld-ContribAuthor ">Junbiao  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">I
              2
              -Mediated transition-metal-free aromatic CâH amination for the synthesis of benzimidazol-2-ones and related heterocycles. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2018,</strong> <em>42 </em>
                                    (16)
                                     , 13790-13796. <a href="https://doi.org/10.1039/C8NJ03166E" title="DOI URL">https://doi.org/10.1039/C8NJ03166E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8NJ03166E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8NJ03166E%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DI%252B2%252B-Mediated%252Btransition-metal-free%252Baromatic%252BC%2525E2%252580%252593H%252Bamination%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bbenzimidazol-2-ones%252Band%252Brelated%252Bheterocycles%26aulast%3DMeng%26aufirst%3DYinggao%26date%3D2018%26date%3D2018%26volume%3D42%26issue%3D16%26spage%3D13790%26epage%3D13796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haythem A.  Saadeh</span>, <span class="hlFld-ContribAuthor ">Mohammad A.  Khasawneh</span>, <span class="hlFld-ContribAuthor ">Abdelouahid  Samadi</span>, <span class="hlFld-ContribAuthor ">Ismail A.  El-Haty</span>, <span class="hlFld-ContribAuthor ">Grzegorz  SataÅa</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>, <span class="hlFld-ContribAuthor ">Lhassane  Ismaili</span>, <span class="hlFld-ContribAuthor ">Ãscar M.  Bautista-Aguilera</span>, <span class="hlFld-ContribAuthor ">Matilde  YaÃ±ez</span>, <span class="hlFld-ContribAuthor ">Jordi  Mestres</span>, <span class="hlFld-ContribAuthor ">JosÃ©  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of Potent Antioxidant 1-(2,5-Dimethoxybenzyl)-4-arylpiperazines and
              N
              -Azolyl Substituted 2-(4-Arylpiperazin-1-yl). </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2017,</strong> <em>2 </em>
                                    (13)
                                     , 3854-3859. <a href="https://doi.org/10.1002/slct.201700397" title="DOI URL">https://doi.org/10.1002/slct.201700397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201700397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201700397%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BPotent%252BAntioxidant%252B1-%2525282%25252C5-Dimethoxybenzyl%252529-4-arylpiperazines%252Band%252BN%252B-Azolyl%252BSubstituted%252B2-%2525284-Arylpiperazin-1-yl%252529%26aulast%3DSaadeh%26aufirst%3DHaythem%2BA.%26date%3D2017%26date%3D2017%26volume%3D2%26issue%3D13%26spage%3D3854%26epage%3D3859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Butini</span>, <span class="hlFld-ContribAuthor ">K.  Nikolic</span>, <span class="hlFld-ContribAuthor ">S.  Kassel</span>, <span class="hlFld-ContribAuthor ">H.  BrÃ¼ckmann</span>, <span class="hlFld-ContribAuthor ">S.  Filipic</span>, <span class="hlFld-ContribAuthor ">D.  Agbaba</span>, <span class="hlFld-ContribAuthor ">S.  Gemma</span>, <span class="hlFld-ContribAuthor ">S.  Brogi</span>, <span class="hlFld-ContribAuthor ">M.  Brindisi</span>, <span class="hlFld-ContribAuthor ">G.  Campiani</span>, <span class="hlFld-ContribAuthor ">H.  Stark</span>. </span><span class="cited-content_cbyCitation_article-title">Polypharmacology of dopamine receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Progress in Neurobiology</span><span> <strong>2016,</strong> <em>142 </em>, 68-103. <a href="https://doi.org/10.1016/j.pneurobio.2016.03.011" title="DOI URL">https://doi.org/10.1016/j.pneurobio.2016.03.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pneurobio.2016.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pneurobio.2016.03.011%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Neurobiology%26atitle%3DPolypharmacology%252Bof%252Bdopamine%252Breceptor%252Bligands%26aulast%3DButini%26aufirst%3DS.%26date%3D2016%26volume%3D142%26spage%3D68%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veronica V.  Angeles-Dunham</span>, <span class="hlFld-ContribAuthor ">David M.  Nickerson</span>, <span class="hlFld-ContribAuthor ">Devin M.  Ray</span>, <span class="hlFld-ContribAuthor ">Anita E.  Mattson</span>. </span><span class="cited-content_cbyCitation_article-title">Nitrimines as Reagents for Metal-Free Formal C(sp
              2
              )-C(sp
              2
              ) Cross-Coupling Reactions. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2014,</strong> <em>126 </em>
                                    (52)
                                     , 14766-14769. <a href="https://doi.org/10.1002/ange.201408613" title="DOI URL">https://doi.org/10.1002/ange.201408613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201408613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201408613%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DNitrimines%252Bas%252BReagents%252Bfor%252BMetal-Free%252BFormal%252BC%252528sp%252B2%252B%252529-C%252528sp%252B2%252B%252529%252BCross-Coupling%252BReactions%26aulast%3DAngeles-Dunham%26aufirst%3DVeronica%2BV.%26date%3D2014%26date%3D2014%26volume%3D126%26issue%3D52%26spage%3D14766%26epage%3D14769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veronica V.  Angeles-Dunham</span>, <span class="hlFld-ContribAuthor ">David M.  Nickerson</span>, <span class="hlFld-ContribAuthor ">Devin M.  Ray</span>, <span class="hlFld-ContribAuthor ">Anita E.  Mattson</span>. </span><span class="cited-content_cbyCitation_article-title">Nitrimines as Reagents for Metal-Free Formal C(sp
              2
              )-C(sp
              2
              ) Cross-Coupling Reactions. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2014,</strong> <em>53 </em>
                                    (52)
                                     , 14538-14541. <a href="https://doi.org/10.1002/anie.201408613" title="DOI URL">https://doi.org/10.1002/anie.201408613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201408613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201408613%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DNitrimines%252Bas%252BReagents%252Bfor%252BMetal-Free%252BFormal%252BC%252528sp%252B2%252B%252529-C%252528sp%252B2%252B%252529%252BCross-Coupling%252BReactions%26aulast%3DAngeles-Dunham%26aufirst%3DVeronica%2BV.%26date%3D2014%26date%3D2014%26volume%3D53%26issue%3D52%26spage%3D14538%26epage%3D14541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Chao  Liu</span>, <span class="hlFld-ContribAuthor ">Rui  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiong-You  Wu</span>, <span class="hlFld-ContribAuthor ">Qiong  Chen</span>, <span class="hlFld-ContribAuthor ">Guang-Fu  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments in the Synthesis and Applications of Isatins. </span><span class="cited-content_cbyCitation_journal-name">Organic Preparations and Procedures International</span><span> <strong>2014,</strong> <em>46 </em>
                                    (4)
                                     , 317-362. <a href="https://doi.org/10.1080/00304948.2014.922378" title="DOI URL">https://doi.org/10.1080/00304948.2014.922378</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00304948.2014.922378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00304948.2014.922378%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Preparations%2520and%2520Procedures%2520International%26atitle%3DRecent%252BDevelopments%252Bin%252Bthe%252BSynthesis%252Band%252BApplications%252Bof%252BIsatins%26aulast%3DLiu%26aufirst%3DYu-Chao%26date%3D2014%26date%3D2014%26volume%3D46%26issue%3D4%26spage%3D317%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Dopamine D<sub>2</sub> receptor ligands: dopamine (<b>1</b>), the dopaminergic stabilizers pridopidine (<b>2</b>) and <i>S</i>-(â)-OSU6162 (<b>3</b>), atypical antipsychotics sertindole (<b>4</b>), risperidone (<b>5</b>), and ziprasidone (<b>6</b>), typical antipsychotic pimozide (<b>7</b>), generic structure of 1-propyl-4-arylpiperidines (<b>8</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overview of 1-propyl-4-arylpiperidines and their bicyclic aryl core building blocks: <b>9</b>, 6-F, R<sup>1</sup> = H; <b>11</b>, 6-F, R<sup>1</sup> = methyl; <b>12</b>, 5-F, R<sup>1</sup> = methyl; <b>19</b>, R<sup>1</sup> = H; <b>20</b> R<sup>1</sup> = methyl.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Serotonin 5-HT<sub>1A/1B</sub> receptor agonist RU 24969 (tetrahydropyridine, <b>25</b>), RU23686 (piperidine, <b>26</b>), and the dopamine D<sub>2</sub> receptor antagonist RU 27592 (<b>27</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of 1-Propyl-4-arylpiperidines Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-iodopropane (PrI), K<sub>2</sub>CO<sub>3</sub>, acetonitrile (ACN), Î; (b) NaH, iodomethane, DMF.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 1-(1-Propyl-4-piperidyl)indoline-2,3-dione (<b>21</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PrI, K<sub>2</sub>CO<sub>3</sub>, ACN, Î; (b) EtOH, HCl.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 3-(1-Propyl-4-piperidyl)-1<i>H</i>-indazole (<b>16</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>n</i>-BuLi (1 equiv), <i>t</i>-BuLi (2 equiv), 1-propylpiperidin-4-one, THF; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, Î; (d) Pd/C, H<sub>2</sub>, EtOH.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 4-(Benzothiophen-3-yl)-1-propylpiperidine (<b>13</b>) and 4-(Benzothiophen-2-yl)-1-propylpiperidine (<b>24</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>n</i>-BuLi, 1-Boc-4-piperidone, diethyl ether, THF; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, Î; (c) PrI, K<sub>2</sub>CO<sub>3</sub>, ACN, Î; (d) Pd/C, H<sub>2</sub>, methanol, HAc, HCl.</p></p></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo DOPAC (% of control) dose response in rat striatum for selected compounds and reference compounds. Controls are indicated with a white bar. <b>9</b>, <b>13</b>, <b>14</b>, <b>16</b>â<b>19</b>, <b>22</b>â<b>24</b> in doses 3.7, 11, 33, and 100 Î¼mol/kg. <b>15</b>: 1.2, 3.7, 11, and 33 Î¼mol/kg. Ziprasidone: 0.2, 0.7, 2.1, and 6.4 Î¼mol/kg. Pimozide: 0.2, 0.6, 1.9, and 5.8 Î¼mol/kg. Risperidone: 0.07, 0.2, 0.7, and 2.4 Î¼mol/kg. Moclobemide: 1.4, 4, 12, and 37 Î¼mol/kg. Statistical significance is assessed using <i>t</i> test (two-tailed) versus controls: (â) <i>P</i> < 0.05, (ââ) <i>P</i> < 0.01, (âââ) <i>P</i> < 0.001. Error bars indicate standard error of the mean (SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structure of monoamine oxidase A (MAO A) inhibitor brofaromine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/medium/jm-2012-00975f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Partial least-squares (PLS) regression on 3,4-dihydroxyphenylacetic acid (DOPAC) was modeled against the binding affinity for dopamine D<sub>2</sub> receptors, monoamine oxidase A (MAO A) and serotonin transporter protein (SERT).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm300975f/production/images/large/jm-2012-00975f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300975f&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43367" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43367" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 95 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Johnson, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanasekaran, N.</span><span> </span><span class="NLM_article-title">The G-protein family and their interaction with receptors</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">â</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1210%2Fedrv-10-3-317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=2550214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaL1MXlvVOlsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1989&pages=317-331&author=G.+L.+Johnsonauthor=N.+Dhanasekaran&title=The+G-protein+family+and+their+interaction+with+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The G-protein family and their interaction with receptors</span></div><div class="casAuthors">Johnson, Gary L.; Dhanasekaran, N.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-31</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    </div><div class="casAbstract">A review, with 130 refs., is given on the structures of GTP-binding proteins (G-proteins), and on the mechanisms by which G-proteins regulate signal transduction from cell surface to effector systems for the control of cell functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8KJIeQf8rzrVg90H21EOLACvtfcHk0li4N_ZesoHtMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlvVOlsLc%253D&md5=c9568a413de1a85704510f50f1929b8e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1210%2Fedrv-10-3-317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fedrv-10-3-317%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DG.%2BL.%26aulast%3DDhanasekaran%26aufirst%3DN.%26atitle%3DThe%2520G-protein%2520family%2520and%2520their%2520interaction%2520with%2520receptors%26jtitle%3DEndocr.%2520Rev.%26date%3D1989%26volume%3D10%26spage%3D317%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Carlsson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span> </span><span class="NLM_article-title">Schizophrenia: from dopamine to glutamate and back</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">â</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.2174%2F0929867043456034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=14965231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1Sqsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=267-277&author=M.+L.+Carlssonauthor=A.+Carlssonauthor=M.+Nilsson&title=Schizophrenia%3A+from+dopamine+to+glutamate+and+back"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Schizophrenia: From dopamine to glutamate and back</span></div><div class="casAuthors">Carlsson, M. L.; Carlsson, A.; Nilsson, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-277</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The first part of the present review describes the exciting journey of dopamine stabilizers, starting in the early 1980s with the development of the partial dopamine agonist (-)-3-PPP of phenylpiperidine structure, via various compds. with aminotetraline structure with preferential autoreceptor antagonist properties, and then back again to phenylpiperidine compds. carrying substituents on the arom. ring that transformed them from partial dopamine agonists to partial dopamine receptor antagonists, such as OSU6162.  OSU6162 was brought to the clinic and has in preliminary trials showed antidyskinetic and antipsychotic efficacy.  The second part of this review describes results from a hypoglutamatergia mouse model for cognitive symptoms of schizophrenia, where the authors have tested traditional neuroleptics, new generation antipsychotics with marked 5-HT2 vs dopamine D2 receptor blockade as well as a dopamine stabilizer belonging to the partial dopamine receptor antagonist category.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJFFyjWDKxJrVg90H21EOLACvtfcHk0li4N_ZesoHtMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1Sqsrw%253D&md5=bd91fb8937d3d3c49e746902c843f54a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F0929867043456034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043456034%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsson%26aufirst%3DM.%2BL.%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DM.%26atitle%3DSchizophrenia%253A%2520from%2520dopamine%2520to%2520glutamate%2520and%2520back%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D267%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Pettersson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponten, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonesson, C.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2510</span><span class="NLM_x">â</span> <span class="NLM_lpage">2520</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901689v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2510-2520&author=F.+Petterssonauthor=H.+Pontenauthor=N.+Watersauthor=S.+Watersauthor=C.+Sonesson&title=Synthesis+and+evaluation+of+a+set+of+4-phenylpiperidines+and+4-phenylpiperazines+as+D2+receptor+ligands+and+the+discovery+of+the+dopaminergic+stabilizer+4-%5B3-%28methylsulfonyl%29phenyl%5D-1-propylpiperidine+%28huntexil%2C+pridopidine%2C+ACR16%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm901689v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901689v%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DF.%26aulast%3DPonten%26aufirst%3DH.%26aulast%3DWaters%26aufirst%3DN.%26aulast%3DWaters%26aufirst%3DS.%26aulast%3DSonesson%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520a%2520set%2520of%25204-phenylpiperidines%2520and%25204-phenylpiperazines%2520as%2520D2%2520receptor%2520ligands%2520and%2520the%2520discovery%2520of%2520the%2520dopaminergic%2520stabilizer%25204-%255B3-%2528methylsulfonyl%2529phenyl%255D-1-propylpiperidine%2520%2528huntexil%252C%2520pridopidine%252C%2520ACR16%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2510%26epage%3D2520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ponten, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kullingsjo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagerkvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonesson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N.</span><span> </span><span class="NLM_article-title">In vivo pharmacology of the dopaminergic stabilizer pridopidine</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">644</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">â</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2Fj.ejphar.2010.07.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=20667452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVejs7fF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=644&publication_year=2010&pages=88-95&author=H.+Pontenauthor=J.+Kullingsjoauthor=S.+Lagerkvistauthor=P.+Martinauthor=F.+Petterssonauthor=C.+Sonessonauthor=S.+Watersauthor=N.+Waters&title=In+vivo+pharmacology+of+the+dopaminergic+stabilizer+pridopidine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo pharmacology of the dopaminergic stabilizer pridopidine</span></div><div class="casAuthors">Ponten, Henrik; Kullingsjoe, Johan; Lagerkvist, Soeren; Martin, Peter; Pettersson, Fredrik; Sonesson, Clas; Waters, Susanna; Waters, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">644</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pridopidine (ACR16) belongs to a new pharmacol. class of agents affecting the central nervous system called dopaminergic stabilizers.  Dopaminergic stabilizers act primarily at dopamine type 2 (D2) receptors and display state-dependent behavioral effects.  This article aims to give an overview of the preclin. neurochem. and behavioral in vivo pharmacol. properties of pridopidine.  Pridopidine was given s.c. to male Sprague-Dawley rats (locomotor, microdialysis and tissue neurochem.) and i.p. to Swiss male mice (tail suspension test).  Pridopidine dose-dependently increased striatal tissue levels of the dopamine metabolite 3,4-dihydroxyphenylalanine (ED50 = 81 Î¼mol/kg), and prefrontal cortex dialyzate levels of dopamine and noradrenaline as measured by HPLC.  The agent reduced hyperlocomotion (D-amphetamine: ED50 = 54 Î¼mol/kg; MK-801: ED50 = 40 Î¼mol/kg), but preserved spontaneous locomotor activity, confirming state-dependent behavioral effects.  In addn., pridopidine significantly reduced immobility time in the tail suspension test.  We conclude that pridopidine state-dependently stabilizes psychomotor activity by the dual actions of functional dopamine D2 receptor antagonism and strengthening of cortical glutamate functions in various settings of perturbed neurotransmission.  The putative restoration of function in cortico-subcortical circuitry by pridopidine is likely to make it useful for ameliorating several neurol. and psychiatric disorders, including Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofLwicFY7QBLVg90H21EOLACvtfcHk0lgQhwh0Om1RZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVejs7fF&md5=35ffeeb53c88c491702e53e4d215620d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2010.07.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2010.07.023%26sid%3Dliteratum%253Aachs%26aulast%3DPonten%26aufirst%3DH.%26aulast%3DKullingsjo%26aufirst%3DJ.%26aulast%3DLagerkvist%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DPettersson%26aufirst%3DF.%26aulast%3DSonesson%26aufirst%3DC.%26aulast%3DWaters%26aufirst%3DS.%26aulast%3DWaters%26aufirst%3DN.%26atitle%3DIn%2520vivo%2520pharmacology%2520of%2520the%2520dopaminergic%2520stabilizer%2520pridopidine%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D644%26spage%3D88%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Dyhring, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonesson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophersen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N.</span><span> </span><span class="NLM_article-title">The dopaminergic stabilizers pridopidine (ACR16) and (â)-OSU6162 display dopamine D(2) receptor antagonism and fast receptor dissociation properties</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">628</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">â</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2Fj.ejphar.2009.11.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=19919834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFOksQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=628&publication_year=2010&pages=19-26&author=T.+Dyhringauthor=E.+O.+Nielsenauthor=C.+Sonessonauthor=F.+Petterssonauthor=J.+Karlssonauthor=P.+Svenssonauthor=P.+Christophersenauthor=N.+Waters&title=The+dopaminergic+stabilizers+pridopidine+%28ACR16%29+and+%28%E2%88%92%29-OSU6162+display+dopamine+D%282%29+receptor+antagonism+and+fast+receptor+dissociation+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The dopaminergic stabilizers pridopidine (ACR16) and (-)-OSU6162 display dopamine D2 receptor antagonism and fast receptor dissociation properties</span></div><div class="casAuthors">Dyhring, Tino; Nielsen, Elsebet O.; Sonesson, Clas; Pettersson, Fredrik; Karlsson, Jonas; Svensson, Peder; Christophersen, Palle; Waters, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">628</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">19-26</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new pharmacol. class of CNS ligands with the unique ability to stimulate or suppress motor and behavioral symptoms depending on the prevailing dopaminergic tone has been suggested as "dopaminergic stabilizers".  The mol. mode-of-action of dopaminergic stabilizers is not yet fully understood, but they are assumed to act via normalization of dopaminergic signaling, through interactions with the dopamine D2 receptor.  Here we have evaluated the dopaminergic stabilizers pridopidine (ACR16) and (-)-OSU6162, as well as the new compd. N-{[(2S)-5-chloro-7-(methylsulfonyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl}ethanamine (NS30678) in a series of cellular in vitro dopamine D2 receptor functional and binding assays.  Neither ACR16, (-)-OSU6162, nor NS30678 displayed detectable dopamine D2 receptor-mediated intrinsic activity, whereas they concn.-dependently antagonized dopamine-induced responses with IC50 values of 12.9 Î¼M, 5.8 Î¼M, and 7.0 nM, resp.  In contrast to the high-affinity typical antipsychotics haloperidol and raclopride, the dopaminergic stabilizers ACR16 and (-)-OSU6162 both displayed fast dopamine D2 receptor dissocn. properties, a feature that has previously been suggested as a contributing factor to antipsychotic atypicality and attributed mainly to low receptor affinity.  However, the finding that NS30678, which is equipotent to haloperidol and raclopride, also displays fast receptor dissocn., suggests that the agonist-like structural motif of the dopaminergic stabilizers tested is a crit. dissocn. rate determinant.  The results demonstrate that dopaminergic stabilizers exhibit fast competitive dopamine D2 receptor antagonism, possibly allowing for temporally variable and activity-dependent dopamine D2 receptor occupancy that may partly account for their unique stabilization of dopamine dependent behaviors in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodx8I0NzUww7Vg90H21EOLACvtfcHk0ljqEXQnT4116A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFOksQ%253D%253D&md5=4e611bae1a80639f12d6e2374de748b8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.11.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.11.025%26sid%3Dliteratum%253Aachs%26aulast%3DDyhring%26aufirst%3DT.%26aulast%3DNielsen%26aufirst%3DE.%2BO.%26aulast%3DSonesson%26aufirst%3DC.%26aulast%3DPettersson%26aufirst%3DF.%26aulast%3DKarlsson%26aufirst%3DJ.%26aulast%3DSvensson%26aufirst%3DP.%26aulast%3DChristophersen%26aufirst%3DP.%26aulast%3DWaters%26aufirst%3DN.%26atitle%3DThe%2520dopaminergic%2520stabilizers%2520pridopidine%2520%2528ACR16%2529%2520and%2520%2528%25E2%2588%2592%2529-OSU6162%2520display%2520dopamine%2520D%25282%2529%2520receptor%2520antagonism%2520and%2520fast%2520receptor%2520dissociation%2520properties%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D628%26spage%3D19%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">de Yebenes, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landwehrmeyer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squitieri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saft, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnet, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sword, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rembratt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedroff, J.</span><span> </span><span class="NLM_article-title">Pridopidine for the treatment of motor function in patients with Huntingtonâs disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1049</span><span class="NLM_x">â</span> <span class="NLM_lpage">1057</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2FS1474-4422%2811%2970233-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=22071279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2gsbrO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=1049-1057&author=J.+G.+de+Yebenesauthor=B.+Landwehrmeyerauthor=F.+Squitieriauthor=R.+Reilmannauthor=A.+Rosserauthor=R.+A.+Barkerauthor=C.+Saftauthor=M.+K.+Magnetauthor=A.+Swordauthor=A.+Rembrattauthor=J.+Tedroff&title=Pridopidine+for+the+treatment+of+motor+function+in+patients+with+Huntington%E2%80%99s+disease+%28MermaiHD%29%3A+a+phase+3%2C+randomised%2C+double-blind%2C+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial</span></div><div class="casAuthors">de Yebenes, Justo Garcia; Landwehrmeyer, Bernhard; Squitieri, Ferdinando; Reilmann, Ralf; Rosser, Anne; Barker, Roger A.; Saft, Carsten; Magnet, Markus K.; Sword, Alastair; Rembratt, Asa; Tedroff, Joakim</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1049-1057</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Huntington's disease is a progressive neurodegenerative disorder, characterised by motor, cognitive, and behavioral deficits.  Pridopidine belongs to a new class of compds. known as dopaminergic stabilizers, and results from a small phase 2 study in patients with Huntington's disease suggested that this drug might improve voluntary motor function.  We aimed to assess further the effects of pridopidine in patients with Huntington's disease.  We undertook a 6 mo, randomised, double-blind, placebo-controlled trial to assess the efficacy of pridopidine in the treatment of motor deficits in patients with Huntington's disease.  Our primary endpoint was change in the modified motor score (mMS; derived from the unified Huntington's disease rating scale) at 26 wk.  We recruited patients with Huntington's disease from 32 European centers; patients were aged 30 years or older and had an mMS of 10 points or greater at baseline.  Patients were randomly assigned (1:1:1) to receive placebo, 45 mg per day pridopidine, or 90 mg per day pridopidine by use of centralised computer-generated codes.  Patients and investigators were masked to treatment assignment.  We also assessed the safety and tolerability profile of pridopidine.  For our primary anal., all patients were eligible for inclusion in our full anal. set, in which we used the last observation carried forward method for missing values.  We used an anal. of covariance model and the Bonferroni method to adjust for multiple comparisons.  We used a prespecified per-protocol population as our sensitivity anal.  The Î± level was 0.025 for our primary anal. and 0.05 overall.  This trial is registered with ClinicalTrials.gov, no. NCT00665223.  At 26 wk, in our full anal. set the difference in mean mMS was -0.99 points (97.5% CI -2.08 to 0.10, p = 0.042) in patients who received 90 mg per day pridopidine (n = 145) vs. those who received placebo (n = 144), and -0.36 points (-1.44 to 0.72, p = 0.456) in those who received 45 mg per day pridopidine (n = 148) vs. those who received placebo.  At the 90 mg per day dose, in our per-protocol population (n = 114), the redn. in the mMS was of -1.29 points (-2.47 to -0.12; p = 0.014) compared with placebo (n = 120).  We did not identify any changes in non-motor endpoints at either dose.  Pridopidine was well tolerated and had an adverse event profile similar to that of placebo.  This study did not provide evidence of efficacy as measured by the mMS, but a potential effect of pridopidine on the motor phenotype of Huntington's disease merits further investigation.  Pridopidine up to 90 mg per day was well tolerated in patients with Huntington's disease.  Funding: NeuroSearch A/S.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVDXQbNRAMqLVg90H21EOLACvtfcHk0ljqEXQnT4116A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2gsbrO&md5=ed31da6ccaad5c90745d35aacbbb6f4a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2811%2970233-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252811%252970233-2%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BYebenes%26aufirst%3DJ.%2BG.%26aulast%3DLandwehrmeyer%26aufirst%3DB.%26aulast%3DSquitieri%26aufirst%3DF.%26aulast%3DReilmann%26aufirst%3DR.%26aulast%3DRosser%26aufirst%3DA.%26aulast%3DBarker%26aufirst%3DR.%2BA.%26aulast%3DSaft%26aufirst%3DC.%26aulast%3DMagnet%26aufirst%3DM.%2BK.%26aulast%3DSword%26aufirst%3DA.%26aulast%3DRembratt%26aufirst%3DA.%26aulast%3DTedroff%26aufirst%3DJ.%26atitle%3DPridopidine%2520for%2520the%2520treatment%2520of%2520motor%2520function%2520in%2520patients%2520with%2520Huntington%25E2%2580%2599s%2520disease%2520%2528MermaiHD%2529%253A%2520a%2520phase%25203%252C%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DLancet%2520Neurol.%26date%3D2011%26volume%3D10%26spage%3D1049%26epage%3D1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Niemegeers, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laduron, P. M.</span><span> </span><span class="NLM_article-title">Pharmacology and biochemistry of haloperidol</span> <span class="citation_source-journal">Proc. R. Soc. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span><span class="NLM_x">â</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1976&pages=3-8&issue=Suppl.+1&author=C.+J.+Niemegeersauthor=P.+M.+Laduron&title=Pharmacology+and+biochemistry+of+haloperidol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiemegeers%26aufirst%3DC.%2BJ.%26aulast%3DLaduron%26aufirst%3DP.%2BM.%26atitle%3DPharmacology%2520and%2520biochemistry%2520of%2520haloperidol%26jtitle%3DProc.%2520R.%2520Soc.%2520Med.%26date%3D1976%26volume%3D69%26issue%3DSuppl.%25201%26spage%3D3%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Casey, D. E.</span><span> </span><span class="NLM_article-title">Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia</span> <span class="citation_source-journal">Schizophr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">â</span> <span class="NLM_lpage">120</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2F0920-9964%2891%2990029-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=1674881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A280%3ADyaK3M3kvVOqsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1991&pages=109-120&author=D.+E.+Casey&title=Neuroleptic+drug-induced+extrapyramidal+syndromes+and+tardive+dyskinesia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia</span></div><div class="casAuthors">Casey D E</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-20</span>
        ISSN:<span class="NLM_cas:issn">0920-9964</span>.
    </div><div class="casAbstract">Neuroleptic (antipsychotic) drug-induced acute extrapyramidal syndromes (EPS) and the late onset tardive dyskinesia (TD) are the major side effects that limit the use of these highly efficacious agents.  The appropriate strategy for controlling these side effects is based on the clinical presentations, pathophysiological mechanisms, and contributions of patient and treatment-related risk factors.  New information about the mechanisms of action of neuroleptics and the long-term outcome of acute EPS and TD provide valuable insights into these syndromes.  The most effective method for maximizing the benefits and minimizing the risks of neuroleptics is to use the lowest effective dose of both neuroleptic and antiEPS drugs in patients who benefit from them.  The next major advancement will be to develop new compounds which effectively control psychotic symptoms and are free of the undesirable acute and tardive motor syndromes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMvSHYz0v3bjMsgLhIoICsfW6udTcc2eatYgydGrbmsbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3kvVOqsg%253D%253D&md5=6b24bae598ccd63cb71ccd1d7b43b86d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2F0920-9964%2891%2990029-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0920-9964%252891%252990029-Q%26sid%3Dliteratum%253Aachs%26aulast%3DCasey%26aufirst%3DD.%2BE.%26atitle%3DNeuroleptic%2520drug-induced%2520extrapyramidal%2520syndromes%2520and%2520tardive%2520dyskinesia%26jtitle%3DSchizophr.%2520Res.%26date%3D1991%26volume%3D4%26spage%3D109%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Seeman, P.</span><span> </span><span class="NLM_article-title">An update of fast-off dopamine D2 atypical antipsychotics</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">1984</span><span class="NLM_x">â</span> <span class="NLM_lpage">1985</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1176%2Fappi.ajp.162.10.1984-a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=16199855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A280%3ADC%252BD2MritlSnsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2005&pages=1984-1985&author=P.+Seeman&title=An+update+of+fast-off+dopamine+D2+atypical+antipsychotics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">An update of fast-off dopamine D2 atypical antipsychotics</span></div><div class="casAuthors">Seeman Philip</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1984-5</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSS-FAqEvkJaeIHSmpohpd0fW6udTcc2eactWrZyYPXtrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MritlSnsQ%253D%253D&md5=8df195e141e5ef694e3a093ea91560df</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.162.10.1984-a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.162.10.1984-a%26sid%3Dliteratum%253Aachs%26aulast%3DSeeman%26aufirst%3DP.%26atitle%3DAn%2520update%2520of%2520fast-off%2520dopamine%2520D2%2520atypical%2520antipsychotics%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2005%26volume%3D162%26spage%3D1984%26epage%3D1985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Seeman, P.</span><span> </span><span class="NLM_article-title">Atypical antipsychotics: mechanism of action</span> <span class="citation_source-journal">Can. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">â</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=11873706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A280%3ADC%252BD387kt1Gmuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2002&pages=27-38&author=P.+Seeman&title=Atypical+antipsychotics%3A+mechanism+of+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Atypical antipsychotics: mechanism of action</span></div><div class="casAuthors">Seeman Philip</div><div class="citationInfo"><span class="NLM_cas:title">Canadian journal of psychiatry. Revue canadienne de psychiatrie</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-38</span>
        ISSN:<span class="NLM_cas:issn">0706-7437</span>.
    </div><div class="casAbstract">BACKGROUND:  Although the principal brain target that all antipsychotic drugs attach to is the dopamine D2 receptor, traditional or typical antipsychotics, by attaching to it, induce extrapyramidal signs and symptoms (EPS).  They also, by binding to the D2 receptor, elevate serum prolactin.  Atypical antipsychotics given in dosages within the clinically effective range do not bring about these adverse clinical effects.  To understand how these drugs work, it is important to examine the atypical antipsychotics' mechanism of action and how it differs from that of the more typical drugs.  METHOD:  This review analyzes the affinities, the occupancies, and the dissociation time-course of various antipsychotics at dopamine D2 receptors and at serotonin (5-HT) receptors, both in the test tube and in live patients.  RESULTS:  Of the 31 antipsychotics examined, the older traditional antipsychotics such as trifluperazine, pimozide, chlorpromazine, fluphenazine, haloperidol, and flupenthixol bind more tightly than dopamine itself to the dopamine D2 receptor, with dissociation constants that are lower than that for dopamine.  The newer, atypical antipsychotics such as quetiapine, remoxipride, clozapine, olanzapine, sertindole, ziprasidone, and amisulpride all bind more loosely than dopamine to the dopamine D2 receptor and have dissociation constants higher than that for dopamine.  These tight and loose binding data agree with the rates of antipsychotic dissociation from the human-cloned D2 receptor.  For instance, radioactive haloperidol, chlorpromazine, and raclopride all dissociate very slowly over a 30-minute time span, while radioactive quetiapine, clozapine, remoxipride, and amisulpride dissociate rapidly, in less than 60 seconds.  These data also match clinical brain-imaging findings that show haloperidol remaining constantly bound to D2 in humans undergoing 2 positron emission tomography (PET) scans 24 hours apart.  Conversely, the occupation of D2 by clozapine or quetiapine has mostly disappeared after 24 hours.  CONCLUSION:  Atypicals clinically help patients by transiently occupying D2 receptors and then rapidly dissociating to allow normal dopamine neurotransmission.  This keeps prolactin levels normal, spares cognition, and obviates EPS.  One theory of atypicality is that the newer drugs block 5-HT2A receptors at the same time as they block dopamine receptors and that, somehow, this serotonin-dopamine balance confers atypicality.  This, however, is not borne out by the results.  While 5-HT2A receptors are readily blocked at low dosages of most atypical antipsychotic drugs (with the important exceptions of remoxipride and amisulpride, neither of which is available for use in Canada) the dosages at which this happens are below those needed to alleviate psychosis.  In fact, the antipsychotic threshold occupancy of D2 for antipsychotic action remains at about 65% for both typical and atypical antipsychotic drugs, regardless of whether 5-HT2A receptors are blocked or not.  At the same time, the antipsychotic threshold occupancy of D2 for eliciting EPS remains at about 80% for both typical and atypical antipsychotics, regardless of the occupancy of 5-HT2A receptors.  RELEVANCE:  The "fast-off-D2" theory, on the other hand, predicts which antipsychotic compounds will or will not produce EPS and hyperprolactinemia and which compounds present a relatively low risk for tardive dyskinesia.  This theory also explains why L-dopa psychosis responds to low atypical antipsychotic dosages, and it suggests various individualized treatment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTiUF-43m1Le8ve_zCu79I8fW6udTcc2eactWrZyYPXtrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387kt1Gmuw%253D%253D&md5=2f9aa5d0349a96146da385b8be523641</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeeman%26aufirst%3DP.%26atitle%3DAtypical%2520antipsychotics%253A%2520mechanism%2520of%2520action%26jtitle%3DCan.%2520J.%2520Psychiatry%26date%3D2002%26volume%3D47%26spage%3D27%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Natesan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reckless, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobrega, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlow, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span> </span><span class="NLM_article-title">The dopamine stabilizers (<i>S</i>)-(â)-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(â)-OSU6162] and 4-(3-methanesulfonylphenyl)-1-propyl-piperidine (ACR16) show high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for motor side effects in the rat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">810</span><span class="NLM_x">â</span> <span class="NLM_lpage">818</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1124%2Fjpet.106.102905" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=16648369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslOltrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=810-818&author=S.+Natesanauthor=K.+A.+Svenssonauthor=G.+E.+Recklessauthor=J.+N.+Nobregaauthor=K.+B.+Barlowauthor=A.+M.+Johanssonauthor=S.+Kapur&title=The+dopamine+stabilizers+%28S%29-%28%E2%88%92%29-%283-methanesulfonyl-phenyl%29-1-propyl-piperidine+%5B%28%E2%88%92%29-OSU6162%5D+and+4-%283-methanesulfonylphenyl%29-1-propyl-piperidine+%28ACR16%29+show+high+in+vivo+D2+receptor+occupancy%2C+antipsychotic-like+efficacy%2C+and+low+potential+for+motor+side+effects+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The dopamine stabilizers (S)-(-)-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-methanesulfonylphenyl)-1-propyl-piperidine (ACR16) show high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for motor side effects in the rat</span></div><div class="casAuthors">Natesan, Sridhar; Svensson, Kjell A.; Reckless, Greg E.; Nobrega, Jose N.; Barlow, Karen B. L.; Johansson, Anette M.; Kapur, Shitij</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">810-818</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">"Dopamine stabilizers" are a new class of compds. that have the ability to reverse both hypo- as well as hyperdopaminergia in vivo.  This class, exemplified by the phenylpiperidines (S)-(-)-3-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [ACR16] although lacking high in vitro binding affinity for dopamine D2 receptor [(-)-OSU6162, Ki = 447 nM; ACR16, Ki > 1 Î¼M], shows functional actions, suggestive of their interaction.  Hence, we evaluated in vivo D2 occupancy of these agents in rats and correlated it to obsd. effects in a series of behavioral, neurochem., and endocrine models relevant to the dopamine system and antipsychotic effect.  Both (-)-OSU6162 and ACR16 showed robust dose-dependent striatal D2 occupancy with ED50 values of 5.27 and 18.99 mg/kg s.c., resp., and functional assays showed no partial agonism.  Over an occupancy range of 37 to 87% (3-60 mg/kg) for (-)-OSU6162 and 35 to 74% (10-60 mg/kg) for ACR16, we obsd. both inhibitory (amphetamine-induced locomotor activity) and stimulatory effects (in habituated rats).  Haloperidol, over a similar occupancy range (33-78%), potently inhibited psychostimulant activity and induced catalepsy, but it failed to activate habituated animals.  In the conditioned avoidance response assay, ACR16 was clearly more efficacious than (-)-OSU6162.  In addn., both these compds. demonstrated significant preferential Fos induction in the nucleus accumbens compared with the dorsolateral striatum, a strong predictor of atypical antipsychotic efficacy.  The results suggest that dopamine stabilizers exhibit locomotor stabilizing as well as antipsychotic-like effects, with low motor side effect liability, in a dose range that corresponds to high D2 in vivo occupancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB1QWPCh_MXrVg90H21EOLACvtfcHk0lgMOmzOQ2bhjg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslOltrY%253D&md5=9afa75bafba644f0ee8462d5f857b98f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.102905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.102905%26sid%3Dliteratum%253Aachs%26aulast%3DNatesan%26aufirst%3DS.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DReckless%26aufirst%3DG.%2BE.%26aulast%3DNobrega%26aufirst%3DJ.%2BN.%26aulast%3DBarlow%26aufirst%3DK.%2BB.%26aulast%3DJohansson%26aufirst%3DA.%2BM.%26aulast%3DKapur%26aufirst%3DS.%26atitle%3DThe%2520dopamine%2520stabilizers%2520%2528S%2529-%2528%25E2%2588%2592%2529-%25283-methanesulfonyl-phenyl%2529-1-propyl-piperidine%2520%255B%2528%25E2%2588%2592%2529-OSU6162%255D%2520and%25204-%25283-methanesulfonylphenyl%2529-1-propyl-piperidine%2520%2528ACR16%2529%2520show%2520high%2520in%2520vivo%2520D2%2520receptor%2520occupancy%252C%2520antipsychotic-like%2520efficacy%252C%2520and%2520low%2520potential%2520for%2520motor%2520side%2520effects%2520in%2520the%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D810%26epage%3D818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lund, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, P. J.</span><span> </span><span class="NLM_article-title">Olanzapine: an atypical antipsychotic for schizophrenia</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">â</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1517%2F14656566.1.2.305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=11249551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFSrtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=305-323&author=B.+C.+Lundauthor=P.+J.+Perry&title=Olanzapine%3A+an+atypical+antipsychotic+for+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Olanzapine: an atypical antipsychotic for schizophrenia</span></div><div class="casAuthors">Lund, Brian C.; Perry, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">305-323</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 104 refs.  Olanzapine is a serotonin-dopamine receptor antagonist primarily used in the treatment of psychotic illnesses.  It has been shown in numerous large trials to be as equally effective as haloperidol in the acute treatment and maintenance treatment of schizophrenia.  However, olanzapine was shown to be more effective than haloperidol in the treatment of neg. symptoms and to cause significantly fewer extrapyramidal symptoms.  Furthermore, early reports suggest that olanzapine produces less tardive dyskinesia than haloperidol, though longer follow-up data are needed.  Current studies have failed to demonstrate the efficacy of olanzapine in the treatment of refractory schizophrenia.  One comparison trial of olanzapine vs. risperidone has indicated similar efficacy.  Clin. trials in acute mania have found olanzapine to be more effective than placebo.  However, there is no role for olanzapine monotherapy in bipolar disorder given current studies.  Although olanzapine has shown a low rate of extrapyramidal symptoms, it is not without adverse effects.  Clin. significant wt. gain has been noted with olanzapine in each of the large clin. trials.  The degree of wt. gain is similar to clozapine and probably greater than that obsd. with risperidone.  The long-term medical consequence of atypical antipsychotic-induced wt. gain is not known at this time.  While generally considered first-line drugs from an efficacy and adverse effect standpoint, pharmacoeconomic studies are needed to justify the large acquisition cost of olanzapine compared to typical agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUh4daVwqMdbVg90H21EOLACvtfcHk0ljKpZtfg2ttDA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFSrtA%253D%253D&md5=96bdd62c4b133bf943d87327a56d2f29</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1517%2F14656566.1.2.305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.1.2.305%26sid%3Dliteratum%253Aachs%26aulast%3DLund%26aufirst%3DB.%2BC.%26aulast%3DPerry%26aufirst%3DP.%2BJ.%26atitle%3DOlanzapine%253A%2520an%2520atypical%2520antipsychotic%2520for%2520schizophrenia%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2000%26volume%3D1%26spage%3D305%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Cosi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carilla-Durand, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">AssiÃÂ©, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ormiere, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maraval, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leduc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span> </span><span class="NLM_article-title">Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">535</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">â</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2Fj.ejphar.2006.01.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=16554049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtFGmu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2006&pages=135-144&author=C.+Cosiauthor=E.+Carilla-Durandauthor=M.+B.+Assi%C3%83%C2%A9author=A.+M.+Ormiereauthor=M.+Maravalauthor=N.+Leducauthor=A.+Newman-Tancredi&title=Partial+agonist+properties+of+the+antipsychotics+SSR181507%2C+aripiprazole+and+bifeprunox+at+dopamine+D2+receptors%3A+G+protein+activation+and+prolactin+release"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release</span></div><div class="casAuthors">Cosi, Cristina; Carilla-Durand, Elisabeth; Assie, Marie Bernadette; Ormiere, Anne Marie; Maraval, Mireille; Leduc, Nathalie; Newman-Tancredi, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">135-144</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dopamine D2 receptor antagonists induce hyperprolactinemia depending on the extent of D2 receptor blockade.  We compared the effects of the new antipsychotic agents SSR181507, bifeprunox, and SLV313 with those of aripiprazole, clozapine, and haloperidol, on functional measures of dopamine D2 receptor activity in vitro and in vivo: [35S]-GTPÎ³S binding to membranes from Sf9 insect cells expressing human dopamine D2 Long (hD2 L) receptors, and serum prolactin levels in the rat.  All compds. antagonized apomorphine-induced G protein activation at dopamine hD2 L receptors.  Antagonist potencies of aripiprazole, bifeprunox and SLV313 were similar to haloperidol (pK b = 9.12), whereas SSR181507 (8.16) and clozapine (7.35) were less potent.  Haloperidol, SLV313 and clozapine were silent antagonists but SSR181507, bifeprunox and aripiprazole stimulated [35S]-GTPÎ³S binding by 17.5%, 26.3% and 25.6%, resp., relative to 100 Î¼M apomorphine (Emax = 100%). pEC50s were: SSR181507, 8.08; bifeprunox, 8.97; aripiprazole, 8.56.  These effects were antagonized by raclopride.  Following oral administration in vivo, the drugs increased prolactin release to different extents.  SLV313 and haloperidol potently (ED50 0.12 and 0.22 mg/kg p.o., resp.) stimulated prolactin release up to 86 and 83 ng/mL.  Aripiprazole potently (ED50 0.66 mg/kg p.o.) but partially (32 ng/mL) induced prolactin release.  SSR181507 (ED50 4.9 mg/kg p.o.) also partially (23 ng/mL) enhanced prolactin release.  Bifeprunox only weakly increased prolactin at high doses (13 ng/mL at 40 mg/kg) and clozapine only affected prolactin at the highest dose tested (41 ng/mL at 40 mg/kg).  Prolactin levels of the corresponding vehicle-treated animals were < 4.3 ng/mL.  These data show that (1) SSR181507, aripiprazole and bifeprunox, but not SLV313, are partial agonists at dopamine hD2 L receptors in vitro; (2) SSR181507, bifeprunox and aripiprazole exhibit reduced prolactin release in vivo compared with drugs that are neutral antagonists at dopamine D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrtKly85ekeLVg90H21EOLACvtfcHk0ljKpZtfg2ttDA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtFGmu74%253D&md5=f3d0bc9e55df9cfd8b48338824545c22</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.01.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.01.051%26sid%3Dliteratum%253Aachs%26aulast%3DCosi%26aufirst%3DC.%26aulast%3DCarilla-Durand%26aufirst%3DE.%26aulast%3DAssi%25C3%2583%25C2%25A9%26aufirst%3DM.%2BB.%26aulast%3DOrmiere%26aufirst%3DA.%2BM.%26aulast%3DMaraval%26aufirst%3DM.%26aulast%3DLeduc%26aufirst%3DN.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26atitle%3DPartial%2520agonist%2520properties%2520of%2520the%2520antipsychotics%2520SSR181507%252C%2520aripiprazole%2520and%2520bifeprunox%2520at%2520dopamine%2520D2%2520receptors%253A%2520G%2520protein%2520activation%2520and%2520prolactin%2520release%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D535%26spage%3D135%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Sonesson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikstrom, H.</span><span> </span><span class="NLM_article-title">Substituted (<i>S</i>)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structureâactivity relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2735</span><span class="NLM_x">â</span> <span class="NLM_lpage">2753</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00043a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2735-2753&author=C.+Sonessonauthor=C.+H.+Linauthor=L.+Hanssonauthor=N.+Watersauthor=K.+Svenssonauthor=A.+Carlssonauthor=M.+W.+Smithauthor=H.+Wikstrom&title=Substituted+%28S%29-phenylpiperidines+and+rigid+congeners+as+preferential+dopamine+autoreceptor+antagonists%3A+synthesis+and+structure%E2%80%93activity+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm00043a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00043a013%26sid%3Dliteratum%253Aachs%26aulast%3DSonesson%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DC.%2BH.%26aulast%3DHansson%26aufirst%3DL.%26aulast%3DWaters%26aufirst%3DN.%26aulast%3DSvensson%26aufirst%3DK.%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DM.%2BW.%26aulast%3DWikstrom%26aufirst%3DH.%26atitle%3DSubstituted%2520%2528S%2529-phenylpiperidines%2520and%2520rigid%2520congeners%2520as%2520preferential%2520dopamine%2520autoreceptor%2520antagonists%253A%2520synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2735%26epage%3D2753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolome, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span> </span><span class="NLM_article-title">Molecular properties affecting fast dissociation from the D2 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2231</span><span class="NLM_x">â</span> <span class="NLM_lpage">2241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2Fj.bmc.2011.02.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=21421319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFeht70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2231-2241&author=G.+Tresadernauthor=J.+M.+Bartolomeauthor=G.+J.+Macdonaldauthor=X.+Langlois&title=Molecular+properties+affecting+fast+dissociation+from+the+D2+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular properties affecting fast dissociation from the D2 receptor</span></div><div class="casAuthors">Tresadern, Gary; Bartolome, Jose Manuel; MacDonald, Gregor J.; Langlois, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2231-2241</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dopamine D2 receptor antagonism is the foundation of antipsychotic treatment.  Antipsychotic agents vary in how fast they dissoc. from the D2 receptors.  It has been proposed that the liability to exhibit side effects such as extra pyramidal symptoms may be the result of a slow rate of dissocn.  Compds. with a faster rate of dissocn., while still blocking efficiently the D2 receptors, will subsequently respond better to physiol. surges in dopamine transmission.  Therefore, work in our labs. has focussed on identifying fast dissocg. and selective D2 antagonists.  Biol. screening was performed to measure the affinity and extent of dissocn. for a large dataset of over 1800 D2 antagonists.  Subsequent univariate and multivariate statistical anal. revealed the mol. properties which differentiate fast and slow dissocg. compds.  It is shown that faster dissocg. antagonists are less lipophilic and have lower mol. wt.  There was a clear and expected inverse relationship with extent of dissocn. and binding affinity with more potent compds. tending to be slower dissocg.  However, within a range of comparable affinity both fast and slow dissocg. compds. were identified.  After de-correlating affinity and dissocn. the anal. revealed the important descriptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqilpQ8-EuD-LVg90H21EOLACvtfcHk0ljA54EaOr47Zw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFeht70%253D&md5=574e106853b1cff1b6975c4bba979031</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DBartolome%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DLanglois%26aufirst%3DX.%26atitle%3DMolecular%2520properties%2520affecting%2520fast%2520dissociation%2520from%2520the%2520D2%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2231%26epage%3D2241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Liljefors, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogeso, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyttel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikstrom, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, A.</span><span> </span><span class="NLM_article-title">Pre- and postsynaptic dopaminergic activities of indolizidine and quinolizidine derivatives of 3-(3-hydroxyphenyl)-<i>N</i>-(<i>n</i>-propyl)piperidine (3-PPP). Further developments of a dopamine receptor model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">â</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00165a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=1015-1022&author=T.+Liljeforsauthor=K.+P.+Bogesoauthor=J.+Hyttelauthor=H.+Wikstromauthor=K.+Svenssonauthor=A.+Carlsson&title=Pre-+and+postsynaptic+dopaminergic+activities+of+indolizidine+and+quinolizidine+derivatives+of+3-%283-hydroxyphenyl%29-N-%28n-propyl%29piperidine+%283-PPP%29.+Further+developments+of+a+dopamine+receptor+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm00165a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00165a020%26sid%3Dliteratum%253Aachs%26aulast%3DLiljefors%26aufirst%3DT.%26aulast%3DBogeso%26aufirst%3DK.%2BP.%26aulast%3DHyttel%26aufirst%3DJ.%26aulast%3DWikstrom%26aufirst%3DH.%26aulast%3DSvensson%26aufirst%3DK.%26aulast%3DCarlsson%26aufirst%3DA.%26atitle%3DPre-%2520and%2520postsynaptic%2520dopaminergic%2520activities%2520of%2520indolizidine%2520and%2520quinolizidine%2520derivatives%2520of%25203-%25283-hydroxyphenyl%2529-N-%2528n-propyl%2529piperidine%2520%25283-PPP%2529.%2520Further%2520developments%2520of%2520a%2520dopamine%2520receptor%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D1015%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Malo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brive, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, P.</span><span> </span><span class="NLM_article-title">Selective pharmacophore models of dopamine D(1) and D(2) full agonists based on extended pharmacophore features</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">â</span> <span class="NLM_lpage">246</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=232-246&author=M.+Maloauthor=L.+Briveauthor=K.+Luthmanauthor=P.+Svensson&title=Selective+pharmacophore+models+of+dopamine+D%281%29+and+D%282%29+full+agonists+based+on+extended+pharmacophore+features"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalo%26aufirst%3DM.%26aulast%3DBrive%26aufirst%3DL.%26aulast%3DLuthman%26aufirst%3DK.%26aulast%3DSvensson%26aufirst%3DP.%26atitle%3DSelective%2520pharmacophore%2520models%2520of%2520dopamine%2520D%25281%2529%2520and%2520D%25282%2529%2520full%2520agonists%2520based%2520on%2520extended%2520pharmacophore%2520features%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D232%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Perregaard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogeso, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyttel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, C.</span><span> </span><span class="NLM_article-title">Noncataleptogenic, centrally acting dopamine D-2 and serotonin 5-HT2 antagonists within a series of 3-substituted 1-(4-fluorophenyl)-1<i>H</i>-indoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1092</span><span class="NLM_x">â</span> <span class="NLM_lpage">1101</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00084a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=1092-1101&author=J.+Perregaardauthor=J.+Arntauthor=K.+P.+Bogesoauthor=J.+Hyttelauthor=C.+Sanchez&title=Noncataleptogenic%2C+centrally+acting+dopamine+D-2+and+serotonin+5-HT2+antagonists+within+a+series+of+3-substituted+1-%284-fluorophenyl%29-1H-indoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm00084a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00084a014%26sid%3Dliteratum%253Aachs%26aulast%3DPerregaard%26aufirst%3DJ.%26aulast%3DArnt%26aufirst%3DJ.%26aulast%3DBogeso%26aufirst%3DK.%2BP.%26aulast%3DHyttel%26aufirst%3DJ.%26aulast%3DSanchez%26aufirst%3DC.%26atitle%3DNoncataleptogenic%252C%2520centrally%2520acting%2520dopamine%2520D-2%2520and%2520serotonin%25205-HT2%2520antagonists%2520within%2520a%2520series%2520of%25203-substituted%25201-%25284-fluorophenyl%2529-1H-indoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D1092%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Strupczewski, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stache, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glamkowski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huger, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. W.</span><span> </span><span class="NLM_article-title">Synthesis and neuroleptic activity of 3-(1-substituted-4-piperidinyl)-1,2-benzisoxazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">â</span> <span class="NLM_lpage">769</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00383a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=761-769&author=J.+T.+Strupczewskiauthor=R.+C.+Allenauthor=B.+A.+Gardnerauthor=B.+L.+Schmidauthor=U.+Stacheauthor=E.+J.+Glamkowskiauthor=M.+C.+Jonesauthor=D.+B.+Ellisauthor=F.+P.+Hugerauthor=R.+W.+Dunn&title=Synthesis+and+neuroleptic+activity+of+3-%281-substituted-4-piperidinyl%29-1%2C2-benzisoxazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm00383a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00383a012%26sid%3Dliteratum%253Aachs%26aulast%3DStrupczewski%26aufirst%3DJ.%2BT.%26aulast%3DAllen%26aufirst%3DR.%2BC.%26aulast%3DGardner%26aufirst%3DB.%2BA.%26aulast%3DSchmid%26aufirst%3DB.%2BL.%26aulast%3DStache%26aufirst%3DU.%26aulast%3DGlamkowski%26aufirst%3DE.%2BJ.%26aulast%3DJones%26aufirst%3DM.%2BC.%26aulast%3DEllis%26aufirst%3DD.%2BB.%26aulast%3DHuger%26aufirst%3DF.%2BP.%26aulast%3DDunn%26aufirst%3DR.%2BW.%26atitle%3DSynthesis%2520and%2520neuroleptic%2520activity%2520of%25203-%25281-substituted-4-piperidinyl%2529-1%252C2-benzisoxazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26spage%3D761%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Colpaert, F. C.</span><span> </span><span class="NLM_article-title">Discovering risperidone: the LSD model of psychopathology</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">â</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1038%2Fnrd1062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=12669030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFWktrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=315-320&author=F.+C.+Colpaert&title=Discovering+risperidone%3A+the+LSD+model+of+psychopathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Timeline: Discovering risperidone: the LSD model of psychopathology</span></div><div class="casAuthors">Colpaert, Francis C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">315-320</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In the 1970s and 1980s, Janssen Pharmaceutica Research, which had a broad interest in central nervous system disorders and nurtured intellectual freedom, developed original, and at times heretical, concepts.  It took decades for the scientific community to endorse some of these concepts.  Among them were such notions as an elementary particle of behavior, the introduction of response quality in receptor theory, and the idea that tolerance does not develop to opioids.  These concepts enabled the discovery of the antipsychotic risperidone, an unique full antagonist of the interoceptive effects of LSD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmM6nIWSVMyrVg90H21EOLACvtfcHk0liSdllZNFFcug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFWktrs%253D&md5=357f8b3ab40c17a9332b4151bd0d5ead</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrd1062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1062%26sid%3Dliteratum%253Aachs%26aulast%3DColpaert%26aufirst%3DF.%2BC.%26atitle%3DDiscovering%2520risperidone%253A%2520the%2520LSD%2520model%2520of%2520psychopathology%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D315%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Howard, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, J. A.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">aSeeger, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zorn, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewing, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrone, J.</span><span> </span><span class="NLM_article-title">3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">â</span> <span class="NLM_lpage">148</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950625l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK2MXpvVaqtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=143-148&author=H.+R.+Howardauthor=J.+A.+Loweauthor=T.+F.+aSeegerauthor=P.+A.+Seymourauthor=S.+H.+Zornauthor=P.+R.+Maloneyauthor=F.+E.+Ewingauthor=M.+E.+Newmanauthor=A.+W.+Schmidtauthor=J.+S.+Furmanauthor=G.+L.+Robinsonauthor=E.+Jacksonauthor=C.+Johnsonauthor=J.+Morrone&title=3-Benzisothiazolylpiperazine+derivatives+as+potential+atypical+antipsychotic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">3-Benzisothiazolylpiperazine Derivatives as Potential Atypical Antipsychotic Agents</span></div><div class="casAuthors">Howard, Harry R.; Lowe, John A. III; Seeger, Thomas F.; Seymour, Patricia A.; Zorn, Stevin H.; Maloney, Patrick R.; Ewing, Frank E.; Newman, Michael E.; Schmidt, Anne W.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">143-8</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of substituted phenethyl derivs. of 3-benzisothiazolylpiperazine incorporating potent D2 and 5-HT2A antagonist activity was investigated as an approach to a novel atypical antipsychotic agent.  The in vitro profile of ziprasidone from this series is a combination of D2 receptor affinity comparable to the typical antipsychotic agent haloperidol and a 5-HT2A/D2 ratio comparable to the atypical agent clozapine.  In vivo ziprasidone possesses activity consistent with an efficacious antipsychotic agent with less tendency to induce extrapyramidal side effects in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0LPgTvSrwLbVg90H21EOLACvtfcHk0liSdllZNFFcug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpvVaqtb8%253D&md5=ef39132ebb9327c6749693e1d356cd53</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm950625l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950625l%26sid%3Dliteratum%253Aachs%26aulast%3DHoward%26aufirst%3DH.%2BR.%26aulast%3DLowe%26aufirst%3DJ.%2BA.%26aulast%3DaSeeger%26aufirst%3DT.%2BF.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DZorn%26aufirst%3DS.%2BH.%26aulast%3DMaloney%26aufirst%3DP.%2BR.%26aulast%3DEwing%26aufirst%3DF.%2BE.%26aulast%3DNewman%26aufirst%3DM.%2BE.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DFurman%26aufirst%3DJ.%2BS.%26aulast%3DRobinson%26aufirst%3DG.%2BL.%26aulast%3DJackson%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DMorrone%26aufirst%3DJ.%26atitle%3D3-Benzisothiazolylpiperazine%2520derivatives%2520as%2520potential%2520atypical%2520antipsychotic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D143%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Chouinard, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, T. A.</span><span> </span><span class="NLM_article-title">Pimozide in the treatment of chronic schizophrenic patients</span> <span class="citation_source-journal">Curr. Ther. Res. Clin. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">â</span> <span class="NLM_lpage">603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=4989691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A280%3ADyaE3c3osF2rtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1970&pages=598-603&author=G.+Chouinardauthor=H.+E.+Lehmannauthor=T.+A.+Ban&title=Pimozide+in+the+treatment+of+chronic+schizophrenic+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pimozide in the treatment of chronic schizophrenic patients</span></div><div class="casAuthors">Chouinard G; Lehmann H E; Ban T A</div><div class="citationInfo"><span class="NLM_cas:title">Current therapeutic research, clinical and experimental</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">598-603</span>
        ISSN:<span class="NLM_cas:issn">0011-393X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFg3NAyoSO8YNpW7w2tapOfW6udTcc2eb_64N2hB0ag7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3c3osF2rtg%253D%253D&md5=280a493535e8bbbee2cc9566185b20e4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChouinard%26aufirst%3DG.%26aulast%3DLehmann%26aufirst%3DH.%2BE.%26aulast%3DBan%26aufirst%3DT.%2BA.%26atitle%3DPimozide%2520in%2520the%2520treatment%2520of%2520chronic%2520schizophrenic%2520patients%26jtitle%3DCurr.%2520Ther.%2520Res.%2520Clin.%2520Exp.%26date%3D1970%26volume%3D12%26spage%3D598%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Goddard, W. A.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrol, R.</span><span> </span><span class="NLM_article-title">3-Dimensional structures of G protein-coupled receptors and binding sites of agonists and antagonists</span> <span class="citation_source-journal">J. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">1528S</span><span class="NLM_x">â</span> <span class="NLM_lpage">1538S</span><div class="note"><p class="first last">; discussion 1548S</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2007&pages=1528S-1538S&author=W.+A.+Goddardauthor=R.+Abrol&title=3-Dimensional+structures+of+G+protein-coupled+receptors+and+binding+sites+of+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoddard%26aufirst%3DW.%2BA.%26aulast%3DAbrol%26aufirst%3DR.%26atitle%3D3-Dimensional%2520structures%2520of%2520G%2520protein-coupled%2520receptors%2520and%2520binding%2520sites%2520of%2520agonists%2520and%2520antagonists%26jtitle%3DJ.%2520Nutr.%26date%3D2007%26volume%3D137%26spage%3D1528S%26epage%3D1538S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">AriÃ«ns, E. J.; Beld, A. J.; Rodrigues de Miranda, J. F.; Simonis, A. M.</span> In  <span class="citation_source-book">The Receptors: A Comprehensive Treatise</span>; <span class="NLM_contrib-group">OâBrien, R. D.</span>, Ed.; <span class="NLM_publisher-name">Plenum Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1979</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">1</span>, pp  <span class="NLM_fpage">33</span><span class="NLM_x">â</span> <span class="NLM_lpage">39</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1979&pages=33-39&author=E.+J.+Ari%C3%ABns&author=A.+J.+Beld&author=J.+F.+Rodrigues+de+Miranda&author=A.+M.+Simonisauthor=R.+D.+O%E2%80%99Brien&title=The+Receptors%3A+A+Comprehensive+Treatise"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAri%25C3%25ABns%26aufirst%3DE.%2BJ.%26btitle%3DThe%2520Receptors%253A%2520A%2520Comprehensive%2520Treatise%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DR.%2BD.%26pub%3DPlenum%2520Press%26date%3D1979%26volume%3D1%26spage%3D33%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Hayashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isogaya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriwaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumagai, H.</span><span> </span><span class="NLM_article-title">Design and synthesis of selective alpha1B adrenoceptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4045</span><span class="NLM_x">â</span> <span class="NLM_lpage">4047</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4045-4047&author=R.+Hayashiauthor=E.+Ohmoriauthor=M.+Isogayaauthor=M.+Moriwakiauthor=H.+Kumagai&title=Design+and+synthesis+of+selective+alpha1B+adrenoceptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DR.%26aulast%3DOhmori%26aufirst%3DE.%26aulast%3DIsogaya%26aufirst%3DM.%26aulast%3DMoriwaki%26aufirst%3DM.%26aulast%3DKumagai%26aufirst%3DH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520selective%2520alpha1B%2520adrenoceptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4045%26epage%3D4047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Hrib, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurcak, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgher, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerman, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roehr, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, A. T.</span><span> </span><span class="NLM_article-title">Benzisoxazole- and benzisothiazole-3-carboxamides as potential atypical antipsychotic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2308</span><span class="NLM_x">â</span> <span class="NLM_lpage">2314</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00041a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2308-2314&author=N.+J.+Hribauthor=J.+G.+Jurcakauthor=K.+L.+Burgherauthor=P.+G.+Conwayauthor=H.+B.+Hartmanauthor=L.+L.+Kermanauthor=J.+E.+Roehrauthor=A.+T.+Woods&title=Benzisoxazole-+and+benzisothiazole-3-carboxamides+as+potential+atypical+antipsychotic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm00041a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00041a009%26sid%3Dliteratum%253Aachs%26aulast%3DHrib%26aufirst%3DN.%2BJ.%26aulast%3DJurcak%26aufirst%3DJ.%2BG.%26aulast%3DBurgher%26aufirst%3DK.%2BL.%26aulast%3DConway%26aufirst%3DP.%2BG.%26aulast%3DHartman%26aufirst%3DH.%2BB.%26aulast%3DKerman%26aufirst%3DL.%2BL.%26aulast%3DRoehr%26aufirst%3DJ.%2BE.%26aulast%3DWoods%26aufirst%3DA.%2BT.%26atitle%3DBenzisoxazole-%2520and%2520benzisothiazole-3-carboxamides%2520as%2520potential%2520atypical%2520antipsychotic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2308%26epage%3D2314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krushinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinn, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nutter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gough, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaus, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. C.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6011</span><span class="NLM_x">â</span> <span class="NLM_lpage">6016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=6011-6016&author=D.+Zhangauthor=D.+Kohlmanauthor=J.+Krushinskiauthor=S.+Liangauthor=B.+P.+Yingauthor=J.+E.+Reillyauthor=S.+R.+Dinnauthor=D.+B.+Wainscottauthor=S.+Nutterauthor=W.+Goughauthor=D.+L.+Nelsonauthor=J.+M.+Schausauthor=Y.+C.+Xu&title=Design%2C+synthesis+and+evaluation+of+bicyclic+benzamides+as+novel+5-HT1F+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DKohlman%26aufirst%3DD.%26aulast%3DKrushinski%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DYing%26aufirst%3DB.%2BP.%26aulast%3DReilly%26aufirst%3DJ.%2BE.%26aulast%3DDinn%26aufirst%3DS.%2BR.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DNutter%26aufirst%3DS.%26aulast%3DGough%26aufirst%3DW.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DSchaus%26aufirst%3DJ.%2BM.%26aulast%3DXu%26aufirst%3DY.%2BC.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520bicyclic%2520benzamides%2520as%2520novel%25205-HT1F%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D6011%26epage%3D6016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ife, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meeson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span> </span><span class="NLM_article-title">Identification of a novel series of selective 5-HT7 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">â</span> <span class="NLM_lpage">1058</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1055-1058&author=I.+T.+Forbesauthor=D.+G.+Cooperauthor=E.+K.+Doddsauthor=S.+E.+Douglasauthor=A.+D.+Gribbleauthor=R.+J.+Ifeauthor=A.+P.+Lightfootauthor=M.+Meesonauthor=L.+P.+Campbellauthor=T.+Colemanauthor=G.+J.+Rileyauthor=D.+R.+Thomas&title=Identification+of+a+novel+series+of+selective+5-HT7+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DCooper%26aufirst%3DD.%2BG.%26aulast%3DDodds%26aufirst%3DE.%2BK.%26aulast%3DDouglas%26aufirst%3DS.%2BE.%26aulast%3DGribble%26aufirst%3DA.%2BD.%26aulast%3DIfe%26aufirst%3DR.%2BJ.%26aulast%3DLightfoot%26aufirst%3DA.%2BP.%26aulast%3DMeeson%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DL.%2BP.%26aulast%3DColeman%26aufirst%3DT.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26atitle%3DIdentification%2520of%2520a%2520novel%2520series%2520of%2520selective%25205-HT7%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1055%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Rocco, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinazze, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigschmidt, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley Wainscott, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlkeld, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span> </span><span class="NLM_article-title">Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2653</span><span class="NLM_x">â</span> <span class="NLM_lpage">2656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2653-2656&author=V.+P.+Roccoauthor=P.+G.+Spinazzeauthor=T.+J.+Kohnauthor=N.+A.+Honigschmidtauthor=D.+L.+Nelsonauthor=D.+Bradley+Wainscottauthor=L.+J.+Ahmadauthor=J.+Shawauthor=P.+G.+Threlkeldauthor=D.+T.+Wongauthor=K.+Takeuchi&title=Advances+toward+new+antidepressants+beyond+SSRIs%3A+1-aryloxy-3-piperidinylpropan-2-ols+with+dual+5-HT1A+receptor+antagonism%2FSSRI+activities.+Part+4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRocco%26aufirst%3DV.%2BP.%26aulast%3DSpinazze%26aufirst%3DP.%2BG.%26aulast%3DKohn%26aufirst%3DT.%2BJ.%26aulast%3DHonigschmidt%26aufirst%3DN.%2BA.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DBradley%2BWainscott%26aufirst%3DD.%26aulast%3DAhmad%26aufirst%3DL.%2BJ.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DThrelkeld%26aufirst%3DP.%2BG.%26aulast%3DWong%26aufirst%3DD.%2BT.%26aulast%3DTakeuchi%26aufirst%3DK.%26atitle%3DAdvances%2520toward%2520new%2520antidepressants%2520beyond%2520SSRIs%253A%25201-aryloxy-3-piperidinylpropan-2-ols%2520with%2520dual%25205-HT1A%2520receptor%2520antagonism%252FSSRI%2520activities.%2520Part%25204%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2653%26epage%3D2656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Andersen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perregaard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begtrup, M.</span><span> </span><span class="NLM_article-title">Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1<i>H</i>-indoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">4823</span><span class="NLM_x">â</span> <span class="NLM_lpage">4831</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00104a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=4823-4831&author=K.+Andersenauthor=J.+Perregaardauthor=J.+Arntauthor=J.+B.+Nielsenauthor=M.+Begtrup&title=Selective%2C+centrally+acting+serotonin+5-HT2+antagonists.+2.+Substituted+3-%284-fluorophenyl%29-1H-indoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm00104a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00104a007%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DK.%26aulast%3DPerregaard%26aufirst%3DJ.%26aulast%3DArnt%26aufirst%3DJ.%26aulast%3DNielsen%26aufirst%3DJ.%2BB.%26aulast%3DBegtrup%26aufirst%3DM.%26atitle%3DSelective%252C%2520centrally%2520acting%2520serotonin%25205-HT2%2520antagonists.%25202.%2520Substituted%25203-%25284-fluorophenyl%2529-1H-indoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D4823%26epage%3D4831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Strupczewski, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordeau, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glamkowski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilmot, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helsley, G. C.</span><span> </span><span class="NLM_article-title">3-[[(Aryloxy)alkyl]piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1119</span><span class="NLM_x">â</span> <span class="NLM_lpage">1131</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00007a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1119-1131&author=J.+T.+Strupczewskiauthor=K.+J.+Bordeauauthor=Y.+Chiangauthor=E.+J.+Glamkowskiauthor=P.+G.+Conwayauthor=R.+Corbettauthor=H.+B.+Hartmanauthor=M.+R.+Szewczakauthor=C.+A.+Wilmotauthor=G.+C.+Helsley&title=3-%5B%5B%28Aryloxy%29alkyl%5Dpiperidinyl%5D-1%2C2-benzisoxazoles+as+D2%2F5-HT2+antagonists+with+potential+atypical+antipsychotic+activity%3A+antipsychotic+profile+of+iloperidone+%28HP+873%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm00007a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00007a009%26sid%3Dliteratum%253Aachs%26aulast%3DStrupczewski%26aufirst%3DJ.%2BT.%26aulast%3DBordeau%26aufirst%3DK.%2BJ.%26aulast%3DChiang%26aufirst%3DY.%26aulast%3DGlamkowski%26aufirst%3DE.%2BJ.%26aulast%3DConway%26aufirst%3DP.%2BG.%26aulast%3DCorbett%26aufirst%3DR.%26aulast%3DHartman%26aufirst%3DH.%2BB.%26aulast%3DSzewczak%26aufirst%3DM.%2BR.%26aulast%3DWilmot%26aufirst%3DC.%2BA.%26aulast%3DHelsley%26aufirst%3DG.%2BC.%26atitle%3D3-%255B%255B%2528Aryloxy%2529alkyl%255Dpiperidinyl%255D-1%252C2-benzisoxazoles%2520as%2520D2%252F5-HT2%2520antagonists%2520with%2520potential%2520atypical%2520antipsychotic%2520activity%253A%2520antipsychotic%2520profile%2520of%2520iloperidone%2520%2528HP%2520873%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1119%26epage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigschmidt, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocco, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinazze, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Threlkeld, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span> </span><span class="NLM_article-title">Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1903</span><span class="NLM_x">â</span> <span class="NLM_lpage">1905</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1903-1905&author=K.+Takeuchiauthor=T.+J.+Kohnauthor=N.+A.+Honigschmidtauthor=V.+P.+Roccoauthor=P.+G.+Spinazzeauthor=D.+J.+Kochauthor=D.+L.+Nelsonauthor=D.+B.+Wainscottauthor=L.+J.+Ahmadauthor=J.+Shawauthor=P.+G.+Threlkeldauthor=D.+T.+Wong&title=Advances+toward+new+antidepressants+beyond+SSRIs%3A+1-aryloxy-3-piperidinylpropan-2-ols+with+dual+5-HT1A+receptor+antagonism%2FSSRI+activities.+Part+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DKohn%26aufirst%3DT.%2BJ.%26aulast%3DHonigschmidt%26aufirst%3DN.%2BA.%26aulast%3DRocco%26aufirst%3DV.%2BP.%26aulast%3DSpinazze%26aufirst%3DP.%2BG.%26aulast%3DKoch%26aufirst%3DD.%2BJ.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DAhmad%26aufirst%3DL.%2BJ.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DThrelkeld%26aufirst%3DP.%2BG.%26aulast%3DWong%26aufirst%3DD.%2BT.%26atitle%3DAdvances%2520toward%2520new%2520antidepressants%2520beyond%2520SSRIs%253A%25201-aryloxy-3-piperidinylpropan-2-ols%2520with%2520dual%25205-HT1A%2520receptor%2520antagonism%252FSSRI%2520activities.%2520Part%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1903%26epage%3D1905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Timms, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boot, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadmore, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tree, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedley, S.</span><span> </span><span class="NLM_article-title">SAR development of a selective 5-HT1D antagonist/serotonin reuptake inhibitor lead using rapid parallel synthesis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2469</span><span class="NLM_x">â</span> <span class="NLM_lpage">2472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2469-2472&author=G.+H.+Timmsauthor=J.+R.+Bootauthor=R.+J.+Broadmoreauthor=S.+L.+Carneyauthor=J.+Cooperauthor=J.+D.+Findlayauthor=J.+Gilmoreauthor=S.+Mitchellauthor=N.+A.+Mooreauthor=I.+Pullarauthor=G.+J.+Sangerauthor=R.+Tomlinsonauthor=B.+B.+Treeauthor=S.+Wedley&title=SAR+development+of+a+selective+5-HT1D+antagonist%2Fserotonin+reuptake+inhibitor+lead+using+rapid+parallel+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTimms%26aufirst%3DG.%2BH.%26aulast%3DBoot%26aufirst%3DJ.%2BR.%26aulast%3DBroadmore%26aufirst%3DR.%2BJ.%26aulast%3DCarney%26aufirst%3DS.%2BL.%26aulast%3DCooper%26aufirst%3DJ.%26aulast%3DFindlay%26aufirst%3DJ.%2BD.%26aulast%3DGilmore%26aufirst%3DJ.%26aulast%3DMitchell%26aufirst%3DS.%26aulast%3DMoore%26aufirst%3DN.%2BA.%26aulast%3DPullar%26aufirst%3DI.%26aulast%3DSanger%26aufirst%3DG.%2BJ.%26aulast%3DTomlinson%26aufirst%3DR.%26aulast%3DTree%26aufirst%3DB.%2BB.%26aulast%3DWedley%26aufirst%3DS.%26atitle%3DSAR%2520development%2520of%2520a%2520selective%25205-HT1D%2520antagonist%252Fserotonin%2520reuptake%2520inhibitor%2520lead%2520using%2520rapid%2520parallel%2520synthesis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2469%26epage%3D2472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Guillaume, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedelec, L.</span><span> </span><span class="NLM_article-title">Tetrahydro-1,2,3,6 pyridinyl-4)-3-1<i>H</i>-indoles: synthese, proprietes serotoninergique et anti-dopaminergiques</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">â</span> <span class="NLM_lpage">43</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1987&pages=33-43&author=J.+Guillaumeauthor=C.+Dumontauthor=J.+Laurentauthor=L.+Nedelec&title=Tetrahydro-1%2C2%2C3%2C6+pyridinyl-4%29-3-1H-indoles%3A+synthese%2C+proprietes+serotoninergique+et+anti-dopaminergiques"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuillaume%26aufirst%3DJ.%26aulast%3DDumont%26aufirst%3DC.%26aulast%3DLaurent%26aufirst%3DJ.%26aulast%3DNedelec%26aufirst%3DL.%26atitle%3DTetrahydro-1%252C2%252C3%252C6%2520pyridinyl-4%2529-3-1H-indoles%253A%2520synthese%252C%2520proprietes%2520serotoninergique%2520et%2520anti-dopaminergiques%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1987%26volume%3D22%26spage%3D33%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Carli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Invernizzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samanin, R.</span><span> </span><span class="NLM_article-title">Neurochemical and behavioural studies with RU-24969 in the rat</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">â</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=3128812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaL1cXhsVegtro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1988&pages=359-364&author=M.+Carliauthor=R.+Invernizziauthor=L.+Cervoauthor=R.+Samanin&title=Neurochemical+and+behavioural+studies+with+RU-24969+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Neurochemical and behavioral studies with RU-24969 in the rat</span></div><div class="casAuthors">Carli, Mirjana; Invernizzi, Roberto; Cervo, Luigi; Samanin, Rosario</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-64</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">The regional brain synthesis of serotonin (5-HT) and dopamine (DA) was studied in rats after various doses of 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole (RU-24969), a 5-HT1 receptor agonist.  The potential anxiolytic and antidepressant properties of the compd. were examd. as well.  RU-24969 at 0.62 mg/kg reduced 5-HT synthesis in the nucleus accumbens and hypothalamus, while with 1.25 and 2.5 mg/kg the effect was also seen in the striatum, hippocampus, brainstem and cortex.  RU-24969 at 2.5 and 5 mg/kg had no effect on DA synthesis in the striatum, while 5.0 mg/kg increased it in the nucleus accumbens.  At 2.5 and 5.0 mg/kg the drug increased the motor activity of rats measured during 1 h in activity cages, while 0.625 and 1.25 mg/kg had no effect.  Doses ranging 0.62-2.5 mg/kg reduced unpunished responding in a test of conditioned suppression of drinking.  Doses of 1.25 and 2.5 mg/kg also reduced punished responding.  Finally, of various doses, only 2.5 mg/kg reduced the duration of immobility of rats in the forced swimming test but the effects were due to running around the cylinder rather than to escape attempts.  Apparently, RU-24969 reduced 5-HT synthesis in all brain areas examd., with a preferential effect for the nucleus accumbens and hypothalamus.  At higher doses, there was also a specific increase in DA synthesis in the nucleus accumbens.  The compd. raised the level of activity of rats but no clear evidence of any potential anxiolytic or antidepressant properties was obtained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4FYd9WzSZiLVg90H21EOLACvtfcHk0lgxfBTf5tPcqQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhsVegtro%253D&md5=0cd25aab06000cb399b11455e3743545</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarli%26aufirst%3DM.%26aulast%3DInvernizzi%26aufirst%3DR.%26aulast%3DCervo%26aufirst%3DL.%26aulast%3DSamanin%26aufirst%3DR.%26atitle%3DNeurochemical%2520and%2520behavioural%2520studies%2520with%2520RU-24969%2520in%2520the%2520rat%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D1988%26volume%3D94%26spage%3D359%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Hunt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberlander, C.</span><span> </span><span class="NLM_article-title">The interaction of indole derivatives with the serotonin receptor and non-dopaminergic circling behaviour</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">â</span> <span class="NLM_lpage">562</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=1981&pages=547-562&author=P.+Huntauthor=C.+Oberlander&title=The+interaction+of+indole+derivatives+with+the+serotonin+receptor+and+non-dopaminergic+circling+behaviour"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DP.%26aulast%3DOberlander%26aufirst%3DC.%26atitle%3DThe%2520interaction%2520of%2520indole%2520derivatives%2520with%2520the%2520serotonin%2520receptor%2520and%2520non-dopaminergic%2520circling%2520behaviour%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1981%26volume%3D133%26spage%3D547%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Doods, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkman, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Jonge, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoolen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilffert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmermans, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Zwieten, P. A.</span><span> </span><span class="NLM_article-title">Differential selectivities of RU 24969 and 8-OH-DPAT for the purported 5-HT1A and 5-HT1B binding sites. Correlation between 5-HT1A affinity and hypotensive activity</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">â</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2F0014-2999%2885%2990782-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=3160596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaL2MXkvFymsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1985&pages=363-370&author=H.+N.+Doodsauthor=H.+O.+Kalkmanauthor=A.+De+Jongeauthor=M.+J.+Thoolenauthor=B.+Wilffertauthor=P.+B.+Timmermansauthor=P.+A.+Van+Zwieten&title=Differential+selectivities+of+RU+24969+and+8-OH-DPAT+for+the+purported+5-HT1A+and+5-HT1B+binding+sites.+Correlation+between+5-HT1A+affinity+and+hypotensive+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Differential selectivities of RU 24969 and 8-OH-DPAT for the purported 5-HT1A and 5-HT1B binding sites.  Correlation between 5-HT1A affinity and hypotensive activity</span></div><div class="casAuthors">Doods, Henri N.; Kalkman, Hans O.; De Jonge, Adriaan; Thoolen, Martin J. M. C.; Wilffert, Bob; Timmermans, Pieter B. M. W. M.; Van Zwieten, Pieter A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">363-70</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">RU 24969  [66611-26-5] and 8-hydroxy-2-(dipropylamino)tetralin (8-OH-DPAT)  [78950-78-4] inhibited the specific binding of 3H-labeled 5-HT  [50-67-9] (2 nM) to rat brain membranes with shallow displacement curves.  The displacement data were best fitted with a model of 2 independent, high- and low-affinity binding sites.  Following addn. of spiperone (1 Î¼M) as a selective ligand for the putative 5-HT1A recognition site of [3H]5-HT, the displacement curve of RU 24969 underwent a leftward shift, whereas spiperone induced a shift to the right for the displacement curve of 8-OH-DPAT.  In contrast to spiperone, pindolol (1 Î¼M) shifted the displacement curve of RU 24969 to the right.  Apparently, RU 24969 possesses preference for the purported 5-HT1B subtype of central 5-HT1 recognition site.  The reported linear correlation between hypotensive activity following i.v. administration to anesthetized rats and affinity for the central 5-HT1 binding site could only be maintained by incorporation of the affinity of RU 24969 for its low- and 8-OH-DPAT for its high-affinity binding site.  Based on the proposal that the 5-HT1A site corresponds to the high-affinity site of 8-OH-DPAT and the low-affinity site of RU 24969, it is hypothesized that the late depressor phase of 5-HT agonists in rats is mediated by activation of peripheral (vascular) 5-HT receptors which have similarities with the 5-HT1A subtype of central 5-HT1 recognition site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXsY4hSk02U7Vg90H21EOLACvtfcHk0lgxfBTf5tPcqQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXkvFymsL0%253D&md5=e6ac3a3923955c56f1c97bc73e1e3e4c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2885%2990782-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252885%252990782-4%26sid%3Dliteratum%253Aachs%26aulast%3DDoods%26aufirst%3DH.%2BN.%26aulast%3DKalkman%26aufirst%3DH.%2BO.%26aulast%3DDe%2BJonge%26aufirst%3DA.%26aulast%3DThoolen%26aufirst%3DM.%2BJ.%26aulast%3DWilffert%26aufirst%3DB.%26aulast%3DTimmermans%26aufirst%3DP.%2BB.%26aulast%3DVan%2BZwieten%26aufirst%3DP.%2BA.%26atitle%3DDifferential%2520selectivities%2520of%2520RU%252024969%2520and%25208-OH-DPAT%2520for%2520the%2520purported%25205-HT1A%2520and%25205-HT1B%2520binding%2520sites.%2520Correlation%2520between%25205-HT1A%2520affinity%2520and%2520hypotensive%2520activity%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1985%26volume%3D112%26spage%3D363%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Deskus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epperson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cipollina, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dextraze, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian-Cutrone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beno, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molski, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taber, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, R. J.</span><span> </span><span class="NLM_article-title">Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">â</span> <span class="NLM_lpage">3104</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3099-3104&author=J.+A.+Deskusauthor=J.+R.+Eppersonauthor=C.+P.+Sloanauthor=J.+A.+Cipollinaauthor=P.+Dextrazeauthor=J.+Qian-Cutroneauthor=Q.+Gaoauthor=B.+Maauthor=B.+R.+Benoauthor=G.+K.+Mattsonauthor=T.+F.+Molskiauthor=R.+G.+Krauseauthor=M.+T.+Taberauthor=N.+J.+Lodgeauthor=R.+J.+Mattson&title=Conformationally+restricted+homotryptamines+3.+Indole+tetrahydropyridines+and+cyclohexenylamines+as+selective+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeskus%26aufirst%3DJ.%2BA.%26aulast%3DEpperson%26aufirst%3DJ.%2BR.%26aulast%3DSloan%26aufirst%3DC.%2BP.%26aulast%3DCipollina%26aufirst%3DJ.%2BA.%26aulast%3DDextraze%26aufirst%3DP.%26aulast%3DQian-Cutrone%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DMattson%26aufirst%3DG.%2BK.%26aulast%3DMolski%26aufirst%3DT.%2BF.%26aulast%3DKrause%26aufirst%3DR.%2BG.%26aulast%3DTaber%26aufirst%3DM.%2BT.%26aulast%3DLodge%26aufirst%3DN.%2BJ.%26aulast%3DMattson%26aufirst%3DR.%2BJ.%26atitle%3DConformationally%2520restricted%2520homotryptamines%25203.%2520Indole%2520tetrahydropyridines%2520and%2520cyclohexenylamines%2520as%2520selective%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3099%26epage%3D3104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Matzen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Amsterdam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rautenberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiner, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyfried, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottcher, H.</span><span> </span><span class="NLM_article-title">5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1149</span><span class="NLM_x">â</span> <span class="NLM_lpage">1157</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9811054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtlKjtrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1149-1157&author=L.+Matzenauthor=C.+van+Amsterdamauthor=W.+Rautenbergauthor=H.+E.+Greinerauthor=J.+Hartingauthor=C.+A.+Seyfriedauthor=H.+Bottcher&title=5-HT+reuptake+inhibitors+with+5-HT%281B%2F1D%29+antagonistic+activity%3A+a+new+approach+toward+efficient+antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT reuptake inhibitors with 5-HT1B/1D antagonistic activity: a new approach toward efficient antidepressants</span></div><div class="casAuthors">Matzen, Lisa; Van Amsterdam, Christoph; Rautenberg, Wilfried; Greiner, Hartmut E.; Harting, Juergen; Seyfried, Christoph A.; Boettcher, Henning</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1149-1157</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of the authors' research program toward new, potential antidepressants, a series of unsym. ureas has been prepd. and evaluated as 5-HT reuptake inhibitors with 5-HT1B/1D antagonistic activities.  The design of these compds. was based on coupling of various indole derivs., previously shown to inhibit 5-HT reuptake, to three different aniline moieties, which are part of known 5-HT1B/1D ligands.  Binding expts. in rat frontal cortex using [125I]iodocyanopindolol, in calf striatum using [3H]5-HT, and in rat hippocampus using [3H]8-OH-DPAT as radioligands, resp., revealed significantly higher affinity at the 5-HT1B receptor as compared to the affinities for the 5-HT1A and 5-HT1D receptors for a no. of compds., among them 4-(5-fluoro-1H-indol-3-yl)piperidine-1-carboxylic acid [4-methoxy-3-(4-methylpiperazin-1-yl)phenyl]amide I (R = R2 = H; R1 = F), the corresponding 4-fluoro-1H-indol-3-yl analog I (R = F; R1 = R2 = H), and the corresponding 6-fluoro-1H-indol-3-yl analog I (R = R1 = H; R2 = F).  Conformational restriction of the aniline moiety in I only slightly enhanced the 5-HT1B affinity, whereas introduction of an aniline moiety with higher conformational flexibility resulted in a less potent 5-HT1B receptor ligand as compared to I.  The functional 5-HT1B/1D antagonistic activity was investigated using the rabbit saphenous vein model as well as the [3H]5-HT release from guinea pig cortical slices.  All new compds. tested in the rabbit saphenous vein model were shown to antagonize the sumatriptan-evoked contractile responses with pA2 values ranging from 7.3 to 8.7.  These observations were consistent with the results of the cortical slice model, in which the ureas were found to block the sumatriptan-induced inhibition of potassium-evoked [3H]5-HT release.  The 5-HT reuptake inhibition of the ureas detd. in rat brain synaptosomes was found to be either increased or decreased as compared to the uncoupled indole derivs. indicating that the reuptake inhibition shown by the ureas is not only due to the indole part but also affected by the aniline moiety of the mol.  Among this series of compds. described the ureas I seem to be the most interesting candidates showing both 5-HT reuptake inhibition and 5-HT1B/1D antagonism in vitro.  This dual pharmacol. profile should in theory lead to a pronounced enhancement in serotonergic neurotransmission and consequently to a more efficient treatment of depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPoXyqYo-xI7Vg90H21EOLACvtfcHk0lgxfBTf5tPcqQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtlKjtrc%253D&md5=339f7c7e7c49ff88559984852971fdd2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm9811054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9811054%26sid%3Dliteratum%253Aachs%26aulast%3DMatzen%26aufirst%3DL.%26aulast%3Dvan%2BAmsterdam%26aufirst%3DC.%26aulast%3DRautenberg%26aufirst%3DW.%26aulast%3DGreiner%26aufirst%3DH.%2BE.%26aulast%3DHarting%26aufirst%3DJ.%26aulast%3DSeyfried%26aufirst%3DC.%2BA.%26aulast%3DBottcher%26aufirst%3DH.%26atitle%3D5-HT%2520reuptake%2520inhibitors%2520with%25205-HT%25281B%252F1D%2529%2520antagonistic%2520activity%253A%2520a%2520new%2520approach%2520toward%2520efficient%2520antidepressants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1149%26epage%3D1157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Lambert, G. A.</span><span> </span><span class="NLM_article-title">Preclinical neuropharmacology of naratriptan</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">â</span> <span class="NLM_lpage">316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=289-316&author=G.+A.+Lambert&title=Preclinical+neuropharmacology+of+naratriptan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DG.%2BA.%26atitle%3DPreclinical%2520neuropharmacology%2520of%2520naratriptan%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2005%26volume%3D11%26spage%3D289%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Sternfeld, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broughton, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiblin, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelley, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Street, L. J.</span><span> </span><span class="NLM_article-title">The chemical evolution of <i>N</i>,<i>N</i>-dimethyl-2-[5-(1,2,4-triazol-4-yl)-1<i>H</i>-indol-3-yl]ethylamine (L-741,604) and analogues: potent and selective agonists for 5-HT1D receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1825</span><span class="NLM_x">â</span> <span class="NLM_lpage">1830</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=1825-1830&author=F.+Sternfeldauthor=R.+Bakerauthor=H.+B.+Broughtonauthor=A.+R.+Guiblinauthor=R.+A.+Jelleyauthor=L.+J.+Street&title=The+chemical+evolution+of+N%2CN-dimethyl-2-%5B5-%281%2C2%2C4-triazol-4-yl%29-1H-indol-3-yl%5Dethylamine+%28L-741%2C604%29+and+analogues%3A+potent+and+selective+agonists+for+5-HT1D+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSternfeld%26aufirst%3DF.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DBroughton%26aufirst%3DH.%2BB.%26aulast%3DGuiblin%26aufirst%3DA.%2BR.%26aulast%3DJelley%26aufirst%3DR.%2BA.%26aulast%3DStreet%26aufirst%3DL.%2BJ.%26atitle%3DThe%2520chemical%2520evolution%2520of%2520N%252CN-dimethyl-2-%255B5-%25281%252C2%252C4-triazol-4-yl%2529-1H-indol-3-yl%255Dethylamine%2520%2528L-741%252C604%2529%2520and%2520analogues%253A%2520potent%2520and%2520selective%2520agonists%2520for%25205-HT1D%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26spage%3D1825%26epage%3D1830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Barf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikstrom, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauwels, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardif, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundmark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundell, S.</span><span> </span><span class="NLM_article-title">5-(Sulfonyl)oxy-tryptamines and ethylamino side chain restricted derivatives. Structureâaffinity relationships for h5-HT1B and h5-HT1D receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1469</span><span class="NLM_x">â</span> <span class="NLM_lpage">1479</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=1469-1479&author=T.+Barfauthor=H.+Wikstromauthor=P.+J.+Pauwelsauthor=C.+Palmierauthor=S.+Tardifauthor=M.+Lundmarkauthor=S.+Sundell&title=5-%28Sulfonyl%29oxy-tryptamines+and+ethylamino+side+chain+restricted+derivatives.+Structure%E2%80%93affinity+relationships+for+h5-HT1B+and+h5-HT1D+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarf%26aufirst%3DT.%26aulast%3DWikstrom%26aufirst%3DH.%26aulast%3DPauwels%26aufirst%3DP.%2BJ.%26aulast%3DPalmier%26aufirst%3DC.%26aulast%3DTardif%26aufirst%3DS.%26aulast%3DLundmark%26aufirst%3DM.%26aulast%3DSundell%26aufirst%3DS.%26atitle%3D5-%2528Sulfonyl%2529oxy-tryptamines%2520and%2520ethylamino%2520side%2520chain%2520restricted%2520derivatives.%2520Structure%25E2%2580%2593affinity%2520relationships%2520for%2520h5-HT1B%2520and%2520h5-HT1D%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1998%26volume%3D6%26spage%3D1469%26epage%3D1479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Brown, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avenell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span> </span><span class="NLM_article-title">BRL 54443 a potent agonist with selectivity for human cloned 5-HT1E and 5-HT1F receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">233P</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=1998&pages=233P&author=A.+M.+Brownauthor=K.+Avenellauthor=T.+J.+Youngauthor=M.+Hoauthor=R.+A.+Porterauthor=D.+N.+Middlemiss&title=BRL+54443+a+potent+agonist+with+selectivity+for+human+cloned+5-HT1E+and+5-HT1F+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DAvenell%26aufirst%3DK.%26aulast%3DYoung%26aufirst%3DT.%2BJ.%26aulast%3DHo%26aufirst%3DM.%26aulast%3DPorter%26aufirst%3DR.%2BA.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26atitle%3DBRL%252054443%2520a%2520potent%2520agonist%2520with%2520selectivity%2520for%2520human%2520cloned%25205-HT1E%2520and%25205-HT1F%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D123%26spage%3D233P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Choi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquess, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, S. D.</span><span> </span><span class="NLM_article-title">Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-<i>N</i>-[3-(1-methyl-4-piperidinyl)-1<i>H</i>-indol-5-yl]benzamide</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3609</span><span class="NLM_x">â</span> <span class="NLM_lpage">3616</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7011722" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3609-3616&author=S.+K.+Choiauthor=D.+Greenauthor=A.+Hoauthor=U.+Kleinauthor=D.+Marquessauthor=R.+Taylorauthor=S.+D.+Turner&title=Designing+selective%2C+high+affinity+ligands+of+5-HT1D+receptor+by+covalent+dimerization+of+5-HT1F+ligands+derived+from+4-fluoro-N-%5B3-%281-methyl-4-piperidinyl%29-1H-indol-5-yl%5Dbenzamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm7011722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7011722%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%2BK.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DA.%26aulast%3DKlein%26aufirst%3DU.%26aulast%3DMarquess%26aufirst%3DD.%26aulast%3DTaylor%26aufirst%3DR.%26aulast%3DTurner%26aufirst%3DS.%2BD.%26atitle%3DDesigning%2520selective%252C%2520high%2520affinity%2520ligands%2520of%25205-HT1D%2520receptor%2520by%2520covalent%2520dimerization%2520of%25205-HT1F%2520ligands%2520derived%2520from%25204-fluoro-N-%255B3-%25281-methyl-4-piperidinyl%2529-1H-indol-5-yl%255Dbenzamide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3609%26epage%3D3616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Nelson, D. L.</span><span> </span><span class="NLM_article-title">Structureâactivity relationships at 5-HT1A receptors: binding profiles and intrinsic activity</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1041</span><span class="NLM_x">â</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1991&pages=1041-1051&author=D.+L.+Nelson&title=Structure%E2%80%93activity+relationships+at+5-HT1A+receptors%3A+binding+profiles+and+intrinsic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DD.%2BL.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520at%25205-HT1A%2520receptors%253A%2520binding%2520profiles%2520and%2520intrinsic%2520activity%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1991%26volume%3D40%26spage%3D1041%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Hansch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J.</span><span> </span><span class="NLM_article-title">The structureâactivity relationship of inhibitors of serotonin uptake and receptor binding</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">â</span> <span class="NLM_lpage">453</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1991&pages=441-453&author=C.+Hanschauthor=J.+Caldwell&title=The+structure%E2%80%93activity+relationship+of+inhibitors+of+serotonin+uptake+and+receptor+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansch%26aufirst%3DC.%26aulast%3DCaldwell%26aufirst%3DJ.%26atitle%3DThe%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520inhibitors%2520of%2520serotonin%2520uptake%2520and%2520receptor%2520binding%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1991%26volume%3D5%26spage%3D441%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Agarwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlgren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herslof, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J. W.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Three-dimensional quantitative structureâactivity relationships of 5-HT receptor binding data for tetrahydropyridinylindole derivatives: a comparison of the Hansch and CoMFA methods</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">4006</span><span class="NLM_x">â</span> <span class="NLM_lpage">4014</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00077a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=4006-4014&author=A.+Agarwalauthor=P.+P.+Pearsonauthor=E.+W.+Taylorauthor=H.+B.+Liauthor=T.+Dahlgrenauthor=M.+Herslofauthor=Y.+Yangauthor=G.+Lambertauthor=D.+L.+Nelsonauthor=J.+W.+Regan&title=Three-dimensional+quantitative+structure%E2%80%93activity+relationships+of+5-HT+receptor+binding+data+for+tetrahydropyridinylindole+derivatives%3A+a+comparison+of+the+Hansch+and+CoMFA+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm00077a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00077a003%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DA.%26aulast%3DPearson%26aufirst%3DP.%2BP.%26aulast%3DTaylor%26aufirst%3DE.%2BW.%26aulast%3DLi%26aufirst%3DH.%2BB.%26aulast%3DDahlgren%26aufirst%3DT.%26aulast%3DHerslof%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLambert%26aufirst%3DG.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DRegan%26aufirst%3DJ.%2BW.%26atitle%3DThree-dimensional%2520quantitative%2520structure%25E2%2580%2593activity%2520relationships%2520of%25205-HT%2520receptor%2520binding%2520data%2520for%2520tetrahydropyridinylindole%2520derivatives%253A%2520a%2520comparison%2520of%2520the%2520Hansch%2520and%2520CoMFA%2520methods%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D4006%26epage%3D4014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Crawforth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodacre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourrain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marwood, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnor, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span> </span><span class="NLM_article-title">3-(4-Piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1<i>H</i>-indoles as bioavailable h5-HT2A antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2701</span><span class="NLM_x">â</span> <span class="NLM_lpage">2703</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2701-2703&author=J.+Crawforthauthor=S.+Goodacreauthor=R.+Maxeyauthor=S.+Bourrainauthor=S.+Patelauthor=R.+Marwoodauthor=D.+O%E2%80%99Connorauthor=R.+Herbertauthor=P.+Hutsonauthor=M.+Rowley&title=3-%284-Piperidinyl%29-+and+3-%288-aza-bicyclo%5B3.2.1%5Doct-3-yl%29-2-phenyl-1H-indoles+as+bioavailable+h5-HT2A+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrawforth%26aufirst%3DJ.%26aulast%3DGoodacre%26aufirst%3DS.%26aulast%3DMaxey%26aufirst%3DR.%26aulast%3DBourrain%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DMarwood%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DD.%26aulast%3DHerbert%26aufirst%3DR.%26aulast%3DHutson%26aufirst%3DP.%26aulast%3DRowley%26aufirst%3DM.%26atitle%3D3-%25284-Piperidinyl%2529-%2520and%25203-%25288-aza-bicyclo%255B3.2.1%255Doct-3-yl%2529-2-phenyl-1H-indoles%2520as%2520bioavailable%2520h5-HT2A%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2701%26epage%3D2703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Iwamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casey, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadden, J. S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">4-(6-Fluorobenzisoxazol-3-yl)piperidine, a risperidone metabolite with serotonergic activity of potential clinical significance</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">â</span> <span class="NLM_lpage">601</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK28Xntlyqu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=593-601&author=T.+Iwamuraauthor=C.+T.+Caseyauthor=R.+Youngauthor=M.+Dukatauthor=M.+Teitlerauthor=J.+S.+P.+Faddenauthor=R.+A.+Glennon&title=4-%286-Fluorobenzisoxazol-3-yl%29piperidine%2C+a+risperidone+metabolite+with+serotonergic+activity+of+potential+clinical+significance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">4-(6-Fluorobenzisoxazol-3-yl)piperidine, a risperidone metabolite with serotonergic activity of potential clinical significance</span></div><div class="casAuthors">Iwamura, Tatsunori; Casey, Christina T.; Young, Richard; Dukat, Malgorzata; Teitler, Milt; Fadden, James S. P.; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">593-601</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser</span>)
        </div><div class="casAbstract">Because 6-FBIP [4-(6-fluorobenzisoxazol-3-yl)piperidine] has been identified as a metabolite of the antipsychotic agent risperidone, and due to its structural resemblance to certain serotonin agonists, it was of interest to det. whether or not this metabolite possesses any 5-HT2 activity of its own.  In comparing the binding of this agent with that of its non-metabolite positional isomer control, 5-FBIP, it was found that 6-FBIP (5-HT2A Ki = 49 nM) binds with only 16-fold lower affinity than risperidone, whereas the affinity of 5-FBIP is approx. 1000-fold lower.  In tests of functional activity (inositol phosphate prodn., stimulus generalization in DOM-trained rats), however, 6-FBIP behaved as a 5-HT2 antagonist.  It is concluded that 6-FBIP, although weaker than risperidone, would likely act as a 5-HT2 antagonist if it was produced to any significant extent upon metab. of risperidone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrPQwYU_o_qbVg90H21EOLACvtfcHk0lidTuv2S64nFg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xntlyqu78%253D&md5=b6f7a0939ffeb639ccd7024873d28c32</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIwamura%26aufirst%3DT.%26aulast%3DCasey%26aufirst%3DC.%2BT.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DFadden%26aufirst%3DJ.%2BS.%2BP.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3D4-%25286-Fluorobenzisoxazol-3-yl%2529piperidine%252C%2520a%2520risperidone%2520metabolite%2520with%2520serotonergic%2520activity%2520of%2520potential%2520clinical%2520significance%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D1996%26volume%3D6%26spage%3D593%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Mattsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonesson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandahl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiner, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gassen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plaschke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leibrock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottcher, H.</span><span> </span><span class="NLM_article-title">2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1<i>H</i>-indoles as novel 5-HT6 receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4230</span><span class="NLM_x">â</span> <span class="NLM_lpage">4234</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4230-4234&author=C.+Mattssonauthor=C.+Sonessonauthor=A.+Sandahlauthor=H.+E.+Greinerauthor=M.+Gassenauthor=J.+Plaschkeauthor=J.+Leibrockauthor=H.+Bottcher&title=2-Alkyl-3-%281%2C2%2C3%2C6-tetrahydropyridin-4-yl%29-1H-indoles+as+novel+5-HT6+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMattsson%26aufirst%3DC.%26aulast%3DSonesson%26aufirst%3DC.%26aulast%3DSandahl%26aufirst%3DA.%26aulast%3DGreiner%26aufirst%3DH.%2BE.%26aulast%3DGassen%26aufirst%3DM.%26aulast%3DPlaschke%26aufirst%3DJ.%26aulast%3DLeibrock%26aufirst%3DJ.%26aulast%3DBottcher%26aufirst%3DH.%26atitle%3D2-Alkyl-3-%25281%252C2%252C3%252C6-tetrahydropyridin-4-yl%2529-1H-indoles%2520as%2520novel%25205-HT6%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4230%26epage%3D4234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merce, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guitart, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Codony, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dordal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andaluz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monroy, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cubi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanfeliu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, H.</span><span> </span><span class="NLM_article-title">Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1781</span><span class="NLM_x">â</span> <span class="NLM_lpage">1795</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049615n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1781-1795&author=J.+Holenzauthor=R.+Merceauthor=J.+L.+Diazauthor=X.+Guitartauthor=X.+Codonyauthor=A.+Dordalauthor=G.+Romeroauthor=A.+Torrensauthor=J.+Masauthor=B.+Andaluzauthor=S.+Hernandezauthor=X.+Monroyauthor=E.+Sanchezauthor=E.+Hernandezauthor=R.+Perezauthor=R.+Cubiauthor=O.+Sanfeliuauthor=H.+Buschmann&title=Medicinal+chemistry+driven+approaches+toward+novel+and+selective+serotonin+5-HT6+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm049615n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049615n%26sid%3Dliteratum%253Aachs%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DMerce%26aufirst%3DR.%26aulast%3DDiaz%26aufirst%3DJ.%2BL.%26aulast%3DGuitart%26aufirst%3DX.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DDordal%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DG.%26aulast%3DTorrens%26aufirst%3DA.%26aulast%3DMas%26aufirst%3DJ.%26aulast%3DAndaluz%26aufirst%3DB.%26aulast%3DHernandez%26aufirst%3DS.%26aulast%3DMonroy%26aufirst%3DX.%26aulast%3DSanchez%26aufirst%3DE.%26aulast%3DHernandez%26aufirst%3DE.%26aulast%3DPerez%26aufirst%3DR.%26aulast%3DCubi%26aufirst%3DR.%26aulast%3DSanfeliu%26aufirst%3DO.%26aulast%3DBuschmann%26aufirst%3DH.%26atitle%3DMedicinal%2520chemistry%2520driven%2520approaches%2520toward%2520novel%2520and%2520selective%2520serotonin%25205-HT6%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1781%26epage%3D1795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Liu, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowal, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Identification of a series of benzoxazoles as potent 5-HT6 ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1115</span><span class="NLM_x">â</span> <span class="NLM_lpage">1117</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1115-1117&author=K.+G.+Liuauthor=J.+R.+Loauthor=T.+A.+Comeryauthor=G.+M.+Zhangauthor=J.+Y.+Zhangauthor=D.+M.+Kowalauthor=D.+L.+Smithauthor=L.+Diauthor=E.+H.+Kernsauthor=L.+E.+Schechterauthor=A.+J.+Robichaud&title=Identification+of+a+series+of+benzoxazoles+as+potent+5-HT6+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%2BG.%26aulast%3DLo%26aufirst%3DJ.%2BR.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DZhang%26aufirst%3DG.%2BM.%26aulast%3DZhang%26aufirst%3DJ.%2BY.%26aulast%3DKowal%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520of%2520a%2520series%2520of%2520benzoxazoles%2520as%2520potent%25205-HT6%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1115%26epage%3D1117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanao, M.</span><span> </span><span class="NLM_article-title">Synthesis of 4-(benzo[<i>b</i>]furan-2 or 3-yl)- and 4-(benzo[<i>b</i>]thiophen-3-yl)piperidines with 5-HT2 anatagonistic activity</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">â</span> <span class="NLM_lpage">451</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1993&pages=445-451&author=Y.+Watanabeauthor=H.+Yoshiwaraauthor=M.+Kanao&title=Synthesis+of+4-%28benzo%5Bb%5Dfuran-2+or+3-yl%29-+and+4-%28benzo%5Bb%5Dthiophen-3-yl%29piperidines+with+5-HT2+anatagonistic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DYoshiwara%26aufirst%3DH.%26aulast%3DKanao%26aufirst%3DM.%26atitle%3DSynthesis%2520of%25204-%2528benzo%255Bb%255Dfuran-2%2520or%25203-yl%2529-%2520and%25204-%2528benzo%255Bb%255Dthiophen-3-yl%2529piperidines%2520with%25205-HT2%2520anatagonistic%2520activity%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1993%26volume%3D30%26spage%3D445%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Freter, K.</span><span> </span><span class="NLM_article-title">3-Cycloalkenylindoles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2525</span><span class="NLM_x">â</span> <span class="NLM_lpage">2529</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00905a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1975&pages=2525-2529&author=K.+Freter&title=3-Cycloalkenylindoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjo00905a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00905a023%26sid%3Dliteratum%253Aachs%26aulast%3DFreter%26aufirst%3DK.%26atitle%3D3-Cycloalkenylindoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1975%26volume%3D40%26spage%3D2525%26epage%3D2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Henning, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattrell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhards, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leven, M.</span><span> </span><span class="NLM_article-title">Synthesis and neuroleptic activity of a series of 1-[1-(benzo-1,4-dioxan-2-ylmethyl)-4-piperidinyl]benzim idazolone derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">814</span><span class="NLM_x">â</span> <span class="NLM_lpage">819</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00388a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=814-819&author=R.+Henningauthor=R.+Lattrellauthor=H.+J.+Gerhardsauthor=M.+Leven&title=Synthesis+and+neuroleptic+activity+of+a+series+of+1-%5B1-%28benzo-1%2C4-dioxan-2-ylmethyl%29-4-piperidinyl%5Dbenzim+idazolone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm00388a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00388a012%26sid%3Dliteratum%253Aachs%26aulast%3DHenning%26aufirst%3DR.%26aulast%3DLattrell%26aufirst%3DR.%26aulast%3DGerhards%26aufirst%3DH.%2BJ.%26aulast%3DLeven%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520neuroleptic%2520activity%2520of%2520a%2520series%2520of%25201-%255B1-%2528benzo-1%252C4-dioxan-2-ylmethyl%2529-4-piperidinyl%255Dbenzim%2520idazolone%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D814%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budhu, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malkowitz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMartino, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrin, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lineberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emini, E. A.</span><span> </span><span class="NLM_article-title">Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2129</span><span class="NLM_x">â</span> <span class="NLM_lpage">2134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2129-2134&author=D.+Kimauthor=L.+Wangauthor=J.+J.+Haleauthor=C.+L.+Lynchauthor=R.+J.+Budhuauthor=M.+Maccossauthor=S.+G.+Millsauthor=L.+Malkowitzauthor=S.+L.+Gouldauthor=J.+A.+DeMartinoauthor=M.+S.+Springerauthor=D.+Hazudaauthor=M.+Millerauthor=J.+Kesslerauthor=R.+C.+Hrinauthor=G.+Carverauthor=A.+Carellaauthor=K.+Henryauthor=J.+Linebergerauthor=W.+A.+Schleifauthor=E.+A.+Emini&title=Potent+1%2C3%2C4-trisubstituted+pyrrolidine+CCR5+receptor+antagonists%3A+effects+of+fused+heterocycles+on+antiviral+activity+and+pharmacokinetic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DBudhu%26aufirst%3DR.%2BJ.%26aulast%3DMaccoss%26aufirst%3DM.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DMalkowitz%26aufirst%3DL.%26aulast%3DGould%26aufirst%3DS.%2BL.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DSpringer%26aufirst%3DM.%2BS.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DKessler%26aufirst%3DJ.%26aulast%3DHrin%26aufirst%3DR.%2BC.%26aulast%3DCarver%26aufirst%3DG.%26aulast%3DCarella%26aufirst%3DA.%26aulast%3DHenry%26aufirst%3DK.%26aulast%3DLineberger%26aufirst%3DJ.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26atitle%3DPotent%25201%252C3%252C4-trisubstituted%2520pyrrolidine%2520CCR5%2520receptor%2520antagonists%253A%2520effects%2520of%2520fused%2520heterocycles%2520on%2520antiviral%2520activity%2520and%2520pharmacokinetic%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2129%26epage%3D2134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Sasakura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugasawa, T.</span><span> </span><span class="NLM_article-title">Simple synthesis of 1-(azacycloalkyl)indoles using exclusive ortho Î±-chloroacetylation of <i>N</i>-(azacycloalkyl)anilines</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">â</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1080%2F00397918808057833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaL1MXlslCmsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1988&pages=265-273&author=K.+Sasakuraauthor=M.+Adachiauthor=T.+Sugasawa&title=Simple+synthesis+of+1-%28azacycloalkyl%29indoles+using+exclusive+ortho+%CE%B1-chloroacetylation+of+N-%28azacycloalkyl%29anilines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Simple synthesis of 1-(azacycloalkyl)indoles using exclusive ortho Î±-chloroacetylation of N-(azacycloalkyl)anilines</span></div><div class="casAuthors">Sasakura, Kazuyuki; Adachi, Makoto; Sugasawa, Tsutomu</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-73</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">Indoles I (n = 1,2; R1 = H, F; R2 = H, halo, OMe) were prepd. from the resp. 2-amino-2-chloroacetophenones II (R3 = Me, PhCH2) by sequential hydride redn., cyclization, dealkylation-acylation with ClCO2Et, and deacylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj8knwOjktlbVg90H21EOLACvtfcHk0lh8p9mIDjqSoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlslCmsw%253D%253D&md5=2300a382688a562b45abff99971142ea</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1080%2F00397918808057833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397918808057833%26sid%3Dliteratum%253Aachs%26aulast%3DSasakura%26aufirst%3DK.%26aulast%3DAdachi%26aufirst%3DM.%26aulast%3DSugasawa%26aufirst%3DT.%26atitle%3DSimple%2520synthesis%2520of%25201-%2528azacycloalkyl%2529indoles%2520using%2520exclusive%2520ortho%2520%25CE%25B1-chloroacetylation%2520of%2520N-%2528azacycloalkyl%2529anilines%26jtitle%3DSynth.%2520Commun.%26date%3D1988%26volume%3D18%26spage%3D265%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Efange, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelson, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, T. P.</span><span> </span><span class="NLM_article-title">Molecular size and flexibility as determinants of selectivity in the oxidation of <i>N</i>-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs by monoamine oxidase A and B</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1278</span><span class="NLM_x">â</span> <span class="NLM_lpage">1283</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00061a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=1278-1283&author=S.+M.+Efangeauthor=R.+H.+Michelsonauthor=A.+K.+Tanauthor=M.+J.+Kruegerauthor=T.+P.+Singer&title=Molecular+size+and+flexibility+as+determinants+of+selectivity+in+the+oxidation+of+N-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine+analogs+by+monoamine+oxidase+A+and+B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm00061a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00061a020%26sid%3Dliteratum%253Aachs%26aulast%3DEfange%26aufirst%3DS.%2BM.%26aulast%3DMichelson%26aufirst%3DR.%2BH.%26aulast%3DTan%26aufirst%3DA.%2BK.%26aulast%3DKrueger%26aufirst%3DM.%2BJ.%26aulast%3DSinger%26aufirst%3DT.%2BP.%26atitle%3DMolecular%2520size%2520and%2520flexibility%2520as%2520determinants%2520of%2520selectivity%2520in%2520the%2520oxidation%2520of%2520N-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine%2520analogs%2520by%2520monoamine%2520oxidase%2520A%2520and%2520B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D1278%26epage%3D1283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">da Silva, J. F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garden, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, A. C.</span><span> </span><span class="NLM_article-title">The chemistry of isatins: a review from 1975 to 1999</span> <span class="citation_source-journal">J. Braz. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">â</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1590%2FS0103-50532001000300002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktFejt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=273-324&author=J.+F.+M.+da+Silvaauthor=S.+J.+Gardenauthor=A.+C.+Pinto&title=The+chemistry+of+isatins%3A+a+review+from+1975+to+1999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">The chemistry of isatins: a review from 1975 to 1999</span></div><div class="casAuthors">Da Silva, Joaquim F. M.; Garden, Simon J.; Pinto, Angelo C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Brazilian Chemical Society</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-324</span>CODEN:
                <span class="NLM_cas:coden">JOCSET</span>;
        ISSN:<span class="NLM_cas:issn">0103-5053</span>.
    
            (<span class="NLM_cas:orgname">Sociedade Brasileira de Quimica</span>)
        </div><div class="casAbstract">A review with 637 refs. on prepn., reactions, characterizations, technol. applications, and pharmacol. activities of isatins and derivs.  Isatins (1H-indole-2,3-dione) are synthetically versatile substrates, where they can be used for the synthesis of a large variety of heterocyclic compds., such as indoles and quinolines, and as precursors for drug synthesis.  Isatins have also been found in mammalian tissue and their function as a modulator of biochem. processes has been the subject of several discussions.  The advances in the use of isatins for org. synthesis during the last twenty-five years, as well as a survey of its biol. and pharmacol. properties are reported in this review and in the accompanying supplementary information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYGv727EJmgLVg90H21EOLACvtfcHk0liKzrcGwg_ebA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktFejt7c%253D&md5=5263f260528fa9bf1a18aae0fef66371</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1590%2FS0103-50532001000300002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0103-50532001000300002%26sid%3Dliteratum%253Aachs%26aulast%3Dda%2BSilva%26aufirst%3DJ.%2BF.%2BM.%26aulast%3DGarden%26aufirst%3DS.%2BJ.%26aulast%3DPinto%26aufirst%3DA.%2BC.%26atitle%3DThe%2520chemistry%2520of%2520isatins%253A%2520a%2520review%2520from%25201975%2520to%25201999%26jtitle%3DJ.%2520Braz.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D12%26spage%3D273%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Welch, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanau, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whalen, W. M.</span><span> </span><span class="NLM_article-title">A novel synthesis of 3-substituted indazole derivatives</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">â</span> <span class="NLM_lpage">939</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1055%2Fs-1992-26268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK3sXmvFWj" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&pages=937-939&author=W.+M.+Welchauthor=C.+E.+Hanauauthor=W.+M.+Whalen&title=A+novel+synthesis+of+3-substituted+indazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A novel synthesis of 3-substituted indazole derivatives</span></div><div class="casAuthors">Welch, Willard M.; Hanau, Catherine E.; Whalen, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">937-9</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">The dianion prepd. from 3-bromo-1H-indazole (I; R= Br) and alkyllithium bases reacts with a variety of electrophiles to give the corresponding 3-monosubstituted 1H-indazole derivs. I [R = Me, Ac, Bz, PhC(:NH), PhCH(OH), PhCMe(OH), Me2C(OH), 1-hyroxy-1-cyclohexyl] in moderate yields.  This procedure is more general and shorter than earlier methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR1wBGc8c7-rVg90H21EOLACvtfcHk0liKzrcGwg_ebA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmvFWj&md5=33db904e64a3471ebbd953771aec1636</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1055%2Fs-1992-26268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1992-26268%26sid%3Dliteratum%253Aachs%26aulast%3DWelch%26aufirst%3DW.%2BM.%26aulast%3DHanau%26aufirst%3DC.%2BE.%26aulast%3DWhalen%26aufirst%3DW.%2BM.%26atitle%3DA%2520novel%2520synthesis%2520of%25203-substituted%2520indazole%2520derivatives%26jtitle%3DSynthesis%26date%3D1992%26spage%3D937%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Grandy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchionni, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stofko, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frothingham, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke-Howie, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Server, A. C.</span><span> </span><span class="NLM_article-title">Cloning of the cDNA and gene for a human D2 dopamine receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">9762</span><span class="NLM_x">â</span> <span class="NLM_lpage">9766</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1989&pages=9762-9766&author=D.+K.+Grandyauthor=M.+A.+Marchionniauthor=H.+Makamauthor=R.+E.+Stofkoauthor=M.+Alfanoauthor=L.+Frothinghamauthor=J.+B.+Fischerauthor=K.+J.+Burke-Howieauthor=J.+R.+Bunzowauthor=A.+C.+Server&title=Cloning+of+the+cDNA+and+gene+for+a+human+D2+dopamine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DMarchionni%26aufirst%3DM.%2BA.%26aulast%3DMakam%26aufirst%3DH.%26aulast%3DStofko%26aufirst%3DR.%2BE.%26aulast%3DAlfano%26aufirst%3DM.%26aulast%3DFrothingham%26aufirst%3DL.%26aulast%3DFischer%26aufirst%3DJ.%2BB.%26aulast%3DBurke-Howie%26aufirst%3DK.%2BJ.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DServer%26aufirst%3DA.%2BC.%26atitle%3DCloning%2520of%2520the%2520cDNA%2520and%2520gene%2520for%2520a%2520human%2520D2%2520dopamine%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1989%26volume%3D86%26spage%3D9762%26epage%3D9766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Tatsumi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richelson, E.</span><span> </span><span class="NLM_article-title">Pharmacological profile of neuroleptics at human monoamine transporters</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">â</span> <span class="NLM_lpage">283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2FS0014-2999%2899%2900005-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=10193665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK1MXhs1OitLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=1999&pages=277-283&author=M.+Tatsumiauthor=K.+Jansenauthor=R.+D.+Blakelyauthor=E.+Richelson&title=Pharmacological+profile+of+neuroleptics+at+human+monoamine+transporters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of neuroleptics at human monoamine transporters</span></div><div class="casAuthors">Tatsumi, Masahiko; Jansen, Karen; Blakely, Randy D.; Richelson, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">277-283</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Using radioligand binding techniques, the authors detd. the equil. dissocn. consts. (KD) for 37 neuroleptics and one metabolite of a neuroleptic (haloperidol metabolite) for the human serotonin, norepinephrine, and dopamine transporters with [3H]imipramine, [3H]nisoxetine, and [3H]WIN35428, resp.  Among neuroleptics, the four most potent compds. at the human serotonin transporter were triflupromazine, fluperlapine, chlorpromazine, and ziprasidone (KD 24-39 nM); and at the norepinephrine transporter, chlorpromazine, zotepine, chlorprothixene, and promazine (KD 19-25 nM).  At the human dopamine transporter, only pimozide (KD=69) ziprasidone (KD=76) had notable potency.  These data may be useful in predicting therapeutic and adverse effects, including drug interactions of neuroleptics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk1A_X0jOFkrVg90H21EOLACvtfcHk0li4E9VV0Avl8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhs1OitLk%253D&md5=607c3d5404d625efb8b6558d78330f77</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2899%2900005-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252899%252900005-9%26sid%3Dliteratum%253Aachs%26aulast%3DTatsumi%26aufirst%3DM.%26aulast%3DJansen%26aufirst%3DK.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DPharmacological%2520profile%2520of%2520neuroleptics%2520at%2520human%2520monoamine%2520transporters%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D368%26spage%3D277%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Cesura, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galva, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imhof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Prada, M.</span><span> </span><span class="NLM_article-title">Characterization of the binding of [<sup>3</sup>H]Ro 41-1049 to the active site of human monoamine oxidase-A</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">â</span> <span class="NLM_lpage">366</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1990&pages=358-366&author=A.+M.+Cesuraauthor=M.+Bosauthor=M.+D.+Galvaauthor=R.+Imhofauthor=M.+Da+Prada&title=Characterization+of+the+binding+of+%5B3H%5DRo+41-1049+to+the+active+site+of+human+monoamine+oxidase-A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCesura%26aufirst%3DA.%2BM.%26aulast%3DBos%26aufirst%3DM.%26aulast%3DGalva%26aufirst%3DM.%2BD.%26aulast%3DImhof%26aufirst%3DR.%26aulast%3DDa%2BPrada%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520the%2520binding%2520of%2520%255B3H%255DRo%252041-1049%2520to%2520the%2520active%2520site%2520of%2520human%2520monoamine%2520oxidase-A%26jtitle%3DMol.%2520Pharmacol.%26date%3D1990%26volume%3D37%26spage%3D358%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Mulheron, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casanas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnovskaya, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gettys, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, J. R.</span><span> </span><span class="NLM_article-title">Human 5-HT1A receptor expressed in insect cells activates endogenous G(o)-like G protein(s)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">12954</span><span class="NLM_x">â</span> <span class="NLM_lpage">12962</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=12954-12962&author=J.+G.+Mulheronauthor=S.+J.+Casanasauthor=J.+M.+Arthurauthor=M.+N.+Garnovskayaauthor=T.+W.+Gettysauthor=J.+R.+Raymond&title=Human+5-HT1A+receptor+expressed+in+insect+cells+activates+endogenous+G%28o%29-like+G+protein%28s%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMulheron%26aufirst%3DJ.%2BG.%26aulast%3DCasanas%26aufirst%3DS.%2BJ.%26aulast%3DArthur%26aufirst%3DJ.%2BM.%26aulast%3DGarnovskaya%26aufirst%3DM.%2BN.%26aulast%3DGettys%26aufirst%3DT.%2BW.%26aulast%3DRaymond%26aufirst%3DJ.%2BR.%26atitle%3DHuman%25205-HT1A%2520receptor%2520expressed%2520in%2520insect%2520cells%2520activates%2520endogenous%2520G%2528o%2529-like%2520G%2520protein%2528s%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D12954%26epage%3D12962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Bonhaus, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSouza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salazar, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuppan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eglen, R. M.</span><span> </span><span class="NLM_article-title">The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">622</span><span class="NLM_x">â</span> <span class="NLM_lpage">628</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1111%2Fj.1476-5381.1995.tb14977.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=7582481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK2MXmtlOht7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1995&pages=622-628&author=D.+W.+Bonhausauthor=C.+Bachauthor=A.+DeSouzaauthor=F.+H.+Salazarauthor=B.+D.+Matsuokaauthor=P.+Zuppanauthor=H.+W.+Chanauthor=R.+M.+Eglen&title=The+pharmacology+and+distribution+of+human+5-hydroxytryptamine2B+%285-HT2B%29+receptor+gene+products%3A+comparison+with+5-HT2A+and+5-HT2C+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors</span></div><div class="casAuthors">Bonhaus, Douglas W.; Bach, Chinh; DeSouza, Andrea; Salazar, R. H. Rick; Matsuoka, Barbara D.; Zuppan, Patricia; Chan, Hardy W.; Eglen, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">622-8</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Scientific & Medical Division</span>)
        </div><div class="casAbstract">Full length clones of the human 5-HT2B receptor were isolated from human liver, kidney and pancreas.  The cloned human 5-HT2B receptors had a high degree of homol. (â¼80%) with the rat and mouse 5-HT2B receptors.  PCR amplification was used to det. the tissue distribution of human 5-HT2B receptor mRNA.  MRNA encoding the 5-HT2B receptor was expressed with greatest abundance in human liver and kidney.  Lower levels of expression were detected in cerebral cortex, whole brain, pancreas and spleen.  Expression was not detected in heart.  Northern blot anal. confirmed the presence of 5-HT2B receptor mRNA (a 2.4 kB sized band) in pancreas, liver and kidney.  An addnl. 3.2 kB sized band of hybridization was detected in liver and kidney.  This raises the possibility of a splice variant of the receptor or the presence of an addnl. homologous receptor.  The human 5-HT2B receptor was expressed in Cos-7 cells and its ligand binding characteristics were compared to similarly expressed human 5-HT2A and 5-HT2C receptors.  The ligand specificity of the human 5-HT2B receptor (5-HT > ritanserin > SB 204741 > spiperone) was distinct from that of the human 5-HT2A (ritanserin > spiperone > 5-HT > SB 204741) and 5-HT2C (ritanserin > 5-HT > spiperone = SB 204741) receptors.  On the basis of a higher affinity for ketanserin and a lower affinity for yohimbine the human 5-HT2B receptor also appeared to differ from the rat 5-HT2B receptor.  These findings confirm the sequence of the human 5-HT2B receptor and they demonstrate that the receptor has a widespread tissue distribution.  In addn., these data suggest that there are differences in ligand affinities between different species homologues of the receptor.  Finally, the finding of two distinct bands on the Northern blots of liver and kidney raises the possibility of splice variants or subtypes of 5-HT2B receptors, within these tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo79mR3s8H2nLVg90H21EOLACvtfcHk0li4E9VV0Avl8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtlOht7k%253D&md5=55752ff530149d3ac96e5d9082c3e5d6</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb14977.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb14977.x%26sid%3Dliteratum%253Aachs%26aulast%3DBonhaus%26aufirst%3DD.%2BW.%26aulast%3DBach%26aufirst%3DC.%26aulast%3DDeSouza%26aufirst%3DA.%26aulast%3DSalazar%26aufirst%3DF.%2BH.%26aulast%3DMatsuoka%26aufirst%3DB.%2BD.%26aulast%3DZuppan%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DH.%2BW.%26aulast%3DEglen%26aufirst%3DR.%2BM.%26atitle%3DThe%2520pharmacology%2520and%2520distribution%2520of%2520human%25205-hydroxytryptamine2B%2520%25285-HT2B%2529%2520receptor%2520gene%2520products%253A%2520comparison%2520with%25205-HT2A%2520and%25205-HT2C%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D115%26spage%3D622%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Monsma, F. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamblin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span> </span><span class="NLM_article-title">Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">â</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=7680751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK3sXktVWisb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1993&pages=320-327&author=F.+J.+Monsmaauthor=Y.+Shenauthor=R.+P.+Wardauthor=M.+W.+Hamblinauthor=D.+R.+Sibley&title=Cloning+and+expression+of+a+novel+serotonin+receptor+with+high+affinity+for+tricyclic+psychotropic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs</span></div><div class="casAuthors">Monsma, Frederick J., Jr.; Shen, Yong; Ward, Raymond P.; Hamblin, Mark W.; Sibley, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">320-7</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The polymerase chain reaction technique was used to selectively amplify a guanine nucleotide-binding protein-coupled receptor cDNA sequence from rat striatal mRNA that exhibits high homol. to previously cloned serotonin receptors.  Sequencing of a full length clone isolated from a rat striatal cDNA library revealed an open reading frame of 1311 base pairs, encoding a 437-residue protein with 7 hydrophobic regions.  Within these hydrophobic regions, this receptor was 36-41% identical to the following serotonin (5-HT) receptors: 5-HT2 > 5-HT1D > 5-HT1C > 5-HT1B > 5-HT1A > 5-HT1E.  Northern blots revealed a â¼4.2-kilobase transcript localized in various brain regions, with the following rank order of abundance: striatum Â» olfactory tubercle > cerebral cortex > hippocampus.  Expression of this clone in COS-7 cells resulted in the appearance of high affinity, saturable binding of (+)-[2-125I]iodolyzergic acid diethylamide ([125I]LSD) with a Kd of 1.26 nM.  Among endogenous biogenic amines, only 5-HT completely inhibited [125I]LSD binding (Ki = 150 nM).  The inhibition of [125I]LSD binding by other serotonergic agonists and antagonists revealed a pharmacol. profile that does not correlate with that of any previously described serotonin receptor subtype.  In addn., this receptor exhibits high affinity for a no. of tricyclic antipsychotic and antidepressant drugs, including clozapine, amoxipine, and amitriptyline.  In HEK-293 cells stably transfected with this receptor, serotonin elicits a potent stimulation of adenylyl cyclase activity, which is blocked by antipsychotic and antidepressant drugs.  The distinct structural and pharmacol. properties of this receptor site indicate that it represents a completely novel subtype of serotonin receptor.  Based on its affinity for tricyclic psychotropic drugs and its localization to limbic and cortical regions of the brain, it is likely that this receptor may play a role in several neuropsychiatric disorders that involve serotonergic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktsaVgvzJ9LVg90H21EOLACvtfcHk0li4E9VV0Avl8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXktVWisb8%253D&md5=c8b46ab9e3591b6ea473459f18f006ea</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DWard%26aufirst%3DR.%2BP.%26aulast%3DHamblin%26aufirst%3DM.%2BW.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26atitle%3DCloning%2520and%2520expression%2520of%2520a%2520novel%2520serotonin%2520receptor%2520with%2520high%2520affinity%2520for%2520tricyclic%2520psychotropic%2520drugs%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D43%26spage%3D320%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Ricci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronzetti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felici, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amenta, F.</span><span> </span><span class="NLM_article-title">Labeling of dopamine D3 and D4 receptor subtypes in human peripheral blood lymphocytes with [<sup>3</sup>H]7-OH-DPAT: a combined radioligand binding assay and immunochemical study</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">â</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2FS0165-5728%2898%2900207-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=9916894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK1cXnvVWisLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=191-195&author=A.+Ricciauthor=E.+Bronzettiauthor=L.+Feliciauthor=S.+Grecoauthor=F.+Amenta&title=Labeling+of+dopamine+D3+and+D4+receptor+subtypes+in+human+peripheral+blood+lymphocytes+with+%5B3H%5D7-OH-DPAT%3A+a+combined+radioligand+binding+assay+and+immunochemical+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Labeling of dopamine D3 and D4 receptor subtypes in human peripheral blood lymphocytes with [3H]7-OH-DPAT: a combined radioligand binding assay and immunochemical study</span></div><div class="casAuthors">Ricci, Alberto; Bronzetti, Elena; Felici, Laura; Greco, Stefania; Amenta, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">191-195</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Mol. biol. studies have demonstrated that human peripheral blood lymphocytes express dopamine D2-like receptors belonging to the D3 and D4 receptor subtypes, whereas the characterization of these receptors using radioligand binding assay techniques provided conflicting results.  The preferential dopamine D3 receptor agonist [3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin ([3H]7-OH-DPAT) was used recently for labeling lymphocyte dopamine D3 receptor.  However, the selectivity of this compd. for the D3 receptor was questioned.  In this study we have investigated human peripheral blood lymphocyte dopamine receptor subtypes labeled by [3H]7-OH-DPAT using a conventional radioligand binding assay technique and antibodies against dopamine D2-like receptor subtypes.  [3H]7-OH-DPAT was specifically bound to intact human peripheral blood lymphocytes with a dissocn. const. (Kd) value of 0.32+0.03 nM and a max. d. of binding sites (Bmax) of 18.2+0.8 fmol/2Ã106 cells.  [3H]7-OH-DPAT binding was unaffected by antibodies against dopamine D2 and D2S receptors.  Anti-dopamine D3 and D4 receptor antibodies reduced [3H]7-OH-DPAT binding by about 53% and 32% resp.  Combination of anti D3 and D4 receptor antibodies reduced remarkably [3H]7-OH-DPAT binding.  The above results suggest that the dopamine receptor agonist [3H]7-OH-DPAT labels dopamine D3 and D4 receptor subtypes in human peripheral blood lymphocytes.  The use of antibodies raised against dopamine receptor subtypes in combination with radioligand binding assay may contribute to define receptor subtypes expressed by human peripheral blood lymphocytes in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8wJD81ec6E7Vg90H21EOLACvtfcHk0ljlB03QjtjIAg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvVWisLw%253D&md5=ed71ff6b6524ef876e5cb285c603b475</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2FS0165-5728%2898%2900207-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-5728%252898%252900207-0%26sid%3Dliteratum%253Aachs%26aulast%3DRicci%26aufirst%3DA.%26aulast%3DBronzetti%26aufirst%3DE.%26aulast%3DFelici%26aufirst%3DL.%26aulast%3DGreco%26aufirst%3DS.%26aulast%3DAmenta%26aufirst%3DF.%26atitle%3DLabeling%2520of%2520dopamine%2520D3%2520and%2520D4%2520receptor%2520subtypes%2520in%2520human%2520peripheral%2520blood%2520lymphocytes%2520with%2520%255B3H%255D7-OH-DPAT%253A%2520a%2520combined%2520radioligand%2520binding%2520assay%2520and%2520immunochemical%2520study%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D1998%26volume%3D92%26spage%3D191%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Tol, H. H. M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civelli, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niznik, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jovanovic, V.</span><span> </span><span class="NLM_article-title">Multiple dopamine D4 receptor variants in the human population</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">â</span> <span class="NLM_lpage">152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=1992&pages=149-152&author=H.+H.+M.+V.+Tolauthor=C.+M.+Wuauthor=H.-C.+Guanauthor=K.+Oharaauthor=J.+R.+Bunzowauthor=O.+Civelliauthor=J.+Kennedyauthor=P.+Seemanauthor=H.+B.+Niznikauthor=V.+Jovanovic&title=Multiple+dopamine+D4+receptor+variants+in+the+human+population"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTol%26aufirst%3DH.%2BH.%2BM.%2BV.%26aulast%3DWu%26aufirst%3DC.%2BM.%26aulast%3DGuan%26aufirst%3DH.-C.%26aulast%3DOhara%26aufirst%3DK.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DCivelli%26aufirst%3DO.%26aulast%3DKennedy%26aufirst%3DJ.%26aulast%3DSeeman%26aufirst%3DP.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26aulast%3DJovanovic%26aufirst%3DV.%26atitle%3DMultiple%2520dopamine%2520D4%2520receptor%2520variants%2520in%2520the%2520human%2520population%26jtitle%3DNature%26date%3D1992%26volume%3D358%26spage%3D149%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Nyronen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pihlavisto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peltonen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffren, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salminen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurster, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marjamaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanerva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katainen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laaksonen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savola, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheinin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. S.</span><span> </span><span class="NLM_article-title">Molecular mechanism for agonist-promoted alpha(2A)-adrenoceptor activation by norepinephrine and epinephrine</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1343</span><span class="NLM_x">â</span> <span class="NLM_lpage">1354</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=1343-1354&author=T.+Nyronenauthor=M.+Pihlavistoauthor=J.+M.+Peltonenauthor=A.+M.+Hoffrenauthor=M.+Varisauthor=T.+Salminenauthor=S.+Wursterauthor=A.+Marjamakiauthor=L.+Kanervaauthor=E.+Katainenauthor=L.+Laaksonenauthor=J.+M.+Savolaauthor=M.+Scheininauthor=M.+S.+Johnson&title=Molecular+mechanism+for+agonist-promoted+alpha%282A%29-adrenoceptor+activation+by+norepinephrine+and+epinephrine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNyronen%26aufirst%3DT.%26aulast%3DPihlavisto%26aufirst%3DM.%26aulast%3DPeltonen%26aufirst%3DJ.%2BM.%26aulast%3DHoffren%26aufirst%3DA.%2BM.%26aulast%3DVaris%26aufirst%3DM.%26aulast%3DSalminen%26aufirst%3DT.%26aulast%3DWurster%26aufirst%3DS.%26aulast%3DMarjamaki%26aufirst%3DA.%26aulast%3DKanerva%26aufirst%3DL.%26aulast%3DKatainen%26aufirst%3DE.%26aulast%3DLaaksonen%26aufirst%3DL.%26aulast%3DSavola%26aufirst%3DJ.%2BM.%26aulast%3DScheinin%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26atitle%3DMolecular%2520mechanism%2520for%2520agonist-promoted%2520alpha%25282A%2529-adrenoceptor%2520activation%2520by%2520norepinephrine%2520and%2520epinephrine%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D59%26spage%3D1343%26epage%3D1354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Pristupa, Z. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niznik, H. B.</span><span> </span><span class="NLM_article-title">Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [<sup>3</sup>H]WIN 35,428 and [<sup>3</sup>H]GBR 12,935 binding</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">â</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=8302271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFemu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=125-135&author=Z.+B.+Pristupaauthor=J.+M.+Wilsonauthor=B.+J.+Hoffmanauthor=S.+J.+Kishauthor=H.+B.+Niznik&title=Pharmacological+heterogeneity+of+the+cloned+and+native+human+dopamine+transporter%3A+disassociation+of+%5B3H%5DWIN+35%2C428+and+%5B3H%5DGBR+12%2C935+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding</span></div><div class="casAuthors">Pristupa, Zdenek B.; Wilson, Julie M.; Hoffman, Beth J.; Kish, Stephen J.; Niznik, Hyman B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-35</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Controversy exists as to whether the functional state of the dopamine (DA) transporter is identical to sites mediating the specific binding of selective DA transporter radioligands.  Therefore, the authors compared the pharmacol. profile of numerous dopamine transport substrates and inhibitors on [3H]DA uptake with the binding of [3H]WIN 35,428 and [3H]GBR 12,935 to COS-7 cells transiently expressing the cloned human DA transporter.  [3H]DA uptake and [3H]WIN 35,428 binding was specific, saturable, and to a single class of binding sites with an estd. Km/Vmax of â¼2 Î¼M and 6 pmol/min/105 cells for DA uptake and Kd/Bmax values of â¼10 nM and 113 fmol/105 cells for [3H]WIN 35,428.  [3H]DA uptake was inhibited in a concn.-dependent and uniphasic manner by dopaminergic agents with an appropriate rank order of potency for the DA transporter.  Although most uptake blockers inhibited [3H]WIN 35,428 binding in a uniphasic manner, WIN 35,428, Lu 19,005, D-amphetamine, and DA clearly displayed the presence of both high and low affinity components.  Comparison of the Ki values for the inhibition of [3H]DA uptake with [3H]WIN 35,428 binding reveals that, for uptake blockers and D-amphetamine, it is the high affinity component that shares pharmacol. identity with effects on DA uptake (r = 0.9985), whereas for DA it is the low affinity site.  In striking contrast, however, [3H]GBR 12,935 binding to COS-7 cells could not be made to exhibit a pharmacol. profile indicative of the DA transporter and suggests that the site regulating functional [3H]DA uptake may not be identical with sites labeled by [3H]GBR 12,935 in these cells.  Moreover, these sites appear unrelated to those previously described in native membranes as "piperazine acceptor" or P 450 proteins.  Comparison of Ki values and rank order of potency for the inhibition of [3H]WIN 35,428 or [3H]GBR 12,935 binding to human caudate membranes reveals pharmacol. homol., but not identity, with that of the cloned DA uptake process.  Taken together, these data suggest that 1) [3H]WIN 35,428 recognizes two sites of the DA transporter, of which only one appears to represent the functional state of the protein, and 2) [3H]WIN 35,428 and [3H]GBR 12,935 do not appear to bind the same functional form/state of the DA transporter.  Whether the nonidentity of binding sites is a manifestation of some post-translational regulatory event (e.g., phosphorylation/accessory binding protein) or caused by the existence of multiple mol. forms of the DA transporter is currently unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU2Vc8HuOAsLVg90H21EOLACvtfcHk0ljlB03QjtjIAg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFemu7c%253D&md5=a6ce271aad17d6f7f282bd716bbd1ddf</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPristupa%26aufirst%3DZ.%2BB.%26aulast%3DWilson%26aufirst%3DJ.%2BM.%26aulast%3DHoffman%26aufirst%3DB.%2BJ.%26aulast%3DKish%26aufirst%3DS.%2BJ.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26atitle%3DPharmacological%2520heterogeneity%2520of%2520the%2520cloned%2520and%2520native%2520human%2520dopamine%2520transporter%253A%2520disassociation%2520of%2520%255B3H%255DWIN%252035%252C428%2520and%2520%255B3H%255DGBR%252012%252C935%2520binding%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D45%26spage%3D125%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Sibley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lean, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creese, I.</span><span> </span><span class="NLM_article-title">Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">6351</span><span class="NLM_x">â</span> <span class="NLM_lpage">6361</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=6176582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaL38XktFyjs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1982&pages=6351-6361&author=D.+R.+Sibleyauthor=A.+D.+Leanauthor=I.+Creese&title=Anterior+pituitary+dopamine+receptors.+Demonstration+of+interconvertible+high+and+low+affinity+states+of+the+D-2+dopamine+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Anterior pituitary dopamine receptors.  Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor</span></div><div class="casAuthors">Sibley, David R.; De Lean, Andre; Creese, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6351-61</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The interactions of dopaminergic agonists and antagonists with binding sites in bovine anterior pituitary membranes have been investigated with radioligand-binding techniques and computer-modeling procedures.  3H-labeled agonist (3H-agonist) binding is stereospecific, reversible, saturable, and of high affinity.  The rank order of catecholamines, phenothiazines, and related drugs in competing for 3H-agonist binding is indicative of interactions with a D-2 dopamine receptor.  Both agonist/3H-agonist and antagonist/3H-agonist competition curves are monophasic and noncooperative, with computer anal. indicating a single class of binding sites.  Sp. 3H-agonist binding can be completely inhibited by guanine nucleotides.  guanyl-5'-yl imidodiphosphate  [34273-04-6] Is the most potent nucleotide, followed by GTP  [86-01-1] and GDP  [146-91-8] which are equipotent.  The equil. binding capacity for 3H-labeled antagonists (3H-antagonists) is twice that for 3H-agonists.  Unlabeled antagonists inhibit 3H-antagonist binding competitively and exhibit antagonist/3H-antagonist competition curves which model best to a state of homogeneous affinity.  In contrast, unlabeled agonists inhibit 3H-antagonist binding in a heterogeneous fashion displaying multiphasic competition curves which can be resolved into high- and low-affinity binding sites.  In the presence of satg. concns. of guanine nucleotides, however, the agonist/3H-antagonist curves model best to a single affinity state which is identical with the low-affinity state seen in control curves.  The binding data can be explained by postulating 2 states of the D-2 dopamine receptor, inducible by agonists but not antagonists and modulated by guanine nucleotides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPIbAAeUc1SLVg90H21EOLACvtfcHk0lhS4ySLeuuC4A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XktFyjs7Y%253D&md5=a5474a2efe8c5e0c50e9bd939f759c9d</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DLean%26aufirst%3DA.%2BD.%26aulast%3DCreese%26aufirst%3DI.%26atitle%3DAnterior%2520pituitary%2520dopamine%2520receptors.%2520Demonstration%2520of%2520interconvertible%2520high%2520and%2520low%2520affinity%2520states%2520of%2520the%2520D-2%2520dopamine%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1982%26volume%3D257%26spage%3D6351%26epage%3D6361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Wreggett, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lean, A.</span><span> </span><span class="NLM_article-title">The ternary complex model. Its properties and application to ligand interactions with the D2-dopamine receptor of the anterior pituitary gland</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">â</span> <span class="NLM_lpage">227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1984&pages=214-227&author=K.+A.+Wreggettauthor=A.+De+Lean&title=The+ternary+complex+model.+Its+properties+and+application+to+ligand+interactions+with+the+D2-dopamine+receptor+of+the+anterior+pituitary+gland"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWreggett%26aufirst%3DK.%2BA.%26aulast%3DDe%2BLean%26aufirst%3DA.%26atitle%3DThe%2520ternary%2520complex%2520model.%2520Its%2520properties%2520and%2520application%2520to%2520ligand%2520interactions%2520with%2520the%2520D2-dopamine%2520receptor%2520of%2520the%2520anterior%2520pituitary%2520gland%26jtitle%3DMol.%2520Pharmacol.%26date%3D1984%26volume%3D26%26spage%3D214%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Hamblin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leff, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creese, I.</span><span> </span><span class="NLM_article-title">Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">â</span> <span class="NLM_lpage">887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1984&pages=877-887&author=M.+W.+Hamblinauthor=S.+E.+Leffauthor=I.+Creese&title=Interactions+of+agonists+with+D-2+dopamine+receptors%3A+evidence+for+a+single+receptor+population+existing+in+multiple+agonist+affinity-states+in+rat+striatal+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHamblin%26aufirst%3DM.%2BW.%26aulast%3DLeff%26aufirst%3DS.%2BE.%26aulast%3DCreese%26aufirst%3DI.%26atitle%3DInteractions%2520of%2520agonists%2520with%2520D-2%2520dopamine%2520receptors%253A%2520evidence%2520for%2520a%2520single%2520receptor%2520population%2520existing%2520in%2520multiple%2520agonist%2520affinity-states%2520in%2520rat%2520striatal%2520membranes%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1984%26volume%3D33%26spage%3D877%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Lahti, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figur, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piercey, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruppel, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. L.</span><span> </span><span class="NLM_article-title">Intrinsic activity determinations at the dopamine D2 guanine nucleotide-binding protein-coupled receptor: utilization of receptor state binding affinities</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">432</span><span class="NLM_x">â</span> <span class="NLM_lpage">439</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1992&pages=432-439&author=R.+A.+Lahtiauthor=L.+M.+Figurauthor=M.+F.+Pierceyauthor=P.+L.+Ruppelauthor=D.+L.+Evans&title=Intrinsic+activity+determinations+at+the+dopamine+D2+guanine+nucleotide-binding+protein-coupled+receptor%3A+utilization+of+receptor+state+binding+affinities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLahti%26aufirst%3DR.%2BA.%26aulast%3DFigur%26aufirst%3DL.%2BM.%26aulast%3DPiercey%26aufirst%3DM.%2BF.%26aulast%3DRuppel%26aufirst%3DP.%2BL.%26aulast%3DEvans%26aufirst%3DD.%2BL.%26atitle%3DIntrinsic%2520activity%2520determinations%2520at%2520the%2520dopamine%2520D2%2520guanine%2520nucleotide-binding%2520protein-coupled%2520receptor%253A%2520utilization%2520of%2520receptor%2520state%2520binding%2520affinities%26jtitle%3DMol.%2520Pharmacol.%26date%3D1992%26volume%3D42%26spage%3D432%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Kongsamut, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roehr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampe, D.</span><span> </span><span class="NLM_article-title">A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">â</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2FS0014-2999%2802%2902074-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=12176106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtlKjsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2002&pages=37-41&author=S.+Kongsamutauthor=J.+Kangauthor=X.+L.+Chenauthor=J.+Roehrauthor=D.+Rampe&title=A+comparison+of+the+receptor+binding+and+HERG+channel+affinities+for+a+series+of+antipsychotic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs</span></div><div class="casAuthors">Kongsamut, Sathapana; Kang, Jiesheng; Chen, Xiao-Liang; Roehr, Joachim; Rampe, David</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">450</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-41</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Many antipsychotic drugs produce QT interval prolongation on the ECG.  Blockade of the human cardiac K+ channel known as human ether-a-go-go-related gene (HERG) often underlies such clin. findings.  In fact, HERG channel inhibition is now commonly used as a screen to predict the ability of a drug to prolong QT interval.  However, the exact relation between HERG channel blockade, target receptor binding affinity and clin. QT prolongation is not known.  Using patch-clamp electrophysiol., the authors examd. a series of seven antipsychotic drugs for their ability to block HERG, and detd. their IC50 values.  The authors then compared these results to their binding affinities (Ki values) for the dopamine D2 receptor, the 5-HT2A receptor and, where available, to clin. QT prolongation data.  The authors found that sertindole, pimozide and thioridazine displayed little (<10-fold) or no selectivity for dopamine D2 or 5-HT2A receptors relative to their HERG channel affinities.  This lack of selectivity likely underlies the significant QT interval prolongation obsd. with administration of these drugs.  Of the other drugs tested (ziprasidone, quetiapine, risperidone and olanzapine), olanzapine displayed the greatest selectivity for dopamine D2 and 5-HT2A receptor binding (100-1000-fold) compared to its HERG channel IC50.  The authors also compared these HERG channel IC50 values to QT interval prolongation and plasma drug levels obtained in a recent clin. study.  The authors found that the ratio of total plasma drug concn. to HERG IC50 value was indicative of the degree of QT prolongation obsd.  Target receptor affinity and expected clin. plasma levels are important parameters to consider for the interpretation of HERG channel data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1PPyFCa8xyrVg90H21EOLACvtfcHk0lhS4ySLeuuC4A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtlKjsbo%253D&md5=8b5879e5d59e01dcd490e71d57844fdf</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902074-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902074-5%26sid%3Dliteratum%253Aachs%26aulast%3DKongsamut%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%2BL.%26aulast%3DRoehr%26aufirst%3DJ.%26aulast%3DRampe%26aufirst%3DD.%26atitle%3DA%2520comparison%2520of%2520the%2520receptor%2520binding%2520and%2520HERG%2520channel%2520affinities%2520for%2520a%2520series%2520of%2520antipsychotic%2520drugs%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D450%26spage%3D37%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Di Santo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Befani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meninno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agostinelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmegiani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirilli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferretti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallinella, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Torre, F.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological activities of pyrrolylethanoneamine derivatives, a novel class of monoamine oxidases inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4220</span><span class="NLM_x">â</span> <span class="NLM_lpage">4223</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050172c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4220-4223&author=R.+Di+Santoauthor=R.+Costiauthor=A.+Rouxauthor=M.+Articoauthor=O.+Befaniauthor=T.+Meninnoauthor=E.+Agostinelliauthor=P.+Palmegianiauthor=P.+Turiniauthor=R.+Cirilliauthor=R.+Ferrettiauthor=B.+Gallinellaauthor=F.+La+Torre&title=Design%2C+synthesis%2C+and+biological+activities+of+pyrrolylethanoneamine+derivatives%2C+a+novel+class+of+monoamine+oxidases+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm050172c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050172c%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BSanto%26aufirst%3DR.%26aulast%3DCosti%26aufirst%3DR.%26aulast%3DRoux%26aufirst%3DA.%26aulast%3DArtico%26aufirst%3DM.%26aulast%3DBefani%26aufirst%3DO.%26aulast%3DMeninno%26aufirst%3DT.%26aulast%3DAgostinelli%26aufirst%3DE.%26aulast%3DPalmegiani%26aufirst%3DP.%26aulast%3DTurini%26aufirst%3DP.%26aulast%3DCirilli%26aufirst%3DR.%26aulast%3DFerretti%26aufirst%3DR.%26aulast%3DGallinella%26aufirst%3DB.%26aulast%3DLa%2BTorre%26aufirst%3DF.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activities%2520of%2520pyrrolylethanoneamine%2520derivatives%252C%2520a%2520novel%2520class%2520of%2520monoamine%2520oxidases%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4220%26epage%3D4223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Brunton, L. L.; Chabner, B. A.; Knollmann, B. C.</span> <span class="citation_source-book">Goodman & Gilmanâs The Pharmacological Basis of Therapeutics</span>, <span class="NLM_edition">12</span>th ed.; <span class="NLM_publisher-name">Macmillan Publishing Co.</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">169</span><span class="NLM_x">â</span> <span class="NLM_lpage">649</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=169-649&author=L.+L.+Brunton&author=B.+A.+Chabner&author=B.+C.+Knollmann&title=Goodman+%26+Gilman%E2%80%99s+The+Pharmacological+Basis+of+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBrunton%26aufirst%3DL.%2BL.%26btitle%3DGoodman%2520%2526%2520Gilman%25E2%2580%2599s%2520The%2520Pharmacological%2520Basis%2520of%2520Therapeutics%26pub%3DMacmillan%2520Publishing%2520Co%26date%3D2012%26spage%3D169%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Svensson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling-Petersen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N.</span><span> </span><span class="NLM_article-title">Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">â</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2F0014-2999%2894%2990718-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=7843260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK2cXmsVKqtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=235-243&author=K.+Svenssonauthor=A.+Carlssonauthor=R.+M.+Huffauthor=T.+Kling-Petersenauthor=N.+Waters&title=Behavioral+and+neurochemical+data+suggest+functional+differences+between+dopamine+D2+and+D3+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors</span></div><div class="casAuthors">Svensson, Kjell; Carlsson, Arvid; Huff, Rita M.; Kling-Petersen, Torben; Waters, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">263</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-43</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">In an in vitro model for mitogenic activity in cloned Chinese hamster ovary (CHO) cells expressing rat dopamine D2 or D3 receptors, the EC50D2/EC50D3 ratios for the agonists, apomorphine, (+)-3-hydroxy-N-n-propyl-phenylpiperidine ((+)-3-PPP), quinpirole, R-(+)-7-hydroxy-2-(di-n-propylamino)tetralin (R-(+)-7-OH-DPAT) and pramipexole (SND919) were 0.36, 0.41, 1.3, 3.7 and 7.0, resp.  In locomotor activity expts. with actively exploring rats, the more dopamine D3 preferring agonists, R-(+)-7-OH-DPAT and pramipexole, were most efficacious to reduce locomotion.  The hypoactivity was also obsd. at doses that did not affect brain dopamine synthesis rate (DOPA accumulation) or release (measured in vivo dialysis expts.).  In contrast, for apomorphine, (+)-3-PPP and quinpirole there was a closer correlation between doses that reduced exploratory activity and doses that reduced brain dopamine release and synthesis.  The present data support the hypothesis that the functional dopamine D3 receptor is a postsynaptic receptor inhibitory on rat locomotion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4oEqICdKMX7Vg90H21EOLACvtfcHk0lhvYGKpQ6ORxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsVKqtLw%253D&md5=50d13ab9aa8207a262092c2c2b7ac4a6</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2894%2990718-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252894%252990718-8%26sid%3Dliteratum%253Aachs%26aulast%3DSvensson%26aufirst%3DK.%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DHuff%26aufirst%3DR.%2BM.%26aulast%3DKling-Petersen%26aufirst%3DT.%26aulast%3DWaters%26aufirst%3DN.%26atitle%3DBehavioral%2520and%2520neurochemical%2520data%2520suggest%2520functional%2520differences%2520between%2520dopamine%2520D2%2520and%2520D3%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D263%26spage%3D235%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Richtand, N. M.</span><span> </span><span class="NLM_article-title">Behavioral sensitization, alternative splicing, and D3 dopamine receptor-mediated inhibitory function</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2368</span><span class="NLM_x">â</span> <span class="NLM_lpage">2375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=2368-2375&author=N.+M.+Richtand&title=Behavioral+sensitization%2C+alternative+splicing%2C+and+D3+dopamine+receptor-mediated+inhibitory+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichtand%26aufirst%3DN.%2BM.%26atitle%3DBehavioral%2520sensitization%252C%2520alternative%2520splicing%252C%2520and%2520D3%2520dopamine%2520receptor-mediated%2520inhibitory%2520function%26jtitle%3DNeuropsychopharmacology%26date%3D2006%26volume%3D31%26spage%3D2368%26epage%3D2375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Kuballa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabrowska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swoboda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwiecinski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostrzewa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brus, R.</span><span> </span><span class="NLM_article-title">Central effects of nafadotride, a dopamine D3 receptor antagonist, in rats. Comparison with haloperidol and clozapine</span> <span class="citation_source-journal">Pharmacol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">â</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=15886414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslSlur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=161-169&author=G.+Kuballaauthor=P.+Nowakauthor=L.+Labusauthor=A.+Bortelauthor=J.+Dabrowskaauthor=M.+Swobodaauthor=A.+Kwiecinskiauthor=R.+M.+Kostrzewaauthor=R.+Brus&title=Central+effects+of+nafadotride%2C+a+dopamine+D3+receptor+antagonist%2C+in+rats.+Comparison+with+haloperidol+and+clozapine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Central effects of nafadotride, a dopamine D3 receptor antagonist, in rats. Comparison with haloperidol and clozapine</span></div><div class="casAuthors">Kuballa, Grzegorz; Nowak, Przemyslaw; Labus, Lukasz; Bortel, Aleksandra; Dabrowska, Joanna; Swoboda, Marek; Kwiecinski, Adam; Kostrzewa, Richard M.; Brus, Ryszard</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-169</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">1734-1140</span>.
    
            (<span class="NLM_cas:orgname">Polish Academy of Sciences, Institute of Pharmacology</span>)
        </div><div class="casAbstract">The aim of this study was to examine behavioral and biochem. effects of nafadotride, the new dopamine D3 receptor antagonist, and to compare it with haloperidol (dopamine D2 receptor antagonist) and clozapine (predominate dopamine D4 receptor antagonist).  Each drug was injected to adult male Wistar rats i.p., each at a single dose and for 14 consecutive days.  Thirty minutes after single or last injection of the examd. drugs, the following behavioral parameters were recorded: yawning, oral activity, locomotion, exploratory activity, catalepsy and coordination ability.  By HPLC/ED methods, we detd. the effects of the examd. antagonists on the levels of biogenic amines in striatum and hippocampus: dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 3-methoxytyramine (3-MT), 5-hydroxytryptamine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA) and noradrenaline (NA).  Addnl., DA and 5-HT synthesis rate was detd. in striatum and 5-HT in hippocampus.  The results of the study indicate that nafadotride, the dopamine D3 receptor antagonist, has a behavioral and biochem. profile of action different from that of haloperidol but partially similar to that of clozapine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppga5XeaA4HLVg90H21EOLACvtfcHk0lhvYGKpQ6ORxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslSlur0%253D&md5=50e518c3acfa79c93d5430aa903c4d26</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuballa%26aufirst%3DG.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DLabus%26aufirst%3DL.%26aulast%3DBortel%26aufirst%3DA.%26aulast%3DDabrowska%26aufirst%3DJ.%26aulast%3DSwoboda%26aufirst%3DM.%26aulast%3DKwiecinski%26aufirst%3DA.%26aulast%3DKostrzewa%26aufirst%3DR.%2BM.%26aulast%3DBrus%26aufirst%3DR.%26atitle%3DCentral%2520effects%2520of%2520nafadotride%252C%2520a%2520dopamine%2520D3%2520receptor%2520antagonist%252C%2520in%2520rats.%2520Comparison%2520with%2520haloperidol%2520and%2520clozapine%26jtitle%3DPharmacol.%2520Rep.%26date%3D2005%26volume%3D57%26spage%3D161%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Beaulieu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainetdinov, R. R.</span><span> </span><span class="NLM_article-title">The physiology, signaling, and pharmacology of dopamine receptors</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">â</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1124%2Fpr.110.002642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=21303898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=182-217&author=J.+M.+Beaulieuauthor=R.+R.+Gainetdinov&title=The+physiology%2C+signaling%2C+and+pharmacology+of+dopamine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">The physiology, signaling, and pharmacology of dopamine receptors</span></div><div class="casAuthors">Beaulieu, Jean-Martin; Gainetdinov, Raul R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-217</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiol. functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension.  Pharmacol. agents targeting dopaminergic neurotransmission have been clin. used in the management of several neurol. and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD1), and Tourette's syndrome.  Numerous advances have occurred in understanding the general structural, biochem., and functional properties of dopamine receptors that have led to the development of multiple pharmacol. active compds. that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics.  Recent progress in understanding the complex biol. of dopamine receptor-related signal transduction mechanisms has revealed that, in addn. to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as Î²-arrestins.  One of the future directions in managing dopamine-related pathol. conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacol.  In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms.  In addn., we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacol. and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplp84qmbSbA7Vg90H21EOLACvtfcHk0lhvYGKpQ6ORxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGis70%253D&md5=53e6841062c98abe60c732692109e498</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.002642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.002642%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26atitle%3DThe%2520physiology%252C%2520signaling%252C%2520and%2520pharmacology%2520of%2520dopamine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D182%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Malmberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohell, N.</span><span> </span><span class="NLM_article-title">Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">â</span> <span class="NLM_lpage">754</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1993&pages=749-754&author=A.+Malmbergauthor=D.+M.+Jacksonauthor=A.+Erikssonauthor=N.+Mohell&title=Unique+binding+characteristics+of+antipsychotic+agents+interacting+with+human+dopamine+D2A%2C+D2B%2C+and+D3+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalmberg%26aufirst%3DA.%26aulast%3DJackson%26aufirst%3DD.%2BM.%26aulast%3DEriksson%26aufirst%3DA.%26aulast%3DMohell%26aufirst%3DN.%26atitle%3DUnique%2520binding%2520characteristics%2520of%2520antipsychotic%2520agents%2520interacting%2520with%2520human%2520dopamine%2520D2A%252C%2520D2B%252C%2520and%2520D3%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D43%26spage%3D749%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Schotte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gommeren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luyten, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gompel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesage, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Loore, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leysen, J. E.</span><span> </span><span class="NLM_article-title">Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">â</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1007%2FBF02245606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=8935801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK28XjsFGktLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=1996&pages=57-73&author=A.+Schotteauthor=P.+F.+Janssenauthor=W.+Gommerenauthor=W.+H.+Luytenauthor=P.+Van+Gompelauthor=A.+S.+Lesageauthor=K.+De+Looreauthor=J.+E.+Leysen&title=Risperidone+compared+with+new+and+reference+antipsychotic+drugs%3A+in+vitro+and+in+vivo+receptor+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding</span></div><div class="casAuthors">Schotte, A.; Janssen, P. F. M.; Gommeren, W.; Luyte, W. H. M. L.; Van Gompel, P.; Lesage, A. S.; De Loore, K.; Leysen, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">57-73</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Risperidone and its active metabolite 9-OH-risperidone were compared to ref. antipsychotic drugs (haloperidol, pipamperone, fluspirilene, clozapine, zotepine) and compds. under development (olanzapine, seroquel, sertindole, ORG-5222, ziprasidone) for in vitro binding to neurotransmitter receptors in brain tissue and on membranes of recombinant cells expressing cloned human receptors and for in vivo occupancy of neurotransmitter receptors in rat and guinea-pig brain following acute treatment (2 h, s.c.).  An ex vivo autoradiog. technique was applied to det. the receptor occupancy by the drugs administered in vivo.  Of particular interest are the central 5HT2A receptors and D2-type receptors.  Predominant 5HT2A receptor antagonism is supposed to add to an atypical profile of the antipsychotics (treatment of the neg. symptoms, low incidence of extrapyramidal side effects).  D2 antagonism is required for the treatment of a pos. symptoms.  A contribution of the new dopamine receptor subtypes D3 and in particular D4 receptors has been proposed.  In vitro, all compds., except the 'typical' antipsychotics haloperidol and fluspirilene, showed higher affinity for 5HT2A than for D2 receptors.  Subnanomolar affinity for human 5HT2A receptors was obsd. for ORG-5222, sertindole, risperidone, 9-OH-risperidone and zotepine displayed nanomolar affinity for human D2 receptors.  Sertindole and olanzapine were slightly less potent.  Pipamperone, clozapine and seroquel showed 2 orders of magnitude lower D2 affinity in vitro.  Clozapine, but even more so pipamperone, displayed higher affinity for D4 than for D2 receptors.  For most other compds., D4 affinity was only slightly lower than their D2 affinity.  Seroquel was totally devoid of D4 affinity.  None of the compds. had nanomolar affinity for D1 receptors; their affinity for D3 receptors was usually slightly lower than for D2 receptors.  In vivo, ORG-5222, risperidone, pipamperone, 9-OH-risperidone, sertindole, olanzapine, zotepine and clozapine maintained a higher potency for occupying 5HT2A than D2 receptors.  Risperidone and ORG-5222 had 5HT2A vs. D2 potency ratio of about 20.  Highest potency for 5HT2A receptor occupancy was obsd. for ORG-5222 followed by risperidone and olanzapine.  Ziprasidone exclusively occupied 5HT2/A receptors.  No regional selectivity for D2 receptor occupancy in mesolimbic vs. nigrostriatal areas was detected for any of the test compds.  Risperidone was conspicuous because of its more gradual occupancy of D2 receptors; none of the other compds. showed this property.  The various compds. also displayed high to moderate occupancy of adrenergic Î±1 receptors, except fluspirilene and ziprasidone.  Clozapine, zotepine, ORG-5222 and sertindole occupied even more Î±1 than D2 receptors.  Clozapine showed predominant occupancy of H1 receptors and occupied cholinergic receptors with equiv. potency to D2 receptors.  A stronger predominance of 5HT2A vs. D2 receptor occupancy combined with a more gradual occupancy of D2 receptors differentiates risperidone and its 9-OH-metabolite from the other antipsychotic compds. in this study.  The predominant 5HT2A receptor occupancy probably plays a role in the beneficial action of risperidone on the neg. symptoms of schizophrenia, whereas maintenance of a moderate occupancy of D2 receptors seems adequate for treating the pos. symptoms of schizophrenia.  A combined 5HT2A and D2 occupancy and the avoidance of D2 receptor overblockade are believed to reduce the risk for extrapyramidal symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLAZ3nduIqXbVg90H21EOLACvtfcHk0ljbiCqifk22Vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjsFGktLk%253D&md5=321c55116d797ff2f1ad67663354b82e</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1007%2FBF02245606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02245606%26sid%3Dliteratum%253Aachs%26aulast%3DSchotte%26aufirst%3DA.%26aulast%3DJanssen%26aufirst%3DP.%2BF.%26aulast%3DGommeren%26aufirst%3DW.%26aulast%3DLuyten%26aufirst%3DW.%2BH.%26aulast%3DVan%2BGompel%26aufirst%3DP.%26aulast%3DLesage%26aufirst%3DA.%2BS.%26aulast%3DDe%2BLoore%26aufirst%3DK.%26aulast%3DLeysen%26aufirst%3DJ.%2BE.%26atitle%3DRisperidone%2520compared%2520with%2520new%2520and%2520reference%2520antipsychotic%2520drugs%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520receptor%2520binding%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D1996%26volume%3D124%26spage%3D57%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Haefely, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesura, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorez, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherschlicht, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Prada, M.</span><span> </span><span class="NLM_article-title">Biochemistry and pharmacology of moclobemide, a prototype RIMA</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">S6</span><span class="NLM_x">â</span> <span class="NLM_lpage">S14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1992&pages=S6-S14&issue=Suppl.&author=W.+Haefelyauthor=W.+P.+Burkardauthor=A.+M.+Cesuraauthor=R.+Kettlerauthor=H.+P.+Lorezauthor=J.+R.+Martinauthor=J.+G.+Richardsauthor=R.+Scherschlichtauthor=M.+Da+Prada&title=Biochemistry+and+pharmacology+of+moclobemide%2C+a+prototype+RIMA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaefely%26aufirst%3DW.%26aulast%3DBurkard%26aufirst%3DW.%2BP.%26aulast%3DCesura%26aufirst%3DA.%2BM.%26aulast%3DKettler%26aufirst%3DR.%26aulast%3DLorez%26aufirst%3DH.%2BP.%26aulast%3DMartin%26aufirst%3DJ.%2BR.%26aulast%3DRichards%26aufirst%3DJ.%2BG.%26aulast%3DScherschlicht%26aufirst%3DR.%26aulast%3DDa%2BPrada%26aufirst%3DM.%26atitle%3DBiochemistry%2520and%2520pharmacology%2520of%2520moclobemide%252C%2520a%2520prototype%2520RIMA%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D1992%26volume%3D106%26issue%3DSuppl%26spage%3DS6%26epage%3DS14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Nair, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kin, N. M.</span><span> </span><span class="NLM_article-title">Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide</span> <span class="citation_source-journal">J. Psychiatry Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">â</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=7905288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A280%3ADyaK2c7ivVOmuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1993&pages=214-225&author=N.+P.+Nairauthor=S.+K.+Ahmedauthor=N.+M.+Kin&title=Biochemistry+and+pharmacology+of+reversible+inhibitors+of+MAO-A+agents%3A+focus+on+moclobemide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide</span></div><div class="casAuthors">Nair N P; Ahmed S K; Kin N M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatry & neuroscience : JPN</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">214-25</span>
        ISSN:<span class="NLM_cas:issn">1180-4882</span>.
    </div><div class="casAbstract">Moclobemide, p-chloro-N-[morpholinoethyl]benzamide, is a prototype of RIMA (reversible inhibitor of MAO-A) agents.  The compound possesses antidepressant efficacy that is comparable to that of tricyclic and polycyclic antidepressants.  In humans, moclobemide is rapidly absorbed after a single oral administration and maximum concentration in plasma is reached within an hour.  It is moderately to markedly bound to plasma proteins.  MAO-A inhibition rises to 80% within two hours; the duration of MAO inhibition is usually between eight and ten hours.  The activity of MAO is completely reestablished within 24 hours of the last dose, so that a quick switch to another antidepressant can be safely undertaken if clinical circumstances demand.  RIMAs are potent inhibitors of MAO-A in the brain; they increase the free cytosolic concentrations of norepinephrine, serotonin and dopamine in neuronal cells and in synaptic vesicles.  Extracellular concentrations of these monoamines also increase.  In the case of moclobemide, increase in the level of serotonin is the most pronounced.  Moclobemide administration also leads to increased monoamine receptor stimulation, reversal of reserpine induced behavioral effects, selective depression of REM sleep, down regulation of beta-adrenoceptors and increases in plasma prolactin and growth hormone levels.  It reduces scopolamine-induced performance decrement and alcohol induced performance deficit which suggest a neuroprotective role.  Tyramine potentiation with moclobemide and most other RIMA agents is negligible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkkbuPrv56yoMcDoIzZtNkfW6udTcc2eYe1GmgTAR35Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7ivVOmuw%253D%253D&md5=6cf0e38d2f70d7771cec6b05f4c5e0a5</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNair%26aufirst%3DN.%2BP.%26aulast%3DAhmed%26aufirst%3DS.%2BK.%26aulast%3DKin%26aufirst%3DN.%2BM.%26atitle%3DBiochemistry%2520and%2520pharmacology%2520of%2520reversible%2520inhibitors%2520of%2520MAO-A%2520agents%253A%2520focus%2520on%2520moclobemide%26jtitle%3DJ.%2520Psychiatry%2520Neurosci.%26date%3D1993%26volume%3D18%26spage%3D214%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Pettersson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonesson, C.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of a set of para-substituted 4-phenylpiperidines and 4-phenylpiperazines as monoamine oxidase (MAO) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3242</span><span class="NLM_x">â</span> <span class="NLM_lpage">3249</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201692d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3242-3249&author=F.+Petterssonauthor=P.+Svenssonauthor=S.+Watersauthor=N.+Watersauthor=C.+Sonesson&title=Synthesis+and+evaluation+of+a+set+of+para-substituted+4-phenylpiperidines+and+4-phenylpiperazines+as+monoamine+oxidase+%28MAO%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm201692d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201692d%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DF.%26aulast%3DSvensson%26aufirst%3DP.%26aulast%3DWaters%26aufirst%3DS.%26aulast%3DWaters%26aufirst%3DN.%26aulast%3DSonesson%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520a%2520set%2520of%2520para-substituted%25204-phenylpiperidines%2520and%25204-phenylpiperazines%2520as%2520monoamine%2520oxidase%2520%2528MAO%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3242%26epage%3D3249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Lotufo-Neto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thase, M. E.</span><span> </span><span class="NLM_article-title">Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">â</span> <span class="NLM_lpage">247</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=226-247&author=F.+Lotufo-Netoauthor=M.+Trivediauthor=M.+E.+Thase&title=Meta-analysis+of+the+reversible+inhibitors+of+monoamine+oxidase+type+A+moclobemide+and+brofaromine+for+the+treatment+of+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLotufo-Neto%26aufirst%3DF.%26aulast%3DTrivedi%26aufirst%3DM.%26aulast%3DThase%26aufirst%3DM.%2BE.%26atitle%3DMeta-analysis%2520of%2520the%2520reversible%2520inhibitors%2520of%2520monoamine%2520oxidase%2520type%2520A%2520moclobemide%2520and%2520brofaromine%2520for%2520the%2520treatment%2520of%2520depression%26jtitle%3DNeuropsychopharmacology%26date%3D1999%26volume%3D20%26spage%3D226%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Wold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">SjÃ¶strÃ¶m, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, L.</span><span> </span><span class="NLM_article-title">PLS-regression: a basic tool of chemometrics</span> <span class="citation_source-journal">Chemom. Intell. Lab. Syst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">â</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2FS0169-7439%2801%2900155-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotF2mtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2001&pages=109-130&author=S.+Woldauthor=M.+Sj%C3%B6str%C3%B6mauthor=L.+Eriksson&title=PLS-regression%3A+a+basic+tool+of+chemometrics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">PLS-regression: a basic tool of chemometrics</span></div><div class="casAuthors">Wold, Svante; Sjostrom, Michael; Eriksson, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Chemometrics and Intelligent Laboratory Systems</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-130</span>CODEN:
                <span class="NLM_cas:coden">CILSEN</span>;
        ISSN:<span class="NLM_cas:issn">0169-7439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review on PLS-regression (PLSR) as a std. tool in chemometrics and used in chem. and engineering.  The underlying model and its assumption and commonly used diagnostics are discussed, together with the interpretation of resulting parameters.  Two examples are used as illustrations: first, a Quant. Structure-Activity Relationship (QSAR)/Quant. Structure Property Relationship (QSPR) data set of peptides is used to outline the development, interpretation, and refinement of a PLSR model.  Second, a data set from the manufg. of recycled paper is analyzed to illustrate time series modeling of process data by means of PLSR and time-lagged X-variables.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIKGNtaZZXqbVg90H21EOLACvtfcHk0lgHQrl7ixdo4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotF2mtLw%253D&md5=2d7fd1e946600e138ac92699ebcc7e29</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2FS0169-7439%2801%2900155-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-7439%252801%252900155-1%26sid%3Dliteratum%253Aachs%26aulast%3DWold%26aufirst%3DS.%26aulast%3DSj%25C3%25B6str%25C3%25B6m%26aufirst%3DM.%26aulast%3DEriksson%26aufirst%3DL.%26atitle%3DPLS-regression%253A%2520a%2520basic%2520tool%2520of%2520chemometrics%26jtitle%3DChemom.%2520Intell.%2520Lab.%2520Syst.%26date%3D2001%26volume%3D58%26spage%3D109%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Wold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trygg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berglund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antti, H.</span><span> </span><span class="NLM_article-title">Some recent developments in PLS modeling</span> <span class="citation_source-journal">Chemom. Intell. Lab. Syst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">â</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2FS0169-7439%2801%2900156-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotF2mtLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2001&pages=131-150&author=S.+Woldauthor=J.+Tryggauthor=A.+Berglundauthor=H.+Antti&title=Some+recent+developments+in+PLS+modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Some recent developments in PLS modeling</span></div><div class="casAuthors">Wold, Svante; Trygg, Johan; Berglund, Anders; Antti, Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Chemometrics and Intelligent Laboratory Systems</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-150</span>CODEN:
                <span class="NLM_cas:coden">CILSEN</span>;
        ISSN:<span class="NLM_cas:issn">0169-7439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The original chemometrics partial least squares (PLS) model with two blocks of variables (X and Y), linearly related to each other, has had several enhancements/extensions since the beginning of 1980.  The multi-block and hierarchical PLS modeling for installing a priori knowledge of the data structure and simplifying the model interpretation, variable correction schemes for PLS with often similar objectives, nonlinear PLS, and prefiltered PLS, orthogonal signal correction (OSC) is discussed.  A very recent development, orthogonalized-PLS is included as a way to accomplish both OSC, and a simpler interpretation of the PLS model.  Time series, batch, and wavelets variants of PLS are discussed.  These PLS extensions are illustrated by examples from peptide quant. structure-activity relationships (QSAR) and multivariate characterization of pulp using NIR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVTh-HkFVRfbVg90H21EOLACvtfcHk0lgHQrl7ixdo4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotF2mtLo%253D&md5=c4796c8028ac3f95c79f6a7e4ff7c5a4</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2FS0169-7439%2801%2900156-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-7439%252801%252900156-3%26sid%3Dliteratum%253Aachs%26aulast%3DWold%26aufirst%3DS.%26aulast%3DTrygg%26aufirst%3DJ.%26aulast%3DBerglund%26aufirst%3DA.%26aulast%3DAntti%26aufirst%3DH.%26atitle%3DSome%2520recent%2520developments%2520in%2520PLS%2520modeling%26jtitle%3DChemom.%2520Intell.%2520Lab.%2520Syst.%26date%3D2001%26volume%3D58%26spage%3D131%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Wold, S.</span><span> </span><span class="NLM_article-title">Crossvalidatory estimation of the number of components in factor and principal components models</span> <span class="citation_source-journal">Technometrics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">â</span> <span class="NLM_lpage">405</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1978&pages=397-405&author=S.+Wold&title=Crossvalidatory+estimation+of+the+number+of+components+in+factor+and+principal+components+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWold%26aufirst%3DS.%26atitle%3DCrossvalidatory%2520estimation%2520of%2520the%2520number%2520of%2520components%2520in%2520factor%2520and%2520principal%2520components%2520models%26jtitle%3DTechnometrics%26date%3D1978%26volume%3D20%26spage%3D397%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Sharp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjorth, S.</span><span> </span><span class="NLM_article-title">Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">â</span> <span class="NLM_lpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2F0165-0270%2890%2990045-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=2259248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK3MXhtlKisrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1990&pages=83-90&author=T.+Sharpauthor=S.+Hjorth&title=Application+of+brain+microdialysis+to+study+the+pharmacology+of+the+5-HT1A+autoreceptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor</span></div><div class="casAuthors">Sharp. Trevor; Hjorth, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">83-90</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    </div><div class="casAbstract">A review, with 38 refs., of the application of in vivo brain microdialysis in detecting extracellular 5-HT derived from serotoninergic neurons and changes with respect to neuronal activity and the actions of 5-HT1A receptor agonists and antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIxajqAjhMYbVg90H21EOLACvtfcHk0lgHQrl7ixdo4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhtlKisrk%253D&md5=cd618503cec2515d00170a6216927cf5</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2F0165-0270%2890%2990045-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0270%252890%252990045-H%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DT.%26aulast%3DHjorth%26aufirst%3DS.%26atitle%3DApplication%2520of%2520brain%2520microdialysis%2520to%2520study%2520the%2520pharmacology%2520of%2520the%25205-HT1A%2520autoreceptor%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D1990%26volume%3D34%26spage%3D83%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Teismann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferger, B.</span><span> </span><span class="NLM_article-title">In vivo effects of the putative cognitive enhancer KA-672.HCl in comparison with 8-hydroxy-2-(di-<i>N</i>-propylamino) tetralin and haloperidol on dopamine, 3,4-dihydroxypheny-lacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions</span> <span class="citation_source-journal">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">â</span> <span class="NLM_lpage">348</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2FS0278-5846%2899%2900088-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=10800755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitlWmsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2000&pages=337-348&author=P.+Teismannauthor=B.+Ferger&title=In+vivo+effects+of+the+putative+cognitive+enhancer+KA-672.HCl+in+comparison+with+8-hydroxy-2-%28di-N-propylamino%29+tetralin+and+haloperidol+on+dopamine%2C+3%2C4-dihydroxypheny-lacetic+acid%2C+serotonin+and+5-hydroxyindoleacetic+acid+levels+in+striatal+and+cortical+brain+regions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo effects of the putative cognitive enhancer KA-672.HCl in comparison with 8-hydroxy-2-(di-N-propylamino) tetralin and haloperidol on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions</span></div><div class="casAuthors">Teismann, Peter; Ferger, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">337-348</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">1. KA-672.HCl (7-methoxy-6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propoxy]- 3,4-dimethyl-2H-1-benzopyran-2-one hydrochloride), designed as a cognitive enhancer, has been investigated through behavioral and binding studies.  However, little is known about its biochem. effects on the dopaminergic and serotoninergic system in vivo.  2. In the present study the authors investigated the effects of KA-672.HCl (0.1 mg/kg and 1 mg/kg), 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) (1 mg/kg), haloperidol (0.1 mg/kg) and a mixt. of haloperidol and 8-OH-DPAT on dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) levels, in striatum and cerebral cortex of rats.  3. Male Wistar rats received an i.p. injection of the drugs or vehicle 1 h before striatal and cortical brain tissues were dissected out for neurochem. anal.  4. KA-672.HCl, 8-OH-DPAT and haloperidol significantly reduced striatal DA levels, whereas only KA-672.HCl significantly reduced cortical DA levels.  8-OH-DPAT and haloperidol induced a significant increase in cortical DOPAC levels but only haloperidol significantly elevated the striatal DOPAC content.  In contrast, only the higher dose of KA-672.HCl elevated striatal DOPAC levels.  Furthermore, KA-672.HCl significantly reduced striatal 5-HT levels and slightly elevated striatal 5-HIAA concns.  8-OH-DPAT significantly decreased striatal 5-HIAA levels.  All substances were able to enhance the cortical and striatal DA turnover.  5. The cortical and striatal 5-HT turnover was significantly decreased following 8-OH-DPAT treatment and significantly increased in the striatum after haloperidol and KA-672.HCl treatment.  6. The data suggest that KA-672.HCl possesses D2 antagonistic as well as 5-HT1A agonistic properties.  However, addnl. mechanisms of actions by interaction with other neurotransmitter systems such as acetylcholine, excitatory or inhibitory amino acids need to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbycKqtGVPSbVg90H21EOLACvtfcHk0lhyU_dw4iQsQA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitlWmsrc%253D&md5=0451e61f77f104cf9cf0c33f08b72c7c</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2FS0278-5846%2899%2900088-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0278-5846%252899%252900088-3%26sid%3Dliteratum%253Aachs%26aulast%3DTeismann%26aufirst%3DP.%26aulast%3DFerger%26aufirst%3DB.%26atitle%3DIn%2520vivo%2520effects%2520of%2520the%2520putative%2520cognitive%2520enhancer%2520KA-672.HCl%2520in%2520comparison%2520with%25208-hydroxy-2-%2528di-N-propylamino%2529%2520tetralin%2520and%2520haloperidol%2520on%2520dopamine%252C%25203%252C4-dihydroxypheny-lacetic%2520acid%252C%2520serotonin%2520and%25205-hydroxyindoleacetic%2520acid%2520levels%2520in%2520striatal%2520and%2520cortical%2520brain%2520regions%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2000%26volume%3D24%26spage%3D337%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Stenfors, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S. B.</span><span> </span><span class="NLM_article-title">Changes in extracellular 5-HIAA concentrations as measured by in vivo microdialysis technique in relation to changes in 5-HT release</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">â</span> <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1007%2Fs00213-003-1736-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=14735290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyktbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2004&pages=119-128&author=C.+Stenforsauthor=S.+B.+Ross&title=Changes+in+extracellular+5-HIAA+concentrations+as+measured+by+in+vivo+microdialysis+technique+in+relation+to+changes+in+5-HT+release"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Changes in extracellular 5-HIAA concentrations as measured by in vivo microdialysis technique in relation to changes in 5-HT release</span></div><div class="casAuthors">Stenfors, Carina; Ross, Svante B.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-128</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  The cerebral microdialysis technique was widely used to monitor the release of 5-hydroxytryptamine (5-HT).  The extracellular concn. of 5-HT has generally been shown to change after pharmacol. manipulation as expected.  Extracellular levels of the metabolite, 5-hydroxyindoleacetic acid (5-HIAA) does not always change in the same direction as 5-HT and has therefore generally been thought to be of no interest as a marker for 5-HT release.  The aim of the present review is to analyze the connection between changes in extracellular levels of 5-HT and 5-HIAA evoked by various pharmacol. means.  Literature on in vivo microdialysis studies measuring extracellular 5-HT and 5-HIAA was analyzed with special attention to the great importance of the 5-HT re-uptake mechanism in detg. their extracellular concns.  When the 5-HT reuptake mechanism is intact changes in extracellular levels of 5-HT and 5-HIAA go in the same directions, e.g decrease after compds. that decrease 5-HT release and increase after compds. that enhance 5-HT release.  Because the extracellular 5-HIAA concns. is 100-1000 times higher than that of 5-HT similar percentage changes imply that a very small part of the released 5-HT reaches the microdialysis probe under these conditions.  When the 5-HT reuptake mechanism is blocked the extracellular 5-HT increases whereas extracellular 5-HIAA decreases mainly because of the 5-HT1B receptor-induced decrease in 5-HT release but in part also because of the inhibition of reuptake of 5-HT, both resulting in decreased formation of 5-HIAA.  Drug-induced changes in extracellular 5-HIAA levels can give valuable information on the effects of these drugs on the 5-HT release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4nRPLe5dLq7Vg90H21EOLACvtfcHk0lhyU_dw4iQsQA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyktbY%253D&md5=34723a838fa068619999c51cb31a999a</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1007%2Fs00213-003-1736-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-003-1736-z%26sid%3Dliteratum%253Aachs%26aulast%3DStenfors%26aufirst%3DC.%26aulast%3DRoss%26aufirst%3DS.%2BB.%26atitle%3DChanges%2520in%2520extracellular%25205-HIAA%2520concentrations%2520as%2520measured%2520by%2520in%2520vivo%2520microdialysis%2520technique%2520in%2520relation%2520to%2520changes%2520in%25205-HT%2520release%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D2004%26volume%3D172%26spage%3D119%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Wong, P. T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, W. L.</span><span> </span><span class="NLM_article-title">Interaction of the dopaminergic and serotonergic systems in the rat striatum: effects of selective antagonists and uptake inhibitors</span> <span class="citation_source-journal">Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">â</span> <span class="NLM_lpage">119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm300975f&amp;key=10.1016%2F0168-0102%2895%2990023-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm300975f&amp;key=7501296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm300975f&amp;key=1%3ACAS%3A528%3ADyaK2MXos1CntL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1995&pages=115-119&author=P.+T.+H.+Wongauthor=H.+Fengauthor=W.+L.+Teo&title=Interaction+of+the+dopaminergic+and+serotonergic+systems+in+the+rat+striatum%3A+effects+of+selective+antagonists+and+uptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of the dopaminergic and serotonergic systems in the rat striatum: effects of selective antagonists and uptake inhibitors</span></div><div class="casAuthors">Wong, P.T.-H.; Feng, H.; Teo, W.L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Research (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-19</span>CODEN:
                <span class="NLM_cas:coden">NERADN</span>;
        ISSN:<span class="NLM_cas:issn">0168-0102</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The effects of some selective dopamine (DA) and 5-hydroxytryptamine (5-HT) antagonists and uptake inhibitors on the outflow of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the striatum were studied using microdialysis in conscious rats.  Eticlopride (D2 antagonist, 2.5 mg/kg) increased HVA but decreased 5-HIAA, while nomifensine (DA uptake inhibitor, 10 mg/kg) decreased both.  Mianserin (5-HT2 antagonist, 2 mg/kg) and citalopram (5-HT uptake inhibitor, 11 mg/kg) also decreased both HVA and 5-HIAA.  The selectivity of these drugs and the time course of their effects on HVA and 5-HIAA suggested that the dopaminergic drugs may affect the serotonergic systems primarily via changes in extraneuronal DA and conversely, serotonergic drugs affect the dopaminergic systems via changes in extraneuronal 5-HT.  The results obtained are consistent with current evidence that DA and 5-HT release from striatal terminals are regulated by D2 and 5-HT1B autoreceptors, resp.  They also support the idea that, in the rat striatum, presynaptic inhibitory heteroreceptors are a major mechanism that contributes to a reciprocal interaction of the dopaminergic and serotonergic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFdTVxpihY_bVg90H21EOLACvtfcHk0lhyU_dw4iQsQA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXos1CntL8%253D&md5=064ec18fba2b43e0f55c39ddf55d76a3</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2F0168-0102%2895%2990023-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0168-0102%252895%252990023-3%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BT.%2BH.%26aulast%3DFeng%26aufirst%3DH.%26aulast%3DTeo%26aufirst%3DW.%2BL.%26atitle%3DInteraction%2520of%2520the%2520dopaminergic%2520and%2520serotonergic%2520systems%2520in%2520the%2520rat%2520striatum%253A%2520effects%2520of%2520selective%2520antagonists%2520and%2520uptake%2520inhibitors%26jtitle%3DNeurosci.%2520Res.%26date%3D1995%26volume%3D23%26spage%3D115%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Alterman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span> </span><span class="NLM_article-title">Fast microwave-assisted preparation of aryl and vinyl nitriles and the corresponding tetrazoles from organo-halides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">7984</span><span class="NLM_x">â</span> <span class="NLM_lpage">7989</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0009954" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=7984-7989&author=M.+Altermanauthor=A.+Hallberg&title=Fast+microwave-assisted+preparation+of+aryl+and+vinyl+nitriles+and+the+corresponding+tetrazoles+from+organo-halides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fjo0009954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0009954%26sid%3Dliteratum%253Aachs%26aulast%3DAlterman%26aufirst%3DM.%26aulast%3DHallberg%26aufirst%3DA.%26atitle%3DFast%2520microwave-assisted%2520preparation%2520of%2520aryl%2520and%2520vinyl%2520nitriles%2520and%2520the%2520corresponding%2520tetrazoles%2520from%2520organo-halides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D7984%26epage%3D7989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i31"><a href="/doi/suppl/10.1021/jm300975f">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_37327"></div></div></div></div></div><hr /></hr><p class="last">Statistical data on in vitro binding, raw data for in vivo DOPAC, PLS methods, linear regression of ED<sub>50</sub>, biological methods, and experimental details of the synthesis of <b>9</b>â<b>12</b>, <b>14</b>â<b>23</b>, <b>28</b>â<b>30</b>; plot of ED<sub>50</sub> vs p<i>K</i><sub>i</sub> in a separate pdf file. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300975f/suppl_file/jm300975f_si_001.pdf">jm300975f_si_001.pdf (706.96 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300975f/suppl_file/jm300975f_si_002.pdf">jm300975f_si_002.pdf (50.47 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300975f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm300975f%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300975f" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991b08af29d203","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
